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ABSTRACT
Ribonucleotide reductase (RNR) catalyzes the conversion of ribonucleotides to
deoxyribonucleotides. Saccharomyces cerevisiae RNR is a class I RNR composed of a dimeric
large subunit (RI), containing the active site and allosteric effector sites, and a dimeric small
subunit (R2) which houses the diferric tyrosyl radical (Ye) cofactor required for RNR activity. S.
cerevisiae has two Rl-like proteins, Y1 and Y3 and two R2-like proteins, Y2 and Y4. In vitro
studies have focused on defining the active form of the R2 subunit. As isolated, Y2 and Y4 are
homodimers and neither can bind iron to generate the Ye cofactor. When mixed, the Y2 and Y4
homodimers rapidly form a heterodimer that can be activated with iron to form the Ye cofactor
located in the Y2 subunit. While the apo-Y2Y4 protein is capable of undergoing slow exchange
of its protomers, loading of iron into the heterodimer prevents this slow reorganization. To
define the role of Y4 in vivo, the concentrations of Y2 and Ye in the wt and Y4 deletion strain
have been determined. Thought deletion of Y4 leads to a >15 fold increase in the concentration
of Y2, the concentration of Ye is at least 15 fold less than the amount observed in the wt yeast
strain. We have concluded form this work and from our work in collaboration with Prof. Amy
Rosenzweig's laboratory in which the structures of Y2, Y4 and the heterodimer were determined
that Y4 plays an important role in assembly of the diiron cofactor in Y2 through stabilization of a
local conformation of Y2 allowing for iron binding and that the active form of yeast R2 is a
Y2Y4 heterodimer.
These conclusions are supported by in vivo experiments. Using a yeast strain containing
an N-terminally tagged Y2 under control of the native promoter, a soluble, active Y2Y4
heterodimer is isolated. This heterodimer contains 0.45±0.08 Y°, 1.45±0.05 irons and a specific
activity of 2.3±0..5 !Rmolmin' -mg 'l. Wt and several deletion strains, including SmllA, RnrlA,
Rnr4A, and Crt 1A strains, have been characterized by Western blotting to quantitate the
concentrations of the RNR subunits, by EPR spectroscopy to quantitate the concentration of Y'
cofactor in vivo and by activity assays with yeast extracts to measure the total amount of RNR
activity. These results demonstrate that in vivo every Y2Y4 heterodimer has a diferric-Y-
cofactor and that the activity of Y1 limits RNR activity in vivo. Furthermore, the information
acquired has allowed us better understanding how the protein concentration, cofactor generation
and subunit localization regulate RNR activity in vivo.
Thesis Supervisor: JoAnne Stubbe
Title: Novartis Professor of Chemistry
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Chapter 1
Introduction to the Structure, Mechanism, and Regulation of Ribonucleotide Reductases
1
1.1 Ribonucleotide reductases - genome stability through regulation
Ribonucleotide reductase (RNR) catalyzes the conversion of ribonucleotides to
deoxynucleotides (Figure 1.1).(1-3) RNR provides the only de novo source of deoxynucleotides
required for DNA replication and DNA repair, serving as the link between RNA and DNA
metabolism. RNR is a key player in the regulation of deoxynucleotide triphosphate (dNTP)
levels in vivo. The concentration and relative pool sizes of dNTPs are critical to the fidelity of
the DNA polymerases as an imbalance in dNTP pools can lead to mutator phenotypes.(4, 5)
The active site of RNR can accommodate four different nucleoside 5'- di-(tri-)phosphate
substrates, ADP(ATP), CDP(CTP), GDP(GTP) and UDP(UTP). The relative activity of RNR
towards each of these four substrates is controlled through allosteric regulation.(6-8) It has been
proposed that this form of regulation controls the relative concentration of dNTPs and matches
these pools to the organism's genomic composition.(9, 10) The overall activity of the enzyme is
also regulated through allosteric regulation at a second site distinct from the specificity site.
Many additional mechanisms including transcriptional regulation, translational regulation,
controlled protein degradation, localization, post-translational modification, cofactor generation,
and protein-protein interactions are also responsible for the exquisite and intricate regulation of
RNR activity in vivo. Each of these mechanisms of RNR regulation will be reviewed in the
following sections following a general introduction to the class I RNRs, with a focus on what is
known about the RNR from the budding yeast Saccharomyces cerevisiae.
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Figure 1.1 The central role of RNR in nucleic acid metabolism.
RNR reduces the 2'OH, highlighted in red, of its four substrate nucleotides. The reducing
equivalents are provided by two cysteines, in the class I and class II enzymes,( 11) or by formate,
in the class III enzymes.(12) Because of its importance in de novo dNTP biosynthesis, RNR is
regulated through binding of dNTPs to the allosteric specificity site and through numerous other
forms of regulation, which serve to activate or inhibit RNR activity.
1.2 The many classes of RNR, similarities and differences
All RNRs utilize a radical-based mechanism for nucleotide reduction and require a
metallocofactor to generate a thiyl radical (So) in the RNR active site. This S. initiates
nucleotide reduction by abstraction of the 3'H atom of the substrate nucleotide (Figure
1.2A).(13) Despite the central importance of RNR in de novo nucleic acid metabolism, the
metallocofactors utilized by RNR have not been evolutionarily conserved. These differing
metallocofactors have served as the basis for categorization of RNRs into three classes (Table
1.1). Class I RNRs are found in numerous aerobic organisms and utilize a diferric-Y* cofactor.
The aerobic Escherichia coli RNR, encoded by nrdA and nrdB, is the prototype. The class I
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Figure 1.2 The three classes of RNR.
A) Each class of RNR utilizes a different metallocofactor to generate a So in the active site of the
a subunit. The active site of the class I E. coli RI is shown to demonstrate the role of the S. and
the conserved amino acids in the active site of a. B) The W/P barrel that forms the common
active site of the three classes of RNR. The cysteine at the tip of the finger loop that becomes the
S. is highlighted with a yellow sphere. Figure was adapted from Sintchak et al. (14)
C4Y42CM
Table 1.1 Guide to the different classes of RNR (adapted from Ref.(2))
Class I Class II Class III
Ib Ic
Ia
Metallocofactor Fe(III)-O- Fe(III)-O- Fe(IV)-O- AdoCbl Fe4S4, AdoMet
and Fe(III) Fe(III) Fe(III)?
Radical deoxyadenosyl G-
initiator Ye Ye Cluster X? radical
Subunit a2 02 a2P2 a2 P2 a 2, a a2
quaternary (a4P4,? a6B6?) (and activase,
structure P2)
Oxygen aerobic aerobic aerobic aerobic or anaerobic
dependence anaerobic
Substrate NDP NDP NDP NDP/NTP NTP
Allosteric sites A-, S- and H- S-site S-site S-site S- and A-siteb
(?) sitesa
Occurrence Eukaryotes Eubacteria Archebacteria Archebacteria Archebacteria
Eubacteria Eubacteria(15) Eubacteria Eubacteria
bacteriophages bacteriophages
viruses
Prototype for E. coli nrdA, S. typhimurim Chlamydia L. leichmannii E. coli
class, gene nrdB nrdE, nrdF trachoatis, nrdJ nrdD,nrdG
names nrdA, nrdB
aS-site, specificity site; A-site, activity site, H-site, hexamerization site.
b In class III RNR, there is a second allosteric site (named the purine site) in addition to the S-site
which binds dATP and ATP. Though the details of allosteric regulation of the class III RNR is
quite different from the class I and II systems, the overall effect is binding of dATP to the purine
site inactivates class III RNR while binding of ATP activates it, similar to effects seen for
clATP/ATP binding to the A-site of class I and class II RNRs.
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RNRs are composed of two subunits, R1 and R2. R1, which is a dimer (a2), is the catalytic
subunit. R2, also a dimer (N), houses the diferric-Y cofactor.(16-18) The class I RNRs are
further subdivided into three subclasses, based on the sequence homology, allosteric regulation
patterns, and the R2 cofactor (Table 1.1).(15, 19) Class II RNRs utilize the 5'-deoxyadenosyl
radical, formed by C-Co bond homolysis of coenzyme B12 (5'-deoxyadenosylcobalamin,
AdoCbl).(20, 21) The RNR from Lactobacillus leichmannii is the most well studied enzyme
from this class. While the RNR from L. leichmannii is a monomeric enzyme (a), RNRs of this
class can also be dimeric (a2).(22, 23) Class III RNRs utilize a glycyl radical (G.) generated in
the catalytic subunit (a2) by the activase (2), which uses an iron sulfur cluster and S-
adenosylmethionine (AdoMet).(24-26) The anaerobic RNR from E. coli is the class III
prototype.
While their metallocofactors and quaternary structures are different, all three classes of
RNRs utilize very similar chemistry.(27) This similarity in mechanism is reflected in the
structural similarity of the ten stranded al/ barrel forming the RNR active site of each class
(Figure 1.2B).(14, 27-29) All RNRs utilize a S., located at the tip of the "finger loop" in the
center of the barrel, to initiate nucleotide reduction. If the structures of the three classes of RNR
are overlaid by superimposition of the active site cysteines, the similarity between them is even
more striking (Figure 1.3). Not only are the positions of the catalytically important amino acids
conserved in the active site, but the location of the radical chain initiator is also conserved. In
the E. coil class I RNR, Tyr730 and Tyr731 are proposed to be involved in generation of the S.
at Cys439. In class II RNR of L. leichmannii, the 5' deoxyadenosyl radical generates the S. on
Cys408. In class III RNR, a G., Gly508 of T4 phage RNR, generates a S. at Cys290. Each of
6
Figure 1.3 Conservation of radical chain initiation in the three classes of RNR.
The a/P barrels of class I, II, and III RNR have been overlaid by superimposition of the active
site cysteines.(14, 28, 29) The S. generating cysteine at the tip of the finger loop is labeled. The
entities proposed to generate the S*, Tyr730/Tyr731, B12 and Gly508 for the class I, II, and III
enzymes, respectively, are shown.
these radical initiators is located at the same place in three-dimensional space in all three classes
(Figure 1.3). Thus, not only is there similarity in the mechanism of reduction between the three
classes of RNR, but there is also conservation in the positioning of radical chain initiators in the
protein structures, despite the different cofactors utilized by each class of RNR.
1.3 Class I RNR-structure and mechanism
The class I RNRs are found in eukaryotes, eubacteria, bacteriophages, and some viruses
and are composed of two non-homologous subunits, designated R1 and R2. R1 contains the
active site and allosteric effector biding sites. R1 is defined as a homodimer (a2). While E. coli
R1 is a homodimer as isolated, many eukaryotic enzymes are monomeric and require allosteric
effector binding to drive dimerization to the active form. R2 is a homodimer (p2) and houses the
diferric-Y. cofactor.(16-18, 30, 31) While the structures of E. coli RI and R2 have been
determined, there is no structure of the R1/R2 complex.(32-34) A docking model has been
generated based on the location of an R2 C-terminal peptide which co-crystallized with R1,
shape complementarity between RI and R2, electrostatics, and amino acid conservation of
Tyr730 and Tyr73 lof RI and Trp48 and Tyr 356 of R2 (Figure 1.4).(32-34)
A few salient features of the RI and R2 structures in the docked complex that directly
relate to the mechanism and regulation of RNR are outlined in Figure 1.4. (32-34) R1 and R2
are homodimers, with the R1 protomers rendered in blue and green and the R2 protomers
rendered in red and yellow. The substrate GDP and effector TTP are shown bound to the active
site and allosteric specificity site of R1. A 20 residue peptide corresponding to the C-terminal
tail of R2 was required for R1 crystallization. The 15 residues of this peptide (Asp340-Leu375)
that are well defined in the R1 structure are rendered in pink. The R2 C-terminal tail is
Figure 1.4 Docking model of R1/R2 complex (next page)
A) R1 (blue and green) and R2 (red and yellow) are shown.(29, 32, 34) The R2 C-terminal
peptide utilized in the crystallization of R1 is shown in pink. GDP (substrate) and TTP
(allosteric effector) are rendered as spacefilling models. The irons are rendered in blue and the
amino acids proposed to play a role in electron transfer are rendered as cyan stick models. B)
Same as A rotated 90°.
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responsible for the interaction of R1 with R2 and a peptide made from the C-terminal tail of R2
acts as a competitive inhibitor of R1/R2 interactions.(35-40). The last 35 amino acids of E. coli
R2 are thermally labile and are not seen in the R2 crystal structure.(33, 34) This thermal lability
of the R2 C-terminal tail has been observed in all R2 structures.(15, 41-49) The R2 C-terminus is
thought to acquire structure in the R1/R2 complex.(39)
This docking model places Tyrl22, the Y. in the active site of R2, and Cys439, which
forms the thiyl radical in the active site of R1, at least 35 A apart.(32-34) This distance is too
long for the direct electron transfer (ET) between these amino acids to be kinetically competent
and therefore, an ET pathway involving amino acid radical intermediates is required.(50) These
amino acids are rendered in cyan in Figure 1.4 and a simplified view of the pathway is shown in
Figure 1.5. In this model, Tyr122 is reduced by Trp48 to generate the Trp48+'.(51-53) The
Trp48., which can be de-protonated by Asp237, generates Tyr356. on the C-terminal tail of
R2.(54-56) Finally, the radical is transferred across the R2/R1 interface, residing at Tyr731,
Tyr730 before generating the active site S..(57, 58) Evidence in support of this model has been
obtained by site-directed mutagenesis studies,(35, 52, 53, 58, 59), in vivo complementation
studies,(60) incorporation of unnatural amino acids at position 356 of R2 using intein mediated
protein semi-synthesis,(54-56), light initiated radical generation,(57) and pulsed electron double
resonance methods (PELDOR).(61)
The proposed mechanism of nucleotide reduction is shown in Figure 1.6. The enzyme
catalyzes the cleavage of the 2'-C-OH bond and formation of a 2'-C-H bond, with retention of
configuration and the proton is derived from solvent.(13) Pre-steady state kinetic experiments
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Figure 1.5 The proposed electron transfer pathway between E. coli R1 and R2.
The amino acids proposed to participate in electron transfer between R2 (left) and RI (right) are
shown. Tyr356 is shown in red to highlight the fact that this amino acid cannot be seen in the R2
crystal structure but is proposed to be located at the RI/R2 interface.
have demonstrated that in the class I RNR from E. coli, a rate limiting physical step precedes
electron transfer.(62) Therefore mechanistic information for the class I system has been obtained
via perturbation of the system with the use of substrate analogs, which function as mechanism
based inhibitors, and site directed mutants.(63-70) Additional mechanistic information has been
obtained with the class II RNR from L. leichmannii as the same chemical mechanism of
nucleotide reduction is utilized.(l 1, 13, 71-77) Following the rate limiting physical step, proton
coupled electron transfer (PCET) between Ri and R2 generates a Cys439* in the active site of
Rl.(32, 50) This S* initiates nucleotide reduction by abstraction of the 3'-H atom from the
substrate.(63, 66, 68, 70, 78) Loss of water, facilitated by general base catalysis by Glu441
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and protonation by Cys225, leads to the 3'-keto-2'-deoxynucleotide radical.(79, 80) This radical
is reduced by two PCET events. The first PCET generates the 3'-keto-2'-deoxynucleotide and a
R -based disulfide radical anion.(81) The second PCET involves protonation of the ketone by
Glu441 concomitant with ET to C3' and generates a 3'-deoxynucleotide radical and the active
site disulfide.(64, 76, 82-84) This product radical then reabstracts the H atom from the Cys439,
which is the same H atom abstracted from the substrate in the first step of nucleotide reduction,
to produce the product and regenerate the S.. ET or PCET between RI and R2 then regenerates
the Y* in R2.(62, 71) Turnover is completed by re-reduction of the active site disulfide, which
occurs through two steps.(83) First, the active site cystine is reduced by two cysteines located on
the C-terminal tail of Ri .(76) This C-terminal tail disulfide is then reduced. In vivo, this
-No- -000-
reduction is carried out by a thioredoxin, thioredoxin reductase pair with the electrons ultimately
coming from NADPH or by a comparable system, like glutaredoxin, glutaredoxin reductase.
11.4 Diferric-Yo cofactor assembly - in vitro and in vivo
Because the Ye of R2 is required to generate the active site S. of R1, the diferric-Y
cofactor is required for RNR activity.(17, 18, 85) A schematic diagram of the E. coli cofactor is
shown in Figure 1.7. The two ferric irons are ligated by two histidines, three glutamates and an
aspartate and the bridging oxygen is derived from 02.(86) R2 can be isolated in its apo form,
which lacks the metallocofactors, and in this form the enzyme is inactive in nucleotide
reduction.(87) The reconstitution of the cofactor from apo-R2 requires two ferrous irons,
oxygen, and a reductant (Figure 1.7).(86, 88-98) These reconstitutions do not yield
stoichiometric amounts of Ye, which would be 2 Ye per R2. Typically stoichiometries of 1.0-1.2
Y. per R2 from E. coli with 3.2-3.6 eq of Fe(III) are observed. This substoichiometric amount of
Yr has been observed in R2 from other organisms with typical stoichiometries being about 1-1.5
Y. per R2.(99-104) Whether R2 in vivo exhibits half sites reactivity or if the substoichiometric
amounts of Ye observed in vitro, which result from our inability to completely assemble the
cofactor due to conformational changes after binding of iron or other artifacts of in vitro
reconstitution conditions, is an area of ongoing research.(105, 106)
The proposed mechanism of in vitro cluster assembly is shown in Figure 1.8. This
mechanism represents the summation of many years of studies of R2, both wild type and site
directed mutant constructs, with numerous biophysical techniques including UV-Vis stopped
flow spectroscopy and rapid freeze quench methodology coupled to analysis with EPR, ENDOR,
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Figure 1.7 In vitro reconstitution of the diferric-Y* cofactor.
This reconstitution requires two ferrous irons, oxygen, and an electron. A schematic diagram of
the E. coli cluster is shown.
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Figure 1.8 Proposed kinetic mechanism of in vitro reconstitution of diferric Y* cofactor.
Figure adapted from Baldwin et al. (88-92, 107)
M6ssbauer, resonance raman and EXAFS spectroscopies.(30, 86, 88-92, 97, 98, 107-109)
Essential to interpretation of these results are numerous structures of R2 in the apo form,(87)
diferric form,(33, 109) diferrous(47, 48, 110), and azide bound states(I 11) in addition to the
structures of numerous mutants,(48, 49, 109, 112, 113). Each active site of apo R2 can
theoretically bind two ferrous irons. Oxygen binding to the diferrous R2 could possibly form a
Il- 1,2-peroxo Fe(III)Fe(III) species(1 14-1 16)and ultimately leads to generation of the first
detectable intermediates with wt-R2, the cluster designated X and a tryptophan cation radical
(W ' ) at Trp48 of E. coil R2.(86, 88-92, 97, 98, 108, 117) X, formally a Fe(III)Fe(IV)
paramagnetic species, directly generates the Ye and becomes the diferric cluster. This step
requires an electron and occurs through one of two possible pathways in vitro, the choice of
which is dictated by the availability of reducing equivalents. In the presence of an external
reductant such as ascorbate or ferrous iron, the assembly pathway partitions through pathway A
in which an external electron reduces the W+ followed by X oxidizing Y122 to generate native
R2 (pathway A, Figure 1.8). Alternately, if a source of reducing equivalents is not readily
available, then the W' directly oxidizes Y122 to generate the X-Y122. species (pathway B,
Figure 1.8).(89, 92, 96, 114) Delivery of the required reducing equivalent reduces X to generate
native R2.
While these studies have been very informative, the early stages of the assembly process
have remained elusive due to our inability to control the delivery of Fe(II) and the reducing
equivalent in vitro. Furthermore, we do not understand how this process occurs in vivo. Apo-R2
is an unstable protein in vitro, and therefore, folding chaperones might play a role in stabilization
of the apo protein in vivo. The source of iron and the mechanism of iron delivery in vivo have
not been established. Recent work has revealed that the biosynthesis of metalloclusters, such as
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Fe-S clusters and molybdopterin, and insertion of redox active metals such as Cu, Fe, Ni and Mo
into metalloenzyme active sites requires a specific cellular machineries.(118) A generic outline
of the required cellular components is depicted in Figure 1.9. Metals are imported though metal
transporters, perhaps in complex with proteins or small molecules. The metal is picked up by
metallochaperones that transport the metal to its target protein or to a compartment within the
cell. Accessory proteins, such as scaffold proteins or redox proteins such as ferredoxin, work
together with the metallochaperones to assemble the metallocofactor and inert it into the
metalloenzyme active site. In S. cerevisiae, the cellular machineries required for Fe-S cluster
biosynthesis and Fe insertion into heme have been identified and many of these proteins are
mitochondrial proteins.(1 19, 120) However comparatively little is known about how non-heme
Fe proteins are biosynthesized and where they are biosynthesized in any system.
1.5 Introduction to Saccharomyces cerevisae RNR
Saccharomyces cerevisiae has four genes encoding RNR subunits, RNR1, RNR2, RNR3,
and RNR4. RNR1 and RNR3 encode the RI-like large subunits Y1 and Y3.(121, 122) RNR2 and
RNR4 encode the R2-like small subunits Y2 and Y4.(123-125) RNRI is essential for mitotic
viability and is expressed at maximal levels at late G1/S.(122) RNR3 is not an essential gene and
deletion of RNR3 has no observable phenotype.(121, 122, 126, 127) While RNR3 is not
normally expressed, when the yeast cells are exposed to DNA damaging agents or if the cell
cycle is blocked, the transcription for RNR3 is induced over a hundred fold.(122, 126, 128)
Over-expression of RNR3 complements the deletion of RNR1 indicating that it encodes a
functional protein. However, the purified Y3 has a very low specific activity, less than 1% of the
specific activity of Y1 even though the Y1 and Y3 sequences are 80% identical.(129, 130) The
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Figure 1.9 Overview of metal homeostasis and metallochaperones
Shown is an overview of the players in metal homeostasis and metallocofactor biosynthesis in
vivo. Metal transporters import the metal into the cell, either in a free or protein or small
molecule bound state. Metallochaperones transport the metal to a diverse array of cellular
targets including metalloenzymes, metallocluster scaffolding proteins, subcellular compartment
metal transporters and others. Metal storage proteins exist which bind excess metal not being
utilized for metallocofactor biosynthesis to protect the cell from the deleterious effects of free
redox active metal ions.
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observed expression profiles of RNR1 and RNR3 have lead to the model that Y1 is the R1 for
normal DNA replication in S phase and that Y3 is the R1, perhaps in combination with Y1,
involved in DNA repair.
The R2-like subunits in S. cerevisiae are Y2 and Y4. RNR2 is absolutely required for
mitotic viability and its transcript is produced both in as a function of the cell cycle and DNA
damage.(123, 131-133) The expression level of RNR4 remains unchanged throughout the cell
cycle and is increased 2-20 fold in response to DNA damaging conditions.(124, 125) In at least
one strain background, Y4 is an essential protein.(124) In other backgrounds, the deletion of
RNR4 generates sick yet viable cells that have a cold sensitivity phenotype and longer doubling
times with a prolonged S phase as compared with the isogenic wt strain.(125, 134) While it is
clear from sequence analysis that Y4 is an R2, it was equally clear that Y4 is a highly unusual
R2. Typically, R2 is 350-400 amino acids in length and only sixteen amino acids are conserved
in R2, which play roles in formation of the diferric-Y cofactor or in PCET between R1 and R2.
However in Y4, six of these sixteen amino acids are not conserved.(125, 134) Most notably,
three of the iron ligands, two histidines and a glutamate are mutated to two tyrosines and an
arginine, respectively, thus preventing formation of a diferric-Y. cofactor by Y4. It has been
established, through work in our laboratory,(44, 129, 135) and the work of Thelander and co-
workers,(136) that the active form of yeast R2 is a Y2Y4 heterodimer, which is utilized both in
normal DNA replication and DNA repair.
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1.6 Regulation of RNR during DNA replication and DNA repair
During the cell's lifetime, there are two instances when dNTPs are required, during S
phase when the DNA is replicated and after the cell senses DNA damage in need of repair. RNR
plays a central role in both of these processes, providing the dNTPs used by the DNA
polymerases. It has been observed that RNR activity is elevated during these times and is
decreased when dNTPs are not required.(137-140) This restriction of RNR activity in S-phase is
thought to be important for genome stability. Over-expression of RNR outside of S phase has
been linked to malignant potential of cancers and resistance to anti-cancer drugs that target RNR,
such as gemcitabine and hydroxyurea.(141-150)
RNR activity is also selectively up-regulated in response to DNA damage in numerous
organisms. This increase in RNR activity is a controlled by the DNA damage and replication
checkpoints, which are intimately linked to the cell cycle. Numerous checkpoints have been
identified, in the G1, S, and G2/M phases of the cell cycle, which serve to sense DNA damage or
replicational stress (Figure 1.1 0).(151-154) These checkpoints are comprised of three basic
components: the sensors, which detect the DNA damage or replicational stress; the transducers,
kinases which serve to amplify the signal from the sensors with the aid of so called mediator
proteins; and the effector kinases, which serve to activate signaling pathways to effect DNA
repair or apoptosis. The effects of checkpoint activation are to slow the cell cycle, to repair the
DNA damage, through transcription of the required proteins and recruitment of these DNA repair
machines to the sites of damage, and finally, to allow for recovery from the cell cycle arrest or
drive the cell to apoptosis, depending on degree of DNA damage and the cell's ability to repair it
(Figure 1.10). Though the molecular details of these checkpoints vary slightly from organism to
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Table 1.2 Checkpoint proteins in mammals
Protein Function S. cerevisiae
Sensors
RFC 1-like Rad24
PCNA-like Ddcl
(9-1-1 complex) Radl7
BRCT-containing
DSB recognition
and/or repair
Replication proteins
* recruits polymerases
* need for replication
* DNA polymerase
* DNA helicase
* Topoisomerase
* clamp loader
* binds ssDNA
Transducers
PIKK
PIKK binding partner
Mediators
Replication fork
stabilizers
Fork associated adaptor
BRCT-containing
Mec3
Rad9
Dpb 11
Mre 1
Rad5O
Xrs2
Dpb 11
Drcl
Po12
Sgsl
Top3
Rfc2-5
Rfa2
Mecl
Tell
Ddc2/Lcdl/Piel
Mrcl
Tofl
Rad9
and yeasts. Table adapted from (151, 153).
S. pombe Mammals
Rad 17
Rad9
Radl
Husl
Crb2/Rph9
Cut5
Rad32
Rad50O
CutS
Drcl
Cdc20
Rhql/Radl2
Top3
Rfc2-5
Rad3
Tell
Rad26
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PCNA, proliferating cell nuclear antigen; RFC replication factor C; PIKK, phosphoinositol-3-
kinase related kinase; FHA, fork-head-associated; BRCT, Brcal carboxy terminal; DSB, double
strand break
Figure 1.10 Overview of DNA damage and replication checkpoints (previous page).
The sensors, transducers and effectors of the S. cerevisiae cell cycle and DNA damage
checkpoints are shown along with the effects of activation of these pathways. Figure adapted
from numerous references.(151, 152, 154)
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organism, the central players are highly conserved in eukaryotic organisms (Table 1.2). Many of
these proteins are known to be mutated in several cancers, thus emphasizing the importance of
these pathways in maintenance of genomic stability. (151, 152, 154)
Specifically in S. cerevisiae, these checkpoints have numerous direct effects on RNR
activity (Figure 1.11). In yeast, the central transducers are Mecl and Tell, homologous to ATM
and ATR proteins in mammals (Table 1.2 and Figure 1.11). These kinases activate the effector
kinases Chkl and Rad53, which in turn activate the DNA damage responsive kinase Dunl. This
kinase directly regulates RNR activity in at least three ways; phosphorylation of the R1 inhibitor,
Smll, which ultimately leads to its proteolysis,(155-160) phosphorylation of Crtl, a
transcriptional repressor regulating RNR2, RNR3, and RNR4 expression,(l61) and the change in
yeast R2 localization, from the nucleus to the cytoplasm (Figure 1.11).(162) In the following
sections, the details of the numerous identified mechanisms of RNR regulation will be discussed.
While the discussion will focus specifically on what is known about RNR of S. cerevisiae, brief
outlines about what is known about other RNRs from eukaryotes and E. coli will also be
presented.
1.7 Multiple RNR subunits
As discussed above, the activity of RNR is generally up-regulated during S-phase or
following DNA damage. One way a cell can differentially regulate the activity of RNR both as a
function of the cell cycle and in response to DNA damage is to encode multiple RNRs in its
genome upon which different mechanisms of transcriptional regulation can be applied.(1, 2) As
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Figure 1.11 Effects of the checkpoints on the regulation of RNR in S. cerevisiae.
DNA damage initiates three cellular responses thus far identified, which are mediated by the
Mecl, Rad53, Dunl kinase pathway. Dunl can phosphorylate Smll, ultimately leading to its
degradation and relief of its inhibition of Y1. The Crtl transcriptional repressor is
phosphorylated, thus removing its inhibition of RNR2, RNR3, and RNR4 transcription. Finally,
the yeast R2, the Y2Y4 heterodimer, undergoes a change in subcellular localization, from the
nucleus to the cytoplasm. The factors mediating this Dunl dependent Y2Y4 localization change
have yet to be identified.
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more genomes are sequenced and annotated, it is becoming clear that almost all organisms
encode multiple RNRs in their genomes.
Some organisms have multiple RNRs of different classes. For example, bacteria,
including E. coli, Salmonella typhimurium, Lactococcus lactis, and Staphylococcus aureus, (1,
163, 164) contain class I and class III RNRs and some organisms contain all three classes,
including Pseudomonas aeruginosa.(164, 165) Since class I RNRs require oxygen to generate
the Ye and the G- of class III RNR is sensitive to oxygen,(166) it is logical to propose that one
class is utilized for growth in aerobic environments while the other RNR is utilized when oxygen
is limited.(167-169) The class II RNR can serve to provide dNTPs in either the presence or
absence of oxygen in the environment as oxygen is not required for activity nor does it inhibit its
enzymatic activity.
The presence of multiple RNRs is not unique to bacteria as eukaryotes also contain
multiple class I RNRs. A second R2 subunit, named p53R2, has been discovered in humans and
this discovery has generated great interest in understanding the roles of these multiple RNRs in
vivo.(170-172) The transcription of this RNR is induced in response to DNA damage and is
regulated by p53 leading to the proposal that it is the R2 subunit active during DNA repair in
mammalian cells.(170-178) Multiple class I RNR R2 subunits have been identified and partially
characterized in numerous other systems including Plasmodium falciparum,(179) Arabidopsis
thaliana,(l80) Candida albicans,(181) and Oryza sativa.(182) Multiple R1 subunits have also
been identified in numerous eukaryotic organisms including yeast S. cerevisiae (121, 122) and
tobacco (Nicotiana tabacum) BY-2 cell line.(183-187) Multiple RNRs of the same class are also
found in the E. coli system which has the class Ia and class lb RNRs. Currently, it is thought that
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the cell utilizes these multiple class I RNRs differently in response to normal DNA replication or
in response to DNA damage.
Recently, many unusual R2s have been identified defining a new class of occurrence of
multiple RNRs in the same genome, in which the catalytically essential amino acids have not
been conserved. The most well studied alternate RNR of this class is the yeast Y4. As already
discussed, this protein is missing several of the amino acids required for iron binding and forms a
heterodimer with diferric-Y. containing Y2 to form the R2 active in nucleotide reduction in
yeast. It is interesting to note that that numerous yeast closely related to S. cerevisiae also have
genes for Y4-like proteins. Furthermore, the three species of Mycoplasma have been sequenced
and all contain an R2 with three diferric cluster ligands that are not conserved, similar to that
observed with Y4.(1, 2, 188-190)
Another unusual R2 has recently been identified in mosquitoes (Anopheles
gambiae).(191) This R2 contains a deletion of 20 kDa out of the 46 kDa protein including a
region important for formation of the cofactor. This R2 is expressed in response to UV light
induced DNA damage and results from alternative splicing that eliminates two R2 exons.
Additionally, an unusual R1 has been identified in the murine cytomegalovirus and herpes virus
7.(192, 193) Sequence analysis of the cytomegalovirus R1 demonstrates that this R1 homolog is
missing 4 of the 5 cysteines required for RNR activity, and the two tyrosines proposed to
participate in ET between R1 and R2. Despite the fact that this protein is not active in in vitro
assays, it was required for viral replication and infectivity in vivo.(192) As more genomes are
sequenced, and alternative splice forms identified, it is likely more of these "non-functional"
RNRs will be identified and perhaps shed light on their function in vivo.
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1.8 Allosteric Regulation and R1/R2 interactions
The allosteric regulation of RNR was the first characterized mechanism of RNR
regulation.(6-8, 194) It is widely accepted that at least two different kinds of allosteric sites
exist. The specificity site (S-site) can bind dNTPs and ATP and influences the relative activity
towards RNR's four substrates. In very general terms, the allosteric regulation of enzymatic
specificity conforms to the same general pattern.(6) Binding of dATP (or ATP) promotes
reduction of CDP and UDP. Reduction of GDP is stimulated by binding of dTTP to the S-site
while binding of dGTP promotes reduction of ADP. Structures of each class of RNR bound to
effector at the S-site are now known. These studies have revealed that the structural basis for
allosteric regulation appears to be conserved between the class I and II enzymes but is different
for the class III RNRs (Figure 1. 12).(29, 195-197) Thus, the allosteric regulation of the class III
RNRs will not be discussed further here. While these early structural studies were successful in
determining the location of the allosteric sites on R1, the molecular details of how this allosteric
signal is propagated from the S-site to the active site were limited due to low resolution and poor
occupancy for the nucleotides.(29) However, recent structural insights into allosteric regulation
by the specificity site have laid the groundwork to provide a detailed understanding of the
Figure 1.12 Structural basis for allosteric regulation in the three classes of ribonucleotide
reductase. (next page)
Class I (left) is shown with one protomer colored red and the other blue.(29) The substrate
(GDP) and effector (dTTP) are shown as space-filling models in the active site and S-site as
labeled. Class II RNR (center) is a monomer (red) with the insert that structurally mimics the
dimer interface in the class I enzyme is rendered in blue to highlight the structural similarities
between the monomeric class II and the dimeric class I.(14) Class III RNR (right) is shown and
like the class I RNR it is rendered with one protomer colored red and the other blue.(196) The
allosteric effector TTP is rendered as a cpk model. While the a subunit has an a/,8 barrel
structure homologous to class I and class II, the relative orientation of the two a subunits are
distinct from that of class I, thus the S-site differs significantly from the class I and class II
enzymes.
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complex allosteric regulation of this enzyme.(197) These findings are discussed in detail in
Section 1.9.
The second well-known allosteric site is the activity site (A-site), which can bind dATP
and ATP and this site is mostly found in the class Ia RNRs (Table 1.1). It is thought that binding
of dATP or ATP to the A-site explains the phenomenological observations that high
concentrations of dATP inhibit RNR activity while high concentrations of ATP lead to an
increase in RNR activity. There is a structure of the E. coli enzyme with the ATP analog
adenylyl imidodiphosphate (AMPPNP) bound to this site, which is located at the N-terminal
portion of R1 (Figure1.12).(29) While this structures is helpful in locating the activity site, the
low resolution of the structure (3.0 A), the fact that the weak density at this site, and the fact that
the crystals were soaked with an analog rather than co-crystallized with the effector (dATP/ATP)
all make it difficult to draw strong conclusions from this one available structure. However, it has
been shown in vitro and in vivo that mutations to this allosteric site (His59 of E. coli R1 or D57
of mouse R1) diminish the inhibitory effects of dATP, thus supporting the structural data.(4,
198-202)
The structural basis behind the A-site allosteric regulation is not understood and two
different models have been proposed to explain the phenomenological observations that ATP
activates RNR and dATP inactivates RNR. These two models, that of Cooperman and co-
workers and that of Reichard, SjOberg, and co-workers, both invoke changes in RNR quaternary
structure.
28
Table 1.3 The influence of allosteric effectors on the Kd of R1 and R2
Organism Kd Effector Technique Reference
(concentration)
E. coli 6.5 Ma dTTP (0.1 mM) SPRb (203)
1. coli 6.1 ,xMa ATP (1 mM) SPR (203)
1. coli 0.1 Ma dATP (0.1 mM) SPR (203)
E. coli 0.02 !Ma dATP (1 mM) SPR (203)
E. coli 1.73 jiMa ATP (1.5 mM) Activity assay (203)
E. coil 0.2 FiM ATP (1 mM) Activity assay (203)
E. coli -0.1 FM ATP (1.5 mM) Activity assay (36)
E. coli 0.001 jiM dATP (0.1 mM) Activity assay (203)
Mouse 0.52 jiM None SPR (204)
Mouse 0.17 iM dTTP (0.1 mM) SPR (52)
Mouse 0.46 jiM dTTP (0.1 mM) SPR (204)
Mouse 0.12 FiM ATP (5 mM) SPR (204)
Mouse 0.05 dATP (0.1 IM) SPR (204)
a In the presence of 0.05% P20 nonionic detergent
b Surface Plasmon Resonance
Reichard, Sjfberg and co-workers have proposed that binding of dATP induces formation
of a tight R1/R2 complex that is inactive in nucleotide reduction. It is well known that the
presence of allosteric effectors can change the Kd of the R1 and R2 interaction.(6, 8, 36, 37, 52,
202-206) Table 1.3 summarizes the R1/R2 Kd determined using several different methods both
in the presence and absence of effector. In general, two methods have been devised to measure
the affinity between R1 and R2. A series of RNR activity assays are carried out in which the
concentration of one subunit is held constant and the other is varied (i.e. - treated almost as a
substrate) and fitting of the calculated activities as a function of subunit concentration can be
used to calculate the R1/R2 Kd. Alternately, the affinity can be measured using Surface Plasmon
Resonance (SRP) though caution should be used when interpreting data obtained from these
experiments due to artifacts associated with the attachment of RNR to a surface or the use of
detergents to obtain useful data (Table 1.3, first 6 rows).(203) In general, the R1/R2 Kd is
estimated to be -0. 1-0.2 pM. However, in the presence of dATP, a Kd as low as 0.001 IM has
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been reported (Table 1.3). In general, dATP is the only allosteric effector thus far identified
which has a dramatic effect on R1/R2 affinity. This observation serves as the basis for the model
that a tight RI/R2 interaction in the presence of dATP leads to formation of an inactive complex.
monomer R1 R1 2 R1 3
ft
Figure 1.13 Cooperman and co-workers' model for the allosteric regulation of mouse
ribonucleotide reductase.
This model proposes that 5 distinct forms of mouse RI can be formed, three of which are active
(green) and two of which are inactive (red) in nucleotide reduction. The interconversion
between these forms is driven through allosteric regulation at three separate allosteric sites, S-
site, A-site and H-site. Figure from Cooperman et al. (207)
Cooperman and co-workers have proposed a different model to explain the dATP
inhibition of RNR and the role of the A-site in RNR oligomerization. In general, eukaryotic
large subunits are monomeric (a) and are therefore inactive in the absence of effector. Binding
of allosteric effectors drives formation of RI (a2) and Cooperman and co-workers have proposed
that higher order RI oligomers (RI 2 and R13) are also physiologically relevant quaternary states
-
= S-site, no (d)NTP Ssite, no (d)TP = A-site. no (d)ATP
= S-site bound to dGTP,
TTP, dATP, or ATP = A-site bound to
ATP or dATP
A = H-site no ATP O = A-site bound to
ATP
S= H-site bound
to ATP
and the equilibrium between this states is controlled by allosteric regulation.(201, 207-209)
Using data collected from dynamic light scattering, analytical ultracentrifugation, and nucleotide
reduction assays that is then fit to equations describing the complex equilibria between the up to
16 species that can be present when mouse R1 is incubated with substrate and effector
nucleotides. These studies have lead Cooperman and co-workers to propose that there is a third
effector binding site of mouse R1, named the hexamerization site (H-site) which binds ATP with
a Kd of -1-4 mM and drives formation of a R13 (a6), which is active in nucleotide reduction.
The model of Cooperman and co-workers is presented in Figure 1.13. In the absence of effector
or substrate, the mouse RNR large subunit is an inactive monomer (a).(209-211) Binding of
effector to the S-site drives formation of R1 (a2). Binding of dATP or ATP to the A-site drives
formation of R12 (a 4), a conformation of which is inactive in nucleotide reduction in the
presence of R2 (colored red) thus explaining RNR inhibition by dATP. Finally, binding of ATP
to the H-site drives formation of the hexamer (R13). While higher order oligomers of R1 from
other organisms have been observed, this model for the allosteric regulation and the presence of
the H-site remains controversial. (130, 201, 207-209, 211, 212)
1.9 The structural basis for allosteric regulation of substrate specificity
Several structures of class I and class II RNR bound to allosteric effectors have revealed
that the structural basis for allosteric regulation of RNR substrate specificity is likely to be very
similar (Figure 1.14).(29, 195, 197, 213) Comparison of these structures has revealed that two
loops are likely to be responsible for most of the communication between the S-site and the
active site. Loop 1 (Loop C), connecting the strand B and the helix aB binds the phosphates
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Figure 1.14 The key loops mediating S-site allosteric regulation.(previous page)
For each protein, helices are rendered in red, sheets in yellow and loops in blue. The effector-
bound structures shown were all obtained by crystal soaking and the effector is shown as sticks
and colored by atom with carbon atoms colored in green. The substrate, also bound to the crystal
by soaking, is also shown as sticks (in A and D) with carbons colored in cyan. A) Class Ia R1
from E. coli (3.2A resolution) bound to GDP (substrate, 0.5 occupancy) and TTP (effector).(29)
B) Class lb R from S. typhmimurim bound to dATP (bound in the S-site) at 3.2A
resolution.(195) C) Monomeric class II RNR from L. leichmannii bound to dGDP. Loop 2 is
disordered and represented as a dashed line.(213) D) Dimeric class II RNR from T. maritima
bound to TTP (effector) and GDP (substrate).(197) Parts B and C were adapted from
Sintchak.(213)
Table 1.4 Important residues for activity and allosteric regulation
characterized class I and class II enzymes
in structurally
E. coli S. typhimurim L. leichmannii T. maritima
Active site residues
S. Cys439 Cys388 Cys408 Cys322
Disulfide forming Cys225, Cys462 Cysl78, Cys415 Cysl 19, Cys419 Cysl34, Cys333
Active site Glu Glu441 Glu390 Glu410 Glu324
Active site Asn Asn437 Asn386 Asn406 Asn320
Allosteric regulation
loops
Loop 1 (Loop C) Ala258-Ile279 Ser212-Ile231 Gly261-Ser272 Ser168-Glyl86
Loop 2 (Loop D) Cys292-Gly300 Ala245-Gly253 Ala313-Ala321 Ser199-Leu211
Loop 3 (Loop A) Lys320-Met333 Lys273-Leu286 Leu220-Arg224 Lys299-Leu243
Turn B (Loop B) Arg251-Gly253 Arg203-Gly205 Met158-Glyl62 Val159-Glyl61
of the effector. Loop 2 (Loop D), connecting aB and 3C RNR, is located between the substrate
and effector sites and is thought to be the mediator of specificity. To simplify the representation
in Figure 1.14, the 4-helix bundle that forms the dimer interface of the dimeric RNRs, and
strands A, B and C are shown along with the effector (in cyan stick models) and, if bound, the
substrate (in green stick models). Table 1.4 summarizes what residues are present in these
regions in the RNRs for which allosteric effector bound structures are known. The molecular
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Figure 1.15 Structural basis for allosteric regulation of the T. maritima RNR.
For three different substrate effector pairs, GDP-TTP (A), ADP-dGTP (B), and CDP-dATP (C),
the detailed hydrogen bonding networks in the active site (left) and effector site (right) is shown.
In the ADP-dGTP and CDP-dATP portions of loop 1 and/or loop 2 are disorderd and represented
by a black dashed line. D) Overlay of loop 2 from substrate effector pairs shown in (A-C).
Coloring is as follows: GDP-TTP, yellow; ADP-dGTP, brown; CDP-dATP, blue. This figure
was adapted from Larsson et al.(197)
details of how the structural dynamics of loop 2 regulate RNR specificity are now coming to
light with the recent structure of T. maritima RNR soaked with different substrate-effector pairs.
Figure 1.15 shows detailed pictures of three different substrate-effector pairs and an overlay of
these to emphasize the structural dynamics of loop 2. In addition to the importance of loop 2 in
mediating substrate specificity, perhaps the biggest surprise from these structures is the role
ordered water molecules and backbone carbonyl and amide groups played in mediating
interactions with the nucleotide (Figure 1.15). It is important to note that this structure was
solved at low pH (pH 4.5), which is true for many of the RNR structures, and that these different
effector substrate pairs were obtained through crystal soaking, rather than co-crystallization, with
the exception of the dATP structure. Furthermore, crystallization of the T. maritima enzyme
required removal of the B12 binding site, last 182 amino acids of the 827 amino acid protein.
Despite these caveats, this structure represents the first detailed model of how the structural
dynamics of RNR control substrate specificity. More insight will be obtained as these structural
M C Ak^40%WI
dynamics are studied in solution with the use of biophysical techniques such use of appropriately
placed fluorescence probes to study loop dynamics in the presence and absence of substrate and
effector.
1.10 Regulation of RNR subunit concentration
The concentration of RNR is an important factor controlling RNR activity because the
enzyme is composed of two subunits with low affinity. Therefore, organisms have come up with
numerous mechanisms to control the concentration of RNR in vivo. These mechanisms include
regulation at the transcriptional level (both activation and repression), regulation of mRNA
stability and translational efficiency, and controlled protein degradation, all of which will be
described in detail in the following sections. The players in regulation of transcription,
translation, and protein stability thus identified to differ from organism to organism the general
theme that RNR concentration increases as a function of the cell cycle or in response to
replicational stress will likely be a form of RNR regulation found in all organisms.
Figure 1.16 Transcriptional regulation of RNR in S. cerevisiae.
A) Cell cycle regulation of RNR1 transcription is regulated by the MluI cell cycle box (MCB)
which activates transcription of genes in the G1 phase of the cell cycle through the heterodimeric
transcription factor made of Mbpl and Swi6. B) Gene chip data demonstrating the periodicity of
RNR and Smll transcription. Note that the cell cycle dependent transcription of Rnrl and Smll
are of similar magnitudes and opposite, the peak of Smll transcription corresponds to the trough
of Rnrl transcription. Red indicates induction of transcription and green indicates inhibition of
transcription. The total fold change observed in Spellman et al.(214) is indicated to the right and
compared to the mRNA expression change measured by northern blot.(122, 123, 126) C) DNA
damage induction of RNR. DNA damage initiates a signaling cascade through the well
characterized Mecl, Rad53, Dunl kinase signaling pathway that ultimately leads to
phosphorylation of the transcriptional repressor protein Crtl and relief of RNR transcriptional
inhibition. The Crtl binding site consensus sequence is shown.(161, 215)
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1.10.1 Cell cycle dependent transcriptional regulation of RNR
In S. cerevisiae, the heterodimeric transcription factor MBF is proposed to be responsible
for the cell-cycle dependent expression of RNRI.(126) MBF (for MCB-binding factor) is a
heterodimer of Swi6, the regulatory protein, and Mbpl, the DNA binding protein that recognizes
the MCB (for Mlul cell cycle box - Figure 1.16A).(216-219) This transcription factor is
responsible for driving transcription many GI-specific genes involved in DNA replication.(220)
The levels of RNRI mRNA fluctuate in a controlled fashion as a function of the cell cycle with
the fold change in transcript level ranging from 8 to 30 fold (Figure 1.16B).(122, 214, 221)
Interestingly, recent studies coupling chromatin immunoprecipitation (ChIP) and DNA
microarrays have identified a SBF binding site in the promoter of RNR1 that is conserved
amongst several Saccharomyces species and is immunoprecipitated with the SBF transcription
factor.(220, 222) SBF (SCB binding factor) is a heterodimeric protein composed of Swi4 and
Swi6, which binds to the Swi4/6 cell cycle box (SCB) upstream of its target genes.(218)
RNR2 shows weak cell cycle dependent expression, with the concentration of mRNA
increasing roughly 1.5-2 fold at the G1/S transition (Figure 1.16B).(123, 214, 221) While the
promoter of RNR2 contains a weak MBF motif,(126) binding of these transcription factors to the
intergenic region upstream of RNR2 have not been identified in ChIP-DNA microarray
experiments nor has the consensus sequence for MBF been evolutionarily conserved amongst
several Saccharomyces species, perhaps demonstrating the stringency applied to these large data
sets filters out actual regulatory events.(220, 222)
RNR4 transcription is relatively constant throughout the cell cycle as measured by
northern blotting and does not show the same kind of cyclic expression as RNRI and RNR2.(124,
214) Recent studies have revealed that the intergenetic region upstream of RNR4 is bound by the
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cell cycle transcription factors Mbpl and Swi6 at sites at least weakly conserved amongst several
Saccharomyces species as judged by recent ChIP coupled to DNA microarray experiments.(222)
This observation is at odds with the lack of RNR4's transcriptional periodicity examined using
northern blots. The transcript for RNR3 cannot be detected during normal vegetative growth.
(122, 124) Consistent with this observation, the promoter does not contain MBF or SBF binding
sites, as judged by ChIP-DNA microarray analysis.(121)
Similar periodic expression of RNR through the cell cycle has been well documented in
numerous systems, though the molecular details of the transcription factors and the RNR subunit
that is regulated (ie either R1 or R2 or both) differ.(223) As described above, S. cerevisiae RNRI
transcriptional levels fluctuate as a function of the cell cycle much more than the RNR2.
However, in S. pombe, expression of both Cdc22 (R1) and Suc22 (R2) transcriptional levels
fluctuate as a function of the cell cycle. Similar to S. cerevisiae, the MBF transcription factor,
which is named I)sc 1 (MBF=DSC, DNA synthesis control), is responsible for driving the cell
cycle dependent transcription of Cdc22 and Suc22.(224-229) In mammals, the periodic
expression of RNR has been demonstrated in both normal and cancer cell lines.(230-233) The
periodic expression of R2 in mammalian cells is proposed to be regulated by the transcription
factor E2F4 and NF-Y while the expression of R1 is at least in part regulated by YY-1.(232, 234-
240) In tobacco cells, RNRla and RNR2 are regulated by E2F and the retinoblastoma tumor
suppressor protein.(183-186, 241) The cell cycle dependent transcription of RNR is not unique
to eukaryotic systems and in fact Fis and DnaA have been found to regulate E. coli nrdA and
nrdB transcription as a function of the cell cycle.(242-254) Clearly, the periodic expression of
RNR is well conserved and an important factor controlling up-regulation of RNR activity during
S-phase.
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1.10.2 Transcriptional regulation of RNR in response to cell cycle checkpoints
Nucleotides are also required under conditions in which the DNA must be repaired and
therefore, RNR transcription is also induced in response to DNA damaging conditions or cell
cycle blocks. The induction of RNR2, RNR3 and RNR4 transcription is regulated by Crtl (also
known as Rfxl).(161, 215, 222) Crtl is a transcriptional repressor that binds to a 13 nt sequence,
the X box or DRE for DNA damage response element (Figure 1.16C), and recruits the
transcriptional repressor complex composed of Ssn6 and Tup 1 to the promoters, thus inhibiting
transcription.(161, 255-260) Phosphorylation of Crtl by the DNA damage responsive kinase
Dunl relieves Crtl induced repression, leading to a up-regulation of RNR transcription. The
reported transcriptional induction of RNR2 and RNR4 varies from 2-20 fold in response to the
DNA damaging agents such as methylmethane sulfonate (MMS), ionizing radiation (IR),
ultraviolet radiation (UV), 4-nitroquinoline- 1 -oxide (4-NQO) while the transcriptional induction
of RNR3 is on the order of 100 fold.(128, 261-263)
This theme of induction of RNR in response to DNA damaging agents or cell cycle
blocks is well known in numerous other systems.(173, 224, 264-266) The system getting the
most attention is the recently discovered p53R2 discussed in the previous section. It seems that
induction of RNR transcription to provide dNTPs for DNA repair will be a universal theme in all
organisms.
1.10.3 Other forms of RNR regulation effecting RNR concentration in vivo
Numerous post-translational mechanisms of RNR regulation have been described in the
literature and two of these mechanisms, regulation of translation initiation and mRNA stability
have been identified in S. cerevisiae. The translation initiation factor eIF4E (gene Cdc33 in S.
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cerevisiae) has been found to regulate the translation of Rnr2 in CHO cells and in S.
cerevisiae.(267) Over-expression of eIF4E leads to a 20-40 fold increase in R2 protein levels
and a temperature sensitive mutant of eIF4E grown at the non-permissive temperature has a
decrease in Y2 protein levels. Regulation of mammalian R2 has also been reported to be
regulated by the translation initiation factor eIF2 (p 170) in human cell lines.(146) The most
dramatic demonstration of regulation of RNR translation is seen in clam oocytes. The mRNA
for R2 is the most abundant mRNA in unfertilized oocytes and is selectively transcribed after
egg fertilization to form an active RNR with the R1 already present in the oocyte.(268, 269)
The expression of RNR is also regulated at the level of mRNA stability. Recently, a
study in yeast has found that the 3' untranslated region of the RNR2 and RNR4 contain AU-rich
elements which bind to the Cth2 protein and target them for degradation in response to iron
deficiency, though the details of how this mechanism of regulation might fit into the overall
picture of RNR regulation are unclear at this point.(270) In S. pombe the protein Cid3, a poly(A)
polymerase, is proposed to play a role in selective poly-adenylation of the 3' end of suc22 (R2)
mRNA thus increasing its stability.(27 1) Mutations of Cid3 led to shortening of scu22 3'-
poly(A) tails, decrease in dNTP pool sizes and HU sensitivity. The authors speculate that the
Cidl3-related proteins, Trf4 and Trf5 could be the S. cerevisiae 3' poly(A) factors. Mammalian
systems also regulate RNR expression at the level of mRNA stability and these mechanisms of
regulation have been recently reviewed and will not be described here.(272)
In addition regulation of RNR protein concentration at the transcriptional and
translational levels, regulated protein degradation can regulate RNR activity. This form of RNR
regulation has been demonstrated for mouse R2. In mammalian cells, R2 is degraded as the cells
enter the G2 phase of the cell cycle, with the half life of the R2 protein changing from more than
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20 hours to about 6 hours in the S and G2 phases, respectively.(273) This specific degradation
of R2 is mediated through the poly-ubiquitination of R2's KEN box by the anaphase promoting
complex (APC) and the activator Cdh1.(274) The authors note that this KEN sequence is found
in mammalian, Caenorhabditis elegans and Drosophila R2 but not in either budding or fission
yeast. These results could mean that controlled protein degradation is used by higher eukaryotes
but perhaps it does not exist in budding and fission yeasts.
1.11 Regulation of RNR subcellular localization
For many years, it was thought that ribonucleotide reduction occurred exclusively in the
cytoplasm.(275) However recently, it has been found that not only can RNR be localized to the
nucleus but its subcellular localization can be dynamic, with R1 and/or R2 changing subcellular
localization in response to endogenous or exogenous signals. While recent studies have revealed
the general theme of the spatial regulation may be a general form of RNR regulation, the details
seem to differ significantly from organism to organism. This dynamic localization of RNR has
been seen in S. cerevisiae, S. pombe, tobacco and mammalian cells and each system will be
explained in detail in the following sections.
In the yeasts S. cerevisiae and S. pombe, the small subunit is localized to the nucleus and
moves to the cytoplasm during S phase or in response to replication stress induced by agents
such as MMS or HU (Figure 1.17 A and B).(162, 276) In both these organisms, the large
subunit is localized to the cytoplasm. This has led to the model in which RNR is regulated
through the differential regulation of the R1 and R2 subunits, separating them when dNTPs are
not required and moving R2 to the cytoplasm with R1 when dNTPs are needed. Studies of the
localization in the pombe system has shown that failure to re-localize the small subunit to the
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Figure 1.17 RNR subcellular localization in response to DNA damage or replication blocks.
A) In S. cerevisiae the large subunit Y1 (red) remains in the cytoplasm after DNA damage while
the small subunit protomers, Y4 (green) and Y2 (not shown) are localized to the nucleus and
move to the cytoplasm after DNA damage. Figure from (162). B) Movement of S. pombe R2.
Each picture has two panels, one showing DAPI staining of the nucleus and the other showing
the signal from FTIC coupled antibody raised to the C-terminal tail of R2. In S. pombe R2
(Suc22) is localized to the nucleus. After the DNA replication lock induced by HU, the subunit
re-distributes to the cytoplasm. In the cytoplasm, the Suc22 antibody epitope is masked, leading
to a loss of nuclear signal intensity without a corresponding increase in cytoplasmic intensity.
Figure adapted from Liu et a1.(276) C) The human RNR, Rl, p53R2 and R2(not shown) move
from the cytoplasm to the nucleus in response to DNA damage. D) Plant RI changes
localization from the cytoplasm to the nucleus in response to IR.
"""~'
cytoplasm results in a delay of S phase progression or genotoxic stress response defects.(276-
278)
Although the subcellular localization patterns are similar in these two organisms, the
molecular details as currently known are quite different. In S. pombe, degradation of Spdl is
required for the re-localization of R2 from the nucleus to the cytoplasm. This observation has
led to the model that the nuclear Spdl acts as an anchor that binds to R2 and retains it in the
nucleus. However, no direct interaction between Spdl and R2 has been demonstrated. Other
proteins found to be important for the regulation of S. pombe R2 localization are regulate the
degradation of Spdl in response to genotoxic stress and include the COP9 signalosome subunits
Csnl and Csn2, the cullin Pcu4, and the proposed adaptor Ddbl .(276, 277) So far, the proteins
required to import R2 into the nucleus of S. pombe are not known.
In S. cerevisiae the importin Kap 122 plays a role in importing Y2Y4 into the nucleus (M.
Huang, personal communication). The WD40 repeat containing proteins Wtml and Wtm2,
which have been found to interact with Y2Y4 (Chapter 6 of this thesis), have also been
implicated in the regulation of Y2Y4 nuclear localization though their role remains to be
completely defined. Currently it is though that the Wtm I and Wtm2 help Y2Y4 interact with the
importin Kap 122 or alternately, they play a role in anchoring Y2Y4 in the nucleus, similar to the
role Spdl in R2 localization in S. pombe.
Very different RNR subcellular localization patterns have been observed in mammalian
and plant cells. The three identified RNR subunits in mammalian cells, RI, R2 and p53R2,
move from the cytoplasm to the nucleus in response to genotoxic stress (Figure 1.17C, R2 not
shown).( 171, 172, 175) It has been proposed that p53 directly regulates the subcellular
localization of the R2 subunits through binding of these subunits in the cytoplasm followed by
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release in response to genotoxic stress to allow the small subunit to travel to the nucleus. These
results support the hypothesis that dNTPs needed for DNA repair are synthesized in the nucleus.
The localization of mammalian RNR in response to the cell cycle has not been re-investigated
and thus the location of dNTP synthesis for DNA replication remains an open question.
In plants, it has been found that R I moves from the cytoplasm to the nucleus in response
to ionizing radiation. (Figure 1.17 D). (183) Currently it is unknown where the small subunit is
localized and if the RNR subunits change localization in response to the cell cycle.
The parasite Leishmania mexica amazonensis, the causative agent of leishmaniasis,
shows a constitutive nuclear localization of R2, which stains in ring-like structures in and around
the nucleus.(279) The location of RI in this organism is unknown. The herpes viral RNR has a
distinct localization pattern, with RI localized predominantly in the cytoplasm while R2 is
localized to the cytoplasm with punctate staining concentrated around the nucleus.(280) A
similar localization pattern of R2 is observed in shrimp hemocytes infected with the shrimp
white spot syndrome virus (WSSV).(28 1) In this system, RI is localized predominantly around
and inside of the nucleus though small amounts of the protein are also observed in the cytoplasm
while the R2 is localized throughout the cytoplasm and concentrated around the nucleus.
Therefore, these three systems, two viruses and one intracellular parasite, display concentration
of R2 around the nucleus, a localization pattern distinct from the diffusely nuclear and/or
diffusely cytoplasmic localization seen in the yeast and mammalian systems.
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1.12 Protein-Protein interactions
Numerous protein-protein interactions are known to regulate RNR activity. As discussed
in Section 1.8 , modulation of the Kd for Ri-Ri interactions or R1-R2 interactions can regulate
the activity of RNR. Recently, a small protein named Sml 1 has been identified in S. cerevisiae
that inhibits RI in vivo.(Figure 1.11). This protein was identified in a genetic screen for
suppressor mutations of Mec 1 lethality.( 158) Smll has been shown to interact directly with Y1
by numerous techniques with an estimated Kd of 0.2-0.4 [tM.(157, 159, 160) The last 30 amino
acids of Smll are proposed to be involved in Y 1 binding, though the binding site on Y1 has not
yet been defined. The expression level of Smll I is lowest in S phase and highest in G2/M,
consistent with the proposal that Smll I inhibits Y 1 during times in the cell cycle when dNTPs are
not required.( 156) During S phase and in response to genotoxic stress, phosphorylation of Smll
by the DNA damage responsive kinase Dun 1 leads to its degradation.(155-157) Smll is
proposed to be a dimer in solution and is thought to bind to the Y1 dimer though the molecular
mechanism through which Smll inhibits Y1 remains to be completely defined.(159, 282) To
date, no Sml I homologues have been identified in other eukaryotic organisms.
1.13 Post-translational modification.
As described in the previous section, RNR activity is regulated on many levels by the
DNA damage response kinase cascade and thus it is perhaps not unexpected that RNR has found
to be modified by a phosphorylation. In S. cerevisiae, Y2 is modified by at least one
phosphorylation, on Serl5, the discovery of which is described in this thesis. Furthermore, Y1
often appears as double band in Western blotting, indicating it might be a phosphoprotein as well
(M. Huang, personal communication). Interestingly, mouse R2 is phosphorylated on its N-
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terminus at Ser20.(283, 284) The kinases p34Cd' 2 and CDK2 have been found to be capable of
phosphorylating R2 in vitro and in vivo. The role of this phosphorylation is unknown, as it does
not seem to affect RNR activity (283) or protein stability, through influencing the Cdh I
dependent polyubiquitination (Discussed in section 1. 10.3).(273, 274)
Furthermore, Y2 has been identified in two of six studies cataloging the sumoylation,
though the abundance seems quite low.(285-290) Perhaps Y2 was identified as a low abundance
sumoylated protein because this post-translational modification regulates Y2 in response to a
specific signal or alternately the identification of Y2 is a false positive, which unfortunately seem
to be common in many of these large-scale proteomics efforts.
1.14 Regulation through cofactor biosynthesis and destruction
Finally, R2 requires insertion of the diferric-Y* cofactor. Thus, cofactor biosynthesis and
destruction could be yet another mechanism of RNR regulation in vivo. Only one enzymatic
system capable of re-generation of the Yo has been described tr E. coli R2.(291-298) The
components were identified based on their ability to catalyze the conversion of metR2, R2 with
the diferric cluster but lacking the Ye due to reduction with hydroxyurea, to holo R2 (Figure 1.18
A). Three components in the crude extract were found to be required, a flavin reductase,
superoxide dismutase (SOD), and a third component that was not identified however, this
fraction could be replaced by the addition of ferrous iron (Figure 1.1 8B). It is thought that the
flavin reductase, in the presence of flavin and NAD(P)H, reduces the irons of the metR2 diferric
cluster.(297) Superoxide formed by flavin reductase is proposed to destroy the Yo of R2, and
therefore, SOD is required to remove the inhibitory superoxide.(295) Finally, fraction 3B,
containing some form of iron in a low molecular weigh complex, is proposed to be the source of
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the extra electron required to assemble holoR2.(293) Deletion of the flavin reductase renders
cells more sensitive to HU, supporting the hypothesis that this system plays a role in activation
of metR2 in vivo. However the importance of this enzymatic system for generation of holoR2 in
other systems remains to be established.(291, 292)
A) B) E.coli Extract
Holo R2
C
A52
clusion
tography
Met R2 Apo R2 Highly unstablebut can be replaced
by ferrous iron
Figure 1.18 Enzymatic System for formation of Ye from MetR2.
A) Outline of the different forms of R2 and components required for interconversion. B) Flow
chart of purification of enzymatic system for reconstitution of metR2.
1.15 The integration of RNR regulation
The regulation of RNR is key to the maintenance of genomic stability. Clearly numerous
mechanisms of RNR regulation have been discovered and characterized. To emphasize the
complexity, Figure 1.19 summarizes the forms of RNR regulation in S. cerevisiae, during S
phase and in response to DNA damage. Clearly, with this many different mechanisms of
"Fraction 8"

= Y2Y4 = MBP (Mbpl, Swi6)
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Figure 1.19 A summary of the many forms of RNR regulation
The mechanisms of RNR regulation in S. cerevisiae outside of S-phase, during S-phase and after
DNA damage are depicted in A, B and C, respectively. In each snapshot, some forms of
regulation are highlighted by number. 1) Transcriptional regulation - MBP drives transcription at
G 1/S transition, and Crt 1 recruits repressor protein complex of Tup 1-Ssn6 unless phosphorylated
by Dunl in response to DNA damage. 2) The spacial and temporal regulation of Y2Y4. When
dNTPs are not required, Kap122 (with the help of Wtml and Wtm2?) import Y2Y4 into the
nucleus. In S-phase and DNA damage and cell cycle blocks, Y2Y4 leaves the nucleus through a
not yet discovered mechanism. 3) Inhibition of Y1 by Smll is relieved by phosphorylation of
Sml 1 leading to its degradation. 4) Y1 oligomerization might be similar to that described for the
mouse enzyme with a hexamer as an active form of Y . 5) Regulation of cofactor biosynthesis
and destruction might be a mechanism of RNR regulation. 6) Increase in Y3 protein
concentration could increase the concentration of RNR complex in vivo although the role of this
protein in vivo is still not clear.
I
W= Y3
regulation acting simultaneously it is hard to predict how these mechanisms are integrated in vivo
in a quantitative manner. The RNR of S. cerevisiae could serve as an informative model to
understand RNR regulation in vivo. Many tools are available including isogenic deletion strains,
affinity tagged strains and a wealth of "-omics" information is known for this model organism.
Furthermore, the ease of genetic replacement technology will allow for integration of i vitro and
in vivo experiments. Only through careful studies of the enzyme in vitro and complementary
studies in vivo, will we begin to understand how this "simple" unicellular system regulates RNR.
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Chapter 2
Purification of Ribonucleotide Reductase Subunits
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2.1 Introduction
The in vitro studies of S. cerevisiae RNR found in the following chapters depend upon
the purification of RNR subunits. Protocols for over-expression and purification of S. cerevisiae
RNR subunits were worked out by Dr. Jie Ge, as described in her Ph.D thesis and papers, and by
Dr. Hiep -Hoa Nguyen.(1-3) Standard purifications of Y1, Hwy2, Y3, HsY4, and Y4, which were
previously described, are briefly reported here.
In addition to reporting these standard yeast RNR purifications, a modification to the
purification of Y1 is described. When using the standard purification procedures previously
described for Y1, problems were experienced as DNA contaminates the Y1 purified by dATP-
Sepharose affinity chromatography. The use of a strong anion exchanger, Q-Sepharose, was
used to separate Y1 from this contaminating nucleotide or DNA.
Furthermore, a new method for purification of the yeast H"Y2-Y4 heterodimer is
described. This method involves co-expression in E. coli and purification of the subunit
followed by in vitro reconstitution of the diferric Ye cofactor. While these methods could give
Y2Y4 with comparable Ye and specific activity, problems were experienced obtaining
heterodimer with reproducible specific activity.
A few new purification procedures are reported here. The purification of N-terminal HA
tagged Y4 (HAY4 ) is described, using standard protocols for the purification of Y4. The
purification of the hexahistitine tagged R1 subunits H'SY1 and Hisy 3 is reported here, along with
construction of the E. coil HiY 3 expression vector.
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2.2 Materials and Methods
2.2.1 Materials
Luria Bertani (LB) broth powder, tryptone, peptone, yeast extract, and agar were
purchased from Difco (Sparks, MD). Competent BL21(DE3) CodonPlus RIL cells were
purchased from Stratagene (La Jolla, CA). Competent B834(DE3) cells, for expression of
selenomethionine substituted Y4, and the pET28a plasmid were obtained from Novagen (part of
EIMD Biosciences, Inc, San Diego, CA). The restriction enzymes NdeI and XhoI were obtained
from New England Biolabs (Beverly, MA). Complete protease inhibitor tablets and Complete
EIDTA-free protease inhibitor tablets, DNaseI, and alkaline phosphates (calf intestine) were
obtained from Roche (Indianapolis, IN). [14C]-CDP (40-60 mCi/mmol, [cytosine - 14C (U)]-CDP
or[ 2-14C]-CDP) was obtained from Moravek Biochemicals, Inc (Brea, CA). Talon metal
(cobalt) affinity resin was obtained from BD Biosciences (San Diego, CA). Isopropyl f3-D-
thiogalactoside (IPTG) and 1,4-ditiothreitol (DTT) were obtained from Mallinckrodt Chemicals
(Paris, KY). DEAE Sepharose Fast Flow, Q Sepharose Fast Flow, Sephadex G-25, Sephadex G-
50 and the pre-packed Sephacryl S-200 (26/60) column were obtained from Amersham
Biosciences (part: of GE Healthcare, Piscataway, NJ). The affinity matrix, dATP-Sepharose, was
synthesized by other members of the Stubbe Laboratory according to standard procedures.(4)
UIltrafiltration membranes (YM30 and PM30), Centricons, and Amicon Ultra centrifugal devices
were obtained from Millipore (Bedford, MA). All other chemicals were purchased from Sigma-
Aldrich (St. Louis, MO) and were of highest purity available. Polyclonal antibodies to Y1, Y2,
Y3, and Y4 were generated in rabbits by Covance Research Products (Denver, CO).(2)
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2.2.2 General Procedures
E. coli thioredoxin (TR) and thioredoxin reductase (TRR) were isolated as described
previously.(5, 6) SDS-PAGE was performed using Mini-PROTEAN II or Mini-PROTEAN 3
electrophoresis kit (Bio-Rad, Hercules, CA). The dimeric concentrations of HY 2 and Y4 were
determined using their known extinction coefficients (280-310), 105,600 M'lcm l and 94,000 M'
lcm', respectively.(l, 3) The concentration of the heterodimer was determined with the 280-310
99,800 M' cm '1, the average of HsY2 and Y4 extinction coefficients. The concentration of Y1
and Y3 were determined with the Bradford assay with bovine serum albumin (BSA) as the
standard.(7) Iron concentration was determined by the ferrozine assay.(8) The plasmid pMH784
for expression of N-terminally HA-tagged Y4 in E. coli was provided by Prof. M. Huang
(University of Colorado Health Sciences Center).
2.2.3 Construction of pHis-Y3
pHisY3 was constructed for expression of Y3 with an N-terminal hexa-histidine tag in an
E. coli expression host. The RNR3 coding sequence was obtained by digestion of pY3J(2, 3)
with NdeI and XhoI. The RNR3 insert was purified on an agarose gel (1% in 40 mM Tris-
acetate (pH 8), 2 mM EDTA) and ligated into the NdeI/XhoI sites of pET28a. A map of the
unique restriction sites in pHisY3 is shown in Figure 2.1. The gene for H"Y 3 is from bp 5131 -
7740. This plasmid expresses Y3 with the N-terminus MGSSHHHHHHSSGLVPRGSHM-Y3
(Thrombin recognition site is underlined and 4 denotes the site of cleavage).
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Figure 2.1 Unique restriction sites of pHis-Y3
Shown is the, lasmid map of pHisY3 with the unique restriction sites marked along with coding
sequence of "Y3 (grey).
2.2.4 Expression of RNR subunits in E. coli
The plasmids used for expression of RNR subunits in E. coli are listed in Table 2.1. For
expression, the plasmid was freshly transformed into BL21(DE3) CodonPlus RIL cells. A single
colony was used to inoculate a 5 mL LB culture with 30 mg/L chloramphenicol and the
appropriate antibiotic for selection of the expression plasmid, 100 mg/L for ampicillin or 75
mg/L for kanamycin. After growing the cells overnight at 37°C, the culture was diluted into 1.5-
2 L LB supplemented with the appropriate antibiotic in 6 L shaker flasks at an inoculum strength
of 1:300-1:2000.
Table 2.1 Plasmids used for expression of RNR subunits in E. coli BL21(DE3) RIL codon
plus.
Plasmid Expressed Protein Antibiotic Resistance Reference
Marker
pYiM Y1 Kan (2)
pHis-Y1 Hsyl Amp (3)a
pY3J Y3 Kan (2)
pHisY3 HsY3 Kan This thesis
pHisY2 HisY 2 Amp (2)
pY4J Y4 Kan (2)
pHisY4 HI'y 2 Amp (1)
pMH784 HAY 4 Amp Gift from Prof. Huang
a Constructed by Dr. Hiep-Hoa T. Nguyen
For expression of Y1, Y2 or Y3, a cold temperature induction protocol was used to obtain
soluble protein. The cells were grown at 37'C until the A600 reached 0.4-0.6 (-4-6 h). At this
point, the temperature of the incubator was lowered to 15°C and one hour later IPTG (0.5-1 mM)
was added to induce protein expression. The culture was grown for an additional 12-16 h at
15'C following IPTG addition. A typical yield was 3-6g of cell paste per L of culture.
For expression of Y4, the cells were grown at 37'C until the A600 reached 0.8. IPTG was
added (0.5 mM) and the culture was grown for an additional 4 h. A typical yield was 3-6g of cell
paste per L of culture.
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Table 2.2 Buffers used in purification of RNR subunits
RNR subunit Buffer Name Buffer Components
Y1 Buffer A 50 mM Tris (pH 7.6), 4 mM DTT, 1 mM PMSF,
15 mM MgC12, 5% (v/v) glycerol
Y3 Buffer B 50 mM Tris (pH 7.6), 15 mM MgC12, 4 mM DTT,
1 mM PMSF, 15% (v/v) glycerol
Hisy1 , HisY2 , HsY 3 HisY4 Buffer C 50 mM Hepes (pH 7.4), 5% glycerol
Hisy2, Hisy4 Buffer D 50 mM Hepes (pH 7.4), 100 mM NaCl, 0.5 mM
PMSF, 5% (v/v) glycerol
HisY2, HisY4 Buffer E 50 mM Hepes (pH 7.4), 10 mM imidazole, 0.5
mM PMSF, 5% (v/v) glycerol
Hisy2, Hisy4 Buffer F 50 mM Hepes (pH 7.4), 200 mM imidazole, 5%
(v/v) glycerol
HAy4, Y4 Buffer G 50 mM Tris (pH 7.6), 0.5 mM PMSF, 5% glycerol
2.2.5 Purification of Y1
Expression of Y1 was achieved by IPTG induction of BL21(DE3) CodonPlus RIL cells
transformed with the expression plasmid pY1M as described in section 2.2.4. A total of 9 L of
culture was grown with a yield of 36g of cell paste.
All protein purification steps were carried out at 4°C. The cell pellet was re-suspended in
120 mL of 50 mM Tris (pH 7.6), 4 mM DTT, 1 mM PMSF, 15 mM MgC12, 5% (v/v) glycerol
(Buffer A). Two Complete protease inhibitor tablets were added. Cells were disrupted by one
pass through the French pressure cell at 14,000 psi. The cell debris was removed by
centrifugation at 20,000 xg for 30 min. The soluble fraction (164 mL) was treated with
streptomycin sulfate to a final concentration of 1% (w/v) from a 10% stock solution in Buffer A.
The crude lysate was stirred for 15 min and precipitated DNA was removed by centrifugation
(20,000 xg, 30 min). Solid ammonium sulfate was added to the supernatant (168 mL) over 30
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min to a final concentration of 50% saturation (52.7g). The protein pellet was collected by
centrifugation (30,000 xg, 30 min) and dissolved with 40 mL with Buffer A. The protein was
desalted by passage through a Sephadex G-25 column (5x45 cm, 800 mL). The desalted protein
(-100 mL) was directly loaded on a dATP-Sepharose column (4.5x6.5 cm, 100 mL). Following
washing with 4 L of Buffer A, the Y1 was eluted with 300 mL of Buffer A supplemented with 10
mM ATP. Fractions (5 mL) containing Y1 as judged by a peak in the A292 elution profile were
pooled (150 mL, 3 mg/mL) and concentrated by ultrafiltration with a PM30 membrane. ATP
was removed by passage through a Sephadex G-25 column (4x30 cm, 375 mL). The protein
containing fractions were pooled and concentrated by ultrafiltration with a PM30 membrane to a
concentration of 8.7 mg/mL. A total of 390 mg of Y1 was recovered or 11 mg/g of cell paste.
2.2.6 Purification of Y1 by anion exchange chromatography
Y1 (20 mg, 4 mg/mL in Buffer A) was loaded onto a Q-Sepharose Fast Flow column pre-
equilibrated in Buffer A (1.5x5.6 cm, 10 mL) by gravity flow. The column was washed with
Buffer A until the A280 < 0.001. The column was eluted with a linear gradient of 0-350 mM
NaCl in Buffer A (50 x 50 mL). Fractions (80 drops, -2.5 mL) were collected and A280 and A260
of each fraction were determined. Fractions containing protein, as judged from the A2so/A260,
ratios were pooled and concentrated to > 5 mg/mL.
2.2.7 Purification of Y3
BL21(DE3) CodonPlus RIL cells were freshly transformed with the Y3 expression
plasmid pY3J. Protein expression was induced using cold temperature induction as described in
Section 2.2.4. All protein purification steps were carried out at 4°C. The cell pellet (54g from 9
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L of culture) was re-suspended with 165 mL of 50 mM Tris (pH 7.6), 15 mM MgCl2, 4 mM
I)TT, 1 mM PMSF, 15% (v/v) glycerol (Buffer B). Cells were lysed by passage through the
French pressure cell at 14,000 psi. Cell debris was removed by centrifugation (20,000 xg, 30
min). Streptomycin sulfate was added to the soluble supernatant to a final concentration of 1%
and the precipitate was removed by centrifugation at 20,000 xg for 30 min. Ammonium sulfate
was added to a final concentration of 40% over 30 min and the precipitated protein was collected
by centrifugation at 20,000 xg for 30 min. The pellet was re-dissolved in 75 mL of Buffer B and
the extract was desalted by passage over a Sephadex G-25 column (5x45 cm, 900 mL). The
desalted protein (170 mL) was loaded on a dATP-Sepharose column (4.5x6.5 cm, 100 mL). The
column was washed with Buffer B until A2 80 <0.01(-450 mL). ATP (1 mM) was added to the
wash (Buffer B) and another 400 mL were used to wash the column. The protein was eluted
with 400 mL of Buffer B supplemented with 10 mM ATP. Fractions (10 mL) were collected and
those containing Y3, as judged by a peak in the A292 were pooled and concentrated by
ultrafiltration with a PM30 membrane. The protein was concentrated to 1.3 mg/mL at which
point protein precipitation began to occur. Total yield was 40 mg of Y3 or 0.7 mg/g of cell
paste.
2.2.8 Purification of HSY1 and HLsy3
The plasmids pHisYl and pHisY3 for expression of H"Y1 and H'Y 3 , respectively, were
transformed into the expression host strain BL21 (DE3) CodonPlus RIL. The cells were grown
and protein over-expression was induced as described in section 2.2.4 for expression of Y1 and
Y3.
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All protein purification steps were carried out at 4°C. For purification of HY, the cell
pellet (9.2g from 4L culture volume) was re-suspended with 50 mM Hepes (pH 7.4), 5% glycerol
(Buffer C) in a final volume of 45 mL. One Complete, EDTA-free, protease inhibitor tablet was
added before disruption of the cells by two passage through a French pressure cell at 14,000 psi.
DNaseI (225 U, 5 U per mL of crude extract) was added and DNA was digested for 20 min. The
lysate was cleared by centrifugation at 30,000xg for 20 min. The supernatant (40 mL) was
diluted with 40 mL of Buffer C and loaded on a Talon metal affinity column (2.5 x 2.5 cm, 12
mL) at a flow rate of 1 mL/min. The column was washed with 400 mL of 50 mM Hepes (pH
7.4), 100 mM NaCl, 10 mM imidazole, 5% (v/v) glycerol. HYl was eluted with 50 mL of
Buffer C with 200 mM imidazole. Fractions (1 mL) were collected and those containing protein,
as judged by A280 .310, were pooled and concentrated with a Centriprep YM30 device. The
protein (30 mg, 15 mg/mL) was stored at -80°C.
Hisy 3 was isolated as described above for HiY 1. Total yield was 10.6 mg from 1.5 g of
cell paste or 7.2 mg/g.
2.2.9 Purification of HbY2 and HY 4
All protein purification steps were carried out at 4 C. For H'Y2, the cell paste (18g,
obtained as described in Section 2.2.4) was re-suspended in Buffer C to a final volume of 80 mL.
Two Complete, EDTA-free, protease inhibitor tablets were added and cells were lysed by
passage through a French pressure cell at 14,000 psi. The lysate was cleared by centrifugation at
20,000xg for 15 min. The supernatant was diluted 1:1 with Buffer C and loaded on a Talon
metal affinity column (2.5 x 19 cm, 30 mL) at a flow rate < 1 mL/min. The column was washed
with 500 mL of 50 mM Hepes (pH 7.4), 100 mM NaCl, 0.5 mM PMSF, 5% (v/v) glycerol
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(Buffer D) and subsequently with 400 mL of 50 mM Hepes (pH 7.4), 10 mM imidazole, 0.5 mM
PMSF, 5% (v/v) glycerol (Buffer E). The protein was eluted with 150 mL of 50 mM Hepes (pH
7.4), 200 mM imidazole, 5% (v/v) glycerol (Buffer F). Fractions (5 mL) were collected and
protein containing fractions, as judged by a peak in the A280, were pooled and concentrated to 12
mL (- 3 mg/mL). Imidazole was removed by passage over a Sephadex G-25 column. Hisy 2 was
concentrated by ultrafiltration with a YM30 membrane to 4.4 mg/mL, giving 40 mg or 2.2 mg/g
of cell paste.
Hi"Y4 was induced as described for Y4 in Section 2.2.4. The protein was purified as
described for HasY2 with a yield of 20 mg/g of cell paste.
2.2.10 Purification ofHAY4
Cell paste was obtained by transforming pMH784 into BL21(DE3) CodonPlus RIL cells
with selection on LB/ampicillin (100 mg/L). Cells were grown and induced as described in
section 2.2.4. A total of 4.5g of cell paste was obtained from 1.6 L of cell culture. Cell pellet
was stored at -80°C.
The cell pellet was re-suspended in 50 mM Tris (pH 7.6), 0.5 mM PMSF, 5% glycerol
(Buffer G) to a final volume of 12 mL. One Complete protease inhibitor tablet was added.
Cells were disrupted by French press (14,000 psi). Following centrifugation at 20,000 xg for 30
min, the soluble extract was treated with streptomycin sulfate to a final concentration of 1% and
precipitated DNA was removed by centrifugation. The supernatant was applied to a DEAE-
Sepharose fast flow column (2.5x8 cm, 50 mL), which was equilibrated in Buffer G. The
column was washed with 50 mL of Buffer G and the protein was eluted with a 200 x 200 mL
gradient from 0 to 250 mM NaCl in Buffer G. Fractions (6.5 mL) were collected and those
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containing HAy4, as judged by SDS-PAGE, were pooled, diluted 1:1 with Buffer G (final volume
-200 mL) and loaded onto a Q-Sepharose fast flow column (2.5x6.5 cm, 30 mL). The column
was washed with 100 mL Buffer G and the protein was eluted with a linear gradient of NaCl
from 70-350 mM in Buffer G. Fractions (5.3 mL) were collected and purity assessed by SDS-
PAGE. Fractions containing HAy 4 were pooled and concentrated by ultrafiltration with a YM30
membrane to a final concentration of 25 mg/mL. Total yield was 75 mg from 4.5 g of cell paste
or 16 mg/g.
2.2.11 Expression and purification of Selenomethionine substituted Y4
Selenomethionine (Se-Met) medium, a defined minimal medium for expression of Se-
Met substituted proteins was used for expression of Y4. Se-Met media consists of 2x M9 salts
(84 mM Na2 HPO4, 48 mM KH2PO4, 18 mM NaCl, 38 mM NH4CI), 0.4% (w/v) glucose, 40
gg/mL of all the amino acids except methionine, 40 gtg/mL Se-Met, 1 g/mL of riboflavin,
niacinamide, pyridoxine mono-hydrochloride, and thiamine, 9 ¢IM FeSO 4,and 2 mM MgSO 4.
The M9 salt stock solution (20x) was autoclaved and all other components were filter sterilized.
FeSO4 stock solution (500x stock solution; 12.5 mg/mL FeSO4 7 H2 0 and 12.5 mg/mL
ascorbate) was filter-sterilized immediately before use.
The Y4 expression plasmid, pY4J, was transformed into the methionine auxotrophic
strain B834(DE3). A single colony was used to inoculate a 50 mL culture of LB (100 mg/L
kanamycin) that was grown overnight at 37°C. The cells were washed two times with 50 mL of
Se-Met medium. The cell pellet was re-suspended in 40 mL of Se-Met medium. These washed
cells were used to inoculate four 1.5 L cultures (10 mL per culture) in 6 L shaker flasks. The
culture was grown to an A600 of 0.6 (6.5 h) and IPTG was added to a final concentration of 1
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rnM. The cells were collected 8 h following IPTG addition with a total yield of 10 g of cell
paste. The cell pellet was stored at -80°C.
The purification procedure for isolation of Se-Met Y4 followed the standard Y4
purification procedure except that EDTA and DTT were added to all buffers to prevent oxidation
of Se-Met. The cell pellet (10g) was re-suspended with 40 mL of 50 mM Tris (pH 7.6), 0.2 mM
EDTA, 10 mM DTT, 5 % (v/v) glycerol (Buffer H). All protein purification steps were carried
out at 4C. The cells were lysed by one passage through a French pressure cell at 14,000 psi.
The cell debris was removed by centrifugation and the DNA was precipitated by the addition of
streptomycin sulfate to a final concentration of 2.5%. Following centrifugation (20,000 xg, 30
nin), the supernatant was applied to a DEAE Sepharose fast flow column (2.5 x 20 cm, 100
mL). The column was washed with Buffer H until the A280 < 0.1. The protein was eluted with a
0-250 mM NaCl gradient (400 x 400 mL) in Buffer H. Fractions (10 mL) were collected and
those containing Y4, as judged by SDS-PAGE analysis, were pooled and diluted 2 fold with
Buffer H. The protein was loaded on a Q Sepharose column (2.5 x 18 cm, 90 mL). The column
was washed until the A280 < 0.1 and the protein was eluted with a 0-400 mM NaCl gradient (300
x 300 mL) in Buffer H. Fractions (7 mL) were collected and those containing Y4, as judged by
SDS-PAGE analysis, were pooled (130 mL) and concentrated to 8.5 mL by ultrafiltration with a
YM30 membrane. The Se-Met Y4 (30 mg/mL) was stored at -80 C. A total of 270 mg was
recovered from the 10 g of cell paste.
A fraction of the Se-Met Y4 (100 mg in 2 mL) was chromatographed on a Sephacryl S-
2'00 gel filtration column (2.6 x 60 cm, 320 mL, Pharmacia Hi-Prep 26/60 Sephacryl pre-packed
column, Amersham Biosciences). The column was equilibrated in and eluted with Buffer H
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without PMSF. Fractions (5mL) were collected and those containing Y4 (Fraction number 15-
30) were pooled and concentrated to 2 mL.
2.2.12 Co-expression and purification of HbY2 -Y 4
Co-expression and isolation of holo-HSY2-Y 4 heterodimer
The expression plasmids pHisY2 and pY4J were co-transformed into BL2 (DE3)
CodonPlus RIL cells. Protein expression was induced as described for H"Y2. A total of 30 g of
cell paste was obtained from 8 L of culture.
All protein purification steps were carried out at 4°C. The cell pellet (lOg) was re-
suspended in a final volume of 50 mL in Buffer C. One Complete, EDTA-free protease inhibitor
tablet was added and the cells were disrupted by two passes through the French pressure cell at
14,000 psi. DNaseI (5 U per mL of extract) and 1 mL of a solution containing 2 mg/mL FeSO4
and 2 mg/mL ascrobate was added and thee mixture was stirred for 15 min. The cell debris was
removed by centrifugation at 10,000 rpm for 30 min. The cleared lysate, 45 mL, was diluted
with 45 mL of Buffer C containing 1 mM PMSF and loaded on a Talon metal affinity column
(2.5 x 2.5 cm, 12.5 mL). The column was washed with 230 mL Buffer D and subsequently with
125 mL of Buffer E. The protein was eluted with 50 mL of Buffer C containing 100 mM
imidazole followed by 50 mL of Buffer C containing 200 mM imidazole. Fractions (1.5 mL)
were collected and those containing a 1:1 ratio of Hi'Y2-Y4, as judged by SDS-PAGE analysis
were pooled and concentrated. Imidazole was removed by several rounds of dilution and
concentration or by passage over a Sephadex G-25 column. Typical yield was 4 mg of
heterodimer per g of cell paste.
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Co-expression and isolation of apo-HIsY2-Y4 heterodimer
Protein expression was carried out as explained above except that 1,10 phenanthroline
(final concentration 100 pM) was added to the medium 15 min before the addition of IPTG.
Purification was carried out exactly as described above except that FeSO4 was not added after
cell lysis. The yield of heterodimer was 1 mg per g of cell paste.
Separate expression of HsY2 and Y4followed by isolation of apo-HsY2-Y4 heterodimer
The Hisy 2 expression plasmid pHisY2 was transformed into BL2 1(DE3) CodonPlus RIL
cells and protein expression was carried out using cold temperature induction protocol described
in Section 2.2.4. The Y4 plasmid was also transformed into BL21(DE3) CodonPlus RIL cells
and expression was induced using the standard protocol.
The cell pellets expressing HisY 2 and Y4 were mixed at a ratio of 2:1 (2g HiY 2 cell pellet
with g Y4 cell pellet). The heterodimer was isolated as described for isolation of the apo-HsY2-
Y4 heterodimer except a linear gradient from 10-200 mM imidazole in Buffer C (60x60 mL)
was used to elute the Talon metal affinity column (2.5x2.5 cm, 12.5 mL). The yield was 5 mg of
heterodimer per g of cell paste.
2.2.13 Reconstitution of diferric-Yo cofactor
A solution ofH'sY2 -Y 4 heterodimer (typically 500 1, 40-50 pM) was placed in a pear
shaped flask (50 mL) in an ice-water bath. The solution was deoxygenated on a Schlenk line by
repeated cycles (>6 times) of evacuation followed by flushing with argon. During evacuation,
great care was taken to monitor the protein solution to avoid excessive bubbling, which can lead
to protein precipitation, by exposing the solution to the vacuum for very short periods of time.
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The stopcock of the pear shaped flask was quickly turned in -180' rotations (from a closed
position to a closed position) so that the flask containing protein was only open to the vacuum
for less than a second. In general, this was done -5-10 times until the bubbling of the protein
solution came -1/3 of the way up the sides of the flask and then the solution was exposed to
argon. A small stir bar was included in the flask so the solution could be stirred in the presence
of argon for >10 min after each evacuation. This constituted one round of evacuation followed
by argon flushing. The deoxygenated protein solution was brought into the glove box (M.
Braun, Stratham, NH) and stored at 4°C until use (30 min - 1 h). A stock solution of 1 mM
FeSO4 was prepared in Buffer C. An aliquot of the iron stock solution was removed from the
box and the exact concentration of iron was determined by the ferrozine assay. The iron was
mixed with the heterodimer, with a stoichiometry of 3-4 eq of Fe per HisY2. The mixture was
incubated for 15 min at the box ambient temperature (-22°C). The protein was removed from
the box and oxygenated by the addition of oxygen saturated Buffer C (100 Rl for every mL of
protein solution). Excess iron was removed by passage through a Sephadex G-25 column.
Alternately, the holo-heterodimer was purified by metal affinity chromatography followed by a
Sephadex G-25 column to remove imidazole.
2.2.14 RNR Activity Assay
The standard assay contained the following components in a typical volume of 175 gtL:
0.3 gM of the RNR subunit being assayed, 3 FM of the complementary subunit, 3 mM ATP, 1
mM CDP ([14C]-CDP, SA=2000 cpm/nmol), 100 IAM E. coli TR, 1 p.M E. coli TRR, 2 mM
NADPH in 50 mM Hepes (pH 7.4), 20 mM MgCl2. All components except CDP were incubated
at 300C for 5 min. The reaction was initiated by the addition of CDP. Aliquots (30 pL) were
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removed over 20 min and quenched in a boiling water bath for 2 min. The pH was adjusted to
8.5 by the addition of 50 pL of 1 M Tris (pH 8.5). Deoxycytidine (dC, 0.5 Rmol) and alkaline
phosphatase (10U) were added and the reaction volume was adjusted to 500 j±L with water. The
dephosphorylation was allowed to proceed for 2 h at 37°C. The products were analyzed by the
method of Steeper and Steuart.(9) One unit is defined as 1 nmol of dCDP produced per min.
The specific activities of the small subunit are reported per mg of H"Y2.
2.3 Results and Discussion
2.3.1 Purification of Y1
Soluble Y1 can be expressed at high levels in the BL21(DE3) CodonPlus RIL cells if
IPTG is added after the cell culture is cooled to 15°C, as most of the Y1 remains in solution after
centrifugation (Figure 2.2, Lanes 3 and 4 are crude extract before and after centrifugation,
respectively). This requirement for low temperature during protein induction to obtain soluble
protein has been observed previously with numerous eukaryotic Rls including the mouse, herpes
simplex virus, vaccinia virus, A. thaliana and T. brucei.(10-15) Y1 is readily purified using the
protocol designed by Dr. Jie Ge, which includes a streptomycin sulfate precipitation, ammonium
sulfate fractionation and affinity chromatography with a dATP-Sepharose column. The Y1
obtained in a typical purification shown in Figure 2.2 is of comparable purity and quantity
routinely obtained. It is important to note that in this purification of Y1 the step in which the
dATP affinity column was washed with 1 mM ATP has been omitted.(2) This wash with a
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Figure 2.2 SDS-PAGE (10%) analysis of Y1 purification.
Lane 1, MW marker; Lane 2, re-suspended cell pellet, Lane 3, crude extract after French press,
Lane 4, crude extract after clarification by centrifugation; Lane 5, streptomycin sulfate
supernatant, Lane 6, ammonium sulfate supernatant; Lane 7, ammonium sulfate pellet, Lane 8,
dATP column wash; Lane 9, pure Y1 (-20 Rg).
relatively low concentration of ATP lead to elution of significant amounts of Y1 from the
affinity column, similar to results observed in the Y3 purification described below and the
observations of Chabes et al.(16) The Y1 purified was of comparable purity to the Y1
previously purified when this low concentration ATP wash was completed before Y1 was eluted.
In total, 390 mg of Y1 was obtained from 36 g of cell paste. Typically, Y1 has a specific activity
of 200-250 nmol-min-'-mg "' when assayed with a 10-fold excess of HLY2-Y4 heterodimer (0.2-
0.3 Y* per heterodimer, SA = 1500-1700 nmol-min-l 'mg').
An extinction coefficient was not calculated for Y1 because the Y purified with this
standard protocol has a ~,nx of 275 nm. This contaminating nucleotide or DNA could not be
removed by gel filtration or repeated dilution and concentration by ultrafiltration. Since higher
purity Y 1 was desired to aid crystallographic studies, anion exchange chromatography was
explored as a method to remove the A260-absorbing material and obtain Y1 of higher purity.
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Figure 2.3 Q-Sepharose purification of Y1.
Elution of Y1 from the Q-Sepharose column with a linear gradient from 0-350 mM NaCi (Left)
and SDS-PAGE (10%) analysis of Q-Sepharose purification of Y 1 (right) are shown. For elution
profile, The A280 and A260 values are plotted in red with a solid line and in blue with a dashed
line, respectively, and the salt gradient is shown in a solid green line. For SDS-PAGE, the lanes
contain: Lane 1, MW marker; Lane 2, Y1 before Q-Sepharose column (5 lg); Lane 3, Q-
Sepharose column flow through, Lane 4, Y1 after Q-Sepharose column (5 Rtg).
Y1 was chromatographed on a Q-Sepharose Fast Flow anion exchange column (Figure 2.3). The
elution of the Q-Sepharose column with a 0-350 mM NaCl gradient resulted in elution of two
distinct peaks. The first, centered at 150 mM NaCl, was Y1 as judged by SDS-PAGE of pooled
fractions 11-25 (Figure 2.3 Lane 4). The pooled protein fraction had a ;Lm of 278 nm. The
second was centered at 300 mM NaCl and was judged to contain the contaminating nucleotide or
DNA, as it had a X,, of 260 nm. Thus, this extra chromatographic step separates the
contaminating nucleotide or DNA from the protein, and serves to purify the Y 1 away from other
protein contaminants as well (Figure 2.3, compare lanes 2 and 4). The addition of an anion
exchange step, ideally before the dATP-Sepharose column, could be a useful change to the
standard Y1 purification protocol as the Y1 purified could be of higher purity. Furthermore,
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partial purification of Y1 before the affinity chromatography step would lead to conservation of
the dATP-Sepharose affinity resin, which decreases its binding capacity with each use when
crude extracts are loaded due to metabolic activities in the extracts.
1 2 3 4 5 6 kDa
Ii'
Figure 2.4 SDS-PAGE (10%) analysis of Y3 purification
Lane 1, crude lysate (25 gLg); Lane 2, streptomycin sulfate supernatant (25 pLg); Lane 3,
ammonium sulfate pellet after Sephadex G-25 column; Lane 4, dATP column flow through;
Lane 5, 1 mM ATP wash; Lane 6, pure Y3 (6.5 jpg).
2.3.2 Purification of Y3
The standard purification of Y3 is analogous to the purification of Y1 described above.
The purification of the protein is followed by SDS-PAGE gel (10%). Soluble Y3 can be readily
overexpressed using the cold temperature induction method. However, numerous problems were
encountered in the purification of Y3. First, a significant amount of Y3 was eluted from the
dATP-Sepharose column during the wash with 1 mM ATP (Figure 2.4, Lane 5). As already
noted above, this has also been observed in the purification of Y1 and this step has been
eliminated from the standard Y1 purification procedure. Second, the Y3 began to precipitate out
of solution when concentrated above 1 mg/mL, possibly because ATP used to elute the Y3 from
the column leads to formation of an aggregation state that is unstable and leads to precipitation of
Y3.(1 7, 18) Again, protein precipitation problems have also been encountered in the purification
of Y 1, though precipitation usually occurs when Y 1 is concentrated above 5 mg/mL and is not
routinely observed at the concentration of 1 mg/mL as seen for Y3. Finally, Y3 isolated using
this procedure was not of comparable purity to that observed for Y1 (Figure 2.4, Lane 6 and
Figure 2.2 Lane 9). To generate Y3 which could be purified using an alternate method to obtain
protein for crystallography and Western blotting studies, a hexa-histidine tagged Y3 was
constructed and purified, as discussed in the following section.
2.3.3 Purification of HbYl and HbY3
Hasy1 was previously reported to be poorly expressed, poorly bound to Talon metal
affinity column, and its isolation resulted in protein of low purity.(3) However, in the isolation
reported here, H"'Y1 is induced to quite a high level and the final product is pure with a decent
yield of 24 mg of >98% pure Hasy1 from 9g of cell paste (Figure 2.5). This yield is roughly 3-4
fold lower than yields typically obtained in standard purifications of Y 1 due to poor binding of
the his-tagged material to the metal affinity column, as discussed in the following paragraph.
Despite the low yield, this protein was >98% pure as assessed by SDS-PAGE analysis. HY1
had a specific activity of 225 nmol min' mg-', comparable to the typical specific activities of Y1
(without a tag), 200-250 nmol min'*lmg'l. If efficient binding of the his-tagged material could be
achieved, then this would be a practical method to isolate large quantities of very pure Y1.
Furthermore, the construct contains a thrombin cleavage site between the His-tag and the N-
terminus of Y1. Therefore, the His-tag could be readily removed after purification if desired, but
this has not yet been attempted with HisyI.
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Figure 2.5 SDS-PAGE (10%) analysis of HbYl purification.
Lane 1, MW marker; Lane 2, total extract from 100 tl culture before induction; Lane 3, total
extract from 100 •l cells after induction; Lane 4, 1 jtg Hisy 1; Lane 5, 2 pg H"'Y1 ; Lane 6, 10 pg
H"Y1; Lane 7, 20 pg His1.
Hisy 1 can be isolated with the Talon metal affinity resin although problems are
experienced getting the His-tagged material to bind efficiently to the column. These problems
have previously been observed by Dr. Jie Ge and Dr. Hiep-Hoa Nguyen who have reported
recoveries of •HY1 of 0.8 and 0.04 mg/g of cell paste, respectively.(3) The recoveries of Hiy 1
and H"Y 3 reported here are 2.7 mg/g cell paste and 7.2 mg/g of cell paste, respectively. Despite
the improved yields, the His-tagged material does not efficiently bind to nickel nitrilotriacetic
acid resin or Talon cobalt metal affinity resins. As seen in the SDS-PAGE analysis of the H"'Y 3
purification shown in Figure 2.6, lane 4 shows that a large amount ofH Y3 is seen in the column
flow through (Figure 2.6, Lane 4). The low efficiency of protein binding to the affinity matrix
lead us to discard this as a method for purifying large quantities of Y1. Recently, Dr. Allison
Ortigosa has optimized the purification of H"Y I by using a batch absorption method to bind the
His-tagged material to the column rather than flowing the extract through at a slow flow rate (Dr.
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Figure 2.6 SDS-PAGE (10%) analysis of the purification of Hsy3.
Lane 1, MW marker; Lane 2, total protein from 80 gl of induced cell culture; Lane 3, soluble cell
extract; Lane 4, metal affinity column flow through; Lane 5, purified HYi3 (20 Ctg).
Ortigosa, unpublished results). This new method leads to isolation of >90% o fHi Y1 in the
soluble extract and could be a useful method to purify large quantities of Y 1 without the addition
of ATP which could help studies of ATP induced oligomerization and allosteric regulation.
2.3.4 Purification of HLY 2 and HLS4.
HisY 2 was isolated using a standard protocol. However, expression of soluble Hiy 2 is
problematic. While a high level ofHi"Y 2 expression is reproducibly achieved with the
BL2 I1(DE3) CodonPlus RIL expression host, the amount that remains in the soluble fraction
varies (Figure 2.7, Lanes 1 and 2). Most likely, this variability comes from the temperature shift
from 37°C to 15°C over an hour, which is accomplished by air-cooling of the shaker flasks in the
incubator. Superior temperature control can be accomplished with the use of a fermentor, which
can achieve the same temperature shift in -10 min. Therefore, the standard purification protocol
of HY 2 presented here and in Jie Ge's Ph.D thesis should be amended to emphasize the
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importance of the superior temperature control that can be accomplished using the fermentor as
opposed to shaker flasks in an incubator.
Hi"Y4 can be obtained using a purification procedure analogous to the one used in the
preparation ofH" Y2. H"Y 4 is obtained in very large quantities and is >98% pure.
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Figure 2.7 SDS-PAGE (12%) analysis of •"Y2 purification.
Lanel, total protein from 1 pl of re-suspended cells before French press lysis; Lane 2, total
soluble protein in 1 jll of soluble crude extract (-15 jpg); Lane 3, Talon metal affinity column
flow through; Lane 4, 60 jag HiY 2 ; Lane 5, 10 tg Hi"Y2 ; Lane 6, 2 Hg isy2.
2.3.5 Purification ofHAy 4
Purification of HAy 4 was readily achieved utilizing the purification protocol for Y4,
consisting of two anion exchange columns (Figure 2.8). The HA-tag did not change the elution
profile of HAy 4, which eluted at 150 mM and 240 mM NaCl from the DEAE- and Q-Sepharose
columns, respectively. In the elution of the Q-Sepharose column, a problem was encountered
early in the gradient leading to the pre-mature application of a high salt buffer to the column
early in the gradient. Consequently some HAy 4 eluted in fractions 6-11. However, when this
problem was corrected, the elution ofHAy 4 proceeded as expected.
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Figure 2.8 Anion exchange column elution profiles from the purification of HAY4.
Elution of fAy4 from DEAE-Sepharose (Top) and Q-Sepharose (Bottom) columns. The HAY4
eluted from the DEAE-Sepharose column at 150 mM NaCl and fractions 28-43 were pooled.
HA4 eluted from the Q-Sepharose column at 240 mM NaCl and fractions 34-49 were pooled.
2.3.6 Purification of Se-Met Y4
Early crystallization trials in Prof. Amy Rosenzweig's laboratory were successful in
obtaining crystals of Y4. To aid phasing, a Se-Met Y4 was produced and purified. The
purification of Se-Met Y4 was carried our according to the standard Y4 purification except that a
minimal media containing Se-Met was used and DTT and EDTA were added to the purification
buffers to prevent oxidation of Se-Met. The protein eluted from the anion exchange columns as
a single well-defined peak at the expected salt concentrations of 150 mM and 240 mM for the
DEAE- and Q-Sepharose anion exchange columns, respectively.
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Since extremely pure Y4 was desired for crystallization trials, a fraction of the Se-Met
Y4 was chromatographed on a size exclusion column because the major impurities were of very
different molecular weight than Y4. Unfortunately, the protein eluted from the S-200 size
exclusion column contained a significant amount of proteolyzed material as the protease
inhibitor PMSF was not included in the buffer used to elute the protein from the column. The
proteolysis of R2 at the N- or C-teminus is a common problem. The observation that removal of
the protease inhibitor leads to extensive proteolysis of Y4 demonstrates that the standard
protocol used to purify Y4 does not remove the contaminating protease(s) and care must be taken
to ensure that Y4 (and Hw"Y2) are always stored in the presence of protease inhibitors to prevent
proteolysis during long-term storage at -80'C. Although this protein never crystallized, further
attempts to purify the full length Se-Met Y4 by anion exchange chromatography led to the
serendipitous discovery that Y4 homodimer is capable of exchanging its protomers as described
in the next chapter of this thesis.
2.3.7 Co-expression and co-purification of apo- and holo-XbY2-Y4
H'Y2-Y4 co-expression was first described by Thelander and co-workers who reported
that co-expression of Hsy 2 and Y4 by co-transformation of E. coli with their pET expression
plasmids gives heterodimer with 0.4 Y. per heterodimer and a specific activity as high as 2500
nmol-min4'mg'.(16) We achieved co-expression of H"Y 2-Y 4 by co-transforming the expression
plasmids pHisY2 and pY4J into the same expression host. Induction trials revealed that the cold
temperature induction protocol is required to obtain soluble heterodimer, as observed when HisY2
is induced in the absence of Y4. The induction level of H'Y2 was much lower than the induction
level of Y4. Since the affinity tag was on the Y2 subunit, this was not a problem as the extra Y4
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is washed away during purification of the heterodimer (Figure 2.9, Lane 1 and 2). Purification
was achieved using the procedure for isolation of HY2. An SDS-PAGE gel showing the elution
from the Talon column is shown in Figure 2.9.
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Figure 2.9 SDS-PAGE (12%) analysis of purification of HfY 2-Y4 after co-expression.
Lane 1, 100 ld cell culture before induction; Lane 2, 100 Il cell culture after induction; Lane 3,
soluble cell extract; Lane 4, metal affinity column flow through; Lane 5, pure co-expressed
HiY2-Y 4 (8 jig).
The specific activity of the holo co-expressed heterodimer isolated using this procedure
varied as summarized in Table 2.3. The first preparation of co-expressed heterodimer had
comparable Ye, iron content, and specific activity as the heterodimer generated by standard
methods, involving separate purification of H"Y2 and Y4, generation of the apo-heterodimer, in
vitro reconstitution of the cofactor and finally isolation of the holo-heterodimer. However, two
subsequent purifications of the co-expressed holo heterodimer gave substantially different
results. In one purification, all of the heterodimer precipitated out of solution before the specific
activity of the preparation could be measured. In the second purification, the heterodimer
remained soluble, though it had a 2-3 fold lower specific activity than that previously observed
for the co-expressed heterodimer. Subjection of the co-expressed heterodimer to in vitro
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reconstitution of the iron cluster did not result in an increase in the Yo content or the specific
activity of the protein.
Table 2.3 Summary of co-expression and purification of HbY2-Y4 heterodimer
Specific activity Iron content
(nmol'min'mg d') (Fe per heterodimer)
Co-expression of holo-""Y2-Y4 914 1.8
Co-expression of apo-H"Y2-Y4 334 1.0
(and following reconstitution with iron) (972) (not determined)
Co-expression of holo-HlsY2-Y4a 355 0.9
Co-isolation of apo- Hs"Y2-Y 4b 520 0.9
(and following reconstitution with iron) (1200) 1.8
aln vitro reconstitution of iron center did not yield any measurable increase in specific activity or
iron content
bHeterodimer made by mixing of cell pellet harboring over-expressed HiY 2 with cell pellet
harboring over-expressed Y4.
Possibly, these problems with reproducibility are due to our inability to control the
loading of iron into the heterodimer during co-expression. This problem has been observed with
the N-terminally His-tagged R2 from E. coli which is isolated with a much lower Ye content than
the wt-R2. With His-R2 from E. coli, this problem was resolved by isolation of the apo-protein
followed by in vitro reconstitution of the diferric-Y. cofactor.(19) Therefore, this approach was
used to purify apo- co-expressed-HY2-Y4 heterodimer. The apo protein is induced following
the addition of phenanthroline to the cell culture medium before the addition of IPTG and no iron
is added into the crude extract following cell lysis by the French press. Although no iron was
added, the "apo-" heterodimer isolated had a specific activity of 355 nmol min'l mg',
demonstrating that the apo-heterodimer must have picked up iron from the crude extracts or the
glassware. If this "apo" heterodimer was reconstituted with iron, the specific activity increased
100
to 970 nmol min'l mg1', which is comparable to the activity observed in the first preparation of
holo co-expressed heterodimer. It should be noted that this co-expression of the apo protein was
only done one time because of the low yield of protein, about 4-5 fold lower than observed with
expression of the holo heterodimer. The total cell yield is also lower than those typically
obtained because the addition of 1,10-phenanthroline inhibits cell growth. Therefore, the low
yield of cells in the growth and low yield of protein in the purification decrease the usefulness of
this method for obtaining large amounts of holo-heterodimer.
Alternately, the problem with reproducible co-expression could be linked to plasmid
compatibility and propagation issues. Both the pHisY2 and pY4J vectors are constructed with a
Novagen pET vector. Therefore, both plasmids contain the same replicon (ColE 1) and are
therefore considered "incompatible" as the plasmids cannot stably co-exist in the same cell in the
absence of external pressure.(20, 21) Since the cells are grown in the presence of ampicillin and
kanamycin, there is external pressure to maintain both plasmids. However with each cell
division, the two plasmids are randomly partitioned meaning that after several cycles of division,
the population of'E. coli can be heterogeneous in terms of the ratio of pHisY2:pY4J found in
each cell. Dr. Jie Ge tried to overcome this problem by construction of a plasmid named
pHelperY4, which contained the compatible origin of replication, p 15A, contained in the plasmid
pACYC 184 (New England Biolabs). However, this plasmid is selected with the antibiotic
chloramphenicol which is required to maintain the plasmid harboring the rare tRNAs in the
BL21 (DE3) RIL CodonPlus expression host. Therefore, this plasmid could not be used in co-
expression studies with this host. Use of a regular BL21 expression host results in low levels of
roSY2 induction. In addition, the problems with reproducibility could also be related to problems
with soluble Hzsy2 expression already discussed.
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Figure 2.10 SDS-PAGE (12%) ofH Y2-Y 4 co-purification.
A) SDS-PAGE analysis of H"Y2 -Y 2 co-purification. Lane 1, total extract (soluble and insoluble
protein, -15 Ipg); Lane 2, soluble extract -15 Ig; Lane 3, Talon metal affinity column flow
through; Lane 4, 10 pg pure Hay2-Y4. B) SDS-PAGE of fractions from imidazole gradient
elution of the Talon metal affinity column.
A new method for purification of the heterodimer was explored which involved mixing
of crude extracts expressing H"Y 2 with extracts expressing Y4 in an attempt to overcome the
variability in HsY2 -Y 4 co-expression. Because H"Y2 cannot form the diferric-Y* cofactor in the
absence of Y4, the H"Y2 expressed in E. coli is an apo protein. Therefore, the purification of an
apo-H'Y2-Y4 heterodimer can be achieved in one chromatographic step if extracts separately
expressing HbY2 and Y4 are mixed and then the heterodimer isolated with a Talon metal affinity
column. HiY 2 and Y4 were separately overexpressed using standard protocols and the induction
levels were checked by SDS-PAGE (not shown). Based on estimation of induction levels by
Coomassie staining and concentrations of •"Y2 and Y4 typically obtained, the cell pellets were
mixed to obtain a 1:1 ratio of H"Y 2 :Y4 (Figure 2.10, lane 1). However, following cell lysis and
centrifugation, a considerable amount of HiY 2 did not remain in the soluble fraction (Figure
2.10, lane 2). Despite problems with the solubility of H•Y2 , a large amount of heterodimer (5
mg/g of cell paste) was obtained. An imidazole gradient (10-200 mM) was used to elute the
heterodimer from the column. At a concentration of -80 mM imidazole (Fraction 9, Figure 2.9
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right SDS-PAGE gel), the heterodimer began to elute from the column. Even though no iron
was added during the purification, the HbY2-Y4 heterodimer had 0.9 irons per heterodimer, a
specific activity of 520 nmol min. mg-1 and 0.1 Yo per heterodimer. The iron content and
specific activity were increased by the addition of ferrous iron and oxygen to yield heterodimer
with twice as much activity, iron and radical content. This heterodimer had activity comparable
to heterodimer generated by separate isolation of H"Y2 and Y4 followed by generation of the
heterodimer and in vitro reconstitution of the cofactor.
2.4 Conclusions
Standard purifications for Y1, HY2, Y3 and Y4 are reported here with minor
modifications to the purification strategies established by Dr. Jie Ge. The purifications of t"Yl
and HiY 3 were not previously reported. The method used to purify these proteins was based on
the protocol used to purify HbiY2. However low affinity of the His-tagged proteins, Hiy1 and
'"Y3, for the Talon metal affinity resin was observed.
The most important results presented in this chapter involve the co-expression and
purification of the HisY2-Y 4 heterodimer. It was hoped that this method would yield a higher Ye
content, but the Ye content, iron content and specific activity of the co-expressed heterodimer
were similar to that observed when H"Y2 and Y4 are expressed separately and the diferric-Y
cofactor is then reconstituted in the apo-heterodimer. However, variability in the specific
activity and stability of the heterodimer isolated after co-expression is observed. Thelander and
co-workers reported isolation of heterodimer using similar methods with 0.4 Ye and a maximal
specific activity of 2500 nmol min' mg-1. Their construct has a different Y2 His tag
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(MHHHHHHM-Y2) than our construct (MGSSHHHHHHSSGLVPRGSHM-Y2). Furthermore,
expression of soluble heterodimer did not require lowering of the cell culture temperature before
induction with IPTG. Thelander and co-workers do not comment if they observed any
variability in the specific activity of the heterodimer they isolated. Similar to what we observe,
they do not isolate heterodimer with stoichiometric amounts of Y.
The problem of sub-stoichiometric amounts of Ye associated with R2 is not unique to the
yeast system. R2 from numerous sources has been expressed, purified, and the cofactor has been
reconstituted. In general, low levels of Ye and iron incorporation are observed.(10, 22-27)
These difficulties in reconstitution of the diferric-Y. cofactor lead us to determine the Ye content
in vivo, as discussed in chapter 5 of this thesis.
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Chapter 3
Early work to understand Y2Y4 heterodimer formation
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3.1 Introduction
Our work to understand the active form of the yeast ribonucleotide reductase has been a
very challenging problem. Thus, these studies have required a large degree of collaboration
between members of the Stubbe Laboratory(1, 2) and between our laboratory and the
laboratories of Prof. Robert Griffin (high field EPR studies of Y., MIT),(1, 3) Prof. Amy
Rosenzweig (structural studies of Y2Y4 heterodimer formation, Northwestern University),(4, 5)
and Prof. Mingxia Huang (immunolocalization and affinity purification of the R2 subunit,
University of Colorado Health Sciences Center).(6) Thus, this chapter contains a summary of
this early work and with an emphasis on the conclusions that inspired the work described in the
next chapters, specifically the contributions made by myself which helped us to form these
hypotheses. For experimental details, refer to the appendices where our published work on this
project are collected.
3.2 Y4 is required to assemble the diferric-Y cofactor of Y2
As the first step, each subunit of ribonucleotide reductase from S. cerevisiae was
expressed in E. coli and purified.(2, 7) However, the Ye cofactor of Y2, expressed as the wt or
the N-terminally His-tagged version (HuY2), could not be reconstituted using standard methods
used in the reconstitution of E. coli R2 in our laboratory. Without Y2 containing cofactor the
yeast reductase proteins could not be assayed for enzymatic activity. Thus, all of the yeast RNR
proteins were expressed in and purified from S. cerevisiae. The HwY2 expressed in yeast
(H'Y2 sc) had a low specific activity of 120 nmol'min' mg '1 , which allowed for assay of the yeast
RNR NDP reduction for the first time in vitro.
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Figure 3.1 Y4 co-purifies with H"Y2s.
Y4 and Hi'Y2s were run on SDS-PAGE (12%) and transferred to PVDF. The PVDF membrane
was stained by Coomassie blue (left) or PVDF membrane with identical samples was probed
with anit-Y4 antibodies by Western blotting (right). A band that cross-reacts with the Y4
antibody is present in H"Y2sc. Figure adapted from Ref (2).
During my efforts to optimize a Western blotting protocol, I serendipitously discovered
that Y4 co-purifies with HsY2sc (Figure 3.1). This was our first indication that Y2 and Y4 could
form a complex in vivo. Though it had been previously reported that if over-expressed, epitope
tagged could be immunoprecipitated, our discovery that HLY2s, forms a complex with yeast's
endogenous Y4 peaked our interest in this protein-protein interaction.(8) Thus, we went on to
show that Y4 was required for assembly of the diferric-Y* of Y2.(2)
3.3 Y4 is required in stoichiometric amounts in the activation of Y2
We noted striking similarities between what we observed with the Y2 and Y4 system and
the copper chaperone for superoxide dismutase (CCS) and Cu,Zn superoxide dismutase (SOD)
system, which lead us to propose that Y4 is a iron chaperone which could act catalytically in the
activation of Y2.(9-15)
We hypothesized that if Y4 was a catalytic iron chaperone then it must be capable of
exchanging its protomers. This demonstration was especially important as Chabes and co-
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workers had concluded that if expressed separately, Hs"Y2 and Y4 formed stable homodimers
which could only slowly exchange their protomers to form a heterodimer.(16) To demonstrate
that Y4 can exchange its protomers, we took advantage of the fact that a version of Y4 (Se-met
Y4, described in the previous chapter) had been isolated which contained a mixture of full-length
and proteolyzed Y4 polypeptides. The proteolysis was determined to occur at the C-terminal tail
through the use of ESI/MS. Since this tail contains several negatively charged residues, we
chose to use anion exchange to separate the full length and proteolyzed material.(l) When this
mixture was chromatographed, three species were isolated, a full length Y4 homodimer, a
proteolyzed Y4 homodimer and a "heterodimer" of one full length Y4 protomer and one
proteolyzed Y4 protomer (Figure 3.2, A and B). This "heterodimer" was then re-
chromatographed and again, three species were observed (Figure 3.2C). Thus, the "heterodimer"
is capable of exchanging its protomer. These results supported our hypothesis that Y4 could be
an iron chaperone for Y2 and served as the inspiration for the in vitro exchange experiments of
heterodimer formation presented in the next chapter of this thesis.
While our work with the Se-met Y4 supported our iron chaperone hypothesis, the results
from numerous other experiments did not. For example, we reasoned that if Y4 was required
only transiently in the activation of Y2, its in vivo concentration would be lower than the
concentration of Y2. The concentrations of Y2 and Y4 were measured by quantitative Western
blotting. These experiments demonstrated that Y2 and Y4 were present at roughly equal
concentrations in vivo (Figure 3.3). Furthermore, Jie Ge demonstrated the Y4 was required in
stoichiometric amounts to achieve maximal Y2 activity in vitro.(1) Thus, these results did not
support our hypothesis that Y4 acted catalytically in the activation of Y2.
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Figure 3.2 Demonstration of the ability of Y4 protomers to reorganize.
A) SDS-PAGE (12%) analysis of anion exchange chromatography of the fractions collected in
the chromatogram shown in B. Lane 1, standards of full length and clipped Se-met Y4; Lane 2-4
represent the proteins found in peaks a, b, and c in the chromatogram in part B. B) Anion
exchange chromatography of Se-met Y4 that was a mixture of full length and clipped material.
C) Anion exchange chromatography of peak b in part B demonstrating that the heterodimer
composed of full length and clipped Se-met Y4 can re-organize. Figure adapted from Ref (1).
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Figure 3.3 Quantitative Western blots to measure the concentration of Y2 and Y4 in vivo
Typical quantitative western blots for Y2 (left) and Y4 (right). The amount of pure HLY 2 and Y4
used to generate the standard curve and the amount of crude extract (shown is PS0799 crude
extract) is indicated above each lane.
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While this work was ongoing, Chabes and co-workers published a paper proposing that
Y4 was required in stoichiometric amounts to correctly fold Y2. They observed that HsY 2 had
significantly less alpha helical character than Y4 or the HiY 2 -Y 4 heterodimer, as assessed by
circular dichroism (CD). (16) Furthermore, their Hi"Y2 could not be chromatographed by anion
exchange chromatography and was inactive in a nucleotide reduction assay. In contrast, co-
expression of Hi"Y 2 and Y4 resulted in isolation of a heterodimer, which had 0.4 Y. per
heterodimer and a specific activity as high as 2500 nmol-min-'-mg-'. They concluded from these
experiments that Y2 cannot fold in the absence of Y4 and thus the role of Y4 is to act as a
stoichiometric folding chaperone of Y2.
We sought to reproduce their results as a first step towards testing this proposed
hypothesis. The heterodimer was co-expressed as described in the previous chapter. This co-
expressed heterodimer could have a specific activity similar to the activity obtained when the Y.
cofactor was reconstituted in a heterodimer formed from HisY 2 and Y4 homodimers which had
been expressed and purified separately.(l) Furthermore, CD experiments completed in
collaboration with Jie Ge demonstrated that Hw"Y2, Y4, the heterodimer formed by mixing the
homodimers and the heterodimer formed by co-expression of H"Y2 and Y4, all had a significant
amount of alpha helical character.(1) Thus, our observations were not consistent with those of
Chabes et al. and they did not support the hypothesis that Y2 could not fold in the absence of Y4.
3.4 Structural studies of HY 2 , Y4 and the HlY2-Y 4 heterodimer
The structures of H"Y2 , Y4 and the HiY2-Y4 heterodimer have been solved by members
of Prof. Amy Rosenzweig's laboratory (Table 3.1).(4, 5) Comparisons of these structures led to
the proposal that the role of Y4 was to stabilize a local conformation of Y2 that allow for iron
112
binding.(4) This conclusion was drawn because helix aB, containing the Fe ligand Asp 145,
could not be modeled in the Y2 homodimer structure. However, this helix becomes ordered in
the heterodimer (Figure 3.4). Interestingly, this same helix of Y4 is not ordered in the H'IY2-Y4
heterodimer but it is ordered in the Y4 homodimer structure (Table 3.2). While it is difficult to
draw strong conclusions from these data due to the low pH used for HisY 2 and HsY2-Y4
crystallization, it is interesting to note that recently published crystal structures of the mouse R2,
in the diferric and diferrous state at pH 6 also showed structural flexibility in this region.(17)
The mouse R2 Fe ligands Asp139 and Glu267, analogous to Y2's Asp145 and Glu273, also have
high B factors. When the two structures of diferrous mouse R2 are superimposed, Asp 139
shows the greatest structural flexibility. When taken together with the data acquired with R2
homologues, these small changes in HY 2 conformation in the homodimer and the heterodimer
are mechanistically informative and allow us to begin to understand the structural changes that
influence iron binding.
Table 3.1 Summary of yeast RNR small subunit structures
Chain Residues Observed a Crystallization Resolution Metal bound
length a pH at active site
Y2 399 26-144, 150-357 -5 3.15 A
(one protomer is missing
58-68)
Y4 345 3-305, 315-325 7.5 3.1 A --
HsY2-Y4: 5.3 2.8 A
Hisy 2 399 26-359 Zn2+ in Fe2
site
Y4 345 11-90, 100-263,275-295
a Numbering from the start of the Y2 sequence, not from the N-terminal His-tag
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Y2 in His-Y2-Y4 heterodimer
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Y2 in His-Y2 homodimer
Y4 in His-Y2Y4 heterodimer Y4 in Y4 homodimer
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Figure 3.4 The iron binding site of yeast RNR.
The ribbon diagram of H'y 2 in the homodimer, H"Y 2 in the heterodimer, Y4 in the heterodimer
and Y4 in the homodimer are shown in A, B, C, and D, respectively. The ribbon is colored from
blue to red from the N- to C-terminus. Below each ribbon representation, a close-up view of the
iron binding/active site region is shown. Regions that were disordered are represented as dashed
lines.
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Table 3.2 Conservation of residues involved in formation of the diferric-Y. cofactor and
electron transfer
Function Y2 Y4a E. coli R2
Iron ligands D145 D93 D84
E176 E124 E115
H179 Y127 H118
E239 E186 E204
E273 R220 E238
H276 Y223 H241
Yo Y183 Y131 Y122
ET W108 W57 W48
D272 D219 D237
Y376 Y323 Y356
a Amino acids not conserved in Y4 are in bold.
To understand more about these structural changes are influenced by formation of the
heterodimer, the interfaces of the homodimers and the heterodimer were compared. Most of the
interactions formed at the dimer interface are the same in the heterodimer and the homodimers.
The center of the interface is formed by a hydrophobic core composed of two Phe and a Met
(Table 3.3). Moving outward from this core, numerous Glu and Lys form salt bridges across the
dimer interface. Overall, the dimeric interfaces are quite similar and the only significantly
different interactions found involved a loop at the outer edge of the dimer interface that connects
a3 with aA (in yellow Figure 3.5).
Figure 3.5 Ribbon representations yeast RNR small subunit structures. (Opposite page)
The Y4 dimer (top), nUY2-Y4 heterodimer (middle), and H"Y2 dimer are shown. The Y4
polypeptides are rendered in blue and the H"Y2 polypeptides are rendered in red and orange. The
Zn found at the Fe2 site in the H"Y2-Y4 heterodimer is shown as an orange sphere. The key loop
proposed to control the relative stability of the dimers is rendered in yellow. The regions not
visible in the electron density are represented by dashed lines. Figure adapted from Ref. (7).
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Table 3.3 Key residues at yeast RNR small subunit dimer interface a
Y2 Y4
Hydrophobic core F107 F56
F171 F119
M174 M122
Salt bridge K101 K50
Elll E60
E181 E129
E104 E53
E150 K98
Loop at interface T86 F35
E84 R33
R85 R34
Interacts with loop F201 F148
H205 A152
N202 K149
E164 E112
E154 E102
aAmino acids not conserved between Y2 and Y4 are in bold
The key loop (yellow, Figure 3.5) has Phe35 and Thr86 at its tip in Y4 and Y2,
respectively. In the Y4 homodimer, Phe35 packs against Lys98 (Figure 3.6). Interestingly,
Lys98 is on helix aB, the same helix described above that becomes disordered upon formation of
the heterodimer, thus linking changes at the Fe binding site to interactions at the dimer interface.
Upon formation of the heterodimer, Phe35 moves -8.5 A and in the heterodimer, it forms a
packing interaction with Phe201 of Y2 (Figure 3.6).
In Y2, Thr86 is at the tip of this key loop. This residue cannot form the same kind of
interactions as Phe thus explaining why the Y2 homdimer is not as stable as the Y4 heterodimer.
The importance of the residues in dimer stability is supported by the observation that most
eukaryotic R2s also contain a Phe in this loop (Figure 3.6 B). However, numerous yeast species
very similar to S. cerevisiae have been sequenced and 6 of the 7 Y2 homologues have a small
polar amino acid, Ser, Thr or His, at this position while all of the Y4 homologues have a
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Figure 3.6 Comparison of the dimer interface
heterodimer.
84
33
84
33
84
33
84
35
52
33
84
33
84
15
87
105
84
74
78
70
15
79
75
82
ERTVLFPI
RRFVMFPI
NRTVLFPI
RRFVMFPI
ERSCLFPI
RRFVMFPI
DRHTLFPI
HRFVMFPI
ERTVLFPI
RRFVMFPI
ERTVLFPI
RRFVMFPI
DRLTLFPI
RRFVMFPI
RRFVLFPI
RRFVLFPI
RRFVLFPI
HRFVLFPI
RRFVIFPI
NRFVI FPI
DRFCMFPI
RRFVVFPI
HRFVIFP I
RRFVIFPI
of the Y4 homodimer and the Y2Y4
The dimer interfaces of the Hi'Y2-Y4 heterodimer (A) and the Y4 homodimer (B) are shown.
The H1 Y2 ribbon is rendered in red while Y4 is rendered in blue. The amino acids at the dimer
interface are shown as sticks. The specific interactions made by Phe35 of Y4 in the heterodimer
and the homodimer are highlighted. Sequence alignment of the loop connecting a3 and aA from
many eukaryotic R2s is shown in part C. The amino acids corresponding to Phe35 are boxed in
yellow.
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Phe. Most interesting is that the yeast Saccharomyces Kluyveri, which does not have a Y4
homolog, has a Phe at the tip of this loop.(l8, 19) Together, these results predict that the loop
connecting a3 and aA is responsible for the specificity and relative stability of the yeast Y2 and
'Y4 homodimers and the heterodimer.
3.5 Conclusions
The work described here laid the groundwork for the experiments described in the
following chapters. In the next chapter, the relative stability of the Y2 and Y4 homodimers and
the heterodimer are examined. The role of Y4 in vivo is examined to test the three proposed
models for the role of Y4. Finally, building upon the quantitative Western blotting experiments
described here, the yeast reductase system is characterized by quantitative Western blotting,
whole cell EPR and RNR activity assays with partially purified extracts.
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Chapter 4
In vitro and in vivo studies of Y2Y4 heterodimer formation
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4.1 Introduction
The previous chapters described the protein purification strategies utilized to obtain large
quantities of RNR subunits and our initial in vitro studies of Y2Y4 heterodimer formation. The
experiments presented here summarize our efforts understand stability of the Y2Y4 heterodimer
and the role of Y4 in the formation of the Y2 cofactor.
Our discovery that, when expressed in S. cerevisiae, H'"Y2 co-purifies with a small
amount of Y4 and our demonstration that Y4 was needed to assemble the diferric tyrosyl radical
of Y2 lead to the model that Y4 is an iron chaperone protein, which could act catalytically in the
activation of Y2.(1) However, further work demonstrated that a 1:1 ratio of Y2 to Y4 is required
to obtain protein with maximal activity in nucleotide reduction and that the heterodimer between
Y2 and Y4 is stable.(2) Additionally, experiments to demonstrate Fe2+ or Fe3+ binding to Y4
have not been successful.(2) These results did not support our hypothesis that Y4 is a catalytic
iron chaperone for Y2.
Thelander and co-workers have proposed that Y4 is a stoichiometric folding chaperone
which must be co-translated with Y2 to form a folded heterodimer.(3) This conclusion was
based on their observation that mixing of HZY2 and Y4 homodimers for 10 min at 30°C in the
presence of iron, DTT and oxygen resulted in reconstitution of 2% of the activity observed with
the HLY2-Y4 co-expressed heterodimer.(3) Based on this result and their observation that HsY2
showed significantly less helical character as accessed by circular dichroism (CD) and that they
were unable to chromatograph this protein on an anion exchange column, Chabes and co-
workers concluded that a soluble, folded Y2 could not be isolated unless it was heterologously
co-expressed with Y4 in Escherichia coli, generating a heterodimer active in nucleotide
reduction. This proposal is not consistent with our observation that a hexa-histidine tagged
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version of the Y2 protein (HisY2) can be heterologously expressed and purified in the absence of
Y4.(2) Furthermore, a crystal structure of the apo-HisY2 homodimer has been solved revealing
that it is folded and structurally homologous to other R2s.(4) These results argue against the co-
translational folding chaperone hypothesis. Thus, the biochemical evidence to date is
inconsistent with the proposed roles for Y4. Furthermore, neither proposal explains the viability
of Rnr4A strains which cannot form a Y2Y4 heterodimer.
As discussed in the previous chapter, our structural studies of yeast R2 completed in
collaboration with Prof. Amy Rosenzweig and co-workers have led to the proposal of a new
model for the role of Y4.(4, 5) Comparison of the crystal structures of apo-H'sY2 and Y4
homodimers and the partially Zn loaded HisY 2-Y 4 heterodimer has lead to a model in which the
role of Y4 is to stabilize local conformations of Y2 which promote iron binding.
Many of the experiments described in this chapter were designed to understand the roles
of Y4 in the activation of Y2 in vitro. This work includes investigations of the relative stabilities
of the Y2 and Y4 homodimers and the heterodimer, the rate of interconversion of the
homodimers to form the heterodimer and the role of the diferric-Yo plays in controlling subunit
stability.
4.2 Materials and Methods
4.2.1 Materials
Talon cobalt metal affinity resin was obtained from Clonetch (part of BD Biosciences,
San Diego, CA). Costar Spin-X microcentrifuge filter tubes with 0.45 FtM cellulose acetate
filters were obtained from Coming (Acton, MA) and all references in the following text to a
"spin filter" or "microcentrifuge filter tube" are referring to the use of this particular product.
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Polyclonal antibodies (Abs) were raised against the soluble RNR subunits, Y1, H'y2, Y3, and
Y4 by Covance Research Products, Inc (Denver, PA).(1) Horseradish peroxidase linked goat
anti-rabbit secondary Abs were purchased from Amersham Biosciences (part of GE Healthcare,
Piscataway, NJ). Biotinylated thrombin and Streptavidin Agarose were obtained from Novagen
(part of EMD Biosciences, San Diego, CA). Amicon ultra YM30 centrifugal devices were
purchased from Millipore (Bedford, MA). PVDF membrane, gradient (5-15%) SDS-PAGE gels,
and silver stain kit was obtained from Bio-Rad (Hercules, CA). Bradford reagent, Anti-Myc
agarose, Anti-HA agarose, Anti-FLAG agarose, 3xFLAG peptide, HA peptide and all other
reagents were obtained from Sigma-Aldrich.
4.2.2 General methods
All RNR proteins were purified as described in chapter 2.(1, 2, 6) The concentration of
HiSY2, Y4 and the H'Y2-Y4 heterodimer were determined using the known extinction
coefficients (280-310) for H"sY 2 (105,600 Ml'cm), Y4 (94,000 M lcm') and HiY2-Y 4 (99,800 M-
Icn'm).(2) The protein concentration for Y1, Y3 and crude extracts were determined by Bradford
assay with BSA as the standard. RNR activity assays were carried out as described in chapter 2
and in previous reports.(1, 2) Iron content was determined by the ferrozine assay.(7)
4.2.3 Differential Scanning Calorimetry (DSC)
Stock solutions of HLY 2 (84 AM) and Y4 (110 IM) were diluted with 50 mM Hepes (pH
7.6), 100 mM NaCl, 5% glycerol (DSC buffer) to final concentrations of 5.2 M for Hi"Y2 and
1.5 FM for Y4. The apo-H'"Y2-Y4 (40 FM) was exchanged into the same buffer by dialysis
(Slide-a-lyzer, 30 kDa MWCO, overnight at 4'C). The dialyzed heterodimer was then diluted
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into the DSC buffer to a final concentration of 4.2 ItM. All buffer and protein solutions were
passed through a 0.2 tm syringe fitted filter and degassed for 5 min using a ThermoVac
(Microcal) at the starting temperature of 10 °C while stirring with a small magnetic stir bar. The
DSC experiments were performed with a VP-DSC microcalorimeter (Microcal) equipped with
matching sample and reference cells (0.52 mL for each). Experiments were performed at a scan
rate of 90C'C for Y4 or 60 C/h for Hi"Y2 and HsY2 -Y4 . A pre-scan equilibration period of 15
min was applied to allow the temperatures in the sample and reference cells to stabilize. The
scans were collected using a passive feedback mode and a filtering period of 16 or 8 sec for Y4
or HsY 2 and HisY 2 -Y 4, respectively. A buffer only sample was acquired under conditions
identical to those used to collect the data on the unfolding of yeast R2s. The buffer-only melting
curve was subtracted from the corresponding melting curve containing protein using the program
Origin supplied by Microcal. No other data manipulation or analysis was completed with these
clatasets as the irreversible nature of the Y2 and Y4 unfolding prohibits acquisition of meaningful
quantitative information about the unfolding thermodynamics. The reported Tm values
correspond to the temperature at the peak of the melting curve and were not obtained by curve
fitting algorithms but by visual inspection of the melting curves.
4.2.4 Rate of heterodimer formation from HiY 2 and Y4 homodimers
H'sY2 was diluted into 25 mM Hepes (pH 7.4), 10% glycerol, 100 mM NaCl, 1 mg/mL
BSA (Buffer A) to a final volume of 900 [tL and a concentration of 1.1 ItM. This solution was
pre-incubated at 25 °C for 5 min. The exchange reaction was initiated by the addition of 100 tL
the Y4 from a 10 [tM stock in Buffer A that had also been pre-equilibrated at 25 °C. The final
concentration of HsY2 and Y4 was 1 FtM. Aliquots (75 L) were removed and passed through a
127
100 tL of Talon metal affinity resin. Immediately after the protein solution soaked into the
column (-5 sec), the column was washed with 3 mL of Buffer A without BSA. The bound
protein was eluted with 300 !xL of 300 mM imidazole in Buffer A without BSA. The eluted
protein was diluted with 5x Laemmli (4 parts eluted protein with 1 part 5x Laemmli ) and was
directly analyzed by 12% SDS-PAGE. Coomassie stained bands were quantified by comparison
to a standard curve of H'sy2 and Y4 (0.1-1 !xg) using a ChemiDoc XRS with the QuantityOne
software (BioRad).
4.2.5 Apo-H4Y2-Y4 exchange with HAY4
H"'Y2 and Y4 were mixed at 25 'C for 15 min to generate the apo- H"'Y2 -Y 4 heterodimer
at a concentration of 1.33 FM in a final volume of 750 p.L of 50 mM Hepes (pH 7.4), 50 mM
KC1, 100 mM NaCl, 10 % glycerol (Buffer B). The exchange reaction was initiated by the
addition of HAy4 to a final concentration of 1 FM from a concentrated stock solution also pre-
incubated at 25 C. Aliquots (120 pL) were removed and incubated with 25 jiL of Talon resin in
a spin filter microcentrifuge tube with gentle mixing for 1 min. The unbound protein was
removed by centrifugation at room temperature at 700 xg for 2 min and the column was washed
with 3 mL of Buffer B in six 500 VL aliquots. This washing step consisted of addition of 500 f4L
of Buffer B, mixing by inversion several times to resuspend the resin and a centrifugation for 1
min at 2,500 rpm. The bound protein was eluted from the resin with 60 gL 25 mM HEPES (pH
7.4), 25 mM KCl, 50 mM NaC1, 500 mM imidazole, 5 % glycerol. The eluted protein was
diluted with 5x Laemmli (1 part 5x Laemmli and 4 parts eluted protein) and analyzed directly on
a 12% SDS-PAGE gel.
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4.2.6 Thrombin cleavage of His-tag from holo- HIY2-Y4
Holo- Hisy2-Y4 (3.4 mg) was mixed with 3 U biotinylated thrombin for 1 h on ice in
Buffer B. The holo- H"Y2-Y4 has a specific activity of 2000 nmole min' mg', 0.3 Ye per
heterodimer and 1.3 irons per heterodimer. The thrombin was removed by incubation with
Steptavidin Agarose (250 jIL of a 1:1 slurry of agarose in storage buffer as supplied by
manufacturer meaning the resin is supplied by the manufacturer as a slurry with 1 mL of resin in
aL total volume of 2 mL) for 30 min on ice with periodic gentle mixing. The mixture was
transferred to a spin filter microcentrifuge tube and the resin-bound protease was separated from
the Y2-Y4 by centrifugation at 700 xg, 1 min at room temperature. The Y2Y4 was incubated
with 250 pL of Talon resin to remove the cleaved His-tag and any remaining HY 2 -Y4
heterodimer. The mixture was transferred to a spin filter tube and the Talon resin was removed
by centrifugation at 700 xg, 1 min at room temperature.
4.2.7 Exchange of Holo-Y2Y4 with HisY2
H'"Y2 and holo-Y2Y4 (isolated in previous section) were mixed in Buffer B at a final
concentration of 1 tM and a final volume of 14 mL. A control reaction was carried out in
parallel which was treated exactly the same as the exchange experiment except that Hisy 2 was
omitted. This control allowed for correction for loss of iron, radical and activity associated with
protein loss during the extensive washing and concentration steps in the experiment. The
exchange reaction was incubated at 25 C for 2 h and the entire mixture was passed through a
750 gL Talon resin in a 10 mL CellThru disposable column (Clontech) by gravity flow (-1
nnL/min). The flow through and the first 2 mL of the wash with Buffer B were collected and
concentrated to less than 500 pL with an Amicon ultra YM30 centrifugal device. The column
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was washed with an additional 4 mL of Buffer B and the bound protein was eluted with 4 mL of
Buffer B with 200 mM imidazole. This elution buffer was made by mixing a 2x stock solution
of Buffer B with a 1 M stock solution of imidazole (pH 7) and water at the appropriate volumes
to obtain the desired concentrations of imidazole and buffer. The eluted protein was
concentrated to less than 500 FL with an Amicon ultra YM30centrifugal device. The
concentration of radical was determined by EPR The RNR activity was determined using the
standard yeast RNR activity assay utilizing Y1 with a specific activity of 200
nmolmin' mg'.(2)
4.2.8 EPR quantitation of Y, content
Two different spin standards were used for Ye determination. E. coli R2 was used to
generate a standard curve with Ye concentration ranging from 1-115 pM. The R2 protein
concentration was determined using the E280 131 mM'cm' l and the Ye content was determined by
the drop-line correction method.(8) The second spin standard was CuSO4 (1.022 mM, >99.99%
pure) in 2 M NaCIO4, 0.01 M HCl, 20% (v/v) glycerol. The concentration of Cu2+ was
determined using E810 11.79 mM1lcm'l.(9) Typically, HY2-Y4 samples used for EPR
quantitation had a protein concentration of about 10-30 pM.
EPR spectra were recorded using a Bruker ESP-300 X-band (9.4 GHz) spectrometer
equipped with an Oxford liquid helium cryostat to maintain the temperature at 30 K for all
samples. For Ye samples, typical instrument parameters were: centerfield, 3340 G; sweep width,
100 G; resolution, 2048 points; frequency, 9.38 GHz; modulation amplitude, 2.0 G; conversion
time, 81.920 ms; time constant, 40.960 ms; sweep time, 167.772 s; gain, 0.2-5xl05; scans, 3-30;
power, 0.201 or 2.526 x 10' 3 mW for the yeast and E. coli Ye, respectively. For copper standard
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typical instrument parameters were centerfield, 3000 G; sweep width, 1000 G; resolution, 2048
points; frequency, 9.38 GHz; modulation amplitude, 8.0 G; conversion time, 20.48 ms; time
constant, 5.120 ms; sweep time, 41.943 s; gain,lx104 ; scans, 3; power, 5.029x10'2 mW. Spin
cluantitation was carried out by double integration and comparison to standards of known spin
concentration after normalization for differences in collection parameters according to the
equation:
DInomi~d = (DI)(sweep width) 2
(mod. amp.)(conv. time)(gain)(# data points- 1)(# scans)(./power)
4.2.9 Yeast strains and plasmids used to demonstrate the presence of the Y2Y4 heterodimer
in vivo
The yeast plasmid pMH176 for expression of the galactose inducible 3x-Myc tagged Y4
(MCy 4 ) was provided by Prof. S. J. Elledge (Harvard Medical School).(10) The genotypes and
source of yeast strains are summarized in Table 4.1. MHY343 expresses an N-terminally Flag-
tagged Y2 integrated into the genome at the RNR2 locus. The "agY2 has the protein sequence -
MDYKDDDDKH-Y2. MHY346 expresses an N-terminally HA-tagged Y4 integrated into the
genome at the RNR4 locus.(l 1) The HAy4 has the protein sequence -
MPYPYDVPDYASLGGHM-Y4.
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Table 4.1 Yeast strains used in study of Y2Y4 heterodimer formation in vivo
Strain Genotype Ref.
BY4741 MATa, his3A1, leu2AO, metlSAO, ura3AO (12)
(S288c)
Rnr4A BY4741 rnr4::KAN (12)
MHY343 MATa, canl-100, ade2-1, his3-11,15, leu2-3,112, trpl-1, (11)
(W303) ura3-1, rnr2::FLAG-RNR2-Kan
MHY346 MATa, canl-100, ade2-1, his3-11,15, leu2-3,112, trpl-1, Prof. M. Huang
(W303) ura3-1, rnr4::HA-RNR4-Kan (UCHSC)
4.2.10 Evidence that Y2 and Y4 form a complex in vivo
Expression and purification ofS cY4 from the Rnr4 strain
The plasmid pMH176 was transformed into the Rnr4A strain using a standard
protocol.(13) The transformants were selected on Synthetic Complete medium without uracil
(SC minus uracil).(14) For expression of mCY4, the Rnr4A strain carrying the plasmid pMH176
was grown at 30'C in 2L of SC minus uracil medium with 2% raffinose as the carbon source
until the culture reached mid-log phase (~2 x 107 cells/mL). The production *Y4 was induced
with the addition of solid galactose to a final concentration of 2% and the cells were grown for
an additional 5 h at 30 °C. Cells were collected by centrifugation (7,500 xg 15 min) and washed
with 50 mL PBS containing 30% glycerol and stored at -80 C. The yield was 6.5 g from 2 L of
cell culture.
The cells (6.5g) were re-suspended in 20 mL 50 mM Hepes (pH 7.4), 1 mM EDTA, 100
mM NaCl, 10% glycerol (Buffer C) supplemented with 25 pg/mL aprotinin, 10 RM E-64, 0.4
mM AEBSF, 100 !tg/ml of pepstatin, 100 Rg/mL leupeptin, 100 !xg/mL chymostatin, 1 mM
benzamidine and 50 U DNaseI. All purification steps were carried out at 4 °C. Cells were lysed
by two passes through the French press at 14,000 psi and cell debris was removed by
centrifugation (30,000 xg, 30 min). The supernatant was passed through a column (1.5 mL) of
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Anti-Myc Agarose two times at a flow rate of 0.1-0.2 mL/min. The column was washed with 15
rnL Buffer C supplemented with a Complete protease inhibitor tablet. The protein was eluted
from the column by the addition of 5 mL of 100 mM ammonium hydroxide. The eluted protein
was collected in 1 mL fractions and 40 tL of each aliquot was analyzed by SDS-PAGE (5-15%
gradient gel) and stained with the Silver Stain Plus Kit according to manufacturer's instructions
(BioRad). The identity Y2 and MYy4 was confirmed by Western blotting utilizing Y2 or Y4
specific polyclonal Abs
Purification of N-terminally Flag-tagged Y2 and N-terminally HA-tagged Y4 with constructs
integrated into the genome
The yeast strains MHY343 and MHY346 for expression of FLGy 2 and HAy4,
respectively, were grown to mid-log phase (1-3 x107 cells/mL, doubling time 90 min) in YPD (2
L) at 30 C. Cells were collected by centrifugation (7,500 xg, 15 min), washed with 50-100 mL
of PBS with 30% glycerol and stored at -80 C. Typically 1-2 g of cell paste is obtained from a
2 L culture.
The protein purification was performed at 4 C. The cell pellets (1-2 g) were re-
suspended in Buffer C supplemented with protease inhibitors as described for the purification of
Ycy4, and 50 U DNaseI. For every g of cell paste, 10 mL of Buffer C was used. Cells were
lysed by two passes through the French press at 14,000 psi. Cell debris was removed by
centrifugation (30,000 xg, 45 min). The crude supernatant was passed through a 500 iL anti-
HiA or anti-FLAG agarose by gravity flow (-1 mL/min). Each column (0.7x-1.3cm) was
vvashed with 75 mL of Buffer C supplemented with a Complete protease inhibitor tablet by
gravity flow (-1 mL/min). The protein was eluted with 5 mL the 3x FLAG peptide solution
133
(100 pg/mL in Buffer C, Sigma-Aldrich catalog number F4799) or HA peptide solution (250
iig/mL in Buffer C, Sigma-Aldrich catalog number 12149). Both the 3xFLAG peptide and HA
peptide are purchased peptides from Sigma-Aldrich and they are sold by this company for use in
elution of epitope tagged proteins from Sigma-Aldrich's commercially available, antibody based
Anti-Flag or Anti-HA agarose affinity resins. As the "3x" in the name implies, the 3xFLAG
peptide consists of 3 tandem copies of the FLAG epitope. All of the eluted protein (5 mL) was
concentrated with an Amicon ultra YM30 centrifugation device. Protein was analyzed on a 12%
SDS-PAGE gel and stained with Coomassie. Protein identity was confirmed by Western blotting
with Y2 or Y4 specific polyclonal Abs.(l)
4.2.11 Co-immunoprecipitation of HAy 4 and Y2 from Rnr4A extracts
The BY4741 and Rnr4A strains were grown in 2 L YPD at 30'C to 2x107 cells/mL. All
of the following steps were performed at 4'C. Cell pellet (1 g) was resuspended with Buffer C
supplemented with protease and phosphatase inhibitors as described above for the purification of
FlagY2 and HAy4 . The cells were lysed by 3 passages through the French press, 14,000 psi. Cell
debris was removed by centrifugation at 30,000 xg for 30 min. The concentration of protein in
the extract was determined by Bradford assay with BSA as the standard.
Crude extract, 0.17-5.4 mg, was mixed with 8 pg (200 pmol) HAy4 in Buffer C (500pL
final volume of the mixture) and the mixture was incubated on ice for 30 min. A slurry of anti-
HA agarose [40 L; 1:1 slurry (1 part resin, 1 part buffer, (v/v)) is added so that the final volume
of resin added is -20 gL] was added and the mixture was incubated for an additional 45 min on
ice with periodic mixing (meaning the resin was resuspended by gentle inversion of a capped
microcentrifuge tube roughly every 5-10 min during the total 45 min incubation time). The resin
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was collected by centrifugation at 4'C, 700 xg for 5 min. The resin was washed two times with
500 F.L of Buffer C, meaning 500 pL of Buffer C was added to the resin pellet to resuspend it
and then the resin was again collected by centrifugation. The resin was transferred to a spin filter
tube where it was washed with an additional three aliquots (500 FL) of Buffer C. For each wash
step, 500 FL of Buffer C was added (the resin was resuspended by the addition of Buffer C) and
then the buffer was washed through the filter by centrifugation at 700xg for 1-2 min. The
protein was eluted with 60 gL of a low pH IgG elution buffer (Purchased from Pierce, exact
contents not disclosed by Pierce); diluted with 5x Laemmli (4 parts eluted protein with 1 part 5x
Laemmli) and was directly analyzed by SDS-PAGE (12%).
4.3 Results
4.3.1 The stability of H"Y2, Y4 and the heterodimer accessed by DSC (DSC)
Our CD and crystallographic studies revealed that HiY 2 (with N-terminal sequence
MGSSHHHHHHSSGLVPRGSHM-Y2) expressed in and isolated from E. coli is a soluble
folded protein.(1, 4) Thelander and co-workers have reported that their H'Y 2 construct (with N-
terminal sequence MHHHHHHM-Y2) was unable to fold correctly when expressed by itself in
E. coli as evidenced by poor expression of soluble protein and low recoveries in the attempted
purifications.(3) We believe differences in HY2 behavior are associated with differences in the
His-tag constructs.
We have further examined the stability ofHlsY2. Previously, we have shown that the
circular dichroism (CD) of HisY 2 is similar to the CD spectrum of Y4 and is predominantly
helical.(2) Comparison of the CD spectra of H"Y 2 upon dilution from 0.5 - 5.0 ,uM revealed a
loss in helical character as the protein concentration decreased.(6) Removal of the His-tag from
hisY2 using thrombin resulted in a large decrease in helical content, with a 30% change in the
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ellipticity value at 208 nm.(6) Reconstitution of Y2 (with the His-tag removed) with Y4, ferrous
iron and 02 generates a heterodimer with only 30-40% of the activity routinely obtained when
H"Y2 -Y 4 heterodimer is reconstituted.(6) We also have observed that when chromatographed on
DEAE- or Q-Sepharose Y2, with and without the His-tag, elutes in multiple broad peaks with
low recoveries.(6) These observations indicate that while our HY 2 is soluble and folded, it is an
unstable protein.
These findings are perhaps not surprising as in general, apo-R2s including the R2 of E.
coli, are considerably less stable than their cofactor assembled counterparts. To quantify the
relative stability, the efforts were made to measure the Tm of the H"Y2 and Y4 homodimers and
the apo- HaY2-Y4 heterodimer was determined using DSC.(6) The melting curves were acquired
at dilute concentrations and neutral pH (Figure 4.1). Unfortunately, the unfolding of these
proteins was followed by aggregation as indicated by a rapid decline in heat capacity at
temperatures >55 'C for HisY 2 and >750C for Y4.(6) The aggregation at temperatures > 60°C
prevented determination of the Tm of the apo- H'Y2-Y4 heterodimer, though it is clear from
comparison with the melting curves that the heterodimer unfolds at a higher temperature than
either of the homodimers. To obtain quantitative information about the thermodynamics of
unfolding, the unfolding must be reversible. Repeated scans of the same Y4 sample gave
irreproducible results demonstrating that the aggregation is irreversible, thus limiting the
Figure 4.1 The melting curves for HAY2, Y4 and the heterodimer. (next page)
A) The melting curves of 1.5 ptM Y4 solution in DSC buffer (50 mM Hepes (pH 7.6), 100 mM
NaCl, 5% glycerol). Three scans were acquired under identical conditions as described in
materials and methods. Figure adapted from Ref (6). B) The melting curves of 5.3 RlMH'SY2 in
DSC buffer. The scans were acquired under identical conditions as described in materials and
methods. Figure adapted from Ref (6). C) The melting curve of 4.2 M heterodimer in DSC
buffer and a buffer-only sample.
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information that can be obtained. The apparent Tins measured under similar conditions reflects
the relative stabilities of Hsy 2 , Y4 and Hs2-Y4. The Tm of Y2 at the peak of the melting curve
is about 30°C as compared to 500C for Y4 and >60°C for the heterodimer. These observations
suggest that Y2 might be one of a growing class of proteins that are partially unfolded in vivo.
Alternately, Y2 could be stabilized in vivo through binding to Y2 or folding chaperones.
4.3.2 In vitro studies of Y2Y4 heterodimer formation
A key unresolved issue with the yeast R2 is the mechanism of heterodimer formation in
vitro and in vivo. Our hypothesis is that the heterodimer can be generated from a Y2 homodimer
and a Y4 homodimer through a tetramer (Y22Y42) or through protomer (monomer) of Y2 and
Y4. Alternately, Thelander and co-workers have proposed that Y2Y4 can only be generated co-
translationally.(3) Our ability to isolate soluble, folded HY 2 has offered the chance to
investigate heterodimer formation from the HY 2 and Y4 homodimers. However, one important
caveat that must be kept in mind is that the Y2 homodimer cannot be isolated in its folded state
without the hexa-histidine tag and thus all the following experiments were carried out using this
affinity tagged material.
H'iY2 and Y4 homodimers rapidly re-organize to form the HiY2-Y4 heterodimer
To measure the rate of heterodimer formation, HY 2 and Y4 were mixed at low
micromolar concentrations similar to their concentration in vivo.(2) Aliquots were removed
from this mixture over 5 min (details of the time each aliquot was removed is shown in Figure
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Figure 4.2 SDS-PAGE and densitometry analysis of the rate of heterodimer formation.
A) SDS-PAGE of TALON column bound fraction. HL"Y2 and Y4 homodimers were mixed at a
final concentration of 1 p.M and incubated at 25 °C in buffer B. At the times (in seconds)
indicated above each lane, an aliquot was removed and subjected to metal affinity
chromatography. The bound protein consisting of H"Y 2 homodimer and/or HIY 2 -Y4
heterodimer was eluted with imidazole and analyzed by SDS-PAGE (12%). B) Densitometry
analysis of the SDS-PAGE gel shown in A. The intensity of each protein band was quantified by
comparison to a standard curve generated using known amounts of H"Y2 or Y4. The ratio of
"HY2:Y4 for each lane is plotted as a function of incubation time before separation of the
products by metal affinity chromatography. The dotted line represents the 1:1 ratio ofH "Y2 :Y4 .
4.2) and quickly passed through columns containing the Talon resin which efficiently binds the
His-tag of H"Y2, either in the H"Y 2 homodimer or the H"Y 2 -Y 4 heterodimer. Control
experiments in which only H"Y 2 was applied to the column and the flow through was checked
for the presence of protein were carried out to ensure that the binding capacity of the resin was
sufficient to quantitatively bind the HbY2. After washing the column to remove any Y4 that had
not exchanged to generate the HirY2 -Y 4 heterodimer, the bound protein was eluted with
imidazole and the products of exchange were directly analyzed by SDS-PAGE (HwY2 48 kDa;
Y4 40 kDa; Figure 4.2). To quantitate the extent of exchange, the ratio of HiY 2 :Y4 at each time
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point was analyzed by densitometry. Y4 rapidly forms a H'"Y2-Y 4 heterodimer as a band for Y4
can be seen within 10 sec of mixing the homodimers and the heterodimer quantitatively forms
within 2 min. These experiments demonstrate that the rate of heterodimer formation is
sufficiently fast to be physiologically relevant. However, one caveat that must be considered is
that the Y2 used in these experiments is modified by a His-tag.
Exchange of heterodimer to reform homodimers- apoH'XY2- Y4 exchanges with HAy4
To understand the stability of the heterodimer, exchange reactions were carried out to test
the ability of the heterodimer to undergo further exchange. HY 2 and Y4 homodimers were
mixed at a final concentration of 1 WlM and allowed to equilibrate to form the apo heterodimer.
An aliquot was removed from this mixture, passed through a metal affinity resin and eluted to
demonstrate that the HiY 2 -Y 4 heterodimer had quantitatively formed (Figure 4.3, Lane 1). HAy 4
(1 LM) was then added to the apo- H"Y2-Y4 heterodimer and the mixture was incubated for 2.5
h. Aliquots were removed over this period as indicated in Figure 4.3 and subjected to metal
affinity chromatography. Following washing and elution of the bound protein, the products of
the exchange reaction were analyzed by SDS-PAGE. A band for HAy 4 can be seen slowly
growing in over time indicating that the apo-heterodimer protomers are capable of undergoing
exchange. Interestingly, the rate at which the heterodimer exchanges its protomers is much
slower than the rate of H"Y2-Y4 heterodimer formation. After several hours of incubation, the
ratio of HAy 4 :Y4 is about 1:3. To ensure that the HA-tag on Y4 does not affect that stability of
the HsY2- HAy 4 heterodimer, a control experiment was completed in which HAy 4 and Y4 were
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Figure 4.3 Apo- H'3Y 2 -Y4 heterodimer can exchange its protomers.
Apo- H"•Y2-Y4 was mixed with the HAY4 homodimer with a ratio of 1:1:1 for HisY2:Y4: HAY4. A
cartoon of exchange components and expected products purified by Talon metal affinity
chromatography are shown in A. At the times indicated above each lane (in B), an aliquot was
removed from the mixture of apo- "HY2-Y4 and HAY4 and the products of the exchange were
isolated by metal affinity chromatography. The bound protein, containing a mixture of HsY2-Y4
that has not undergone any protomer exchange and HfaY2- HAY 4 heterodimer, was eluted and the
products were analyzed by SDS-PAGE (12%). For the lane marked control, the HAy 4 and Y4
homodimers were mixed before addition of H"Y2 homodimer to generate the heterodimer
mixture containing an equal concentration of HaY 2 -Y4 and HiY2-HAY4 heterodimers.
mixed together at equimolar concentrations before the addition of an equimolar amount of H"Y2.
If the HA-tag does not have an effect on the relative stability of the heterodimer then the HisY2-
Y4 and HiY2-HAY 4 heterodimer should be formed in equal amounts. This mixture was passed
through a Talon column to isolate any heterodimer that had formed during this exchange reaction
control. As seen in the last lane in Figure 4.3, the ratio of HAY4:Y4 in this isolated heterodimer
mixture is 1:1 demonstrating that the presence of the HA-tag does not affect heterodimer
formation. These results demonstrate that protomer exchange is possible in the apo- HiY 2 -Y4
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heterodimer. However, the slow rate of exchange when incubated at physiological
concentrations indicates that it is probably not physiologically relevant.
Exchange of heterodimer to reform homodimers - holo-H'Y2-Y4 exchange with H'sY2
Having demonstrated that the apo-heterodimer can exchange its protomers, we wanted to
determine if the holo-heterodimer also exchanges its protomers. Specifically, the following
experiment was designed to determine if a Y2 homodimer that contains the diferric-Yo cofactor
could be generated from an apo-XHY2 homodimer and a holo-Y2Y4 heterodimer (Figure 4.4).
To differentiate between Y2 originating from the Y2 homodimer and the Y2 in the Y2Y4
heterodimer, the His-tag was removed from a holo-HUY2-Y4 using thrombin. Therefore, Y2
originating from the apo-Y2 homodimer will have a His tag, and the Y2 originating from the
holo-heterodimer will not have an affinity tag. One caveat to this experiment is the holo-Y2Y4
heterodimer used contains 1.3 irons and 0.3 Yo per heterodimer due to our inability to completely
load iron and stoichiometrically assemble cofactor. Therefore, only 30% of the holo-Y2Y4 has
fully assembled diferric-Y° cofactor and the remaining 70% of the holo-Y2Y4 sample contains
apo-Y2Y4 or partially iron loaded heterodimer. The low protein concentrations used in this
experiment, which were required so the experiment could be carried out with physiologically
relevant concentrations, and the difficulties associated with the instability of H"Y2 , which were
discussed in Section 4.3.1, resulted in typical protein recoveries of -80% (Table 4.2). To control
for this loss an experiment was carried out in parallel in which the holo-Y2Y4 heterodimer was
subjected to the same conditions in the absence of HY2.
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Figure 4.4 Holo-Y2Y4 does not undergo any protomer re-organization.
A) Outline of exchange experiment and possible observed products: (1) holo-Y2Y4 heterodimer
exchanges with itself to generate a holo-Y2 homodimer that would be isolated in the flow
through fraction. (2) the holo-Y2Y4 heterodimer exchanges with HisY 2 to generate a holo- Hi"Y2 -
Y2 protein in the column bound fraction. (3) no exchange resulting in isolation of holo-Y2Y4 in
the flow through fraction and H"Y 2 homodimer in the bound fraction,. B) SDS-PAGE analysis
of the observed products present in the flow through (FT) and bound (B) fractions.
Table 4.2 Recovery of RNR activity, iron and Yo when He'Y 2 is mixed with holo-Y2Y4
heterodimer
Flow through fraction Bound fraction
Experiment" (control)b Experiment (control)
Activity 84% (79%) 1% (ND)c
Iron 76% (93%) 24% (19%)
Radical 86% (83%) 1% (ND)
The percent recovery of the activity, iron and radical present in the initial 14 nmol of Y2Y4
heterodimer added to the exchange experiment
b The control consisted of only the holo-Y2Y4 heterodimer in the absence of HiY 2 to control for
loss of activity, iron and radical due to loss of protein and not an exchange process.
c ND - none detected
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Three different outcomes are possible in this experiment and are illustrated in Figure
4.4A, 1-3. Part 1 describes the products expected if the holo-Y2Y4 heterodimer exchanges only
with itself and not with H"Y2. All of the iron, radical and enzymatic activity would be found in
the Talon column flow through. Our previous studies have shown that once the cofactor is
assembled, the holo-H"Y2-Y4 heterodimer is stable and the ratio of H"Y 2 :Y4 remains 1:1 even
after metal affinity chromatography followed by anion exchange chromatography.(2) Since we
know the holo-HY2-Y4 does not spontaneously reorganize to generate the holo-HiSY2 and Y4
homodimers, only two other kinds of exchange processes are possible each resulting in different
partitioning of the Y. containing Y2 into either the metal affinity column bound or flow through
fractions. The holo-Y2Y4 heterodimer could exchange with the H"Y2 homodimer (Part 2 of
Figure 4.4A). If this exchange occurs, then the column bound fraction should contain Y. as a
result of re-organization generating holo-HLsY2-Y2. Alternately, no exchange between HY 2 and
holo-Y2Y4 occurs, which would result in recovery of Y, iron and activity in the column flow
through (Part 3 of Figure 4.4A). As shown in Table 4.2, the flow through fraction contains 75-
85% of the total activity, iron and Y-, supporting the hypothesis that diferric-Y. cofactor
prevents exchange.
Analysis of the bound fraction revealed that this fraction had a small amount of iron, Y.
and activity above the amounts observed in the control (Table 4.2). As revealed in Figure 4.4B,
the bound fraction also contained small amounts of Y4, suggesting the presence of cofactor
assembled HiY2-Y4. A likely explanation of these observations is associated with our inability
to completely load the cofactor in the H"Y2-Y4 heterodimer, meaning our "holo-Y2Y4"
heterodimer is a mixture of apo and holo protein. As already demonstrated, apo-Y2Y4
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heterodimer is capable of exchanging its protomers. Therefore, apo-Y2Y4 can exchange with
1 1s'Y2 to generate an apo- HisY2-Y4 heterodimer, which can subsequently pick up small amounts
of advantageous iron during the experiment to assemble the small amount of diferric-Y cofactor
observed in the bound fraction.
Of course, it is possible that this small amount of cofactor associated with the column
bound fraction arose from the exchange process outlined in Figure 4.4A scenario 2. Even if this
small amount of iron, Ye and activity is associated with a true exchange process, 1% exchange
over 2 hours is not fast enough to be physiologically relevant. Therefore, we conclude that the
active form of the yeast small subunit in vitro is the Y2Y4 heterodimer and furthermore this
heterodimer is likely to be the active form of the yeast small subunit in vivo as well, unless other
proteins can catalyze this exchange process in vivo.
4.3.4 Y2 and Y4 form a heterodimer in vivo
The experiments described in the previous chapter and by Huang and Elledge (10)
demonstrated that Y2 and Y4 can form a complex in vivo. However, we observed that H"Y2
over-expressed in wt yeast did not have stoichiometric amounts of Y4 associated with it.(Chapter
3 and (1)) To further explore the formation of heterodimer in vivo, *Y4 was over-expressed
fiom a plasmid transformed into the Rnr4A strain. This experiment was designed to replace
yeast's endogenous Y4 with a plasmid based epitope tagged Y4. Anti-Myc Agarose was used to
purify MCy 4 and a complex of Y2- m"Y4 was isolated (Figure 4.5A). Visual inspection of the
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Figure 4.5 Isolation of yeast R2 using an N-terminally epitope tagged Y2 or Y4 constructs.
SDS-PAGE analysis of products purified using antibody based affinity resin specific for the
Myc-tag to bind the *Y4 protein over-expressed in the Rnr4A strain (A), for the HA tag to bind
fAY4 protein integrated into the RNR4 locus under control of the RNR4 promoter (B), and for the
FLAG tag to bind the FLGY2 protein integrated into the RNR2 locus under control of the RNR2
promoter (C).
silver stained SDS-PAGE gel revealed that the ratio of Y2:MY4 was close to 1:1. These results
fiurther support the model that Y2 and Y4 are present in a heterodimeric complex in vivo.
To ensure that the isolation of the heterodimeric complex was not an artifact of over-
expression of mY4, similar experiments were carried out with two additional yeast strains
chosen to allow for rapid isolation of yeast R2. The yeast strain MHY346 contains a gene
replacement of wt Y4 by HAy4. The HA tag was appended to the N-terminus of Y4 and the
fusion protein was integrated into the genome under control of the RNR4 promoter. This strain
grew with a similar doubling time to wt yeast in rich media. The HAY4 was isolated from crude
extract generated from MHY346 with Anti-HA Agarose. As shown in Figure 4.5B, a 1:1
complex of Y2-HAY 4 was isolated. To further confirm these results, the heterodimer was isolated
from the yeast strain MHY343, containing an exact replacement of Y2 with a FLAG tag at its N-
terminus. MHY343 was grown in rich media to mid-log phase and the Anti-FLAG Agarose
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resin was used to isolate FLAGy 2 from the crude extract. Again, a 1:1 FLAGy 2-Y 4 heterodimer
was isolated (Figure 4.5C). These results strongly support our in vitro observations that under
these growth conditions the Y2Y4 heterodimer does not undergo re-organization to form Y2 and
Y4 homodimers. They also strongly support the hypothesis that the Y2Y4 heterodimer is the
active form of yeast R2 in vivo.
4.3.3 Exchange of HAy 4 with Y2 expressed in Rnr4A yeast crude extracts
The proposal of Thelander and co-workers that Y4 is a folding chaperone for Y2 lead to
the suggestion that Y2 and Y4 need to be co-translated to generate a soluble folded
heterodimer.(3) This hypothesis makes a prediction that Y2 expressed in the Rnr4A strain has a
defect in cluster assembly due to improper folding. We tested the ability of the Y2 produced in
the Rnr4A strain to form a heterodimer with Y4 as a probe of the folded state of Y2 in the crude
extract. Crude extract from the Rnr4A strain was mixed with HAy4 that was subsequently
immunoprecipitated with anti-HA agarose. If the Rnr4A strain had a defect in cofactor
biosynthesis due to improper folding of Y2, then it would not be capable of undergoing the
exchange reaction to form a heterodimer with HAy4 . Y2 readily co-immunoprecipitates with
Ay4 (Figure 4.9). Furthermore, as increasing amounts of Rnr4A extract is added, the band
corresponding to Y2 grows in. We calculated, based on quantitative Western blotting results, the
pmol of Y2 present in each aliquot of crude extract used in the immunoprecipitation with 200
pmol HAy4 (above each lane in Figure 4.9, quantitative Western blotting results are reported in
Chapter 4). In lane 3, the amount of Y2 is about half the amount of HAy 4 and thus, the band for
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Figure 4.6 Co-immunoprecipitation of HAY4 and Y2 from the Rnr4A yeast strain.
Crude extract was generated from the Rnr4A strain and increasing amounts of the extract was
mixed with 200 pmol of HAY4. The total amount of Y2 in each sample, as predicted from
quantitative Western blotting results (Chapter 5), is indicated above each lane.
Y2 is of lower intensity than that for Y4. However, in lane 4, which contains about 1.5 fold
more Y2 than HAY 4 , the bands appear to be 1:1. Consistent with our in vitro observations, if wt
crude extract is used instead of the Rnr4A extract, no band for Y2 immunoprecipitates with
HAY4, demonstrating the holo-Y2Y4 heterodimer does not exchange its protomers (data not
shown). Since the majority of Y2 in the Rnr4A extract is capable of participating in heterodimer
exchange, we conclude that Y2 can fold in the absence of Y4 as it is capable of forming an apo-
heterodimer if Y4 is present.
4.3.4 Correlation of Ye content and specific activity
The results presented thus far demonstrate that Y2-Y4 heterodimer is the active form of
the yeast RNR in vitro and in vivo. To understand more about the enzymatic activity of this
heterodimer, we investigated the dependence of the enzymatic activity on the amount of Ye
associated with the heterodimer. In the previous work of Dr. Jie Ge as presented in her Ph.D.
thesis, it noted that the Ye content of the holo-H"LY2-Y4 heterodimer did not correlate with
specific activity.(6) The results that lead to this conclusion are presented in Table 4.3 (data
collected at 139.5 GHz EPR experiments) and Figure 4.7 (red circles). This lack of correlation
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was attributed to variations in the extent of proteolysis of the C-terminal tail of Y2 and Y4 and
the variability in Y1 specific activity. The specific activity of the same preparation of
heterodimer can increase from about 300 nmol-min-'mmg " to about 900 nmol-min-'1mg-' when
the Y1 used in the assay has a specific activity of 30 nmol-min-'-mg-1 or 100 nmol-min'1-mg 1 ,
respectively.(6) These issues made it difficult to demonstrate a correlation between the specific
activity of the small subunit and its Y* content in our initial studies of Y2Y4.
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Figure 4.7 The specific activity of the Y2Y4 heterodimer correlates with its Y* content.
The specific activity is plotted as a function of Y* content determined at 9.4 GHz (black
diamonds, data reported here in Table 4.3) or determined at 139.5 GHz (red circles, reported in(2, 6)). The data recorded at 9.4 GHz is fit to a line (linear least squares), predicting one Y* per
heterodimer would have a specific activity of 6000 nmol-min- -mg" .
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Figure 4.8 Standard curve used for spin quantitation of 9 GHz EPR spectra.
The standard curve generated with both the E. coli R2 Y* (black circles, left) and Cu2+ (blue
squares, left) was used to determine the concentration of Y* in the yeast R2. The region from 1-
115 RtM Yo (right) is shown to demonstrate the linearity of signal intensity.
With these caveats in mind, the correlation of Yo content and specific activity were
investigated again, with the use of a 9.4 GHz EPR spectrometer to measure the amount of Ye. It
should be noted that the stoichiometries determined here do not agree with our previous
published stoichometries of 0.6-0.8 Y* per heterodimer (Table 4.3). The quantitation carried out
with the 9.4 GHz spectrometer reported here were thus confirmed independently with two
different standards to ensure the quantitation reported here is accurate.
For the determination of spin concentration at 9 GHz, two different spin standards were
used, the Y* of E. coli R2 and Cu2+. The Yo of E. coli R2 in a range from 1-115 pM and Cu2+ at
0.5 and 1 mM were used to generate a standard curve used in spin quantitation (Figure 4.8). For
quantitation, the double integral (DI) value was calculated and normalized for differences in
collection parameters according to the following equation:
DInorra~ad = (DIXsweep width)2
(mod. amp.Xconv. time)(gain)(# data points-1)(# scans)(4power)
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This normalized value has to be corrected further for differences in the g value for the E. coli R2
~(. and Cu2+ of2.19132 and 2.0047, respectively. Once the normalized DI value is divided by
the g value, then a plot of this normalized intensity vs spin concentration should be linear as
shown in Figure 4.8 (left). Since concentration ofY· predicted using these two standards agreed
to within 5%, only the standard curve ofE. coli R2 y. (Figure 4.8, right) was routinely used in
spin quantitation as the additional correction factor for g value differences was not required to
c:alculate the radical content in the yeast R2 samples.
The results of the investigation of the spin quantitation at 9 GHz and specific activity of
the heterodimer are presented in Table 4.3 and Figure 4.7 (black squares). Although there is
scatter in the data, due to the caveats already discussed, it is clear that the specific activity of the
heterodimer is proportional to the y. content. A fit to this data predicts that a heterodimer with
one y. should have a specific activity of 6000 nmol·min-1·mg-1.
lSI
Table 4.3 Correlation of Yo and specific activity of the Y2Y4 heterodimer
Ye Specific Activity
(radical/dimer) nmol-mix'mg
0.11 622
0.14 465
0.16 794
0.19 1651
0.21 1002
0.24 955
0.25 1812
0.32a
(0.25) 806
1030
49n
(0.29) 654
"Yo content determined by 139.5 GHz pulsed EPR spectrometer. The original reported radical
content is reported first followed by the concentration of Ye calculated from a standard curve fit
to pass through the origin (in parenthesis).
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4.4 Discussion
Here we present several in vitro and in vivo experiments that establish the relevance of
the heterodimer observed in vitro to the active form of yeast R2 in vivo. Using differentially
tagged subunits in our in vitro studies, we demonstrate that mixing of H"Y2 homodimer with Y4
homodimer rapidly forms a heterodimer that, once loaded with iron to generate the diferric-Y.
cofactor, does not undergo any further reorganization to form a holo-Y2 homodimer. We
conclude from experiments with tagged Y2 and Y4 constructs expressed in yeast under control
of their endogenous promoters that the heterodimer is the prevalent form of yeast R2 in vivo.
While these results establish that Y2Y4 is the active form of R2 in vivo, they do not
define the role of Y4. Thelander and co-workers have proposed that the function of Y4 is to
correctly fold and stabilize Y2 and that these two proteins need to be co-translated for efficient
heterodimer formation to occur.(3) Our results do not support this hypothesis. We observe rapid
formation of the heterodimer when HfLy2 and Y4 are mixed at physiologically relevant
concentrations, which we do not think would occur if our Hi"Y 2 was misfolded. Previous work
by Jie Ge has also shown that apo H"Y2 is an unstable protein with a Tm of 30°C as measured by
I)SC.(6) This phenotype is associated with all apo R2s as they are prone to aggregation and
proteolysis. These experiments can be criticized because they have been carried out on His-
tagged protein. However, we have demonstrated that Y2 present in crude extracts generated
from a Rnr4A strain, which does not have any affinity tag, is also capable of participating in a
very similar exchange reaction further supporting our in vitro observations. We establish that
most of the Y2 present in the crude extracts is capable of forming a heterodimer with Y4,
arguing against a model that only a small fraction of the Y2 is properly folded. The cell has
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some mechanism to stabilize apo-Y2 produced in the Rnr4A. These data together suggest that
co-translation of Y2 and Y4 is not essential.
Previously, we have proposed that Y4 is a catalytic iron chaperone, required transiently
in the assembly of the cofactor of Y2, similar to the role proposed for Ccs (Lys7), the copper
chaperone for copper zinc superoxide dismutase, and its target, Sodl.(1, 2, 15) However, our
previous finding that Y4 was needed in stoichiometric amounts to activate Y2 and that no iron
could be detected bound to Y4 were in consistent with this proposal.(2) Furthermore, the results
presented here using different tagged R2s under control of their native promoters demonstrate
that the Y2-Y4 heterodimer is the predominant species in vivo and again does not support the
proposal that Y4 is needed catalytically in the activation of Y2.
Our recent structures of HwY2, Y4 and H"Y2 -Y 4 suggested an alternative role for Y4; to
stabilize a local conformation of Y2 that would promote iron binding. Specifically, helix aB of
Y2, harboring the diiron cluster ligand Asp 145, becomes ordered upon heterodimer formation.
Our results presented here support this proposal.
As we learn more about the insertion of metals into enzyme active sites in vivo, it is
becoming clear that in the case of copper, nickel, and iron (for iron-sulfur clusters), metallo-
chaperones are required to deliver the metal and perhaps required reducing equivalents in a
regulated fashion to assemble holo-metalloproteins. Perhaps the role of Y4 in vivo is to stabilize
Y2 to allow for metal binding as proposed above or facilitate interactions with the cellular
machinery required for cofactor insertion. Results presented in the next chapter of this thesis
demonstrate that the Rnr4A strain over-expresses Y2 however, most of this Y2 must be in an apo
state as we cannot detect any Y. in this strain (Chapter 5). We have shown that the cell must
sense this defect in RNR activity, perhaps through sensing the low levels of dNTPs through cell
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cycle checkpoints, and responds to this defect through up-regulation of Y1 and Y3 protein
concentrations in addition to a dramatic up-regulation of Y2 protein concentration (Chapter 5).
Perhaps, the cell also up-regulates the machinery required for cofactor insertion, thus setting the
stage for us to use this strain to search for the RNR iron chaperone protein.
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Chapter 5
Development of whole cell techniques: quantitative Western blotting, whole cell EPR and
crude extract activity assays
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5.1 Introduction
The long-term goal of our studies of the yeast ribonucleotide reductase system is to
understand how the numerous mechanisms of regulation serve to control RNR activity in vivo.
In the previous chapters, our in vitro studies of yeast RNR have been described, including
purification of the four yeast RNR proteins and reconstitution of the small subunit.(1, 2) More
information must be known about how the activity is regulated in vivo, so that in vitro assays can
be designed with conditions that are physiologically relevant.
Towards this end, a series of assays have been designed that can be used to characterize
RNR in vivo. As described in Chapter 3, quantitative Western blotting was successfully used to
show that Y2 and Y4 are present at roughly equal concentrations in vivo.(1) This technique was
optimized and used to measure the concentration of Y1, Y2, Y3 and Y4 in the wild type (wt),
Rnr4A, RnrlA, and SmllA strains. Additionally, a whole cell EPR technique was developed so
the concentration of Ye containing Y2Y4 can be estimated by measurement of the Ye
concentration in vivo. Building on previous work of Vitols, Lammers, Follmann and co-workers,
a method to measure RNR activity in partially purified yeast crude extracts was developed.(3-6)
In addition to describing development of these techniques, results from our studies of the
RNR4, RNR1 and SMLA deletion strains are presented. We chose to study these strains to help
define the roles these protein play in vivo. In the previous chapter, our attempts to understand
the role of Y4 in the activation of Y2 were described. We have concluded from this work that
Y4 is required in the assembly of the diferric-Y. cofactor of Y2, perhaps through stabilizing a
local conformation of Y2 that allows for iron binding.(l, 2, 7) Evidence is presented which
shows for the first time that Y4 plays a role in formation of the diferric-Y. cofactor of Y2 in
vivo.
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Data is also presented on the role of Y3 in vivo. It is known from genetics experiments
that over-expression of RNR3 can complement the lethality of RNRI deletion meaning RNR3
encodes a protein which can form an active RNR complex with Y2Y4.(8) However, our
laboratory has found that Y3, purified from an E. coli expression host, has significantly lower
activity than Y1 in an in vitro assay with HL'Y2 -Y4.(2) Thelander and co-workers have reported
that Y3, purified from a RnrlA yeast strain, has a specific activity of- 1-2 nmol min'l mg-', less
than 1% of the activity of Y1.(9) It is unknown if this low specific activity is due to the inability
of E. coli to properly fold Y3 or perhaps Y3 requires a post-translational modification to be
active. Using crude extracts from the RNR1 deletion strain, we can directly test if the low
activity of Y3 was due to its over-expression.
Characterization of the SAMLI deletion strain is also presented in this chapter.
Interestingly, we find that Smll does not significantly inhibit Y1 in our RNR assay in partially
purified yeast crude extracts. This observation has allowed us to set a lower limit of Sml 1
concentration in vivo.
Finally, previous studies have shown that the mRNA levels of RNRI, RNR2 and SMLI
fluctuate as a function of the cell cycle as does the catalytic activity of RNR.(5, 10) To
investigate the changes in protein levels, yeast cells were synchronized with alpha factor and the
expression levels of Y1, Y2, and Y4 were determined using Western blot analysis. We found
that the concentration of Y1 fluctuates as a function of the cell cycle with maximal amounts in S
phase whereas the concentration of Y2Y4 remains relatively constant.
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5.2 Materials and Methods
5.2.1 Materials
The wt strain BY4741 (MA4Ta his3A1 leu2A0 metlSAO ura3AO), Rnr4A (isogenic with
BY4741 with RNR4::KAN), RnrlA strain (isogenic with BY4741 with RNR1::KAN), and SmllA
(isogenic with BY4741 with SML1::KAN) strains were obtained from Open Biosystems
(Huntsville, AL).(11) PS0799 (Mata ade2-1, his3-11,15, leu2-3,115, ura3, trpl-1, canl-100), the
yeast strain used for the cell cycle synchronization experiments, was provided by Prof. P. Sorger
(MIT). The apparatus for SDS-PAGE and Western blotting (Criterion Gel system), Sequi-blot
PVDF membrane, were obtained from Bio-Rad (Hercules, CA). Glass beads (0.5 mm diameter)
were purchased from BioSpec Products (Bartlesville, OK). The Dura-West Chemiluminescence
reagent used in Western blotting was obtained from Pierce Biotechnology, Inc (Rockford, IL).
The horseradish peroxidase linked goat anti-rabbit antibody and Sephadex G-50 chromatography
resin was obtained from Amersham Biosciences (part of GE Healthcare, Piscataway, NJ).
Polyclonal antibodies (Abs) to Y1, Hi'y2, Y3, and Y4 were generated in rabbits by Covance
Research Products (Denver, CO).(2) Polyclonal Abs to Clb2 and Prcl were provided by Prof.
Angelika Amon (Massachusetts Instituted of Technology). [cytosine-'4 C(U)]-CDP (40-60
mCi/mmol) was obtained from Moravek Biochemicals, Inc (Brea, CA). Microcon YM3
centrifugal devices were obtained from Millipore (Bedford, MA). Complete and Complete
EDTA-free protease inhibitor tablets, DNaseI, and alkaline phosphates (calf intestine) were
obtained from Roche (Indianapolis, IN). Alpha mating factor, RNaseA, pronase, RNaseA,
Bradford reagent and all other reagents unless otherwise noted were obtained from Sigma-
Aldrich (St. Louis, MO).
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5.2.2 Whole cell Activity Assays
A yeast culture (2 L) was grown at 30 C to mid-log phase (1-3 x107 cells/mL) in YPD.
The cells were collected by centrifugation at 7,500 xg for 15 min. If the activity assay was not
done on the same day as the cell growth, the cell pellet was washed with 50-100 mL of ice-cold
phosphate buffered saline (PBS) with 30% glycerol, flash frozen in liquid nitrogen and stored at
--80 C. Typically 0.5-1 g/L was obtained.
The cell pellet (1 g) was re-suspended with 10 mL of 50 mM TRIS-HCl (pH 7.9), 5%
glycerol, 10 mM MgCl 2, 300 mM (NH4)2SO4, 1 mM EDTA, 1 mM DTT, 25 tg/mL aprotinin, 10
ILM E-64, 0.4 mM AEBSF, 100 gg/ml of pepstatin, 100 gg/mL leupeptin, 100 pg/mL
chymostatin, 1 mM benzamidine, 10 mM NaF, 100 mM 1-glycerophosphate, (buffer A). All
steps were carried out at 4°C. Cells were lysed by three passes through the French press (14,000
psi) and cell debris was removed by centrifugation (30,000 xg, 30 min). DNA was removed by
the dropwise addition of polyethylenimine (2% stock solution adjusted to neutral pH) to a final
concentration of 0.2%. The precipitate was removed by centrifugation (30,000 xg, 30 min). The
supernatant was treated with solid ammonium sulfate to 65% saturation (430 mg/mL). The
precipitated proteins were collected by centrifugation (30,000 xg, 30 min). The protein pellet
was dissolved in a minimal volume of buffer A and 3 mL of the protein was desalted with a
Sephadex-G50 column (0.7 x 16 cm) equilibrated in 25 mM Hepes (pH 7.2), 25 mM MgSO 4, 50
mM (NH4)2SO4 supplemented with the Complete protease inhibitor tablet. The protein
concentration was determined by Bradford assay and immediately used in an activity assay
without freezing. Freezing and storage at -80 C was found to decrease the activity in crude
extracts.
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The extract assays contained 2-5 mg/mL partially purified extract, 30 mM DTT, 3 mM
ATP, 1 mM [ 4C]-CDP (5000 cpm/nmol), 100 mM Hepes (pH 7.2), 10 mM MgSO4, and 10 mM
NaF. All components except crude extract were mixed and pre-incubated at 30 C for 5 min.
The assay was initiated by the addition of crude extract that was also equilibrated to 30 °C.
Aliquots (30 VtL) were removed over 30 min and quenched in a boiling water bath for 2 min.
After adjusting the pH to 8.5 by the addition of 50 [AL of 1 M TRIS (pH 8.5), alkaline
phosphatase (60 U) and dC (0.5 !Rmol) were added and the mixture was incubated at 37 °C for 3
h. The products were analyzed by the method of Steeper and Steuart.(12)
5.2.3 Quantitative Western blotting
Typically an aliquot of crude extract (100-500 !L) was removed from the sample
generated for whole cell activity assays as described above, before the precipitation of DNA. A
portion of this aliquot was utilized to determine the protein concentration by a Bradford assay.
The crude extract used for Western blotting was diluted into 4x Laemmli (1 part Laemmli to 3
parts crude extract), frozen in liquid nitrogen and stored at -80 °C. Purified RNR subunits, HisY1,
HisY2, Y3 or Y4 (2-100 ng) and crude extract (1-10 Gg) were run on a 10% SDS-PAGE gel
(BioRad Criterion Gel) and transferred to PVDF (Sequiblot PVDF, BioRad) using a tank transfer
unit in transfer buffer (25 mM Tris, 192 mM glycine, 10% methanol, 0.1% SDS, 4 C) at 56 V
for 90 min. Western blots were carried out as described previously except blots were developed
with the DuraWest Chemiluminescent Reagent (Pierce).(1, 2) The chemiluminescent signal was
detected with a CCD camera (ChemiDoc XRS, BioRad). Bands were quantified using BioRad's
QuantityOne software.
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5.2.4 Determination of Ye concentration in vivo by whole cell EPR
Yeast cultures (1 L) were grown to mid-log phase (2 x 107 cells/mL) in YPD at 30 C.
The doubling times were 90 min, 180 min, and 160 min for the wt (and SmllA), Rnr4A, and
RnrlA strains, respectively. The cells were collected by centrifugation at 7,500 xg for 15 min.
The cell pellet was washed two times with 1 L of ice-cold PBS. The pellet was then re-
suspended in PBS with 30% glycerol to a final concentration of 1-3 x 1010 cells/mL. The
concentration of cells in the sample was determined by cell counting using a hemacytometer.
For each sample, three independent dilutions were made and the average was used as the cell
concentration for the data analysis. The standard deviation was typically 15-20%. The cell
suspension was transferred to an EPR tube and frozen in liquid nitrogen.
EPR spectra were recorded using a Bruker ESP-300 X-band (9.4 GHz) spectrometer
equipped with an Oxford liquid helium cryostat to maintain the temperature at 30 K for all
samples. Quantitation was carried out by double integration of the EPR spectrum followed by
comparison to a standard curve as described in the previous chapter. The concentration of spin
in each sample, as determined by EPR, the concentration of cells in each sample, as determined
by cell counting using a hemacytometer, and a cell volume were used to calculate the
concentration of Y. in vivo. The cell volume used for BY4741 (and SmllA), Rnr4A and RnrlA
was 41 fL, 68 fL, and 84 fL, respectively.(13)
5.2.5 HPLC analysis of metabolism products generated during RNR assay of cell extracts
Crude extracts were partially purified through the ammonium sulfate fractionation and
assayed as described in Section 5.2.3 except at 30 min a 60 gL aliquot was removed and
quenched in a boiling water bath. The precipitated protein was removed by centrifugation and
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the supernatant was passed through an Amicon microcon YM3 membrane. An aliquot of the
recovered small molecules (1.5 IL, -1.5 nmol ['4C]-labeled material) were added into a solution
containing about 25-50 nmol each of CMP, CDP, dCDP, UDP in 100 gL of 60 mM potassium
phosphate (pH 4.5), 5 mM tetrabutyl ammonium phosphate (TBAP, buffer B). The mixture was
injected on a Nucleotide-Nucleoside column (7 glm, 4.6x250mm, Alltech). The column was
washed for 5 min in buffer b at a flow rate of 1.2 mL/min. Following this step was followed by a
linear gradient from 0-50% methanol with 5 mM TBAP over 20 min and 50-100%
methanol/TBAP over 10 min. Fractions (0.42 mL) were collected and the entire fraction was
analyzed for the presence of 14C by liquid scintillation counting. The retention time for standards
were: dC, 6.07 min; CDP, 17.01 min; dCDP, 18.54 min; ATP, 18.85 min; UDP, 18.87 min.
5.2.6 Cell cycle synchronization and Western blotting to examine the cell cycle dependent
expression of RNR subunits
The wt W303 strain (PS0799) was grown to early log phase (2 x 106 cells/mL; OD600 ~1)
in YPD (400 mL) at 30'C. Alpha factor was added to a final concentration of 15 gg/mL from a 1
mg/mL stock solution in water. The cells were incubated in the presence of alpha factor at 30°C
for 2 h. The cells were collected by centrifugation (5 min, 3,000 rpm), re-suspended in pre-
warmed YPD (30'C) with 10 gRg/mL pronase, and the culture was returned to the shaker (30'C).
Aliquots of 14 mL were removed over 2 h. A part of this aliquot (12 mL) was
centrifuged at 5,000 rpm for 4 min. The cell pellet was resuspended with 1.50 mL ice cold
water, transferred to a microcentrifuge tube and cells were again collected by centrifugation.
The supernatant was removed and cell pellet was frozen in liquid nitrogen and stored at -80C.
This cell pellet was used for Western blotting as described in the following section.
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The cells from other 2 mL of the 14 mL aliquot was also collected by centrifugation. The
cell pellet was resuspended inl.5 mL ice-cold water and cells were fixed by the addition of
ethanol to a final concentration of 70% (v/v). The cells were gently mixed during the addition of
ethanol to avoid aggregation of the cells. Following ethanol addition, cells were stored at 4°C
overnight (16 h). The cells were collected by centrifugation and resuspended with 1 mL of 50
mM sodium citrate (pH 7.5) containing 0.25 mg/mL RNaseA (2,500 U). The cells were
incubated for 2 h at 37°C. Proteinase K (1 mg, -30 U) was added and the mixture was incubated
for another hour at 370C. Propidium iodide (PI) solution (1 mL of 16 Rg/mL PI in 50 mM
sodium citrate (pH 7.4) was added and the mixture was incubated overnight at 4°C. After PI
addition, the samples were protected from light by wrapping them in foil or by keeping them in a
covered container until they could be analyzed by flow cytometry. Flow cytometry experiments
were carried out at the MIT Flow Cytometry Facility with a FACScan cytometer (BD
Biosciences).
5.2.7 Western blots of RNR subunits as a function of the cell cycle
Cell pellets from alpha factor synchronization were resuspended in 150 ,uL of Laemmli
with 5 ltg/mL aprotinin, 5 [.g/mL leupeptin, 2 g/mL E-64, 2.5 g/mL pepstatin A, and 1 mM
PMSF. Glass beads were added to one half the height of the liquid in the microcentrifuge tube.
The samples were vortexed for 2 min and centrifuged in a microcentrifuge (14,000 rpm, 5 min).
The supernatant (10-15 L) was analyzed by 10% SDS-PAGE. The proteins were transferred to
PVDF membranes by electroblotting for 3 h at 100 V using a Semi Dry Transfer unit (Semi-Phor
TE70, Hoefer) in a transfer buffer composed of 25 mM Tris (pH 8.3), 200 mM glycine, 20%
(v/v) methanol, 0.2% SDS. Western blotting was carried out as described in Section 5.2.3 except
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the chemiluminescence reagent and method of detection differed. The membranes were
incubated in a solution containing 65 mM Tris (pH 8), 1.25 mM luminol, 0.2 mM coumaric acid
and 0.01% H202. Luminol chemiluminescence was detected by exposure to film.
5.3 Results
5.3.1 Development of whole cell activity assay
Vitols et al. first described an assay for RNR in yeast crude extracts and Lammers et al.
developed the partial purification of crude extracts to measure RNR activity.(4, 6) Lammers and
Follmann reported that it was essential to partially purify the crude cell extract through an
ammonium sulfate fractionation to avoid metabolism of the nucleotide substrate. In accordance
with their observations, no activity was observed in crude extracts immediately after cell lysis
using extract at 5-10 mg/mL and [14C]-CDP with a specific activity of-5000 cpm/nmol.
Therefore, the crude extracts were treated with polyethyleneimine (PEI) to remove DNA
followed by ammonium sulfate to partially purify RNR.
To ensure that both subunits of RNR were precipitated with ammonium sulfate, crude
extracts were treated with increasing concentrations of ammonium sulfate (from 0-80%). In each
case, the supernatant was tested for the presence of Y1, Y2 and Y4 by Western blotting. This
experiment revealed that 65% ammonium sulfate was sufficient to quantitatively precipitate the
RNR subunits.
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Figure 5.1 Development of crude extract assays in which the concentration of extract was
varied.
The nmol of CDP reduced per mg of crude extract is plotted as a function of time. The final
concentration of extract in the assay was 18.4 mg/mL (green triangles), 9.2 mg/mL (red circles),
4.6 mg/mL (blue diamonds) and 4.9 mg/mL (black squares). NaF (10 mM) was included in the
assay at a protein concentration of 4.9 mg/mL and this data was fit to a line (least squares fit) to
calculate a specific activity of 0.07 nmol-min' -mg'.
Once RNR was partially purified, the concentration of extract used in the activity assay
was optimized. A range of partially purified extract concentrations from 4-20 mg/mL was used
in an assay in the absence of NaF (Figure 5.1). While all of these assays had roughly the same
activity in the first 5 min, all assays deviated from linearity and followed the general trend that
the more concentrated the extract used in the assay the earlier the deviation from linearity. These
results indicated that metabolism of the substrate was interfering with the assay.
To determine the metabolic fate of CDP in the partially purified extract assay, the small
molecules were isolated after 20 min of incubation and analyzed by ion-pairing HPLC. A
method to resolve the likely metabolic products, CMP, CDP, CTP, and UDP was developed
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(Figure 5.2A). The [14C]-CDP metabolites (1.5 nmol) were isolated from an extract assay
containing 9.2 mg/mL extract, 1 FM Y1 and no NaF. The isolated small molecules were diluted
into a solution containing CMP, CDP, dCDP, and UDP (-25-50 nmol each) and the mixture was
analyzed by ion-pairing HPLC. Fractions were collected and subsequently analyzed by liquid
scintillation counting (Figure 5.2B). Greater than 50% of the radioactivity was found to co-elute
with the CMP peak and only -20% of the radioactivity eluted with the CDP peak. Since only
small amounts of radioactivity co-eluted with the UDP peak, dephosphorylation was established
as the major form of metabolism. To inhibit dephosphorylation, NaF (10 mM) was added into
the crude extract assay. The addition of NaF increased the time during which dCDP production
was linear (Figure 5.1, black squares). HPLC analysis revealed that the addition of NaF
inhibited dephosphorylation of CDP. After 30 min in the presence of 4.9 mg/mL crude extract,
>50% of the radioactivity co-eluted with CDP. Therefore, crude extract assays routinely carried
out with about 5 mg/mL crude extract and in the presence of 10 mM NaF.
The CDP reduction activity in partially purified wt extracts was determined to be
0.07±0.01 nmol min'1 mg'. This activity was calculated from eleven assays completed with a
range of crude extract concentrations that varied from 1.6-9.3 mg/mL (Table 5.1). This value is
similar to activities of RNR in crude extracts that have previously been reported. Vitols et al.
reported a CDP reduction activity of 0.03 nmol min'l mg' with crude extracts purified through
an ammonium sulfate fractionation and Lammers and Follmann reported a GDP reduction
activity with similarly purified RNR of 0.27 nmol min''mg'.(4, 6) All of these values are much
higher than the CDP reduction activity reported by Wang et al. who reported a specific activity
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Figure 5.2 HPLC analysis of the CDP metabolites isolated from RNR extract assays.
A) HPLC analysis of standards; CMP, CDP, dCDP and UDP (-25-50 nmol of each). B) CDP
metabolites isolated RNR extract assay (9 mg/mL partially purified extract, 1 IM Y1, no NaF)
after 20 min. C) CDP metabolites isolated RNR extract assay (4.9 mg/mL, 10 mM NaF) after 30
min. Elution of nucleotides was monitored by UV (260 nm, black) and scintillation counting
(fractions of 0.42 mL, blue). Peak 1, CMP; Peak 2, CDP; Peak 3, dCDP; Peak 4, UDP; Peak 5,
AMP; Peak 6, CTP and ADP; Peak 7, AMP.
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Table 5.1 CDP reduction activity of partially purified wt yeast crude extracts
Protein concentration in assay Specific activity
(mg/mL) (nmol min' mg ' )
1.6a 0.08
2.7a 0.08
4.6 0.05
4.7 0.06
4.9 0.07
5.0 0.06
7.0 0.08
7.0 0.07
7.5 0.06
9.0 0.05
9.3 0.09
a Assays contained SmllA crude extract
of 2.5x10' 5 nmol min''mg', about 3000 fold lower than the activity reported here in wt
extracts.(14) Possibly, low activity was observed because the crude extracts were frozen and
stored at -70°C before they were assayed. We have found that storage of the extracts at -80°C
leads to a reduction in the CDP reduction activity.
Interpretation of the data from crude extract assays is quite complex because the active
RNR complex (Y1 in complex with Y2Y4) is in a complex equilibrium with multiple species
(Figure 5.3A). At the very least, Y1 is present as a mixture of monomers and dimers, with only
the dimeric form being capable of forming a complex with Y2Y4 to be active in nucleotide
reduction. If Y1 is similar to the mouse enzyme (-.60% sequence identical) then tetramers and
hexamers of Y1 might also be present in the partially purified extract. The nucleotide reduction
activity of these Y1 oligomeric state have not been investigated. Furthermore, Smll, an inhibitor
of Y1, is present at an unknown concentration in the partially purified extract. Thus, Y1/Smll
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Figure 5.3 The multiple species of RNR present in partially purified crude extracts
Shown is an outline of the complex equilibria between the multiple RNR oligomeric states
present in partially purified yeast extracts (A), yeast extracts with 3 PtM Y1 added (B), and yeast
extracts with 3 tM Hi"Y2-Y4. Y1 (purple) can be a mixture of oligomeric states and possibly
inhibited by Smll (green). In the RNR assay with only yeast extracts, the concentration of
Y1-Y2Y4 complex is likely to be low. To drive complex formation, excess Y1 is added to
saturate Y2Y4 in the extract (B) and similarly the addition of HLY 2-Y4 saturates the Y1 present
in the extract (C).
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complexes could also be present in the extract assay, adding yet another layer of complexity to
this complex equilibrium.
To drive the equilibrium of species to formation of the Y1 Y2Y4 complex, assays for
RNR activity in partially purified extracts were also carried out after the addition of an excess of
Y1 or H"Y2-Y4, which increases the specific activity of the extracts. Previously, Wang et al.
have reported that addition of Y1 (1.25 KM) increased the RNR activity in crude extracts about
15 fold to 4x10 4 nmol.min'l mg'.(14) Presumably, this observed increase in activity upon the
addition of Y1 occurs because the Y2Y4 present in the crude extract is saturated with Y1 under
these conditions (Figure 5.3B). The amount of Y1 Y2Y4 complex can be estimated using the
[Ye] in the partially purified extracts as an internal standard and the concentrations of the RNR
subunits and Ye in vivo (described in the following sections). Given a Kd of-0.2 gM (from
mouse R1-R2 Kd), the concentration of Y1 and Y2Y4 a wt extract assay carried out at 5 mg/mL
crude extract, the estimated concentration of Y1 monomer is about 0.1-0.2 AM and the
concentration of Y2Y4 heterodimer is also 0.1-0.2 FM, the concentration of RNR complex is
0.015-0.044 FM. Thus a majority of Y1 and Y2Y4 in the extract is not in an active Y1 Y2Y4
complex.
A series of assays were carried out to determine the concentration of Y1 required to
achieve maximal activity in the crude extract assays (Figure 5.4). The specific activity reached a
maximum with the addition of 3 gM Y1. Therefore, for each crude extract assay, one assay was
done in which Y1 was added to 3 1AM and another was done in which Y2Y4 was added to 3 FM.
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Figure 5.4 CDP reduction activity in crude extracts as a function of Y1 concentration.
5.3.2 Development of the whole cell EPR technique
Harder and Follmann first reported the EPR doublet signal for yeast R2 in crude extracts
subjected to an ammonium sulfate fractionation and noted in passing that this signal could also
be observed in whole cells.(15) Initial attempts to acquire an EPR spectrum of whole cells were
unsuccessful due to the presence of a large, sharp signal at a g value of 2. It was found that
extensive washing of the cells with ice cold PBS effectively removed this signal, revealing an
EPR spectrum with a line shape very similar to the spectrum acquired from holo-Y2Y4 (Figure
5.5).
While this spectrum was very similar to that of the Yo, it deviated slightly from the
spectrum of Y* especially from g = 2.04-2.02 (Figure 5.6 compare red and yellow spectra). This
deviation indicated that there were additional signals present not originating from the Ye of the
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Figure 5.5 The EPR spectra of pure HbY2-Y4 heterodimer and whole yeast cells.
A) The EPR spectrum of Hi"Y2 -Y4 heterodimer (20 CIM, 0.2 Y./heterodimer) was acquired with
10 scans at a receiver gain of 1x105. B) The EPR spectrum of whole cells (BY4741; 1.12x10'0
cells/mL) was acquired with 32 scans at a gain of 1.78x105.
yeast Y2Y4 heterodimer, which of course is not unexpected considering these spectra acquired
from whole yeast cells. To obtain the spectrum of only the Ye in whole cells, HU (150 mM) was
added into the YPD and the culture was grown in the presence of HU for 2 h. Aliquots were
removed from the culture 0.5 h, 1 h and 2 h after HU addition and the degree of Ye reduction in
the whole cells was accessed with whole cell EPR. While a small amount of Ye remained 30
min after the addition of HU, no Ye could be detected in the sample collected 1 h after the
addition of HU. If the spectrum acquired with HU treated cells is integrated and the spin is
quantitated by comparison to the standard curve, a value of 0.96 gM spin is calculated.
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Figure 5.6 Subtraction of background signal from whole cell EPR spectra.
EPR spectra of whole yeast cells (red) and following HU treatment (150 mM HU, 60 min, blue)
are shown after normalization for the concentration of cells in the sample. These spectra were
subtracted and the resultant spectrum is shown in black. The spectrum of pure Y2Y4 is shown
for reference (yellow).
This amount of spin is significant relative to the concentration of spin calculated to be present in
wt untreated cells, 1.78 RM. Thus, this background signal must be subtracted from the EPR
spectrum of wt whole cells to accurately determine the Ye content in vivo. Thus, the EPR
spectrum of wt and HU treated whole cells were normalized for the concentration of cells in the
sample and number of scans and then these spectra were subtracted (Figure 5.6, blue (HU treated
cells) and black (subtraction)). After double integration of the subtracted spectrum the
concentration of Y* in BY4741 was determined to be 0.82±0.18 ViM. The error associated with
EPR quantitation is estimated at -10% while the error in cell counting is as much as 20%.
Therefore the error associated with the Y* concentration was estimated to be 22%.
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5.3.3 Quantitative Western blotting
Our initial efforts to measure the concentration of Y2 and Y4 in whole yeast cells were
described in the Chapter 3.(1) We determined the concentration of Y2 and Y4 homodimers
ranges from 0.5-2.3 gM in vivo. This number has a large amount of error associated with it for
at least two reasons. First, the cells used in these experiments were lysed by a glass bead method
on a small scale. The efficiency of cell lysis could not be quantitated and therefore any variation
in cell lysis efficiency leads to error in the calculated in vivo concentration. Second, the
chemiluminescence signal was detected by exposure to film, with a small experimentally
determined linear range from 8-40 ng of Y2 or Y4. Furthermore, it was difficult to obtain a film
image with an exposure time sufficiently long to observe a signal from the lowest point on the
standard curve without over-exposing the film resulting in saturation of the signal at high RNR
amounts. This small dynamic range, the extra processing of the film image into a computer
image file required to carry out quantitation, and the variation in cell lysis likely contributed to
the error.
The Western blots reported in this chapter had two significant changes when compared to
our initial efforts to measure RNR concentration in vivo. The cells were grown on a larger scale
(1-2 L vs 50 mL) and were cracked by passage through the a French pressure cell. The
efficiency of cell lysis could be monitored using two different methods. First, the cell
concentration before and after cracking could be measured directly by cell counting with a
hemacytometer. Whole yeast cells have a very distinct appearance in the light microscope and
are easily differentiated from lysed cells. The cell lysis efficiency determined by direct cell
counting could be confirmed with EPR. An EPR sample of the re-suspended cells before
passage through the French press was compared to the sample collected after lysis and
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centrifugation. The difference in Ye concentration in these two samples is a direct measure of
the amount of cells that were not lysed by French press. Using these techniques, it was
determined that if a cell pellet was re-suspended with 5-10 mL of lysis buffer per g of cell paste
(2-4x 109 cells/mL), -80-90% lysis efficiency was routinely obtained. The second change
implemented was the use of a camera to capture the chemiluminescence signal as opposed to the
use of film. Figure 5.7 shows a typical standard curve acquired for HIY2. The curve was linear
from 2-52 ng of Hisy 2, a linear range 5-fold greater than that observed with film.
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Figure 5.7 A typical standard curve for a Y2 quantitative Western blot
A final factor that affects the calculated concentration of RNR in vivo is the cell volume
used in the calculation of in vivo concentration. This is especially important with the deletion
mutants discussed in this chapter as their cell size is much larger than the wt cell. Jorgenson et
al. measured the volume of all of the viable haploid gene deletions strains and determined the
volume of the wt, Rnr4A, and RnrlA strain is 41 fL, 68 fL, and 84 fL, respectively. These
volumes were used to convert the protein amounts determined by Western blotting into the
concentration of the polypeptide in vivo.
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5.3.4 Characterization of the wt and Rnr4A strains: Y4 plays a role in cluster assembly in
vivo
Having confirmed the presence of the Y2Y4 heterodimer in vivo (Chapter 3), we wanted
to probe the role of Y4 in generating active yeast R2. Isogenic strains of wild type S288C
(BY4741) and Rnr4A strains were examined using quantitative Western blotting, whole cell
EPR, and activity assays to gain a better understanding of the phenotypic consequences of RNR4
deletion.( 1)
Table 5.2 Concentration of RNR subunits in the wt, Rnr4A, RnrlA and SmllA strains.
Strain Cell volume [Y.] [Y2] [Y4] [Y1] [Y3]
fL M R a Ma 
Wt (BY4741) 41 0.82±0.18 0.82±0.24 0.50±0.15 0.76±0.23 <0.03
Rnr4A 68 <0.05 13.53±4.06 -- 0.87±0.26 1.81+0.54
RnrlA 84 9.41±2.07 7.61±2.28 7.81±2.34 -- 0.53±0.16
SmllA 41 0.84±0.18 0.79±0.24 0.80±0.24 0.65±0.20 <0.03
a concentrations are reported as the concentration of the polypeptide chains, not the concentration
of the dimer.
RNR subunit concentrations in the wt and Rnr4A strains were determined using
quantitative Western blotting. As shown in Figure 5.8 and Table 5.2, the RNR subunits, Y1, Y2
and Y3, are over-expressed in the Rnr4A strain. Y2 is expressed at a concentration of 0.82-0.24
jM in this wt strain background. In the Rnr4A strain, the concentration of Y2 increases to
13.53±4.06 ptM. The amount of Y1 polypeptide per cell increases -2.5 fold but because the cell
volume of the Rnr4A strain is larger than the wt strain, the concentration of Y1 is 0.87 p1M, very
similar to the concentration in the wt strain. Y3 cannot be detected in wt extracts but is induced
to a monomeric concentration of 1.81±0.54 VM in the Rnr4A strain.
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Figure 5.8 Quantitative Western blots of wt and Rnr4A strains
Western blots to determine the concentration of Y2, Y4, Y1 and Y3 in wild-type (wt), Rnr4A and
RnrlA strains are shown in (A), (B), (C) and (D) respectively. The total ng of standard or the
total p.g of crude extract loaded is indicated above each lane.
The effect of the RNR4 deletion on RNR activity was measured in partially purified crude
extracts. Partially purified wt extract typically has a specific activity of 0.07±0.01 nmol-min"
I.mg "' (Figure 5.8, inset, Table 5.3). The addition of Y1 (1 pM) to the crude extract results in a
60-fold increase in CDP reduction activity. On the other hand, no activity was detected in the
Rnr4A extracts, even after Y1 was added to a final concentration of 3 pM (Figure 5.9). Even
though Y2 is over-expressed in the deletion strain relative to the wt strain, it has a specific
activity that is at least 100 fold less than the activity of Y2Y4 in wt extract.
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Table 5.3 Yeast crude extract RNR activity in the wt, Rnr4A and RnrlA strains
Strain Specific activity Specific activity with 3 gIM Specific activity with 3 pM
(nmol'min"'.mg'') Y1 His2Y4
BY4741 0.07 3.69 ND b
Rnr4A <0.01 <0.01 0.29
RnrlA <0.01 8.55 <0.01
SmIlA 0.08 5.23 0.22
a 1 iM Y1 was used instead of 3 pM Y1
b ND = not determined
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Figure 5.9 Assays of RNR activity in wt and Rnr4A crude extracts.
The total nmole of dCDP produced as a function of time are plotted for the wt extract ( O•), wt
extract supplemented with 1 IM Y1 ( ), RNR4A extract ( O ) and RNR4A extract
supplemented with 3 pM YI ( ).
To understand the basis for the dramatic drop in RNR activity, the concentration of Ye in
vivo was measured using whole cell EPR. The EPR spectrum acquired from the Rnr4A strain
looked remarkably different from that of the wt yeast cells. No Y* could be detected above the
background signal in the Rnr4A strain and the line shape was reminiscent of the spectra acquired
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Figure 5.10 EPR spectra of Rnr4A whole cells
The EPR spectra of wt cells (blue), HU treated wt cells (green) and Rnr4A strain (black) are
shown. EPR parameters and cell concentrations were similar to those reported in Figure 5.5.
from wt yeast cells treated with hydroxyurea (Figure 5.10). Based on our estimation of the lower
limit of detection, the Yo concentration in the Rnr4A strain must be at least 20 fold lower than in
wt cells, even though the Y2 concentration is elevated almost 30-fold. This observation explains
why the strain lacking Y4 has a dramatic decrease in RNR activity support the hypothesis that
Y4 plays a crucial role in Y2 diferric-Y* assembly in vivo. Based on our estimated concentration
of Y2, the doubling time and the size of the yeast genome, we predict that the specific activity of
Y2 is -5 nmol-min-'lmg"'. For comparison, our HWY2-Y4 has 0.2-0.3 Ye per heterodimer and a
specific activity of -1500-1800 nmol-min'l*mg-'. These results demonstrate that care must be
taken when interpreting data about the concentration of RNR subunits in vivo as in this case, the
concentration of Y2 polypeptide is not proportional to the RNR activity.
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5.3.5 Y3 has very low activity in vivo
To understand more about the activity of Y3 in vivo, the RnrlA strain was characterized
by whole cell EPR, quantitative Western blotting, and crude extract activity assays. Previously it
was established that RNR1 is essential for mitotic viability, however this particular RnrlA strain
has acquired an extra chromosomal copy of RNR3 and thus remains viable.(16, 17) This strain
grows with a long doubling time of 140 min in YPD (wt cells have a doubling time of 90 min).
Additionally, the cells are twice the size of wt cells with a volume of 84 fL.(13) Quantitative
Western blotting has shown that the concentration of Y2Y4 increases almost 10 fold relative to
the concentration in wt cells, from -0.8 M to -7.5 StM (Table 5.2). Whole cell EPR was used
to measure a similar increase in Ye, from 0.8 FVM to 9.4 FaM (Table 5.2). Furthermore, Y3 is
expressed at a concentration of 0.53:0.16 pM, which is similar to the concentration of Y1 in wt
cells. However, similar to the Rnr4A strain, the cell volume of the RNRI deletion strain is twice
as large as wt cells and therefore, the [Y3] [Y1] however, the amount of Y3 polypeptide per
cell is much larger. Despite the large over-expression of Y2Y4 and induction of Y3 expression,
no CDP reduction activity could be detected in crude extracts generated from the RnrlA strain
unless Y1 was added into the extract (Table 5.3). The lower limit of detection in our RNR
extract assay is -0.01 nmol min'l mg ' and there is 0.81 ng Y3 per Rg of crude extract,
determined by quantitative Western blotting. Thus Y3 has a specific activity less than 10
nmol min' mg in partially purified extracts. The specific activity of Y3 in vivo can also be
calculated as the concentration of Y3, the size of the yeast genome and the doubling time is
known. Thus, the specific activity of Y3 must be at least 59-18 nmol min'l mg '1 to duplicate the
yeast genome (12,052 kb) in the 160 min it takes the RnrlA strain to divide if the concentration
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of Y3 is 0.53 pM and the cell volume is 84 fL. It is unknown why Y3 has such a low specific
activity and what role it plays in vivo. We know from analysis of sequence alignments that the
amino acids that play a role in nucleotide reduction are conserved. However, these results do
demonstrate that the low specific activity of RNR in vitro is not likely to be an artifact of its
heterologous over-expression.
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Figure 5.11 Comparison of the specific activity of wt and SmlIA crude extracts
The nmol of CDP reduced per mg of wt (black) and Sml A (red) crude extract are plotted as a
function of time. Assays containing only crude extract are plotted with triangles. Assays
containing 3 CIM Y1 and 3 tM HisY 2-Y4 in addition to the crude extract are plotted with squares
and circles, respectively.
5.3.6 Characterization of the SmilA strain
Recently, Smll was identified as a regulator of yeast RNR which binds to and inhibits Y1
activity in vivo.(18-22) To understand more about how Smll regulates Y1 in vivo, an SmllA
strain was characterized by quantitative Western blotting, whole cell EPR and crude extract
assays. The concentrations of Y1, Y2, Y4 and Y* were similar to the wt strain (Table 5.2).
Interestingly, the specific activity in SmllA extracts was similar to that of wt extracts (Figure
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5.11 and Table 5.3). Based on this observation, we can set an upper limit on the concentration of
Smll in vivo. Smll does not significantly inhibit Y1 in these crude extract assays, which have a
Y1 concentration of < 0.08 VM when the concentration of crude extract is -5 mg/mL. The
amount of Smll inhibition, if it is present, must be less than the error in determination of the
activity in crude extracts, which is 15%. Based on the estimated Kd between Y1 and Smll of
0.2-0.4 gM,(21) Smll must be present at a concentration less than 0.08 pM in the extract assay
or an in vivo concentration less than 0.4 pM. It is possible that we do not observe Smll
inhibition in our assays because we cannot do the assays at extract concentrations near that
would have RNR closer to their physiological concentrations due to problems with CDP
metabolism at high extract concentrations. Furthermore, it is known that the concentration of
Smll fluctuates as a function of the cell cycle, being lowest in S phase and highest in G2/M
phase. Thus, the concentrations of Smll and Y1 as a function of the cell cycle must be
determined to accurately model this system with in vitro assays.(19)
5.3.6 Cell cycle dependent expression of RNR
While it has been shown that the Smll protein levels fluctuate as a function of the cell
cycle, the changes in RNR concentration through the cell cycle have not been examined. The
transcription of RNRI and RNR2 is linked to the cell cycle with maximal expression at the G1/S
transition.(8, 10, 16, 23, 24) Lowdon and Vitols demonstrated that the activity of RNR also
fluctuates as a function of the cell cycle and that this fluctuation was dependent on new protein
synthesis.(5) These results strongly suggest that the concentration of Y1 and/or Y2Y4 is
changing in a cell cycle dependent fashion.
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To examine the cell cycle dependent expression of Y1, Y2, and Y4, a yeast culture was
synchronized with alpha mating factor. Aliquots were removed after release from alpha factor
arrest and the expression level of Y1, Y2, and Y4 was accessed with Western blotting (Figure
5.12). Y1 is present in cells synchronized with alpha factor, however 10 min after release from
alpha factor arrest, the band for Y1 is much less intense. A peak of Y1 expression is seen from
20-40 min and a second peak is seen at 70-110 min as the population enters a second round of
DNA replication. This correlates with the cell cycle dependent mRNA expression which shows
that the expression level of RNRI peaks at 21 and again at 77 min after release from alpha factor
arrest (shown below the Y1 blot in Figure 5.12).(23, 25) Samples for flow cytometry were
collected from the same culture and analyzed for DNA content, which showed S-phase has
started 30 min after release from alpha factor arrest and is completed by 45 min (FigureS. 12E).
Together, this data demonstrates that the concentration of Y1 is at a maximum in S phase. To
ensure that the fluctuation in Y1 concentration is due to the cell cycle dependent expression of
Y1 and not uneven loading, a western blot for carboxypeptidase Y (Prc 1) was used as a lane
loading control. As shown in Figure 5.12D, the amount of Prcl was constant. The aliquots were
also probed with an anti-Clb2 antibody. Clb2 is cyclin which regulates the activity of Cdc28, the
main cyclin dependent kinase in yeast and is expressed at the G2/M phase of the cell cycle. As
shown in Figure 5.12B, a cell cycle dependent expression of Clb2 was observed as expected
which matched its mRNA expression profile. The cell cycle dependent expression of Y2 and Y4
was also investigated. Unlike Y1, their concentrations did not significantly change as a function
of the cell cycle.
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Figure 5.12 Cell cycle dependent expression of Y1, Y2 and Y4.
Aliquots were removed from a synchronized yeast culture every 10 min and lysates were
analyzed for the presence of YI (A), Clb2 (B), Y2 (C), Y4 (C), and Cpyl (D) by Western
blotting. The time at which the aliquot was removed after the culture was transferred into a
media without alpha mating factor is indicated above each lane in the Western blot. For Y1 and
Clb2, the mRNA expression profile is shown with the time after release from alpha factor arrest
overlaid on top of the data (red=induction; green=repression).(23) Flow cytometry to measure
DNA content in aliquots removed every 15 min revealed that 30 min the cells have entered S
phase and by 45 min S-phase is completed.
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5.4 Discussion
A series of assays are described which together can be used to measure the concentration
of active RNR in vivo. The concentrations of RNR subunits is measured by quantitative Western
blotting. The concentration of holo-heterodimer can be accessed directly with whole cell EPR
without any perturbation of the cell. Finally, the RNR activity in crude extracts can be
determined.
,Table 5.4 The concentration of RNR calculated using other methods
This study Other methods without Measurement by
tagging epitope tagging (26)
Y1 0.76 p[M 0.35-0.70 ItM (9) 6.1-12.2 M
Y2 0.82 FM 1.2-2.5 FM (27) 0.01-0.02 p.M
Y3 <0.03 FM -- 0.03-0.05 !FM
Y4 0.50 M 1.0-1.8 M (29) 2.1-3.7 I.M
Quantitative Western blotting was used to measure the concentrations of RNR subunits.
The concentrations of Y1, Y2 and Y4 in a wt strain are 0.76 aM, 0.82 !FM and 0.5 aM,
respectively while Y3 could not be detected in wt crude extracts meaning it must be expressed at
a concentration less than 0.03 !FM, based on the lower limit of detection in the quantitative Y3
Western blot. These concentrations agree with the concentrations previously determined for the
wt subunits, which were determined by Western blotting (Y1 and Y2) or by 2D-electrophoresis
(Y4). However, these results do not agree with the published concentrations determined using
strains containing a genomically encoded C-terminal epitope tag perhaps indicating that these
tags interfere with RNR activity in vivo.(26) This is not unexpected as the C-terminus of R1 is
required for re-reduction of the active site cysteines and the C-terminal tail of R2 is required for
RI/R2 interaction. These results further emphasize that even though large scale proteomics
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efforts provide enormous quantities of potentially useful information, the data from these studies
should be considered with caution.
While the determined concentrations of the yeast RNR subunits are in agreement with
previous work, we have demonstrated here that the concentration of Y1 fluctuates as a function
of the cell cycle, with the highest concentration during S-phase. The concentration of Smll 1 also
fluctuates as a function of the cell cycle, with its peak in concentration at the G2/M phase.
Therefore, the concentration of Y1 and the upper limit of the concentration of Sml 1 reported here
are only the average concentrations in a population of growing cells. This is especially important
when thinking about the concentration of Y1 Y2Y4 and Y1 Smll complex in vivo as the
concentrations of these proteins are close to the Kd for complex formation, 0.2 PM and 0.2-0.4
MM for the Y1Y2Y4 and Y1Smll complex. The implications of these protein concentrations
on the concentration of active RNR complex or inhibited Y Smll 1 complex are discussed in
detail in Chapter 6.
Interestingly, this data also allows for the estimation of the specific activity of Y1 and
Y2Y4 in vivo. For example, in the SmllA extract assay, the concentration of Y1 and Y2Y4 in
the assay can be calculated from Western blotting and EPR. Thus the activity per Y1 or Y2 can
be calculated. We calculate a Y1 activity of 16050 nmol min 'lmg" in crude extracts, which
is similar to the activity of our purified Y1, 200-250 nmol min" mg' l. Similarly, the activity of
Y2 is calculated to be 6800±2000 nmol'min' 'mg, which is especially interesting as the
correlation of activity with Y. per heterodimer (Chapter 4) predicts that completely assembled
heterodimer should have a specific activity of -6000 nmol'min 'mg'.
Finally, these assays with the deletion strains have provided insight into the roles of Y3
and Y4 in vivo. Our characterization of the Rnr4A strain demonstrates that Y4 plays a role in
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cofactor assembly in vivo. This supports our in vitro observations that Y4 was required for Y2
cluster assembly. The low activity of Y3 in extracts is also informative. The concentration of
Y3 in the RnrlA strain is 0.53 FM. Assays of RNR activity in RnrlA crude extracts revealed
that Y3 has a specific activity of less than 10 nmol min' mg' l and a calculation of the specific
activity based on the RnrlA strain doubling time and the concentration of Y3, -60 nmol min'
l'mg'l. These activities agree with the findings of Thelander and co-workers that Y3 has a very
low specific activity in vitro. who found the activity of Y3, purified from an RnrlA strain, was
--1-2 nmol.min' mg.(9) These results demonstrate that the low activity of Y3 in vitro is most
likely not a result of its heterologous over-expression though these results do not help us to
understand the role of Y3 in vivo.
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Chapter 6
Quantitation of metallocofactor stoichiometry in vivo and isolation of yeast's endogenous
ribonucleotide reductase small subunit
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6.1 Introduction
Since the seminal identification of Y122 as the amino acid residue harboring the Ye in E.
coil R2,(1) numerous R2s from a diverse range of organisms have been cloned, overproduced in
heterologous expression systems and purified utilizing anion exchange chromatography or, more
recently, metal affinity chromatography with N-terminally hexa-histidine tagged R2s. Often R2
is isolated in an apo state or in a substoichiometrically assembled cofactor state. Reconstitutions
of the iron-Y. cofactor with iron, oxygen and reductant have provided holo, or cofactor loaded
protein, for mechanistic studies. While the in vitro reconstitution leads to an increase in the
amount of cofactor, stoichiometric amounts of Ye (one Ye per polypeptide or two Ye per R2)
have never been observed in any system. Typical stoichiometries for the E. coli R2 observed are
1.1-1.3 Ye and 3.4-3.6 Fe per R2. The Ye content of R2s isolated from numerous other sources
and expression systems range from 0.3-1.5 Ye per dimer, never reaching stoichiometric
amounts.(2-6) While much has been learned about the mechanism of in vitro cofactor assembly
and the role of the Ye in nucleotide reduction, little is understood about how the cofactor is
generated in vivo. Here we present the first rapid isolation and characterization of any R2 from
its endogenous source without overexpression.
To understand the radical stoichiometry and RNR activity in vivo, an N-terminal Flag
tagged-Y2 (FlagY2) was generated and integrated into the genome to replace Y2 in a wild type,
Crtl A (the repressor controlling RNR2, RNR3, and RNR4 expression) and Rnr4A strains. These
constructs have allowed rapid isolation of R2 from crude extracts. The specific activity and
amount of diferric-Y. cofactor of the F"aY2 isolated from each strain has been determined.
Quantitative Western blotting, whole cell EPR and crude extract activity assays have determined
the RNR subunit concentration, Ye concentration and RNR activity in vivo in each strain
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background. Together these experiments demonstrate that the Y1 activity, not Y2Y4, is limiting
RNR activity in vivo. Furthermore, a fraction of FagY 2 was modified by phosphorylation at
Serl5 and two proteins, Wtml and Wtm2 reproducibly co-purified with FagY2 isolated from the
wt strain.
6.2 Materials and Methods
6.2.1 Materials
[Cytosine-14C(U)]-CDP (50 mCi/mmol) was obtained from Moravek Biochemical (Brea,
CA). Poly(vinylidene) difluoride (PVDF, sequi-blot) membranes and Criterion SDS-PAGE gels
were obtained from BioRad. Secondary antibodies (Abs, horseradish peroxidase conjugated
donkey anti-rabbit Abs), complete protease inhibitor tablets, calf intestinal alkaline phosphatase,
and DNaseI were obtained from Roche. HY 2-Y 4 heterodimer was isolated from an E. coli
expression system as described previously and typically contained 0.2-0.3 Ye per heterodimer
and a specific activity of 1.5-1.8 utmol min'.mg'.(7) Anti-Flag Agarose, 3x Flag peptide, Anti-
Myc Agarose, Bradford reagent and all other reagents and chemicals were obtained from Sigma-
Aldrich (St. Louis, MO) unless otherwise noted.
6.2.2 Yeast strain construction
The yeast strains used in this study are listed in Table 6.1. The FagY 2 expressed in these
strains (MHY343, MHY619, MHY614) is integrated at the RNR2 locus and therefore expresses
FiagY 2 (Y2 with the additional N-terminal amino acids MDYKDDDDKH) under control of its
native promoter. The isogenic gene deletion strains BY4741 (wt strain), SmllA, CrtlA, and
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Rnr4A were obtained from Open Biosystems.(8) The strains for expression of ¢Wtml and
'"Wtm2 were provided by Prof. Young (Whitehead Institute).(9)
Table 6.1 Yeast strains used to determine stoichiometry of di-iron-Yo in vivo
Strain Genotype Ref.
BY4741 MATa his3A 1 leu2A0 metl5A0 ura3A0 (8)
(S288c)
SmllA BY4741 smll::KAN (8)
CrtlA BY4741 Rfxl::KAN (8)
Rnr4A BY4741 Rnr4::KAN (8)
MHY343 MATx, canl-100, ade2-1, his3-11,15, leu2-3,112, trpl-1, ura3-1, (10)
(W303) rnr2::FLAG-RNR2-Kan
MHY619 MATa his3, ura3, rnr2::FLAG-RNR2-Kan, crtl::LEU2 Provided by
Prof. Huang
MHY614 MATa his3 leu2, ura3 rnr4::LEU2 rnr2::FLAG-RNR2-Kan Provided by
Prof. Huang
Z1256 MATa, ade2-1, trpl-l, canl-100, leu2-3,112, his3-11,15, ura3, (11)
(W303) GAL+, psi+
Myc- Z1256 Wtml::18-Myc-Wtml (9)
Wtml
Myc- Z1256 Wtm2::18-Myc-Wtm2 (9)
Wtm2
6.2.3 Growth and isolation of Fl9Y2 from MHY343
A single colony was used to inoculate a 5 mL YPD culture, which was grown overnight
to saturation at 30'C. The starter culture was diluted into the 10 L YPD in a fermentor and
grown at 30 °C for 8-12 doubling times (12-18 h (overnight) with typical doubling times of 90
min) to a cell density of 1-3 x 107 cells/mL. Cells were harvested by centrifugation at 7,500 xg
for 15 min. Typically, 1-2g of wet cell paste were obtained per L of cell culture.
All protein purification steps were carried out at 4'C. A cell pellet (20g) was
resuspended in 40 mL 50 mM Hepes (pH 7.4), 1 mM EDTA, 100 mM NaC1, 10% glycerol
(buffer A) supplemented with protease and phosphatase inhibitors (25 Rg/mL aprotinin, 10 pM
E-64, 0.4 mM 4-(2-aminoethyl)benzenesulphonyl fluoride (AEBSF), 100 g/ml of pepstatin, 100
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Rg/mL leupeptin, 100 Ctg/mL chymostatin, 1 mM benzamidine, 30 mM NaF, 30 mM 0B-
glycerophosphate). DNaseI (2 U/mL lysate) was added before cell lysis. The cells were lysed
with 3 passes through the French Press at 14,000 psi. Cell debris was removed by centrifugation
at 30,000 xg for 30 min. Crude extract was incubated with 1 mL of Anti-Flag agarose (Sigma-
Aldrich) for 1 h with gentle agitation. The mixture was transferred to a column which was
subsequently washed with buffer A supplemented with a Complete protease inhibitor tablet until
the A280 was <0.01. The heterodimer was eluted from the column with 8 mL buffer A
supplemented with 150 Rg/mL 3x FLAG peptide (Sigma-Aldrich catalog number F4799, as the
'3x" in the name implies, the 3xFLAG peptide consists of 3 tandem copies of the FLAG
epitope). Fractions of 500 !xL were collected and the ones containing heterodimer, as judged by
the presence of a UV-Vis spectra characteristic of the diferric-Y. cofactor, were pooled and
concentrated with a Centricon YM30 (Millipore) followed by several rounds of
dilution/concentration to remove any 3x FLAG-peptide. Alternately, FlagY2 was passed through
a. G50 column to ensure complete removal of the peptide, as noted in the Results section. The
yield of heterodimer ranged from 30-75 [ig per g of cell paste.
6.2.4 Isolation of FhgY2-Y4 from MMS treated cells
The strain MHY343 was grown as described above, with the following modifications.
When the culture reached a density of 2x 107 cells/mL, methylmethane sulfonate (MMS) was
added to a final concentration of 0.01% (v/v). The cells were harvested 1.5 h following MMS
addition.
The cell pellet (20 g from a 10 L fermentation) was re-suspended with 40 mL buffer A
supplemented with protease and phosphatase inhibitors. FgY 2-Y 4 was isolated as described
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above except that 1.5 mL Anti-Flag Agarose was used. The column was washed with 600 mL of
buffer A supplemented with the Complete protease inhibitor tablets and FagY2-Y 4 was eluted
with buffer A containing 100 !ig/mL 3x Flag peptide. Heterodimer containing fractions were
pooled and concentrated as described above. The yield was 700 !g of heterodimer.
6.2.5 Isolation of FLgY2-Y4 from CrtlA strain background
The yeast strain MHY619 was grown and FlagY2-Y4 was isolated from 7.5 g of cell paste
(from a 10 L fermentation growth) as described for MHY343. The yield was 2.7 mg ofFlagY2-
Y4. The heterodimer contained a small amount DNA contamination (mx of 276) preventing
reliable determination of the protein concentration by extinction coefficient and therefore, the
protein concentration was determined by Bradford assay using HY2-Y 4 as a standard.
6.2.6 Isolation of FIaY2 from Rnr4A strain background
Yeast strain MYH616 was grown in 10 L YPD at 25C and had a doubling time of 8-9 h.
Flagy 2 was isolated as described above with a yield of 1 mg from 10 g cell paste. This protein
contained a significant amount of DNA contamination with a ma, of 269 and therefore the
protein concentration was determined by Bradford assay using HL'Y2-Y 4 as a standard.
6.2.7 Protein and iron concentration determination
The concentration of HiY2-Y4 and Fla8Y2-Y4 isolated from MHY343 was determined
using the known extinction coefficient (E280-310) per dimer of 99,800 M 1cm l. The concentration
of F"gY2 -Y 4 isolated from MHY619 and FlagY2 isolated from MHY614 was determined by
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Bradford assay using HmY2-Y4 as the standard. Iron concentration was determined by ferrozine
assay.(12)
6.2.8 Fa8gY2 -Y4 specific activity determination
A typical reaction mixture had a final volume of 150 tl and contained 100 mM Hepes
(pH 7.4), 20 mM MgCl2, 3 FxM Y1 (specific activity 200 nmol min'l mg'), 0.3 FM Y2Y4, 3 mM
ATP, 1 mM [ 4C]-CDP (specific activity of 1-2 x 103 cpm/nmol), 100 tM E. coli
thioredoxin,(13) 1 tM E. coli thioredoxin reductase,(14) and 2 mM NADPH. The assay mixture
was incubated at 30°C and 30 Rl aliquots were removed over 20 min and quenched in a boiling
water bath. dCDP was analyzed by the method of Steeper and Stewart.(15) The specific activity
was calculated per mg of Y2.
6.2.9 Absorption spectrum of HY 2 -Y4 diferric-Y. cofactor
The light absorption spectra were recorded on an Agilent 8453 UV-Vis
spectrophotometer. H"Y 2-Y 4 reconstituted as previously described utilizing H'Y 2 and Y4
isolated from E. coli.(7) For hydroxyurea (HU) subtractions, 39 FM HbY 2 -Y 4 (0.3 Y. per
heterodimer) in 50 mM Hepes (pH 7.4), 5% glycerol was treated with 20 mM HU (added from a
240 mM stock solution) for 45 min at room temperature. Spectra before and after HU treatment
were collected and subtracted.
6.2.10 RNR activity assay with partially purified S. cerevisiae extract
A yeast culture (2 L) was grown at 30 C to mid-log phase (1-3 x107 cells/mL) in YPD.
The cells were collected by centrifugation at 7,500 xg for 15 min. If the activity assay was not
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done on the same day as the cell growth, the cell pellet was washed with 50-100 mL of ice-cold
PBS with 30% glycerol and stored at -80 C.
All steps were carried out at 4C. The cell pellet (1 g) was re-suspended with 10 mL of
50 mM Tris-HCl (pH 7.9), 5% glycerol, 10 mM MgC 2, 300 mM (NH4)2S04, 1 mM EDTA, 1
mM DTT, 25 gg/mL aprotinin, 10 pM E-64, 0.4 mM AEBSF, 100 gg/ml of pepstatin, 100
!xg/mL leupeptin, 100 !Rg/mL chymostatin, 1 mM benzamidine, 10 mM NaF, 100 mM -
glycerophosphate, (buffer D). Cells were lysed with three passes through the French press
(14,000 psi) and cell debris was removed by centrifugation (30,000 xg, 30 min). DNA was
removed by the dropwise addition of polyethylenimine (2% stock solution adjusted to neutral
pH) to a final concentration of 0.2%. The precipitate was removed by centrifugation (30,000 xg,
30 min). The supernatant was treated with solid ammonium sulfate to 65% saturation (430
mg/mL). The precipitated proteins were collected by centrifugation (30,000 xg, 30 min). The
protein pellet was dissolved in a minimal volume of buffer D (2-3 mL) and 3 mL of the protein
was desalted with a Sephadex G-50 column (0.7 x 16 cm) equilibrated in 25 mM Hepes (pH
7.2), 25 mM MgSO4, 50 mM (NH4)2SO4 supplemented with the Complete protease inhibitor
tablet. The protein concentration was determined by Bradford assay using BSA as the standard
and immediately used in activity assay without freezing. Freezing and storage at -80 °C was
found to decrease the activity in crude extracts.
The assays contained 2-5 mg/mL extract, 30 mM DTT, 3 mM ATP, 1 mM [14C]-CDP
(5000 cpm/nmol), 100 mM Hepes (pH 7.2), 20 mM MgSO4, and 10 mM NaF. All components
except crude extract were mixed and pre-incubated at 30 C for 5 min. The assay was initiated
by the addition of crude extract that was also equilibrated to 30 'C. Aliquots (30 L) were
removed over 30 min and quenched in a boiling water bath for 2 min. After adjusting the pH to
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8.5 by the addition of 50 FAL of 1 M TRIS (pH 8.5), alkaline phosphatase (60 U) and 2'-
dcleoxycytidine (0.5 Rmol) were added and the mixture was incubated at 37 C for 3 h. The
products were analyzed by the method of Steeper and Steuart.(15)
6.2.11 Western Blotting
An aliquot of crude extract (100-500 tIL) was removed from the sample generated for
whole cell activity assays as described above, before the precipitation of DNA. A portion of this
aliquot was utilized to determine the protein concentration by a Bradford assay. The crude
extract used for Western blotting was diluted into 4x Laemmli (1 part Laemmli to 3 parts crude
extract), frozen in liquid nitrogen and stored at -80 C.
For Western blot analysis, purified RNR subunits, H'sY1, HbY2, Y3 or Y4 (2-100 ng) and
crude extract (1-10 jig) were run on a 10% SDS-PAGE gel (BioRad Criterion Gel). Protein was
transferred to PVDF (Sequiblot PVDF, BioRad) using a tank transfer unit in transfer buffer (25
mM Tris, 192 mM glycine, 10%/ methanol, 0.1% SDS, 4 C) at 56 volts for 90 min. The
polyclonal Abs used were raised against each RNR subunit purified from E. coli expression
systems as described.(16) The Y1 antibodies were incubated with an acetone powder (1% (w/v)
solution, 2 h) generated from a RnrlA strain as described(17) before use in Western blotting. For
Y2 and Y4 blots, the polyclonal antibodies were used at a 1:10,000 dilution, while the Y1 and
Y3 blots used a 1:1,000 dilution. Western blots were carried out as described previously except
that the blots were developed with the DuraWest Chemiluminescent Reagent (Pierce).(7) The
chemiluminescent signal was detected with a CCD camera (ChemiDoc XRS, BioRad). Bands
were quantified using BioRad's QuantityOne software.
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6.2.12 Preparation of whole cell EPR samples
A yeast culture (1 L) was grown to mid-log phase (2 x 107 cells/mL) in YPD at 30 °C.
The doubling time was 90 min for all strains. For treatment of BY4741, MMS was added to a
final concentration of 0.02% (v/v) for the last 2 h of cell growth. For treatment with
hydroxyurea, solid HU was added to a final concentration of 150 mM for the last h of cell
growth. The cells were collected by centrifugation at 7,500 xg for 15 min. The cell pellet was
washed two times with 1 L of ice-cold phosphate buffered saline (PBS). The pellet was then re-
suspended in PBS with 30% glycerol to a final concentration of 1-3 x 1010 cells/mL. The
concentration of cells in the sample was determined by cell counting using a hemacytometer.
For each sample, three independent dilutions were made and the average was used as the cell
concentration for the data analysis. The standard deviation was typically 15-20%. The cell
suspension was transferred to an EPR tube and frozen in liquid nitrogen.
6.2.13 EPR quantitation of Ye content
Two different spin standards were used for Ye determination. E. coli R2 was used to
generate a standard curve with Ye concentrations ranging from 1-115 FM. The R2 concentration
was determined using the E280 131 mM'lcm l and Ye content was determined by the drop-line
correction method.(18) The second spin standard was CuSO4 (1.022 mM, >99.99% pure) in 2 M
NaC104, 0.01 M HC1, 20% (v/v) glycerol. The concentration of Cu2+ was determined using e810
11.79 mM'cm '.(19) Typically, purified '9Y2-Y4 samples used for EPR quantitation had a
protein concentration of about 10 AM. Whole cell EPR samples were prepared as described
above.
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EPR spectra were recorded using a Bruker ESP-300 X-band (9.4 GHz) spectrometer
equipped with an Oxford liquid helium cryostat to maintain the temperature at 30 K for all
samples. For Ye samples, typical instrument parameters were: centerfield, 3340 G; sweep width,
100 G; resolution, 2048 points; frequency, 9.38 GHz; modulation amplitude, 2.0 G; conversion
time, 81.920 ms; time constant, 40.960 ms; sweep time, 167.772 s; gain, 0.2-5x105; 3-30 scans;
power, 0.201 or 2.526 x 10' 3 mW for the yeast and E. coli Ye, respectively. For copper standard
typical instrument parameters were: centerfield, 3000 G; sweep width, 1000 G; resolution, 2048
points; frequency, 9.38 GHz; modulation amplitude, 8.0 G; conversion time, 20.48 ms; time
constant, 5.120 ms; sweep time, 41.943 s; gain,lxl104 ; scans, 3; power, 5.029x102 mW. Spin
quantitation was carried out by double integration and comparison to standards of known spin
concentration.
6.2.14 Fourier-transform mass spectrometry to identify the site of F'Y 2 phosphorylation
The determination of site of Y2 phosphorylation was completed by Leslie Hicks in the
laboratory of Prof. Neil Kelleher at the University of Illinois, Urbana-Champaign, IL. Cyanogen
bromide (CNBr) digestion of the F7agy2-Y 4 heterodimer (100 ng) was performed by the addition
of 60 tl of 100% formic acid and 40 pl of 5M CNBr in CH3CN. The final reaction volume was
200 ld. The sample was incubated at 4°C for 15 h in the dark. The entire sample was frozen and
lyophilized to dryness. The residue was solubilized in 400 gl of 100 mM NH4OAc (pH 4), 6 M
urea, 5 mM Tris(2-carboxyethyl)phosphine (TCEP) and 10%/ CH3CN for 1 h at room
temperature and injected onto a Jupiter C4 reverse-phase column (4.6 x 150 mm, Phenomenex).
A linear gradient from 30%-70% CH3CN with 0.1% TFA was applied over 40 min at 1 mL/min
for fractionation/desalting prior to FTMS analysis. The species of interest eluted in the 18-19
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min fraction. Fractions of interest were lyophilized and solubilized in ESI buffer (49% H2 0,
49% CH3OH, 2% formic acid) for FTMS analysis.
Electrospray ionization (ESI) was used with a custom Q-FTMS instrument operating at
8.5 Tesla.(20) The ions were directed through a heated metal capillary, skimmer, quadrupole,
and multiple ion guides into the ion cell (-10-9 Torr) of the FTMS. Scans were acquired every
200 ms - 8s and data stored with a MIDAS datastation (21) as 512 K data sets. Spectra were
calibrated externally using bovine ubiquitin (Mr = 8559.62 Da) and theoretical isotopic
distributions were generated using Isopro v3.0 and fit to experimental data by least squares to
assign the most abundant peak. Tandem mass spectrometry (MS/MS) was achieved through
either collisionally activated dissociation (CAD) or electron capture dissociation (ECD).
High-resolution mass spectrometry of large molecules results in isotopic distributions
within the mass spectra.(22, 23) The molecular weights derived from FTMS data are reported as
monoisotopic values, which refers to the molecular ion peak composed of the most abundant
isotopes of the elements including the mass defect (i.e. C=12.000000, N=14.00307, etc.).
Assignment of isotopic distributions to the corresponding CNBr peptide involved correlating the
experimental monoisotopic molecular weights to the theoretical monoisotopic molecular weights
for the enzyme carrying the post-translational modification, with a maximum error tolerance of
15 ppm.
6.2.15 Identification of proteins co-purifying with FIY2-Y4
Samples of F"aY4-Y4 (40 !tg) were analyzed on a 5-15% gradient gel (Biorad).
Following staining by Coomassie brilliant blue, bands were cut out of the gel and submitted to
the Protein Sciences Facility at the University of Illinois (Urbana-Champaign, IL). Each sample
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was digested with 25 IAL of sequencing grade modified trypsin (Promega) reconstituted in 25
mM ammonium bicarbonate at 12.5 ng/RL. The trypsin digestion proceeded at 37°C for 8 h. At
the end of digestion, peptides were extracted three times using a solution containing 50%
CH3CN, 5% formic acid. The pooled extract was lyophilized to dryness and the sample was
solubilized in 12 RtL of 5% CH3CN, 0.1% formic acid and used directly for LC\MS. The
resulting peptides were separated and identified by MS/MS analysis using a Waters CapLC
system with a C-18 NanoEase Symmetry column (150mm, 3.5 micron particles, 300 A pore)
coupled to a Micromass Q-TOF Global Ultima using the Waters software package ProteinLynx
Global Server 2. 1.
6.2.16 Purification of Myc-tagged Wtml and Myc-tagged Wtm2
The yeast strains expressing genomically encoded 18x-Myc epitope tag appended to the
C-terminus of Wtml or Wtm2 were grown in YPD (6 L) to mid-log phase.(9) The cells were
harvested by centrifugation at 8,000 xg for 15 min and the cell pellets were stored at -80°C.
All protein purification steps were carried out at 4'C. The cell pellet (6-7g) was
resuspended with 50 mL buffer A with protease and phosphatase inhibitors as described for the
isolation of FlagY2. The cells were disrupted by 3 passes the French Press at 14,000 psi. Cell
debris was removed by centrifugation at 30,000 xg for 20 min and the supernatant was incubated
with 750 1L of Anti-Myc Agarose with gentle agitation for 1 h at 4°C. The mixture was poured
into a column and the column was washed with 100 mL of Buffer A supplemented with two
Complete protease inhibitor tablets. The bound protein was eluted with 5 mL of 100 mM
NH4OH. The eluate was neutralized by the addition of 1M acetic acid and then concentrated
vvith a Centriprep YM10 to <500 CIL.
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6.3 Results
6.3.1 Rapid Isolation of R2 from S cerevisiae
Determination of R2's cofactor stoichiometry in vivo requires rapid isolation of R2
without over-expression. The yeast strain MHY343, with an amino-terminal fusion of the
FLAG epitope (MDYKDDDDKH) to Y2 under control of the RNR2 promoter, was constructed
for this purpose. The N-terminus of Y2 was chosen, as the C-terminus is required for R1-R2
interaction.(24-29) If the presence of this tag negatively affects Y2 activity in vivo, it is expected
that the strain would have a slow S-phase progression and thus a longer doubling time and/or
sensitivity to genotoxic stress induced by hydroxyurea (HU), a reductant of the Y. resulting in
inactive R2. MHY343 has the same doubling time as the wild type (wt) strain and the cells have
a normal size and appearance. The strain also grows similar to a wt strain on solid YPD medium
containing 50 mM HU (M. Huang, personal communication). Consistent with this observation,
MHY343 has the same concentration of Y. as wt cells, as judged by whole cell EPR (data not
shown). Finally, the tagged Y2 shows the same nucleus to cytoplasm shuttling seen with wt-Y2
in response to S phase or genotoxic stress.(10) These observations suggested that presence of the
10 amino acid tag does not grossly effect Y2 function in vivo.
The FLAG tag allowed for rapid isolation of yeast R2 from the bulk of proteins in the
crude extract within 2 h of cell disruption. The entire isolation was completed in about 4 h. To
ensure that the amount of Y. was not changed due to storage (of the cell pellet or the purified
protein at -80'C), a number of control experiments were carried out. EPR spectroscopic
experiments established that freezing and thawing of the whole cells does not affect the radical
content. Furthermore, the concentration of Y. in crude extracts does not decrease during a 4 h
incubation on ice. Finally, freezing and thawing of the purified heterodimer does not change its
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Yo content as judged by UV-Vis spectroscopy. Thus this procedure does not lead to a decrease
in the heterodimer Ye content and therefore, the amount of Ye associated with the purified
protein should be indicative of the amount of Ye in MHY343 and therefore the Ye content in wt
cells if the Flag-tag does not interfere with the assembly of Ye in vivo.
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Figure 6.1 SDS-PAGE (10%) of purified F"Y2
A) na'Y2 from MHY343 (lane 1), MHY619 (lane 2) and MHY614 (lane 3). Lanes 1 and 2
contain 3 Ctg of protein and lane 3 contains 1.5 jpg. The major co-purifying protein is marked
with a *. B) same as A with ten fold more protein loaded per lane.
FlaY2-Y 4 has been isolated from MHY343 in three separate experiments. Figure 6.1 shows a
SDS-PAGE gel of a typical isolation. In all cases, one protein reproducibly co-purified with the
F4aY 2-Y4 heterodimer (marked with an * in Figure 6.1A and B, lane 1). Densitometry of
Coomassie stained SDS-PAGE gels revealed that the heterodimer was >90% pure with this co-
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purifying protein constituting -5% of the total protein in the sample, assuming it stains with the
same intensity as FlagY2 and Y4. The Xa o f FlagY2-Y4 heterodimer was 279 nm. Therefore, the
previously determined E280-310 for the apo-HY2-Y4 heterodimer was used to determine the
concentration of FlagY2-Y4. However, it should be noted here that the E for the heterodimer has
not been independently determined and is an average of the extinction coefficients of the HY 2
homodimer and the Y4 homodimer.(7, 30) This E differs from the theoretical E and the E
determined by Thelander and co-workers by ~10%.(31) Furthermore, this E is calculated for the
apo protein. The extinction coefficient of apo and holo E. coil R2 is 121 mM'1cm'l vs. 131 mM'
cm', respectively. Considering these caveats, the error associated with determination of protein
concentration using this method is 30 %.
The amount of heterodimer recovered by affinity purification is reasonable given our
previous determinations of the heterodimer concentrations in vivo.(7) For example, in the
isolation that gave the highest recovery of heterodimer, 120-240 pg was expected from 4 x 10 °0
cells (2g) given an in vivo concentration of 0.5-1 jpM and 150 pg was recovered. Other
isolations resulted in lower yields (ca 15-30 gg per g of cell paste, Table 6.2), which is
attributable to variable lysis efficiency at low volume to g cell ratios used. Two mL of lysis
buffer per g of cells was typically used despite the variability in cell wall disruption as this
method led to the isolation of larger amounts of co-purifying proteins, which facilitated their
identification.
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Table 6.2 Summary of results from "pY2 isolations
Strain Yield Specific Activity Iron content Ye content
(pg per g of cell paste) (nmol min' l mg') (irons per heterodimner) (Ye per heterodimer)
MHY343 a 75 1895 qDb 0.4
MHY343 16 2190 1.4 0.5
MHY343C 27 2835 1.5 0.4
MHY343-
MMS treated 35 2100 1.6 0.5
MHY619 360 ND ND 0.5
MHY614 100 < 5 ND <0.03
a Resuspended with 10 mL of buffer A per g of cell paste instead of 2 mL per g of wet cell paste
used for all other isolations.
b ND - not determined
C 3x FLAG peptide removed by G50 column rather than repeated dilution and concentration.
The FlagY2-Y 4 heterodimer has a specific activity of 2.3 + 0.5 !xmol min'lmg'L. The iron
and radical content were 1.45 ± 0.05 irons per heterodimer and 0.45 + 0.08 Ye per heterodimer
(Table 6.2). The UV-Vis spectrum of 'Y2-Y4 is indistinguishable from that of HWY2-Y4,
obtained by reconstitution of the cluster from H"Y2 and Y4 expressed in E. coli (Figure 6.2A).
To further characterize the yeast diferric-Y. cofactor, the heterodimer was treated with
HU to determine the UV-Vis spectrum of the Ye. HY2-Y4 was incubated with HU and spectra
before and after treatment were recorded and subtracted (Figure 6.2B). The region from 300-800
nm has absorption features characteristic of a diferric-Y. cofactor. Features at 330 and 370 nm
are attributed to the diferric cluster and the features at 400 and 416 nm are attributed to the Y.
The feature at 416 is quite broad as compared to the light absorption spectrum of E. coli R2. The
difference spectrum (trace 3 and inset, Figure 6.2B) resembles those previously reported for
mouse, Arabidopsis, and vaccinia virus R2.(32, 33)
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Figure 6.2 Characterization of diferric-Y. cofactor by UV-Vis and EPR spectroscopy.
A) UV-Vis spectra of diferric-Y* cofactor comparing H"Y2 -Y4 (black) generated by in vitro
reconstitutions and OzY2-Y4 (red) isolated from yeast crude extracts. B) Spectra of HbY 2-Y4
heterodimer before (1) and after (2) treatment with HU (20 mM, 45 min) and the subtraction (3
and inset). C) EPR spectra of H"Y2-Y4 heterodimer (red) and F·Y2-Y4 (blue).
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The EPR spectrum of the F1~Y2-Y4 heterodimer is shown in Figure 6.2C and again, it is
similar to the spectrum acquired with H"Y2-Y 4 heterodimer. In the Chapter 4, the specific
activity of the H"Y2 -Y4 heterodimer was shown to be correlated with its Ye content for the first
time. When corrected for the amount of Ye, the "FY2-Y4 isolated from yeast crude extracts has
activity comparable to that of our in vitro reconstituted HiY2 -Y 4 (Figure 6.3).
2.0-
ii 1.0
0-
0.1 0.3 0.5
Ye per Heterodlmer
Figure 6.3. Quantification and characterization of the diferric-Y* cofactor
The specific activity of yeast R2 is proportional to the Ye content. Results from several in vitro
reconstitutions of the H"Y2-Y4 heterodimer (*) are plotted along with Fl*rY2-Y4 isolated from wt
strain (n) and MMS treated cells (.).
6.3.2 Isolation of R'9Y2 from MMS treated cells
Our results demonstrate that while the heterodimer isolated from yeast crude extracts has
more diferric-Y* cofactor than the heterodimer isolated after heterologous over-expression in an
E. coli expression host, we do not observe stoichiometric amounts of Y* (Table 6.2). This result
indicated to us that, the cell might uses the assembly and destruction of the diferric-Y* cofactor
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as a mechanism of RNR regulation in vivo. We hypothesized that a system exists in yeast that is
similar to the system characterized in E. coli crude extracts which allows for assembly of holo-
R2 from met-R2 (R2 with the diferric cluster but reduced Y.).(34-39) To test this hypothesis and
to understand how the Ye stoichiometry might change under conditions in which more RNR
activity is required in vivo, we treated MHY343 with MMS to induce a DNA damage response
and isolated the FlagY2-Y4 heterodimer from these MMS treated cells.
FagY2-Y 4 was isolated from cells which had been treated with 0.01% MMS for 1.5h.
This heterodimer had a purity comparable to that of FlagY2 -Y4 isolated from MHY343 without
MMS treatment (not shown). FagY2 -Y4 from MMS treated cells had 0.5 Ye, 1.6 irons per
heterodimer and a specific activity of 2100 nmol min'l mg' (Table 6.2). Therefore, under these
conditions, MMS treatment did not lead to considerably more cofactor associated with the
heterodimer.
6.3.3 Isolation of FlgY2 from CrtlA strain
Induction of Y2 and Y4 transcription in response to genotoxic stress is regulated by the
transcriptional repressor Crtl.(40, 41) Deletion of this repressor leads to up-regulation of RNR2
and RNR4 transcript levels. We wanted to investigate if deletion of this repressor also leads to
increase in the Y2 and Y4 protein levels (discussed in the following section) and more
importantly if this induced protein assembles a diferric-Y. cofactor. FasY 2 -Y 4 was isolated from
MHY619, a CrtlA strain expressing the Flag epitope tagged Y2. Consistent with the measured
increase in Y2 and Y4 concentration upon deletion of CRTI, 360 g of FlaY 2 -Y4 heterodimer
was isolated per g of MHY319 cell paste, which is roughly 15 fold higher than the amount
routinely isolated from MHY343 (Table 6.2). While the isolated protein is homogenous by SDS-
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PAGE gel (Figure 6.1, lane 2), the FagY2-Y 4 heterodimer has an A260/A280 ratio different from
that of the heterodimer isolated from MHY343 due to the presence of DNA in the sample.
Therefore the Bradford assay was used to determine the protein concentration. This protein had
0.5 + 0.05 Ye. These results demonstrate the over-expression of Y2 and Y4 induced by deletion
of the Crtl repressor protein results in an increase in active R2, with comparable cofactor loading
as observed in wt cell background.
6.3.4 Isolation of Fl'Y2 from the Rnr4A strain
We know that Y4 is required to assemble the diferric-Y. cofactor in vitro and in vivo (as
described in the previous two chapters).(7, 16, 31) Whole cell EPR experiments have
demonstrated the Rnr4A strain has at least 15 fold less Ye than the wt strain. However, the
presence an overlapping signal in the EPR spectrum of the whole cells prevented determination
of the exact Ye concentration. Thus efforts were made to measure the Ye associated with FlagY 2
isolated from a Rnr4A strain.
MHY614 grows considerably slower than the wt strain with a doubling time of 8-9 hours
at 25°C in rich media. The cells are large and elongated, a phenotype characteristic of a defect in
I)NA replication, which is expected as this yeast strain has a defect in RNR activity due to a
defect in Y2 cofactor assembly. 7lagY2 was isolated from this strain and was homogeneous by
SDS-PAGE (Figure 6.1, lane 3). The protein remained soluble during the purification,
demonstrating that Y2 is capable of at least partially folding in the absence of Y4 in vivo. As
observed with FagY 2 - Y 4 from MHY619, Flagy2 from MHY614 has a significant amount of DNA
contamination (, of 262 nm). Therefore, the protein concentration was determined by
Bradford assay. As predicted, the Flagy2 had significantly less Ye and activity than FlagY2-Y4.
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No Ye could be detected in a 16 pM sample, meaning the protein must have less than 0.03 Y. per
homodimer or 30 fold less Ye per Y2 protomer when compared to Yo content of the heterodimer.
Furthermore, Fr"gY2 could not catalyze nucleotide reduction in vitro, meaning the activity must
be less than 5 nmol min' mg' l or roughly 500 fold less activity than the FlagY2-Y4 heterodimer
isolated from wt cells.
6.3.5 Characterization of diferric-Yo cofactor in wt whole cells by Western blotting and
whole cell EPR
The reproducible substoichiometric amounts of Y. per F4lgY2 -Y4 caused us to be
concerned about the effects of the Flag-tag on di-iron cluster assembly in vivo. Thus, we have
characterized RNR in vivo using quantitative Western blotting, whole cell EPR and crude extract
activity assays.
As already described in the previous chapter, the concentration of Y2 and Y4 in BY4741
was measured by quantitative Western blotting to be 0.82 0.24 M and 0.50 ±0.15,
respectively (Figure 6.4A and B, Table 6.3). The concentration of Ye in vivo was measured by
whole cell EPR to be 0.82t0.16 FM Ye. Therefore, these results predict that all of the
heterodimer in vivo should have a di-iron Ye cofactor as the concentration of Ye is equal to the
concentration of Y2.
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Figure 6.4 Quantitative Western blotting to determine RNR concentration in wt, MMS
treated wt, and CrtlA strains.
Shown for each subunit is the standard curve generated with the purified RNR subunit. The
amount of protein used to generate each point is indicated above each lane (in ng quantities for
the purified RNR subunits and pg quantities for crude extracts). Determination of the
concentrations of Y2, Y4, Y1 an Y3 are shown in parts A, B, C, and D, respectively.
Table 6.3 Concentration of RNR in vivo determined by quantitative Western blotting
Strain [Y*] [Y2] [Y4] [Y1] [Y3]
(OtM) (SAM monomer) (RlM monomer) (4M monomer) (4&M monomer)
BY4741 0.82±0.16 0.82±0.24 0.50±0.15 0.63±0.19 <0.03
Sml1A 0.84±0.17 0.79±0.24 0.80-0.24 0.65-0.20 <0.03
CrtlA 13.97±2.79 14.17±4.25 24.38±7.32 0.42±0.13 2.26±0.68
BY4741-
3.89±0.78 3.02±0.91 3.19±0.96 1.01±0.30 0.43±0.13MMS treated
215
To confirm this stoichiometry, we investigated the concentration of Y2, Y4 and Ye in the
MMS treated wt cells and in the CRT deletion strain. After treatment with MMS (0.02%, 2 h),
the Ye concentration increased to 3.89±0.78 VI. Again, the concentration of Ye in the MMS
treated cells was roughly equal to the concentration of Y2Y4 heterodimer, determined to be
3.02+0.91 IAM and 3.19±0.96 paM for the concentrations of the Y2 and Y4 polypeptide,
respectively (Table 6.3 and Figure 6.4). The amount of Y. and Y2Y4 was also equal in the
CrtlA strain with the concentration of Ye, Y2, and Y4 being 13.97±2.79 PM, 14.17±4.25 PM
and 24.38+7.23 PM, respectively.
These results all suggest that the in vivo there is one Ye per heterodimer and are not
consistent with the stoichiometries measured with the F"agY2 heterodimer isolated from wt and
CrtlA strains. The initial characterization of the F4agY2 strains included determination of the
doubling time, phenotypic appearance, and HU sensitivity. These qualitative assays may not
reveal a defect in diferric-Y. cluster assembly if Y2Y4 activity does not limit RNR activity in
vivo.
6.3.6 Determination of Y1 and Y3 concentration in vivo
To determine what limits RNR activity in vivo, the concentrations of Y1 and Y3 in the wt
strain, MMS treated wt strain and CrtlA strain were measured. In wt cells, the concentration of
Yl(monomer) was found to be 0.63±0.19 pM (Table 6.3 and Figure 6.4). Y3 could not be
detected in wt crude extracts meaning its concentration is less than 0.03 pVM. Treatment of the
cells with MMS increased the concentration of Y1 to 1.01+0.3 pM. The concentration of Y3 in
MMS treated cells was determined to be 0.43±0.13 aM. Deletion of the CRTI leads to a
significant increase in the concentration of Y3 (2.26±0.68 pM). However, deletion of CRTI had
216
little effect on the concentration of Y1, which was expected as Crtl does not repress RNRI
transcription.(9, 40, 41) Thus, with the exception of the CrtlA strain, it is difficult to draw
conclusions about what limits RNR activity in vivo, as the concentrations of Y1, Y2 and Y4 are
similar. However, in the CrtlA strain, clearly Y1 is the limiting subunit.
6.3.7 Determination of RNR activity in vivo by CDP reduction assays with yeast crude
extracts
The ability to determine the concentrations of all the RNR subunits as well as the Y in
various deletion strains provided the opportunity to understand how changes in RNR subunit
concentration effects the activity of RNR in vivo. Therefore, the CDP reduction activity in
partially purified yeast crude extracts was measured as described in the previous chapter.(42-45)
As described in Chapter 5, the activity could not be measured in crude extracts and thus RNR
was partially purified by removal of the DNA followed by ammonium sulfate fractionation.
Therefore, all the assays described in this section were carried out using this partially purified
extract.
In the wt strain, the rate of dNDP formation in the partially purified extract is 0.07±0.01
nmol min' mg-' (Figure 6.5A and Table 6.4). As already described in chapter 5, the addition of
Y1 into the extract increased the reductase activity in crude extracts to 3.69 nmol-min mg-'.
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Figure 6.5 RNR activity assays in yeast crude extracts
The RNR activity in BY4741 (A, black), SmllA (A, red), MMS treated BY4741 (B), and CrtlA
(C) crude extracts. The amount of dCDP produced per mg of crude extract in crude extracts
(triangles), crude extracts with 3 pM H"Y2-Y 4 (circles) and in crude extracts with 3 xpM Y1
(squares) is shown for each crude extract. The inset shows the amount of dCDP produced per
mg of crude extract for the crude extract assays with and without H"Y2-Y4 .
218
04 0
0 AoS 0 AA
40
20
0
0
0
15
A A
0 20 40
0 A
A A
· &
Tr -
4
4
U
0 20 40
| o * • A
k
~-- -r
Table 6.4 CDP reductase activity in yeast crude extracts
Strain Specific activity (SA) SA with 3 tM Y1 SA with 3 M Hi'Y2-Y4
nmol-min'l-mg nmol-min'l-mg' nmol-min'l'mg
BY4741 0.0740.01 3.7±0.6 a NDb
Smll 1A 0.08±0.01 5.2+0.8 0.224-0.03
BY4741
0.44±0.070 8.5±1.3 0.59±0.09MMS treated
CrtlA 0.19 + 0.03 8.3±1.2 0.22+0.03
a only 1 M Y1 was added
bND - not determined
As already discussed in the previous chapter, the specific activity of the extract generated
from the SmllA strain had the same activity as the wt crude extracts. Addition of HbY 2 -Y 4 into
the extract stimulated CDP reduction activity to 0.22±0.03 nmol min mg"' (Table 6.4).
Therefore, without the addition HbY2 -Y4, there is a large amount of Y1 not present in the
Y1 Y2Y4 complex.
We also determined the CDP reductase activity in extracts generated from the CrtlA and
BY4741 MMS-treated wt crude extracts. The MMS treated extracts had a CDP reduction
activity of 0.44±0.07 nmol minl mg', -6 fold more activity than observed in untreated extracts
(Table 6.4 and Figure 6.5B). Interestingly, the addition of HY 2 -Y 4 into the extract did not lead
to a large increase in RNR activity as was observed with the wt extracts (Figure 6.5B, inset).
The activity increases to from 0.44±0.07 nmol min'-lmg' l to 0.59±0.09 nmol min-'lmg l1 or 1.3
fold. In contrast, the addition of Y1 into the extract again leads to a large increase in RNR
activity to 8.5±1.3 nmol min 1 mg' 1. These results show that Y1 activity is limiting RNR activity
in MMS treated extracts. Thus, in the MMS extract assay, the Y1 is almost completely saturated
with Y2Y4.
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The CrtlA extract also had higher activity than the wt extracts, 0.19±0.03 nmol min' mg-
'. The addition of H"Y2 -Y 4 into the extract did not lead to an increase in activity (Figure 6.5C,
inset). Therefore, the deletion of CRTI leading to a -15-20 fold increase in holo-Y2Y4 leads to
complete saturation of Y1 in the crude extract assay. The addition of Y1 again leads to a 40-fold
increase in RNR activity to 8.3±1.2 nmol min mg 'l. Thus, deletion of the repressor leads to a
huge up-regulation of Y2Y4 which serves to completely saturate Y1 in vivo.
6.3.8 Identification of a Y2 phosphorylation site
While our goal with the FlagY2-Y 4 isolations was to determine the cofactor stoichiometry
in vivo, we noted that a fraction of our Flagy 2 was modified by phosphorylation. Since we were
able to isolate g quantities of FagY2, the site of post-translational modification could be
identified by mass spectrometry. Before we began these experiments, we had some indications
that Y2 is a phosphoprotein (M. Huang, personal communication). Y2 often appears as a double
band in Western blots and these two bands collapse into one upon treatment with a phosphatase
(Figure 6.6A, lanes 1 and 2). Since transcription of RNR2 is regulated by the
Mecl/Rad53/Dunl kinase pathway, it was hypothesized that this phosphorylation might be
related to DNA damage response. However, treatment of the cells with HU or MMS did not
change the relative abundance of this phosphorylated species (Figure 6.6A, Data from M.
Huang). We also observed a phosphorylated species in our preparations of FagY2 isolated from
wt and CrtlA strains. SDS-PAGE analysis ofFlagY2 from the wt or CrtlA backgrounds reveals
the presence of a faint, slower migrating band (Figure 6.6B). Treatment of FlagY2-Y4 with a
phosphatase resulted in disappearance of this upper band, supporting the hypothesis that
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Figure 6.6. Identification of the Y2 phosphorylation site
A) Western blot of Y2 (top) and Y4 (bottom) from untreated cells (UN) and cells treated with
150 mM HU and 0.025% MMS for 1 h. The slower migrating band in the Y2 blots disappears
upon treatment with lambda phosphatase. B) SDS-PAGE of phosphorylated "'Y2. C) FTMS
spectrum of the 18-19 min fraction of CNBr digested ^"Y2-Y4; expansion of the 931-952 m/z
region containing 5+ ions of unmodified (4651.38 Da) and phosphorylated (4731.35 Da) Pro2-
Met43. Also visible are unrelated peptides (designated by their respective charge states) and
commonly observed adduct peaks (designated with asterisks). D) The fragment ion map
correlating the MS/MS ions derived from ECD (data not shown) of the phosphorylated peptide
(4731.35 Da) to the sequence for the Serl5 (circled) phosphorylated CNBr peptide Pro2-Met43
of '"g2. Eight c type (N-terminal containing) and five z" type (C-terminal containing) fragment
ions correspond to +79.97 Da above the unmodified from, localizing the modification to Aspl 1l -
Asp20.
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this slower migrating band was a phosphorylated form of ^agY2 (data not shown).
As a first step towards understanding the role of phosphorylation of Y2 in vivo, we
sought to identify the site of phosphorylation. To determine of the phosphorylation site, we
initiated a collaboration with the laboratory of Prof. Neil Kelleher. His group specializes in
Fourier-transform mass spectrometry, a high resolution mass spectrometry technique that can be
used to precisely identify sites of post-translational modification even if these modifications are
present at low abundance. Thus, all of the data presented in the following paragraphs was
collected by Leslie Hicks in the Kelleher Laboratory.
To identify the site of phosphorylation the FagY2-Y4 heterodimer was digested with
CNBr followed by HPLC fractionation of the products. The ESI/FTMS mass spectrum of the
peptides eluting in the 18-19 min fraction identified a 4651.38 Da peptide (Figure 6.6C), which
further analysis by CAD MS/MS revealed tto be Pro2-Met43 (data not shown). Also visible in
Figure 6.6C is a 4731.35 Da peptide that correlates to a phosphorylated form of the Pro2-Met43
peptide (+ 79.97 Da). This phosphorylated species was selectively isolated and subjected to
MS/MS by ECD, with the corresponding fragmentation map displayed in Figure 6.6D. The
fragment ion masses indicate the phosphorylation site is localized to the region between Aspl 1 -
Asp20O, a 10 amino acid stretch containing Serl5. Although phosphorylation of Asp and Lys are
possible, the inherent lability of these modifications make it highly improbable that these are the
modified sites in this peptide. Furthermore, efforts to identify co-purifying proteins as discussed
in the following section serendipitously identified a phosphopeptide corresponding to a peptide
from the N-terminus of Y2, Ala9-Lys23 with a phosphoserine at position 15 (data not shown).
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6.3.9 Identification of several proteins co-purifying with F'Y2
One co-purifying species and several minor species reproducibly co-purified with fagY2-
Y4 isolated from MHY343 (marked with * in Figure 6.1). The amount the co-purifying protein
varied slightly in different preparations of "'gY2-Y4 but it always accounted for 5% of the total
protein in the sample. To ensure this interaction was dependent on f7aY2 , a control isolation
using BY4741, which does not express any FLAG-tagged proteins, was carried out in parallel
with an isolation of Fg"Y2 - Y4 from MHY343. As shown in Figure 6.7, these co-purifying
proteins were only present in the sample in which RagY 2 was expressed and were not seen in the
control isolation. In this particular isolation, we observed less of the most abundant co-purifying
species however SDS-PAGE of this particular preparation clearly demonstrates the presence of
at least 5 distinct protein present in regions 1-3 (Figure 6.7). Interestingly, significantly less of
this co-purifying species was observed associated with the heterodimer isolated from the CrtlA
and Rnr4A strains (Figure 6.1).
1 2 kDa
r3 ,- 150Co-purifying 3 
- 100
proteins 2 1007
L ---
F18y2 4P 50
Y4 .. , 37
w,25
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Figure 6.7 SDS-PAGE (8%) of co-purifying proteins.
Lane 1 contains isolation of F49Y2 wt(flag) while lane 2 contains a mock isolation of from
BY4741 which does not contain a flag-tagged protein.
The regions marked 1-3 in Figure 6.7 were cut out of Coomassie stained gels, the protein
was digested with trypsin and the resulting peptides extracted and identified by MS/MS analysis.
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From band 1, 15 different peptides covering 48% of the sequence for Wtml and 10 peptides
covering 40% of the sequence for Wtm2 were identified. Attempts to identify the less abundant
proteins present in band 2 and band 3 were un-successful, resulting in identification of a small
number of peptides matching the folding chaperones Ssal and Ssbl. Since these are highly
abundant proteins that are found to co-purify with numerous tagged proteins, it is likely this is
not a specific protein-protein interaction that regulates RNR activity in vivo.(49, 50)
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Figure 6.8 SDS-PAGE analysis demonstrating that Y2Y4 co-purify with m-Wtml and
MYcWtm2.
Lane 1 and 4, Y2Y4 heterodimer; Lane 2 and 5, MW marker; Lane 3, mWtm2 purification;
Lane 6 *Wtml purification.
To firther confirm the interaction between Wtml, Wtm2 and Y2Y4, C-terminally
(Myc) 1s-tagged Wtml and (Myc)1s-tagged Wtm2 were purified from yeast crude extracts. The
cells were grown to mid-log phase and the *Wtml or *Wtm2 were isolated using Anti-Myc
Agarose. The two proteins co-purifying with *Wmt2 were Y2 and Y4 (Figure 6.8) and
densitometry analysis of the Coomassie stained SDS-PAGE gel revealed that M*Wmt2, Y2 and
Y4 were present in roughly equal amounts. Very different results were observed with *Wtm 1.
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Only a small amount of Y2Y4 were found to co-purify. However, these results clearly
demonstrate that Y2Y4 and Wtml and Wtm2 can form a complex in vivo.
6.4 Discussion
The ultimate goal of our studies of the yeast ribonucleotide reductase system is to
understand how the cell regulates the activity of RNR in vivo. While much is known about the
transcriptional regulation of RNR and two new forms of RNR regulation have been discovered in
S. cerevisiae, the R1 inhibitor Smll and the spacial and temporal regulation of Y2Y4
localization, surprisingly little is known about the enzymology of the system in vivo. As a first
step towards characterization of the yeast ribonucleotide reductase system two basic questions
have been addressed. First, what is the concentration of RNR in vivo, both during normal cell
growth and during response to replicational stress? Second, do changes in RNR concentration
specifically correspond to increases in RNR activity? This second question is particularly
important when interpreting data about the concentration of Y2Y4 polypeptides in vivo as the
diferric-Y cofactor must be assembled for this subunit to be active in nucleotide reduction. As
already demonstrated in the previous chapter, RNR activity is not necessarily proportional to
protein concentration. Though the Rnr4A strain has a Y2 concentration -15 fold higher than wt
cells, the total Y2 activity is at least 300 fold less than the activity of the Y2Y4 heterodimer
observed in crude extracts.
These findings led us to investigate the stoichiometry of Y2Y4 diferric-Y. cofactor in
vivo. We chose to study this problem through integration of a small affinity tag at the N-
terminus of the genomic copy of RNR2. This tag has allowed us to rapidly isolated FagY2-Y4
within hours of cell disruption. We found that FlgY2-Y4 isolated from wt yeast crude extracts
225
has 0.45±0.08 Ye, 1.45±0.05 irons and a specific activity of 2.3±0.5 Rmol min'mg' l.
Hypothesizing that the cell might assemble more co-factor in response to replicational stress, we
isolated FlagY2-Y4 from MMS treated cells and also from a cell in which the Crtl transcriptional
repressor was deleted. In both cases, we isolated protein with comparable radical and specific
activity as the l"agY2-Y4 isolated from wt cells.
In light of our findings that F'lgY2-Y4 had substoichiometric amounts of Ye cofactor, we
sought to characterize the cofactor stoichiometry in vivo by studying the Ye and Y2Y4 protein
concentration using whole cell EPR and quantitative Western blotting. These studies revealed in
the wt cells, wt cells treated with MMS and CrtlA cells, the concentration of Ye was equal to the
concentration of Y2. Thus these studies predicted that our FlagY2-Y4 should have 1 Ye per
heterodimer and not 0.5. While our initial characterization of Fa'gY2 strain had led us to the
conclusion that the Flag-tag was not interfering with Y2Y4 activity in vivo, the results from
characterization of the wt, untagged strain, caused us to re-consider this conclusion. Therefore,
we investigated what is limiting RNR activity in vivo to understand why a 50% reduction in the
concentration of active Y2Y4 in vivo did not lead to an observable phenotype in the FlagY2 strain.
As discussed in the previous chapter and here in this chapter, the CDP reductase activity
in wt and SmllA crude extracts is 0.07 nmol min lmg. The addition of Y1 or Y2Y4 into the
SmllA extract assays increases the activity to 0.22 and 5.2 nmol'min' 'mg', respectively.
Clearly, there is significantly more activity per mg of extract when HL'Y 2-Y 4 is added then when
Y1 is added. Since the concentration of Y2Y4 is roughly equal to the concentration of Y1 in
vivo, these results demonstrate that the specific activity of Y1 is lower than the specific activity
of Y2Y4 in vivo. This is similar to what we observe in vitro where the specific activities are
200-250 vs 1500-1700 nmolmin'l·mg l for Y1 and HaY2, respectively.
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Examination of the MMS treated wt and CrtlA strains support the hypothesis that Y1
limits RNR activity in vivo. In these assays, the addition of HLY2 -Y 4 into the crude extract CDP
reductase assay did not lead to a significant increase in the specific activity of these crude
extracts, however addition of Y1 led to a -20 fold increase in the specific activity of these crude
extracts.
Together, these results demonstrate that Y1 limits RNR activity in S. cerevisiae and
furthermore provide an explanation for why we did not observe a phenotype with the MHY343
that would have led us to believe that the insertion of the N-terminal Flag-tag interfered with
cluster assembly in vivo. Currently, it is unknown how the metallo-cofactor is assembled in vivo
and thus it cannot be predicted what effect an N-terminal tag would have on this process.
However, there is precedent that appendage of a C-terminal epitope tag can effect the
concentration of Y1 and Y2 in vivo as discussed in the previous chapter.
In addition to providing insight into the stoichiometry of Y2Y4 cofactor insertion in vivo,
these results provide the foundation for building a quantitative model of Y1 Y2Y4 complex
formation in vivo. To do this analysis, we made the following assumptions to simplify the
situation, which in reality is quite complex. First, we assumed that all Y2Y4 is available for
complex formation. However, it is known that Y2Y4 is normally localized to the nucleus while
most of Y1 is localized to the cytoplasm.(10, 51) In S-phase or following genotoxic stress,
Y2Y4 leaves the nucleus and enters the cytoplasm thus allowing for formation of Y1 Y2Y4
complex. The second assumption we made is that the Y1 concentration we measured using
quantitative Western blots is concentration of Y1 in all cells in vivo. As described in the
previous chapter, this is also not an accurate representation of what is known as it has been
demonstrated that the amount of Y1 changes as a function of the cell cycle. However, since we
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do not know the concentration of Y1 in S-phase, we have used the average concentration of Y1
measured here. Finally, we estimated that the Kd for Y1/Y2Y4 interaction is 0.2 pM, based on
estimations of the Kd of E. coli and mouse R1/R2 interactions. With these caveats in mind, we
can calculate that the concentration of Y1Y2Y4 complex in vivo is 0.23 pM. This calculation
predicts that 26% of the cell's Y1 is not involved in formation of this complex and 71% of the
cell's Y2Y4 is free. It was noted that with the CrtlA strain, the addition of H'Y2-Y4 into crude
extract assays did not lead to an increase in the CDP reductase activity of crude extracts meaning
that in this extract, Y1 is completely saturated with Y2Y4. Our calculations support this
hypothesis. In the CrtlA extracts the concentration of Y1 Y2Y4 complex is 0.31 pM and the
amount of free Y1 free drops from 26% (in wt extract) to only 1.5%. Most interesting is the
calculation with the MMS treated cells. The concentration of Y1 Y2Y4 complex is 0.47 FM,
with the free Y1 and Y2Y4 being 7% and 85%, respectively. This is the highest calculated
concentration of complex in vivo and we also observe the highest activity in MMS crude
extracts.
As a bonus to our attempts to isolate yeast R2 without overexpression, we have identified
a Y2 phosphorylation site and a specific protein-protein interaction with Wtml and Wtm2. The
significance of the substoichiometric amounts of phosphorylation (Serl5) in the regulation of Y2
in vivo remains to be unraveled. Sequence alignments with other eukaryotic R2s reveals that this
particular amino acid is not conserved, though in general, alignments in the N-terminal region of
R2 are poor. Interestingly, Wright and co-workers have previously characterized a
phosphorylation site at the N-terminus of the mammalian R2.(52, 53) They demonstrated that
Cdc2 can phosphorylate Ser20 of mammalian R2 in vitro and in vivo. However, the role of this
phosphorylation is not known. Alignment of >40 sequences of known eukaryotic R2s reveal that
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the sequence context surrounding these two sites are very different, indicating that different
kinases phosphorylate these residues in vivo. Further work is required to understand the role of
these phosphorylation events in vivo.
Finally, Wtml and Wtm2 were found to constitute 5% of the total protein in the sample
of Fas'Y2-Y4 isolated from MHY343. This interaction has previously been identified in a strain
in which epitope-tagged Wtm2 was over-expressed and purified.(49) The isolation of *Wtm2
resulted in near stoichiometric co-purification of Y2Y4 while purification of MCWtml gave
much lower amounts of Y2Y4. These results suggest that Wtm2 is responsible for the
interaction with Y2Y4 in vivo however a caveat to this conclusion that must be considered is the
huge C-terminal tags used in these isolations.
Previous experiments in which Wtml and Wtm2 were first identified, it was proposed
that these proteins are transcriptional repressor proteins involved in meiosis.(54) However,
investigations into the regulation of Y2Y4 localization in vivo have revealed that these proteins
play a role in the nuclear localization of Y2Y4 (M. Huang, personal communication). When
Wtml is deleted, Y2Y4 is localized predominantly in the cytoplasm. The importing Kap 122 has
also been identified to play a role in Y2Y4 localization in vivo and furthermore, a protein-protein
interaction between Wtml and Kap 122, an importin protein which shuttles between the nucleus
and the cytoplasm to import proteins into the nucleus, has been identified by co-
immunoprecipitation (M. Huang, personal communication). Thus, it appears this protein-protein
interactions found by co-purification with FRagY2 plays an important role in the subcellular
localization of Y2Y4 in vivo.
Thus, the identified protein-protein interaction identified with ~fagY2-Y4 and Wtml and
WNtm2 plays a role in regulating the nuclear localization of yeast R2 in vivo. To isolate pure
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F"gY2 -Y 4 for its characterization, the Anti-Flag agarose was washed with >100 column volumes
of buffer. Therefore, perhaps many other interesting protein-protein interactions could be
identified if these experiments were repeated and the column washed with less buffer to identify
lower affinity interactions. It is hoped that these future experiments will reveal insights into
other protein-protein interactions regulating RNR in vivo particularly proteins potentially
involved in diferric-Y. cofactor insertion in vivo.
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Purification of ribonucleotide reductase subunits Y1,
Y2, Y3, and Y4 from yeast: Y4 plays a key role in
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Ribonucleotlde reductases (RNRs) catalyze the conversion of nu-
cleotides to deoxynucleotides. Class I RNRs are composed of two
types of subunits: RNR1 contains the active site for reduction and
the binding sites for the nucleotide allosterk effectors. RNR2
contains the dllron-tyrosyl radical (Y.) cofactor essential for the
reduction process. Studies In yeast have recently Identified four
IRNR subunits: Y1 and Y3, Y2 and Y4. These proteins have been
expressed In Saccharomyces cerevislae and in Escherichla coil and
purified to =90% homogeneity. The specific activity of Y1 Isolated
from yeast and E. col is 0.03 gsmolmin-l-mg-1 and of (HIs)-VY2
[(His)6-Y2-K387N] from yeast Is 0.037 Amolmin--mg - 1' (0.125
smoimin-'mg- 1 ). Y2, Y3, and Y4 isolated from E coil have no
measurable activity. Efforts to generate Y. in Y2 or Y4 using Fe2+,
,02, and reductant have been unsuccessful. However, preliminary
studies show that Incubation of Y4 and Fe2+ with Inactive E. coil Y2
followed by addition of 02 generates Y2 with a specific activity of
0.069 ptmomln-'-mg- and a Y.. A similar experiment with (HIs)6-
Y2-K387N, Y4, 02, and Fe2+ results in an Increase in ts specifk
activity to 0.30 trmolin-ng- 1. Studies with antibodies to Y4
and Y2 reveal that they can form a complex in vivo. Y4 appears to
play an Important role in dllron-Y- assembly of Y2.
ibonucleotide reductases (RNRs) in all organisms catalyze
the reduction of nucleotides to deoxynucleotides, an essen-
tial step in DNA biosynthesis. These enzymes play a central role
in maintaining a balanced pool of cellular deoxynucleotides
required for fidelity of DNA replication and repair (1-3). The
aerobic Escherichia coli RNR is the prototype for class I RNRs
found in all eukaryotes and most prokaryotes. The class I RNRs
are composed of two homodimeric proteins: RNRI (a 2, 171
kDa) and RNR2 (2, 87 kDa). RNRI contains the site where
NDPs are reduced and the sites for the allosteric effectors that
govern activity and specificity. RNR2 contains a diiron cluster-
tyrosyl radical (Y.) cofactor required for nucleotide reduction
activity (4).
The mechanism by which the diiron-Y. cofactor is generated
in vitn) has been studied extensively (5, 6). However, the
mechanism by which the cluster is assembled in vivo has re-
rnained largely unexplored. The completion of the Sacchanmnv-
ces cen'tisiae genome sequencing project and the identification
of a large number of yeast mutants involved in iron homeostasis
(7, 8) have suggested that yeast may be an excellent system to
investigate diiron-Y- cofactor assembly and its relationship to
nucleotide reduction in iw.
Recent studies have identified four genes encoding RNR
subunits in S. cerevisiae: RNRI and RNR3 (designated Y1 and
Y3) and RNR2 and RNR4 (designated Y2 and Y4) (9-13). Y1
and Y3. analogous to RNRI of E. coli RNR, share -80%
sequence identity. Y I expression is cell cycle-regulated, and the
gene is essential for mitotic viability. In contrast, Y3 is not
expressed under normal vegetative conditions. However, the
presence of high copy numbers of the Y3 gene has been shown
to suppress a lethal mutation in the YI gene, suggesting that Y3
encodes a functional protein (11). Transcription of Y1 and Y3
genes is inducible by DNA damage, the latter 100-fold (11). The
Y2 gene encodes a protein analogous to E. coli RNR2 and is
essential for mitotic viability. The Y4 gene encodes a protein
sharing 56% sequence identity with Y2. Y4, however, contains
several unusual features not found in Y2 and mammalian
RNR2s. These features include a deletion of 51 aa residues at its
N terminus and a substitution of 6 of the 16 aa residues
conserved in all class I RNR2s (12, 13). The most notable
substitutions are the replacement of two histidines and one
glutamate, ligands of the diiron center, by two tyrosines and an
arginine. Such substitutions would be expected to alter Y4's
ability to bind iron. Y4 also appears to be important for mitotic
viability, although its essentiality depends on the genetic back-
ground (12, 13). RNR subunits in yeast play not only an essential
role in DNA replication but also in signal-transduction pathways
sensing and responding to DNA damage and DNA replication
blocks (1).
Studies in 1984 (14) and 1990 (15) from Follmann's lab
reported the partial purification of RNR(s) from S. cerevisiae and
that all efforts to purify these proteins to homogeneity failed
because of rapid loss of activity. As a first step in using yeast as
the vessel to understand diiron-cluster assembly and allosteric
regulation of RNRs, access to purified yeast RNR subunits is
essential. In this paper, we report the expression, purification,
and initial characterization of Yl, Y2, Y3, and Y4 from S.
cerevisiae and E. coli. Preliminary studies indicate that Y4 plays
an important role in the assembly of the diiron-Y- cofactor in Y2.
Materials and Methods
Immun-blot poly(vinylidene difluoride) membranes (0.2-ACm
pore) were purchased from Bio-Rad. Kanamycin was obtained
from Eastman Kodak. ["4C]Cytidine 5'-diphosphate (CDP) was
purchased from Moravek Biochemicals (Brea, CA). DEAE-
Sepharose Fast Flow and QAE-Sephadex A-50 were purchased
from Amersham Pharmacia. Talon cobalt metal affinity resin
was purchased from CLONTECH. Restriction endonucleases
and T4 DNA ligase were obtained from New England Biolabs or
Boehringer Mannheim. Competent E. coli BL21(DE3)pLysS
cells and pET vectors were obtained from Novagen. Competent
DHSa cells were obtained from Life Technologies (Grand
Island, NY). Pefabloc and calf intestine alkaline phosphatase
were obtained from Boehringer Mannheim. E. coli thioredoxin
(TR) (16) and thioredoxin reductase (TRR) (17) were isolated,
and dATP-Sepharose affinity resin was prepared as described
(18). Protein concentrations were determined by the Lowry
AbbrevlaUtions EPR, electron paramagnetic resonance; IPTG, Isopropyl o-thlogalactoside;
Y., tyrosyl radical; TR, E. coil thloredoxlrn TRR, E. coil thioredoxln reductase; RNR, rlbonu-
cleotide reductase; RNR1 and RNR3arethe large subunits of RNR and are designated Y1 and
Y3; RNR2 and RNR4 are the small subunits of RNR and are designated Y2 and Y4; kb,
kilobase; CDP, cytidine S'-dlphosphate.
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method using BSA as a standard (19). YEp 13rnr, containing the
Y2 gene, was a gift from R. Hurd (Cornell University, Ithaca,
NY) (10). pSE734, containing Y3 gene was obtained from S.
Elledge (Baylor College of Medicine, Waco, TX) (11). pRC-
ROX, containing the Y4 gene, was provided by R. Casagrande
(Cornell University) (13). YEpI3 yeast genomic DNA library
and GAL promoter-driven 2 expression plasmid pYES2 (In-
vitrogen) were obtained from LGuarente (Massachusetts Insti-
tute of Technology). The protease-deficient yeast strain BJ5465
(genotype: MATa, ura3-52, trpl, leu2A1, his3A200, pep4::HIS3,
prblAl.6R, canl, GAL+) was obtained from Yeast Genetic
Stock Center (University of California, Berkeley, CA). Site-
directed mutagenesis was carried out with QuikChange kit from
Stratagene. Oligonudeotides were ordered from Research Ge-
netics (Huntsville, AL). DNA and N-terminal sequencing were
performed by the Massachusetts Institute of Technology
Biopolymers Laboratory. Antibodies to Y 1, Y2, Y3, and Y4 were
generated in rabbits by Covance Research Products (Denver,
PA). Horseradish peroxidase-conjugated donkey anti-rabbit IgG
was obtained from Amersham Pharmacia.
E coli Expression Plasmid Constructions pY1A, pY2, pY3J, and pY4J.
The Y1 gene was amplified by using PCR with primers 5'-
GGGA ATTCCA TA TGTACGTTTATAAAAGAGACG-3'
(NdeI) and 5'-CGCGGATCCTTAACCCGAACACATTTC-
AC-3' (BamnHI), using YEp13 genomic DNA library as a tem-
plate. The 2.7-kilobase (kb) fragment obtained was digested with
Ndel and BamHI and inserted into pET24a(+), cut with the
same enzymes, to give pY1A.
The Y2 gene was amplified by PCR using primers 5'-TACCC-
ATATGCCTAAAGAGACCCCITCC-3' (Ndel) and 5'-TTCG-
GATCCTTAAAAGTCTTCGTTGAAGG-3' (BamHI) and
YEpl3mr as the template. The 1.2-kb fragment was digested with
NdeI and BamHI, as was pET24a(+). Ligation of these two pieces
of DNA resulted in pY2K. Sequencing of the resulting plasmid
revealed a G -- C transversion giving rise to a K387N mutation in
Y2. Site-directed mutagenesis was performed to correct this mu-
tation, yielding pY2M.
The 27-kb Y3 gene was amplified with primers 5'-GCCAAT-
TGCATATGTACGTTATTAAAAGAGACG-3' (NdeI) and 5'-
CCGGCTCGAGTC4AC CGGAACATGACTCAC-3' (XhoI) us-
ing pSE734 as the template and introduced into the NdeI-XhoI sites
of pET24a(+) to give pY3J.
The 1.0-kb Y4 gene was amplified by using PCR with primers
5'-TATTACCATG GAAGCACATAACC-3' (NcoI) and 5'-C-
GCGGATCCTTAGAAGTCATCATCAAAGTT-3' (BamHI).
The resulting 1.0-kb fragment was ligated into NcoI-BamHI sites
of pET24d(+), resulting in pY4J. All of the above constructs
were verified by sequencing.
Constructions of pYES-Y1 and plls-Y2 (pHis-Y2-K37N) for Expression
in S. cevisiae. pYES-Yl. pY1Awas cut with NdeI and filled in with
E. coli DNA polymerase Klenow fragment. A second digestion
with BamHI gave a 2.7-kb 5'-blunt end/3'-BamHI end Y1
fragment, which was ligated into pYES2 vector cut with PvuII-
BanHI, to give pYES-Y1.
pHis-Y2. A double-stranded DNA linker was constructed by
annealing and extending two primers: 5'-GGCCGGTTTA-
AAATGCACCACCATCACCACCACGATGATG (DramI) and
5'-CCGGGAAGCTTTTATCGTCATCATCGTGGTGGTG-
ATG-3' (HindIII). The 59-bp double-stranded DNA product
was then digested with Drai and HindIII, and ligated into pYES2
cut with PvuII and HindIII. The resultant plasmid, pYES-His,
was a general-purpose His-tagged expression vector that pro-
duces proteins with N-terminal 6x His sequence and a DDDDK
enterokinase cleavage site. pYES-His was digested with HindIII.
Blunt ends were generated with mung bean nuclease and di-
gested with BamnHI to create the 5'-blunt/3'-BarnHI fragment.
The 1.2-kb Y2 gene was excised from pY2K (pY2M) by
successive NdeI digestion, 5' overhang removal with mung
bean nuclease, and a second digestion with BamHI. This insert
was ligated into digested pYES-His to give pHis-Y2-K387N
(pHis-Y2).
Expression of Y1, Y2, Y3, and Y4 in E coi. An overnight culture of
BL21(DE3)pLysS cells containing one of the expression plas-
mids (pYlA, pY2M, pY3J, or pY4J) was grown in LB medium
containing 100 mg/liter kanamycin and 50 mg/liter chloram-
phenicol at 30 or 37C. This culture was used to inoculate 6x
6-liter flasks containing 1.5 liter of LB medium with the same
concentration of antibiotics as above (1:300 inoculum strength).
When the A6 0 0 reached 0.5-0.6, the culture was chilled to 15°C
before adding isopropyl P-D-thiogalactoside (IPTG) to a final
concentration of 0.5 mM. The cultures were grown for 12-15 h
at 15°C until A600 reached 1.8-2.0. The cells (5-6 g/liter) were
harvested by centrifugation, frozen in liquid nitrogen, and stored
at -80°C.
Expression of Y1 and (His)s-Y2 [(His)-Y2-K387N] in Yeast UB5465. The
proteinase-deficient yeast strain BJ5465 was transformed with
one of the expression plasmids (pYES-YI, pHis-Y2, pHis-Y2
K387N) (20). A single colony of the transformed yeast grown on
plates of yeast minimal medium minus uracil was used to
inoculate 100 ml of the same medium containing 2% raffinose
as the carbon source. After -36 h at 30°C, this culture was used
to inoculate 10 liter of yeast minimal medium minus uracil
containing 2% wt/vol raffinose. After growth at 300 C for 24 h
(A6so of 1.6-1.8), solid galactose (2% wt/vol) was added. Yeast
cells (6-8 g/liter) were harvested -3-4 h later by centrifugation,
frozen in liquid nitrogen, and stored at -800C.
Puification of Y1 and Y3. All purification steps were performed at
4°C. E. coli cells (40 g) were thawed and suspended in buffer A,
which contained 50 mM Hepes, 5 mM DTT, 5 mM MgC2, 100
mM KCI, 5% glycerol, 1 mM PMSF, and 0.6 mM Pefabloc (pH
7.0) in a final volume of 200 ml. Cells were lysed by one passage
through a French press (12,000 psi; 1 psi = 6.89 kPa). Cell debris
was removed by centrifugation (12,300 x g, 30 min). Strepto-
mycin sulfate (10% wt/vol) was added dropwise to the extract to
a final concentration of 1.5% wt/vol, and the DNA was removed
by centrifugation (12,300 x g, 30 min). Solid (NH4)2SO4 was
added to the supernatant to 40% saturation (0.29 g/ml) over a
period of 30 min, and the precipitate was collected by centrif-
ugation (12,300 x g, 40 min). The pellet was dissolved in 40 ml
of buffer A and desalted either by passage through a Sephadex
G-25 column (5.5 x 80 cm) with buffer A as eluent or by dialysis
against 2 liters of buffer A for 2-3 h. This solution was diluted
with buffer A to 80 ml and loaded onto a dATP-Sepharose
column (2.5 x 4 cm). The column was washed with 200 ml of
buffer A, followed by 300 ml of buffer A plus 1 mM ATP. YI and
Y3 were eluted with 50 ml of buffer A plus 10 mM ATP followed
by 50 ml of buffer A plus 20 mM ATP. Protein-containing
fractions were pooled, concentrated by ultrafiltration with a
PM30 membrane (Amicon) to >7 mg/ml, frozen in liquid
nitrogen, and stored at -80°C. Typically -5-7 mg of Y1 or Y3
of -90% purity, judged by SDS/PAGE, were obtained.
Isolation of Y2 from BL21(DE3)pLysS/pY2M. E. co/i cells (40 g) were
thawed and suspended in buffer B containing 50 mM Tris (pH
7.6), 5% glycerol, 1 mM PMSF, and 0.6 mM Pefabloc to give a
final volume of 100 ml. The cells were disrupted by a single
passage through a French pressure cell at 12,000 psi. FeSO4 (0.1
g) and sodium ascorbate (0.1 g) were added to the cell lysate
before centrifugation (19,800 x g, 30 min). Streptomycin sulfate
(10% wt/vol in buffer B) was added dropwise to the extract to
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a final concentration of 1.5% wt/vol, and the DNA was removed
by centrifugation (12,:300 g, 30 min). Solid (NH4) 2SO4 was
added to the supernatant to 60% saturation (0.39 g/ml). After
stirring the suspension for 30 min, the precipitated proteins were
collected by centrifugation (12,300 x g, 40 min). The pellet was
dissolved in 50 ml of buffer B and desalted by passage through
a Sephadex G-25 columnt (5.5 x 100 cm) with buffer B as eluent.
'The protein-containing fractions were pooled, diluted with an
equal volume of buffer B, and loaded onto a DEAE-Sepharose
column (5.5 x 10 cm) preequilibrated with buffer B. After
washing sequentially with buffer B (300 ml) and buffer B plus 50
mM NaCI (300 ml), Y2 was eluted with buffer B plus 80 mM
NaCI (300 nil). Fractions (20 ml) were collected, and those
containing Y2, as judged by SDS/PAGE, were pooled and
concentrated by ultrafiltration (PM30 membrane) to >10 mg/
mil. Y2 was frozen in liquid nitrogen and stored at -80 0 C. This
procedure yielded -5(0 mg of -50-60% pure Y2 protein.
Isolation of Y4 from BL21(DE3)pLysS/pY4J. E. coli cells (40 g) were
thawed and suspended in buffer C containing 50 mM Hepes (pH
7.0), 5% glycerol, I mM PMSF, and 0.6 mM Pefabloc in 200 ml.
The work up through the desalting of the ammonium sulfate
precipitate was identical to that described for isolation of Y2.
The appropriate fractions were pooled, diluted with equal
volume of buffer C and loaded onto a DEAE-Sepharose column
(5.5 x 7 cm) equilibrated with buffer C. The column was washed
with buffer C (300 ml), buffer C plus 50 mM NaCI (300 ml), and
buffer C plus 80 mM NaCI (300 ml) before Y4 elution with buffer
C plus 110 mM NaCI (300 ml). Fractions containing Y4, as
judged by SDS/PAGE. were pooled, diluted with an equal
volume of buffer C to 200 ml, and loaded onto a QAE-
Sephadex column (3 cm x 7 cm) preequilibrated with buffer C
plus 80 mM NaCI. After washing the column sequentially with
buffer C plus 80 mM NaCI (250 ml) and buffer C plus 160 mM
NaCI (250 ml), Y4 was eluted with buffer C plus 210 mM NaCI.
Fractions (20 ml) were collected, and those containing high-
purity Y4 (by SDS/PAGE) were pooled and concentrated by
ultrafiltration (PM30 membrane) to >10 mg/ml. Y4 (60 mg of
-- 90% purity) was frozen in liquid nitrogen and stored at -80°C.
Ilsolation of (His)-Y2 and (His)-Y2 K387N. Yeast cells (40 g) were
thawed and suspended in buffer D containing 50 mM Hepes (pH
:.0), 10% glycerol, 300 mM (NH 4 )2SO 4, 100 mM KCI, 1 mM
PMSF, and 0.6 mM Pefabloc in a final volume of 80 ml. The cells
were lysed either by a Bead Beater (Biospec Products, Bartles-
villc, OK) or by passage through a French press (three passes at
12,000 psi). Additional buffer was added to the cell lysate to
bring the total volume to - 100 ml. FeSO 4 (20 FM) and sodium
ascorbate (I mM) were added to the cell lysate before centrif-
ugation (19,800 x g, 40 min). The extract was clarified by
filtration through a glass filter (Gelman) and applied onto a
Talon cobalt metal affinity column (2.5 x 4 cm). The column was
washed sequentially with buffer E [200 ml, buffer D minus
(NH4)_SO 4], buffer E (300 ml) plus 10 mM imidazole, and 200
ml of buffer E adjusted to pH 7.0. The His-tagged proteins were
eluted with 50 ml of buffer E (pH 7.0) plus 100 mM imidazole
followed by 75 ml of buffer E (pH 7.0) plus 150 mM imidazole.
Fractions (1.5 ml) containing Y2 were pooled, concentrated by
ultrafiltration (PM30 or YM30 membrane) to >15 mg/ml,
frozen in liquid nitrogen, and stored at -800 C. Typically, 9-12
mg of (His),-Y2 or 3-4 mg of (His),-Y2 K387N of 90% purity
based on SDS/PAGE, were obtained.
Isolation of Y1 from Yeast BJ5465/pYES-Y1. Yeast cells (40 g) were
thawed and suspended, in 80 ml of buffer F containing 50 mM
Hepes (pH 7.0), 300 mM (NH 4 )2SO4, 5 mM DTT, 5 mM MgCI,,
110` glycerol. 1 mM PM SF, and 0.6 mM Pefabloc. The cells were
Iysed as described alx e. Additional buffer F was added to the
cell lysate to give a final volume of 120 ml. Cell debris was
removed by centrifugation (19,800 x g, 40 min.). The extract was
clarified by filtration through a glass filter and applied to a
dATP/Sepharose column (2.5 x 5 cm) equilibrated with buffer
G [buffer F minus (NH 4 )2 SO4]. The column was washed with
buffer G (200 ml) and buffer G plus 1 mM ATP (250 ml). Y I was
eluted with buffer G plus 10 mM ATP (50 ml) and 20 mM ATP
(50 ml) Fractions (1.5 ml) containing pure Y (based on
SDS/PAGE) were pooled, concentrated by ultrafiltration
(PM30 membrane), frozen in liquid nitrogen, and stored at
-80°C. The typical yield was - 1.5 mg of - 90% pure Y I.
Enzyme Activity Assay. The combinations of yeast RNRs used in
the assays were Y1/(His),-Y2 K387N, Y1/(His)0-Y2, and Y3/
(His),-Y2 K387N. In each case, the second protein component
was present in 5-fold molar excess (1.25-5 gAM) over the protein
being assayed (0.25-1 tM). The assay mixture contained (in a
final volume of 200-500 tl) I mM [14C]CDP (specific activity,
2.2 x 103 cpm/nmol), 100 AM E. coli TR, 1 AM E. coli TRR. 2
mM NADPH, 2 mM ATP, 100 mM Hepes (pH 7.2), 20 mM
MgCI, and 20 mM DTT. All components except CDP were
incubated at 30'C for 10 min. The reaction was initiated by
adding [ 4C]CDP. Aliquots (25-100 al1) of the reaction mixture
were withdrawn at various times, 0-30 min, and quenched in a
boiling water bath. After adjusting the pH to 8.5 with 2 M Tris
(pH 85), alkaline phosphatase (10 units) was added, and the
mixture was incubated at 3T7C for 6 h. Products were analyzed
by the method of Steeper and Steuart (21). One unit of RNR
activity is defined as 1 nmol of dCDP formed in I min.
Electron Paramagnetic Resonance (EPR) Spectroscopy. EPR spectra
were recorded by using a Bruker ESP-300 X-band (9.4-GHz)
spectrometer equipped with an Oxford liquid helium cryostat.
Spin quantitation of the His-tagged Y2s was achieved by double
integration of EPR spectra acquired at 25 K with I mW of
microwave power, by comparison to a sample of E. coli R2 whose
Y' concentration had been established by UV-visible spectros-
copy at 412 nm by the drop-line correction method (22).
Recombinant Y2 Activation by Y4 and Fe2 +. All manipulations were
carried out in an anaerobic wet box (M. Braun, Newburyport.
MA). Deoxygenated FeSO 4 was added to deoxygenated Y4, to
yield an anaerobic solution with 157 taM Y4 and 1.62 mM Fe' +
in 200 mM Hepes (pH 7.2). The mixture was incubated at 2-4°C
for 12 h. This activated Y4 solution (0.5 ml) was then dialyzed
against 500 ml of 200 mM Hepes (pH 7.2), and at various times,
100 p.l aliquots were removed. At 2.5 h, 25 1 of an aliquot was
used to determine an iron concentration of 150 AM by using a
ferrozine assay. Deoxygenated Y2 from E. coli (25 Al1, 30 mg/ml,
175 AM of 50% pure, as judged by SDS/PAGE) was then mixed
with 25 tl of the dialyzed Y4/Fe 2+ mixture and 50 p.l of 200 mM
Hepes buffer (pH 7.2), resulting in a mixture of Y2:Y4:Fe' + of
40 pM (assuming 50% purity), 39 aM, and 39 pAM, respectively.
This mixture was incubated at 2-4°C (in the anaerobic box
refrigerator) for 12 h and subsequently removed from the box
and exposed to air for I h. Spin quantitation by 9.4-GHz EPR
spectroscopy indicated that Y2 contained 18 + 3 F.M Y, and an
assay indicated a specific activity of 0.061 pAmol-min- mg-'. A
control in which Y4 was replaced with buffer under otherwise
identical conditions gave Y2 with no Y. and no activity.
Antibodies and Western Immunoblot Analysis. Purified Y 1, Y3, Y4,
and Y2 purified from E. coli inclusion bodies were used to
generate rabbit polyclonal antibodies. S. cerevisiae cell-free
extracts and purified RNR subunits were analyzed on SDS/ 12 %
PAGE. The proteins were then transferred to poly(vinylidene
difluoride) membranes by electroblotting (3 h at 100 V) using a
Semi-Phor TE70 Semi Dry Transfer unit (Hoefer) The mcm-
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Table 1. Specifk activity of purified yeast RNR subunits
Expression Specific activity,
Subunit source nmoi of dCDP'min-'-mg-'
As isolated
Y1 E. col 34
Y1 Yeast 24
Y3 E. oIl 0
Y2 E. col 0
(Hi)s-Y2 Yeast 37
(His)6-Y2 K387N Yeast 125
Y4 E. coll 0
After activating with Y4
and Fe(I)
Y2" E. coil 69
(His)-Y2 K387N' Yeast 300
(His)6-Y2t Yeast 121
*Reconstitution experiments were carried out with Y4:Fe2+:Y2 of 153 pM: 1.S
mM: 13.2 pM. Incubation of Y4 and Fr+ were underanawrobic cond•tonsfor
3 h at 4C, and this solution was then incubated with Y2 for an additlonal 3 h.
The solution was then exposed to air for 1 h and assayed.t Reconstitution was as above with Y4:FeW+:Y2 of 90 IM: 297 FM: 9 pM. The
starting specific activity of thi (His)-Y2 was 6.
branes were blocked with a casein solution (3% casein, 50 mM
Tris, pH 8.0) followed by incubation for 3 h with serum diluted
in blocking buffer (1:10,000 for the anti-Y4 serum). The mem-
branes were washed with Tris-buffered saline (TBS) (20 mM
Tris, 500 mM NaCI, pH 7.5), followed by incubation with donkey
anti-rabbit IgG conjugated to horse radish peroxidase for 3 h.
After washing the membranes with TBS, the bands were visu-
alized with a 5:1 mixture of TBS and ethanol containing 4-chlo-
ronaphthol (3 mg/ml) and 0.01% H202 following the manufac-turer's instructions.
Reitsu
Expression of V1, Y2 Y3, and Y4. Construction of pET vectors using
IPTG induction for expression of RNR subunits in E codi and
vectors using induction on galactose for expression in yeast are
described in detail in Materials and Methods. Initial efforts to
express the yeast RNR subunits used E col as the host. Under
growth conditions of either 30 or 37"C, YI, Y2, and Y3 were
found as inclusion bodies with no NDP reduction activity. In the
case of Y4 grown at 30*C, the protein was soluble and -50% of
the crude extract. When the growth temperature of the E. coli
was lowered to 15*C before the induction with IPTG, Y1, Y2,
and Y3 were all soluble. In yeast, it was essential to express Y2
and Y2 with a K387N mutation as (His) 6 tag constructs tofacilitate their rapid purification. Y2 K387N was originally
isolated as the result of a mutation arising from PCR during
construction of the Y2 expression vector. The stability and
amount of the Y- in this Y2 mutant assisted us in the early stages
of obtaining RNR activity.
Purification of MNR Subuits. Affinity chromatography using y-p-
aminophenol-linked dATP has previously been successfully used
to isolate the large subunits of RNR from many organisms (18).
By using this procedure, Y1 and Y3 expressed in E. coli cells have
been purified to -90% homogeneity within 10 h of cell lysis(Table 1, Fig. 1, lanes 2 and 3). SDS/PAGE was initially used to
monitor column elution profiles because insufficient quantities
of active Y2 were available for nudeotide-reduction assays.
Overexpression of RNR2s in E coki results predominantly in
the formation of inactive apo RNR2 because the equipment for
iron cluster insertion is not present. In contrast to RNRI, no
affinity column procedure exists for rapid isolation of RNR2s,
although anion-exchange chromatography has in general been
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Fig. 1. SDS/PAGE analysis of purified yeast RNR subunits. Lane 1. high
molecular weight protein markers; lane 2 Y1 isolated from E. col; lane 3., Y3
isolated from E colt lane 4. Y1 Isolated from yeast lane 5, low molecular
weight protein marker lane 6, (His)s-Y2 K387N isolated from yeast; lane 7.(His)&-Y2; lane 8, Y4 isolated from E coil.
used successfully in their purification. Y2 was purified to - 50%
homogeneity by using a DEAE-Sepharose column (data not
shown). The fractions containing Y2, as judged by SDS/PAGE,
were pooled. No nucleotide reductase activity was detected. For
many RNR2s isolated from E coli, addition of Fe24, 02, and
ascorbate to the purified recombinant proteins with little or no
activity results in generation of the active diferric-Y- cofactor,
and consequently, NDP reduction activity. In the case of recom-
binant E coi Y2, however, this activation method was unsuc-
cessful under a variety of conditions.
Y4 expressed in E. codi was purified by successive anion
ion-exchange steps using DEAE-Sepharose and QAE-Sephadex
A-50, to >90% homogeneity (Fig. 1, lane 8, Table 1). Y4
contained no iron, Y-, or detectable catalytic activity.
The identity of each purified RNR subunit was confirmed by
N-terminal sequence analysis. In the case of recombinant Y1,
Y3, and Y4 sequencing began with the N-terminal methionine,
while in the case of Y2, a mixture of methionine and proline(N-1) proteins were obtained.
Purificatieo of T1 and (Hi)-V2 l(fishrY2 K387N1 from Yeast. Our
inability to obtain active nucleotide reductase activity from any
combination of RNR subunits expressed in E. coli, provided the
impetus for expression of these proteins in S. cerevisiae. The
procedure for purifying Y1 is similar to its isolation from E. coli.
However, because the expression level of Y1 in yeast is low,
cell-free extract was applied directly onto the dATP-Sepharose
column. Elution with ATP affords Y1 with purity and activity
similar to E. coi-expressed Y1 (Fig. 1, lane 4 and Table 1).
Attempts to purify Y2 from yeast were frustrating because of
low levels of expression, inability to assay, and problems with
proteolysis. N-terminal (His)6-tagged Y2s were therefore con-
structed and expressed in a proteinase-deficient yeast strain
BJ5465. This modification allowed rapid isolation of functional,
nearly homogenous Y2swithin hours of cell lysis through the use
of cobalt metal affinity column. Although the (His)6-tagged tail
could bind iron and prevent appropriate metal duster assembly
in Y2, this method has allowed us to obtain protein that has been
successfully incubated with YI to obtain nucleotide reductase
activity. Active Y2s [(His)6-Y2 (wild-type and Y2-K387N)] with
a purity >90% by SDS/PAGE are obtained (Fig. 1, lanes 6 and
7).
EN Spectrescepy of the Y. of (Ois)-Y2 and (His)k-2 K387N. The
purified His-tagged Y2 proteins exhibit a Y- signal by EPR (9.4
GHz) readily observed at <77 K and similar to the one first
reported by Harder and Follmann in yeast (15). The Y- is stable
to storage at 4'C for 24 h and to repeated freeze-thaw cycles asjudged by EPR intensity.
Spin quantitation of the amount of Y- relative to the amount
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of wild-type (His)b-Y2 revealed only 0.05 radicals per Y2.
(His)e-Y2 K387N, on the other hand, exhibits a stoichiometry of
-0.15-0.16 radical per dimer. The radical content of purified
Y2s stands in contrast to a stoichiometry of 1.2 Y" per dimer for
fully active E. coil RNR2 (23). The addition of Fe- + or Fe2+ in
combination with ascorbate and 02 to the purified proteins did
not result in an increase in Y. or nucleotide reductase activity,
as has been observed with many other RNR2s.
Activities of Yeast RNR Subunits. The assay for nucleotide reduction
requires RNRI, RNR2, substrate, the appropriate allosteric
effector and a reducing system to reduce the disulfide generated
concomitant with dNDP formation. The yeast reducing system
is most likely a TR/TRR/NADPH (24) or a glutaredoxin/
glutathione reductase/NADPH (25), in common with other
RNRs. In vitro, reductants such as DTT can also supply the
reducing equivalents, although less efficiently. In the assays
described subsequently, the combination of DTT, E. coli TR/
TRR. and NADPH, with CDP as substrate and ATP as allosteric
effector, has afforded the highest activities for purified yeast
RNRs.
In standard activity assays for RNRs, each subunit is assayed
separately. Because (His),-Y2 K387N affords higher activity
because of its increased Y* content, most YI activity assays were
performed by using this mutant. Assays using the (His) 6-Y2 were
carried out for comparison. Y1 expressed in E. coli and yeast
exhibit similar levels of activity, typically in the range of 24-34
units/mg (Table 1). The similarity in activity and the increased
expression levels of Y1 from E. coli made this source preferable
for Y2 activity assays. In contrast to the YI from E. coli, Y3 from
E. coli exhibited no detectable activity under similar assay
conditions (Table 1).
The specific activities of the (His)t-Y2 proteins were found to
be concentration-dependent. This is not surprising, because the
interactions between RNR1 and RNR2 are weak (Kd - 0.1 AM).
At high Y2 concentrations (I AtM), there was a correlation
between the specific activities of the (His)6-Y2 K387N and(His),-Y2 proteins (120-130 units/mg and 33-37 units/mg,
respectively) and their Y. content.
Y4. as isolated from E. coli, contained no bound metal ions
and exhibited no activity. Y4 was unable to substitute for Y2 in
assays for YI activity and further inhibited the rate of dNDP
formation when (His)b-Y2 is assayed with Y1.
Possible Role for Y4 in Cluster Assembly of YZ Y4 is highly homol-
ogous to Y2 but lacks several conserved residues that are ligands
to the irons in the essential diferric cluster-Y* cofactor. Despite
these significant changes, a rnr4 deletion is lethal (12) or
conditionally lethal (13). In addition, using (myc)3-tagged Y4
and hemagglutinin-tagged Y2 under the control of a galactose
promoter, Huang and Elledge (12) showed that immunoprecipi-
tation of proteins in crude yeast extracts with myc antibodies
gave Y2 as well as Y4. These observations and recent studies on
the role of Lys-7 in copper insertion into apo copper-zinc
requiring superoxide dismutase (26), suggested to us that Y4
could potentially function as a chaperone for iron insertion into
Y2. Several preliminary experiments have been carried out that
support this proposal.
Although previous studies with apo E. coli and mouse RNR2s
have shown that Fe- +, 02, and reductant are sufficient to
generate diferric-Y, cluster (27. 28), similar experiments with Y2
have been unsuccessful. If Y4 were to function as a chaperone,
then its addition might allow cluster assembly. To test this
proposal, Y4 was incubated under anaerobic conditions with
Fe2'+ and was then incubated anaerobically with Y2. The entire
mixture was then mixed with oxygenated buffer and assayed for
nucleotide reductase activity. The results of an experiment in
which the Y4:Fc-+:E. coli Y2 is ;--40 AM:40 gLM:40 ALM arc
E
C
Time (min)
FIg 2. Effect of addition of Y4 and Fe* on the nucleotide reductase activity
of Y2 from E. coil. (A) Y2 activity as Isolated from E. coil or by attempted
reconstituton with Fz2*and 02. (8) Y2 activity after activation by Y4 prein-
cubated with Fe* folowed by 02 addition.
shown in Fig. 2. The activity is now 0.061 p•mol'min- .mg- , and
we are able to detect Y. (18 AM) in the E. coli Y2. Under ia
second set of conditions in which the concentration of free Fez'
relative to Y4 and Y2 was substantially higher, the activity of
(His)6 -Y2 K387N was increased from 0.090 to 0.30
munol-min-1'mg-', and the E. coli Y2 now has an activity of 0.069
CAmol'min-'-mg - ' (Table 1). Control experiments with iron and
no Y4 reveal no changes in activity. These preliminary studies
thus suggest that Y4 is required for iron cluster assembly.
Detection of Complex Formation Between Y2 and Y4. For Y4 to
function as a chaperone, it would need to form a complex with
Y2. To probe the function of Y4 under normal growth condi-
tions, Y4 and Y2 antibodies were generated. Control experi-
ments show that Y4 antibodies possess no cross-reactivity with
Y2 (Fig. 3, lanes 4 and 6). These antibodies were used to probe
the purified (His)S-Y2 and crude cell extracts of yeast. Y4 can be
detected in yeast cell-free extracts (Fig. 3, lanes 2 and 7) and in
purified Y2 (Fig. 3, lanes 4 and 6). No Y4 was observed in Y2
isolated from E. co/i. Furthermore, immunoprecipitation of Y4
from crude cell extracts and probing with Y2 antibodies revealed
the presence of Y2 (data not shown). These results support the
earlier observations with epitope-tagged, overexpressed RNR2
and RNR4 (12). They indicate that a complex can be formed
between Y2 and Y4 under normal growth conditions, a prereq-
uisite for Y4 to function as a chaperone.
RNRs have been the topic of intense investigation since their
discovery in the 1960s. In vitro, the mechanism of nucleotide
reduction is now moderately well understood (3). as arc the gross
features of the allosteric regulation of these enzymes (2). The
mechanism in vitro of iron cluster assembly has been pushed to
the present technological limits with the wild-type proteins (6).
How all of this information can be used to understand nucleic
5 6 7
05k a
45k M
36 kN
29 M
Fig. 3. Antibodies to Y4 detect Y4 in purified (HIs)6-Y2. (A) Coomassie
staining of proteins separated by SDS/12%PAGE. Lane 1, low molecular
weight protein markers; lane 2. yeast ceil-free extract; lane 3, purified Y4; lane
4, purified (His)6-Y2 (note: Y4 copurifies with Y2). (B) Western blots using Y4
antibodies. Lane 5, purified Y4; lane 6, purified (His)6-Y2 that also contains Y4;
lane 7. yeast ceil-free extracts.
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acid metabolism under normal growth conditions and under
conditions of environmental stress in vivo is the next frontier.
In the past few years, elegant studies from a number of labs
have begun to investigate in vivo the functions of the two large
subunits of RNR1 (Y1 and Y3) and two small subunitsof RNR2
(Y2 and Y4) (1, 11-13). To investigate metal cluster assembly,
the possibility that this cofactor is assembled and disassembled
as a control mechanism for deoxynucleotide formation, and
allosteric regulation in vivo and their importance in replication
and repair, we initially set out to reclone, express, and purify
these proteins. Y2 and Y4 have been successfully purified to near
homogeneity from E. coil. As isolated, neither have a Y, and
they are consequently inactive in the nucleotide-reduction assay.
The Y2 gene was therefore placed into a vector with an
N-terminal (His)6 tag and transformed into yeast in an effort to
obtain an active form of Y2. This construction facilitated its
isolation using metal affinity chromatography and provided the
first active Y2, with iron bound and a detectable, stable Y.
Active Y2 could now be used to assay Y1 for dNDP formation.
Y1 was expressed in E. coil and in yeast and purified using a
dATP affinity column. The activity measured with (His) 6-Y2 was
detectable and identical from the two sources. Y3 was expressed
and purified only from E. coi and using the same (His)6-Y2 that
successfully generated dNDPs with Y1, gave no detectable
activity. Y4 had no detectable activity with either Y1 or Y3.
YI and Y2, as previously proposed, constitute the active RNR
involved in normal nucleic acid metabolism. The activity of 0.03
tumol-min-mg - t for Y1 and 0.30 pmol-min-'lmg - for Y2 is
substantially higher than previously reported activities (13). As
we still don't understand the mechanism of reconstitution of the
required diferric-Y- cofactor, the activity of Y2 and consequently
Y1 will ultimately be higher.
Y3, the large subunit that is induced 100-fold in the presence
of DNA-damaging agents (11), has thus far no detectable
activity. It can be rapidly isolated in soluble form by the affinity
column procedure that has resulted in active Y1. The absence of
activity in Y3 is not understood, but given its role in DNA repair,
we speculate that posttranslational modification by phosphory-
lation could be required for catalytic activity.
Most intriguing is Y4. Y4, as noted above, is 56% sequence
identical to Y2, lacks 51 amino acids at its N terminus, and has
a preponderance of acidic amino acids at its C terminus in
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comparison to Y2 and mouse RNR2. In Y4, the histidine
coordinated to each of the irons in the Y2 diiron cluster is
replaced by a tyrosine, also a possible metal ligand, and a key
glutamate, the one that is most flexible, determined from a
variety of RNR2 structures from E. coli (29), is replaced by an
arginine. Y4 in certain genetic backgrounds is essential and
under normal growth conditions, can form a complex with Y2.
Preliminary studies using size exclusion chromatography indi-
cate that in their apo forms, both Y2 and Y4 are dimers. Our
thinking about the function of Y4 has been strongly influenced
by recent studies in yeast that link iron and copper homeostasis
and the discovery that metal chaperones (26, 30) play an
important role in cluster assembly in copper-requiring proteins.
These studies have recently shown that Lys-7 is essential in the
assembly of active cofactor of the copper zinc superoxide
dismutase (31). In addition, one of the domains of Lys-7 is
structurally similar to one of the domains of the superoxide
dismutase (32). The proposal has been made that Lys-7 binds to
superoxide dismutase and delivers the copper essential for
activity. Y4, which can form a complex with Y2, could function
in a similar capacity.
Most apo RNR2s studied to date can assemble into active
diiron-Y cofactors, by addition of Fe 2 +, 02, and reductant (28).
These standard procedures have been unsuccessful with Y2.
Thus, our preliminary results are quite intriguing that anaerobic
incubation of Y4, Fe 2+ , and Y2, followed by 02 addition is
capable of assembling active cofactor in Y2. If Y4 is omitted
from these experiments, no active cofactor is obtained. Our
preliminary studies suggest that Y4 plays a role in cluster
assembly of Y2 that may be similar to that proposed for Lys-7 and
superoxide dismutase (26, 31, 32). Reconstitution studies of
RNR2s in general have typically yielded stoichiometries of iron
to Y. of 3:1 with 1.2 Y. per RNR2. Our studies with yeast suggest
that one of the protomers of the dimeric RNR2s, in general, may
function as an unrecognized chaperone. The stage is now set to
use yeast as our test tube to study metal ion homeostasis and its
effect on nucleotide reduction and to study the regulation of
dNTP production under a variety of growth condtions.
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Ribonucleotide reductases (RNRs) catalyze the conversion of nu-
cleotides to deoxynucleotldes. Class I RNRs are composed of two
homodimeric subunits: R1 and R2. R1 Is directly Involved In the
reduction, and R2 contains the dlferric-tyrosyl radical (Y) cofactor
essential for the Initiation of reduction. Saccharomywcs erevislae
has two RNRs; Y1 and Y3 correspond to R1, whereas Y2 and Y4
correspond to R2. Y4 Is essential for dlferric-Y. formation In Y2 from
apoY2, Fez+, and 02. The actual function of Y4 Is controversial. Y2
and Y4 have been further characterized In an effort to understand
their respective roles In nudeotide reduction. (Hls)e-Y2, Y4, and(His)6-Y4 are homodimers, isolated largely In apo form. Their CD
spectra reveal that they are predominantly helical. The concentra-
tions of Y2 and Y4 In vivo are 0.5-2.3 ,M, as determined by
Western analysis. Incubation of Y2 and Y4 under physiological
conditions generates apo Y2Y4 heterodimer, which can form a
diferric-Y when Incubated with Fe2+ and 02z. Holo Y2Y4 het-
erodimer contains 0.6-0.8 Y. and has a specific activity of 0.8-1.3
pmolmlnmg. Titration of Y2 with Y4 in the presence of Fe2 + and
o2 gives maximal activity with one equivalent of Y4 per Y2. Models
for the function of Y4 based on these data and the accompanying
structure will be discussed.
D ibonucleotide reductases (RNRs) play an essential role in DNA
Rreplication and repair by providing all of the monomeric
dcoxynucleotides required for these processes. The genome se-
quencing projects have revealed that both prokaryotes and eu-
karyotes possess multiple RNRs, whose functions remain to be
elucidated (). Class I RNRs are composed of two homodimeric
subunits: RI (a2) and R2 (2). Both subunits are essential for
activity. RI contains the binding sites for the nudeoside diphos-
phate substrates and the deoxynucleotide and ATP allosteric
effectors that govern which nucleotide is reduced and its rate of
reduction. R2 possesses a diferric-tyrosyl radical (Y) cofactor
essential for initiation of nudeotide reduction on RI (2, 3).
Four genes have been identified that encode RNR subunits in
Saccharontrces cerevisiae: RNRI and RNR3 (their gene products
designated Y and Y3) are RI homologues, and RNR2 and
RNR4 (their gene products designated Y2 and Y4) are R2
homologues (4-9). Y and Y3 share 80% sequence identity (4).
RNRI expression is cell cycle regulated, and the gene is essential
for mitotic viability (5, 10). In contrast, RNR3 is not expressed
under normal growth conditions. Transcription of RNRI and
RNR3 is inducible by DNA damage; the mRNA of the latter is
up-regulated >500-fold (5). Y2 and Y4 share 56% sequence
identity. Y4 contains several unusual features relative to a
canonical R2. It lacks about 50 amino acid residues from the N
terminus, and of the 16 amino acid residues conserved in almost
all class I R2s. six have been replaced in Y4. The most notable
substitutions are two histidines and a glutamate, ligands of the
di-iron center. which have been replaced by two tyrosines and an
arginine. Such substitutions would be expected to disrupt the
ability of Y4 to bind iron. RNR2 is essential for mitotic viability
( 10), 11 ). RNR4 also appears to be important for mitotic viability,
but its essentiality varies with genetic background (8, 9. 12). In
the one case where a Y4 knockout was shown to be lethal,
the lethality could be suppressed by overexpression of YI and
Y3 (8).
The transcriptional regulation of the yeast RNR genes has
been studied extensively. However, little is known about the
biochemical properties of yeast RNR proteins, their structures,
or their complex posttranscriptional and allosteric regulation.
Recently, we (13) and Chabes et al. (14) reported the isolation
and purification of the yeast RNR proteins. One of the most
notable results from our In vitro studies was that Y4 was essential
for the assembly of the diferric-Y. cofactor of apo Y2. Further-
more, coimmunoprecipitation studies by using Y4 antibodies on
crude yeast cell extracts suggested that Y2 and Y4 can form a
complex in vivo, substantiating earlier studies by using myc-
tagged proteins and a myc antibody (8). On the basis of these
results, we suggested that Y4 plays an important function in the
cofactor maturation of Y2. We speculated that this role might be
as a metallo-chaperone. based on recent discoveries of copper-
chaperone proteins in yeast (15).
The most notable result from the recent studies of Chabes et
al. (14) was the isolation of a stable heterodimer of Y2Y4
expressed in Escherichia coli. The heterodimer was active in
nucleotide reduction and contained 0.4 radicals and 1.2 irons. On
the basis of these studies, they concluded that the active form of
yeast R2 is the heterodimer both in vitro and in viv'o. In the same
article, they reported that recombinant Y2 expressed in E, coli
was only partially folded based on its chromatographic proper-
ties and its CD spectrum. These observations allowed them to
suggest that Y4 functions as a chaperone protein assisting the
folding of apoY2 and, consequently, cofactor assembly on Y2 to
form the active protein.
We now report that recombinant Y2 and Y4 expressed in E.
co/i are homodimers and under physiological conditions in vitro
can assemble into a heterodimer. The heterodimer is moderately
stable in its apo form, and upon addition of ferrous ion and 02
rapidly generates 0.6-0.8 equivalents (eq) of Y. per Y2Y4. The
significance of these in vitro observations to the active form of
R2 in vivo has been addressed by Western blotting. which has
revealed that both proteins are present at micromolar concen-
trations. Their localization, however, remains to be established.
Studies are presented that suggest Y4 is not essential for Y2 to
fold, nor does it appear to bind iron and deliver it to Y2. Thus.
further studies of Y4, essential for the formation of diferric-Y
cofactor in vitro, are required to define its function in vivo.
Several models for the function of Y4 are put forth based on our
studies and the recent structure of the Y2Y4 heterodimer (16).
Abbrevlatons: RNR rlbonucleotlde reducta; eMet, selenormethloninl; Y., tyrosyl radi-
cal; SEC size exclusion chromatography; CV, column volume(s); e equivalents; SOD,
superoxide dsmuta,
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Materials and Methods
Competent E. coli CodonPlus BL21(DE3) RIL cells were pur-
chased from Stratagene. Complete EDTA-free protease inhib-
itor tablets were purchased from Roche Biochemicals. Iron
content was determined by the ferrozine assay (17). Yeast strain
PS0799 (MATa, ade2-1, his3-11,15, leu2-3,112, ura3, trpl-1,
canl-100) was a gift of P. K. Soger (Massachusetts Institute of
Technology). Oligonucleotides were ordered from the Massa-
chusetts Institute of Technology Biopolymers Laboratory or
Research Genetics. Plasmids pHis-Y2, pYlA, pY2 M, and pY4J
have been described (13). Protein concentrations were deter-
mined by using extinction coefficients (e2o31o0nm) per dimer
[105,600 M-'-cm- ' for (His)6-Y2, 94,000 M-l cm-' for Y4, and
99,800 for M-'-cm- ' for (His)6-Y2:Y4]. The concentration of Y1
was determined by Bradford assay with BSA as standard.
Expresion Plamids for 2 and Y4 In E col. The Y2 gene (1.2 kb)
was obtained by digesting pY2 M with NdeI/BamHI (13). It was
purified by agarose gel electrophoresis and ligated into the
Ndel/BamHI sites of pET-14b to produce p(His)6-Y2. (His)6-Y2
contains the following N terminus: MGSSHHHHHHSSGLV-
PRGSH-native protein.
The Y4 (1.0 kb) and the AY4 (UAA stop codon at Glu-338)
genes were amplified by PCR by using pY4J as template with
primers 5'-AGGAGATATCATATCGAAGCACAT-3' and 3'-
AAGATTCCTAGGCTrAAGCTC-5', 5'-AGGAGATATCA-
TATCGAAGCACAT-3' and 3'-TTCATlTAATTGAAACTA-
CTGAAGATTCCTAGGCTT-5', respectively. The PCR products
were digested with NdeI/BamHI, purified on agarose gel, and
ligated into NdeI/BamHI sites of pET-14b to give pHis-Y4 and
pHis-Y4. All constructs were verified by sequencing.
Expression and Puriatlon of RN Subont. Y1, (His)6-Y2 from
yeast, and Y4 were expressed and purified by using procedures
described earlier (13) with the following modifications: E. coli
BL21 CodonPlus (DE3) RIL replaced BL21(DE3) pLysS as the
expression host; Y4 (pHis-Y4, pHis-Y4A, and pY4J) growth and
expression were conducted at 37°C; bacterial cells were lysed in
the presence of Complete EDTA-free protease inhibitors;
(His)6-Y2 from yeast was purified with buffers that included 4
mM p-mercaptoethanol/2 pM leupeptin/5 taM pepstatin A; and
an additional purification step using DEAE-Sepharose FastFlow
chromatography (Amersham Pharmacia) on a BioCAD Sprint
FPLC station (Perkin-Elmer) was added to the Y4 isolation. The
newly constructed p(His)6-Y2 was expressed in E. coli BL21
CodonPlus (DE3) RIL as described for pY2 M (13).
Recombinant (His)6-tagged proteins [(His)6-Y2, (His)6-Y4,
(His)6-Y4A] were purified by using the following general pro-
cedures. Frozen bacterial cell paste was resuspended in 4 vol of
buffer A (50 mM Hepes/5% glycerol/1.0 mM PMSF, pH 7.4) at
4°C. One EDTA-free protease inhibitor tablet was added per 50
ml of cell suspension. The suspension was passed through the
French press at 14,000-16,000 psi. The cell lysate was centrifuged
at 19,800 x g for 30 min. The supernatant was treated with
streptomycin sulfate to a final concentration of 1% (wt/vol), and
the pellet was removed by centrifugation. The supernatant was
loaded onto a TALON cobalt affinity column (2.5 x 5 cm),
which had been pre-equilibrated with buffer A. The column was
subsequently washed with 40 column volumes (CV) of buffer A
containing 100 mM NaCI, followed by 16 CV of buffer A
containing 10 mM imidazole. The protein was eluted first with
10 CV of buffer A containing 100 mM imidazole, then with 10
CV of buffer A containing 200 mM imidazole. Fractions con-
taining protein monitored by A28 0 am were combined and con-
centrated to >5 mg/ml. Imidazole was removed either by
Sephadex G-25 chromatography or dialysis. All proteins were
concentrated to >5 mg/ml, frozen in liquid nitrogen, and stored
at -80°C.
Coxpresn and PwIfcation of (Hs),-Y2:Y4 Complex. Plasmids
p(His)6 -Y2 and pY4J were cotransformed into E. coli BL21
CodonPlus (DE3) RIL cells. The heterodimeric complex was
expressed and isolated as described above for (His)6-Y2 with the
following changes. If apo heterodimer was isolated, 1,10-
phenanthroline (100 aM) was added to the growth media 10 min
before induction with isopropylthio--D-galactoside (18). DNase
I was added to remove DNA in place of the streptomycin sulfate
precipitation step. In the isolation of holo heterodimer,
Fe(NH4)2(SO4)2 was added to the crude lysate at a final con-
centration of 170 taM.
Isolation of Apo (Hkk-Y2:Y4. A 50-ml solution containing equal
molar amounts of apo (His)6-Y2 (2.0/ M) and Y4 (2.0 JIM) in
buffer A was incubated for 1 h at 4°C. The mixture was loaded
on a TALON column (2.5 x 5 cm) and washed with 20 CV of
buffer A. The protein was eluted with 50 ml of buffer A
containing 100 mM imidazole, followed by 50 ml of buffer A
containing 200 mM imidazole. Fractions containing the het-
erodimer as monitored byA2 s0 and SDS/PAGE were pooled
and concentrated to >5 mg/ml. The protein solution was directly
applied to a DEAE-Sepharose FF column (1.6 x 10 cm). The
bound protein was eluted from the column by using a (100 x 100
ml) linear gradient of 0-500 mM NaCI in buffer A. Fractions
were monitored byAzs ,nm and SDS/PAGE, and those contain-
ing a 1:1 (His)6-Y2:Y4 complex were collected.
Activaton of Apo (H)r2:Y4. Stock solutions of (His)6-Y2 and Y4
[(His)6 -Y4, or (His)6-Y4A] were deoxygenated by allowing 50-AIl
aliquots to equilibrate in an anaerobic glove box (M. Braun,
Newburyport, MA) for >3 h at 4C. Alternatively, samples of
>500 AlI were deoxygenated by repeated cycles of vacuum
pumping and argon flushing on a Shlenk line. A 1:1 mixture of
(His)6 -Y2 and Y4 (2 p.M each) was prepared from these
solutions, to which 3 eq of Fe(I) per (His)6-Y2:Y4 heterodimer
was added from a deoxygenated FeSO4 solution (2 mM in buffer
A). The resulting mixture was incubated at 4C for 1 h, then
exposed to air for 15 min with mixing. EPR analysis, activity
assays, and iron determination were carried out.
holatin of Holo (Hisk-Y2:l4. The heterodimer containing assem-
bled iron cluster was purified by using procedures described
above for apo heterodimer complex. Holo (His)6-Y2:Y4 was
subsequently analyzed for Y- by EPR methods as well as for
enzymatic activity and iron content.
Size Exduslon Chromatography (SEC). SEC was performed on a
Bio-Silect SEC 250-5 column (7.6 x 300 mm, Bio-Rad) on a
BioCAD Sprint station. Gel filtration standards from Bio-Rad
were used for molecular weight calibration.
Selnoethiolne (Seet) Y4 Anion Exchande Chromatography. Se-
Met Y4 was expressed in E. coli B834(DE3) in M9 minimal
media supplemented with SeMet and purified as described for
Y4 (13), except 10 mM DTT and 0.2 mM EDTA were added to
all buffers. The protein was chromatographed on a POROS 20
HQ anion exchange column (4.6 x 100 mm) on a BioCAD Sprint
station. The column was washed with 10 CV of 50 mM Tris-HCI,
pH 6.5, and the protein was eluted with a (60 x 60 ml) linear
gradient of 0-350 mM NaCI in the same buffer.
One Eq of Y4 Is Required for Maximal Nudeotide Reduction Activity
of Y2. (His)6-Y2 isolated from yeast orE. coli and Y4 were made
anaerobic as described above. The proteins were mixed with a
deoxygenated FeSO4 solution to give final concentrations of 2.0
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1%M (His)6-Y2, 0-10 IzM Y4, and 12 AsM FeSO 4 (3 eq per
heterodimer). After I h at 4*C, the samples were removed from
the glove box and exposed to air on ice. Enzyme activity assays
in the presence of 10 eq of YI per heterodimer were performed
immediately after reconstitution.
Activity Assay. A typical reaction mixture contained in a final
volume of 0.28 ml was as follows: 50 mM Hepes buffer, pH
7.0/3.0 /IM Y1/0.3 piM (His)6-Y2:Y4/2.0 mM ATP/1.0 mM[2-' 4C]CDP (specific activity 1.0 x 10- cpm/nmol)/100 $IM E.
coll thioredoxin/1.0 pM E. coli thioredoxin reductase/2.0 mM
NADPH/20 mM Mg(OAc)2. The assay mixture was incubated at
30*C. Aliquots of 50 p. were removed over a 20-min time period
and quenched in a boiling water bath. dCDP was analyzed by the
method of Steeper and Stewart (19). One unit of activity is
defined as I pinol of dCDP formed/min. The specific activity
was calculated per mg of (His),-Y2
EPR Spectroscopy. EPR spectra (139.5 GHz) were recorded at 12
K on a custom-designed pulsed EPR spectrometer equipped
with an Oxford liquid helium flow cryostat (20). Before each
measurement, the cavity was calibrated at room temperature
with a,y-bisdiphenylene-A-phenylallyl radical. All echo-detected
EPR spectra were measured by using the stimulated echo
sequence !(w/2), - 7 - (w/2), - T - (v/2)x - 7 - echo). w/2
pulses of 100 ns were used with spacing of r - T - 200 ns. Each
data point was averaged over 10 shots with a repetition rate of
400 ms/point. Spin concentration was determined by compari-
son of the signal intensities of yeast RNR samples to a calibration
curve established with E. coli R2 Y* (50-170 g$M).
CD Spectroscopy. CD spectra were recorded at 20*C on an Aviv
CD 62 DS spectrometer by using a quartz cuvette with 1.0-mm
path length. Samples (1.0-5.0 pM dimer) were diluted into 10
mM sodium phosphate buffer, pH 7.0. Five scans were averaged.
Molar ellipticity 101] was calculated with a macro program written
by Aviv Associates (Lakewood, NJ).
Quantitative Western Bot. A midlog phase culture of yeast cells
(BJ5465 or PS0799) was harvested by centrifugation. The cells
were washed with water and resuspended in ice-cold lysis buffer
(50 mM Hepes, pH 7.4/200 mM NaCI/10 mM EDTA/5 pg/ml
aprotinin/5 Apg/ml leupeptin/2p g/ml E-64/2.5 Ig/ml pepstatin
A/I mM PMSF). Glass beads were added, and cells were cracked
with eight 30-s rounds of vortexing and cooling on ice. Cell debris
was removed by centrifugation. Extract was stored at -80*C.
Protein concentration was determined by Lowry with BSA as
standard.
A typical quantitative Western blot contained a standard
curve of the purified RNR subunit (8-60 ng) and crude extracts
(5-12 p/g) and was carried out as described (13), except that the
proteins were visualized with luminol chemiluminescence. Mem-
branes were incubated in luminol solution (1.25 mM luminol/65
mM Tris, pH 8.0/0.2 mM coumaric acid/0.01% H202) for I min
and then exposed to film. Bands were quantitated by using the
public domain National Institutes of Health IMAGE program
(http://rsb.info.nih.gov/nih-image/).
Results
Y2 and Y4 Are INomodlms. (His)6-Y2 and Y4 were isolated asdescribed (13). The native molecular weights of (His) 6-Y2 and
Y4 were determined by SEC. For comparison. apo and holo E.
coli R2, both known to be homodimers, were characterized as
well. (His)6-Y2 and Y4 exhibit apparent molecular masses of 133
kDa and 102 kDa (95 kDa and 80 kDa predicted), respectively.
Holo and apo E. coli R2 exhibit apparent molecular masses of
120 kDa and 124 kDa (87 kDa predicted), respectively. The
comparative data suggest that recombinant Y2 and Y4 are both
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Fig. 1. Demonstration of the ability of Y4 protomers to reorganize. Anion
exchange chromatography and SDS/PAGE of full-length and clipped SeMet
Y4. (A) SDS/PAGE. Lane 1, fullkngth SeMet Y4 and clipped Y4 standards.
Lanes 2-4 represent proteins found In peaks a. b. and c of the chromatogram
shown In 8. (B) Anion exchange chromatogrphy of SeMet Y4. (C) Peak b In B
was collected and rechromatographed.
homodimers. Furthermore, heterodimers of apo and holo(His)6-Y2:Y4, discussed subsequently, have apparent molecular
masses of 99 kDa and 113 kDa, respectively.
Y4 Dimr Is Capable of Protomr Reoreanizatlon. To make SeMet-
labeled Y4 to facilitate its structure determination, a fortuitous
observation was made that demonstrates that the Y4 dimer is
capable of protomer reorganization. Purified SeMet Y4 was a
mixture of full-length and clipped proteins (Fig. IA. lane 1).
When this mixture was analyzed on a DEAE anion exchange
column, three protein-containing peaks were observed (Fig. IB).
SDS/PAGE analysis (Fig. 1 A and B) revealed clipped Y4 in
peak a, a 1:1 mixture of clipped and unclipped Y4 in peak b. and
unclipped Y4 in peak c. Mass spectrometric analysis and N-
terminal sequencing of the clipped Y4 revealed that the C
terminus had been cleaved between residues Ser-330 and Lys-
331. The observed 1:1 ratio of proteins in peak b and the fact that
the two polypeptides, full-length and clipped Y4, generated three
different species provide additional support for the conclusion
from SEC studies that Y4 is a dimer.
The observation of a clipped and unclipped SeMet-Y4 dimer
offered an opportunity to test the possibility that Y4 protomers
are capable of re-equilibration. The protein eluted in peak b (Fig.
IB) was pooled, concentrated, and reinjected onto the same
column. The results shown in Fig. IC are almost identical to
those in Fig. lB. These results demonstrate a re-equilibration of
the Y4 mixed dimer, although the mechanism of such equilibra-
tion through either monomers or tetramer has not yet been
established.
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ratio in the heterodimer. This protein was analyzed by UV/Vis
leM t dfY4 per Y2 and EPR spectroscopy for Y-. The spectrum reveals a diferric
cluster (features at 325 nm and 360 am) and a very broad Y*
contstuUon of (Hs•Y2 mpressd In yeast and ln E. co wIth Y4. feature at 416 rm. The Y- feature is similar to that reported for%. (HIs-Y2 xpressd In cwwame ()was oMWtd wuith mouse M2 (21). Quantitation of the Y- by high field EPR gave
an nd 6 eq of rSo4 p Y12 dlnwr. (Hsk-2 eprused in E. of ( os)autnd wi 0- q of Yo pr eq of s prSo s n v2 d cm(. 0.6-0.8 radicals per heterodimer. These results contrast with the
in viv& reconstitution experiments on E. coil apo R2 in which
1.0-1.2 radicals were observed per homodimer (22, 23).
atalytl or Stalchimaetrk Actaer of Y2 for udedtde Chabes et aL (14) reported that coexpression of Y2 and Y4 in
? Y4 as isolated contains no iron and consequently no E. coil resulted in an active heterodimer with 0.4 radicals and a
). Our working hypothesis for the function of Y4 has specific activity of 2.5 #amol-min-mg. The assay conditions in-
it is a metallo-chaperone protein that delivers iron to cluded ferric ion and used DTT as reductant. In our assay system,
is a metallo-chaperone, one would predict that it may E. coil thioredoxin, thioredoain reductase, and NADPH are used
catalytically in the assembly of diferric-Y- cotactor in as reductant, and no iron is added. When we assayed our yeast
riments were carried out in which apo Y2 (2.0 pM) was expressed and reconstituted Y2 under the conditions of Chabes
I with 0-5 eq of Y4 in the presence of 3 eq of ferrous etal., the activitywas 32% of the activity using our assay. We then
2 monomer under anaerobic conditios. 02 was added coexpressed (His)5 -Y2 and Y4 in E. coil and isolated het-
erodimer in the apo and iron-loaded forms. The Y- and specific
c the cluster, and the resulting mixture was assayed for activity were similar to those obtained from the heterodimer that
e reduction ability. The results of these experiments are was assembled from individual homodimers, and there were 1.8
Fig. 2. Approximately one eq of Y4 gives maximal eq of iron per heterodimer.
a..IVILy Ui 1.. ILIMU U.O a8UmlUm -UJImg o11r IsM- 1 xpresaUd 1m
yeast and inE. co/i, respectively. These results suggest that, under
the conditions investigated, Y4 acts stoichiometrically rather
than catalytically and suggest that the active R2 may be a
heterodimer.
Gemration of Ape YY4. To test this model, a 1:1 mixture of
(His)6-Y2 and Y4 (2-10 tpM dimer) were incubated at 4'C. The(His)6 tag facilitates separation of the possible combinations of
subunits by using a cobalt affinity column. Y4, if in excess, elutes
during the extensive washes. As shown in Fig. 3, a 1:1 mixture of
(His)6 -Y2 and Y4 elutes with 100 mM imidazole. Additional
LIm
1 2 3 4 5
O0 kDa in
45 kDa
1g. 3. SDOS/PAGE of (Hls-Y2:Y4 heterodienwr in apo and holo foms reeal
the stablity of heterodme through two dhroatographc steps. Lame 1. low
MW SigmaMarker lane 2. apo (HIs)rY2Y4 after TALON colnnm lane 3, apo
complex after DEAE Sephro comr lar 4 and 5. holo O(NlsY2:Y4 afte
TALON and DEAE Spharose columr, mrespectly.
CD Spectroecepy m YZ W4 and mY24 Studies of Chabes et at. (14)
suggested that their recombinant (His)6-Y2 was partially dena-
tured as shown by the CD spectrum. Therefore, we acquired the
CD spectra of Y2, Y4, apo Y2Y4, and iron-loaded Y2Y4 under
conditions identical to those reported (14). The CD spectra of
Y4, (His)e-Y2, and the apo and holo heterodimers appear to be
very similar and predominantly helical (Fig. 4). Thus, our
(His)6 -Y2 protein appears tobe folded. Chabeset al. were unable
to purify Y2 using strong anion exchange chromatography. We
were able to chromatograph Y2 by using weak anion exchange
chromatography, but the recoveries were poor, suggesting in-
stability of the protein in high salt.
Ira lading to Y4? Several experiments were carried out to
determine whether iron in the ferrous or ferric state can bind to
Y4. Incubation of Y4 with a 5-fold excess of 55Fe2+ in an
anaerobic box, followed by Sephadex G-25 chromatography,
failed to detect any Fe(II) associated with the protein fractions.
A similar experiment carried out with [55Fe]ferric citrate also
failed to reveal any iron binding. A control experiment to
determine ferrous ion binding to apo E. coli R2 revealed -0.2
eq of iron per monomer. Thus, if iron does bind to Y4, its Kd mustbe high.
One additional experiment was performed to test the model of
iron delivery to Y2 by Y4. In the case of yCCS, the chaperone
protein for superoxide dismutase (SOD), its C terminus (last 30 aa)
has been shown to play a key role in copper delivery in vio (15, 24).
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(His)6-Y2 homodimer elutes with 200 mM imidazole. The
fractions containing the heterodimer were rechromatographed
on a DEAE anion exchange column [(His)6-Y2 and Y4 have
isoelectric points of 5.5 and 5.1, respectively]. The heterodimer
eluted at 250 mM NaCI using a linear NaCI gradient, and
SDS/PAGE (Fig. 3) revealed a 1:1 mixture of Y2 and Y4. These
studies indicate that Y2 and Y4 can re-equilibrate to form
heterodimer and that in the apo form the interactions between
these proteins is sufficiently strong to survive two chromato-
graphic steps. As noted above, SEC studies verified that Y2Y4
is also a dimer.
Generatlm of Act• Iloterodimer. Optimized conditions were
established for Y- generation from apo heterodimer. A 1:1
mixture of apo (His)6-Y2 and Y4 (2 #sM dimer of each protein)
was mixed under anaerobic conditions with 3 eq of ferrous ion
per (His)6-Y2 monomer. After 1 h at 4*C, the solution was
aerated and then purified on a TALON column followed by an
-L h h_ l -T .l h2 i F l
cofactor formation. This information is crucial for understand-
ing the active form(s) of RNR in vivo. Our thinking about the
mechanism of formation of the cofactor in R2 has been influ-
enced by our in vitro reconstitution experiments of E. coi R2 and
by the recent discovery of copper chaperone proteins (15.
32-34). The studies with apoE. coil R2 have demonstrated that
the diferric-Y- cofactor can be assembled in vitro by addition of
ferrous ion, 02, and reductant (22, 35). Much has been learned
about the chemistry and the kinetics of this assembly process.
However, further studies have been hampered because of our
inability to uniquely load ferrous ion into R2 and deliver the
required reducing equivalent by a single pathway. Thus, to
understand the details of cluster assembly requires knowledge of
the proteins that deliver Fe(II) and the protein that provides the
reducing equivalent.
Studies on copper delivery to proteins in yeast provided the
basis for our proposal that Y4 may be involved in Fe(II) delivery
to Y2. These studies revealed that no free nnper ions exist
180 190 200 210 220 230 240 250 inside yeast cells and that specific chaperone proteins deliver
copper to specific targets (32, 36, 37). The chaperone protein
WaUP lnt/l/nlm yCCS, for example, delivers Cu(I) to copper-zinc SOD (15.
spectra of (His)-'Y2, Y4, and apo and holo forms of the het- 32-34). Crystallographic studies of yCCS and SOD revealed that
ed line represents (His).-Y2 protein eapressed in E. colt black lne they are structurally homologous (38). yCCS is not active as a
Y4; green and dashed blue lines represent (His);-Y2:Y4 het- SOD, as the active site ligands for the metal have been altered.
apo and holeo forms, respectively. It has been proposed that copper-loaded yCCS delivers copper
to SOD by transient formation of a heterodimer (33) or het-
erotetramer (34). The analogy between the yCCS/SOD system
ion of the C-terminal sequence of Y4 in comparison with and our Y2/Y4 system is striking. Our results show that Y4 is
equences revealed a preponderance of caiboxylates that essential for diferric-Y- cofactor formation in Y2 in vitro. Y4 is
ction as ligands to iron. Therefore. we constructed a Y4 homologous to Y2 with three of the six conserved iron ligands
mutant [(His)6-Y4)] in which the last eight amino acid replaced, presumably abolishing iron binding to the active site.
ere deleted. This construct was examined for its ability to Recently. Chabes et al. (14) suggested, based on coexpression
active heterodimer in vitro. (His)6-Y44 gave the same of Y2 and Y4 in E. coll, that Y4 is a structural chaperone protein
f Y- per heterodimer as did Y4 [(His)b-Y4]. These results assisting in the folding of Y2 to form an active heterodimer in
uggest that Y4 homodimer does not bind iron tightly in vivo. The ability of chaperone proteins to function in the folding
Fe(II) or Fe(III) oxidation state and that Fe(II) can be of other proteins is well documented. However. to our knowl-
ted into Y2Y4 heterodimer in the absence of the C- edge, there is no example of a structural homologue stoichio-
egion of Y4. metrically assisting in folding. Our ability to chromatograph Y2
and its CD spectrum in comparison with other R2s (Fig. 4)
tion of Y2 and Y4 Concentrations o Using Quantitative suggest that Y2 does not require Y4 for folding. However, our
lots. We and others have shown that a Y2Y4 complex Y2 protein contains a (His).-tag that differs from the construct
tected in viva using antibodies (8, 13). Furthermore, reported by Chabes et al.. which could account for our different
al. (14) recently proposed, based on In vitro studies, observations. At present, we believe that Y2 can fold indepen-
eterodimer is the active form of R2 in vivo. Our in vitro dently of Y4 and that Y4 is not a folding chaperone.
so support this model. However, this model requires A number of important conclusions can be drawn from the
nd Y4 be present in similar amounts in vivo and that experiments described here, which have been designed to elu-
ocalized in the same compartment inside the cell. cidate the function of Y4. It is clear that in vitro, Y2 and Y4 can
ive Western blot studies have been carried out to form an active heterodimer as recently reported (14). Our
the Y2:Y4 ratio. Two different yeast strains, BJ5465 experiments differ in that their active heterodimer was obtained
99, were examined. The results show that Y2 dimer is only through coexpression of Y2 and Y4 in E. coil. In our case.
0.4-2.3 pM and Y4 dimer at 0.5-1.3 p.M, assuming a Y2Y4 heterodimer can be generated by coexpression, activation
ne of 7 x 10- lp1. This calculated concentration of Y4 of Y2 by Y4 with Fe(ll)/O2, or activation of apo Y2Y4 byd agreement with the amount of Y4 calculated from Fe(II)/0 2. Our holo heterodimer possesses 0.6-0.8 tyrosyl
nsional gel electrophoresis, which estimated a concen- radicals and is active in nucleotide reduction. The relevance of
44,000 copies per yeast cell or 0.5 p.M if the same cell this heterodimer to the active R2 in vivo is supported by
7 x 10- s p8l is assumed (25). These results suggest that coimmunoprecipitation studies, as well as by the determination
'4 could exist as a heterodimer in viMo. in two different yeast strains that Y2 and Y4 are present in
similar amounts.
In our opinion, the active form of R2 in vive still remains an
nt discovery of a second R2 subunit in mammalian open question (13, 14). First, we do not know whether Y2 and
rked to p53 (26) and the success of gemcitabine in the Y4 reside in the same location within the cell. Second. if the
of pancreatic cancer (27) makes understanding the heterodimer is the active R2 in DNA replication, one would
of RNRs, which play a central role in DNA replication expect that the deletion of RNR4 would be lethal. Studies from
r, of primary interest. We have chosen yeast as a model the Elledge lab support this proposal (8). However. overexpres-
understand the complex regulation of these enzymes sion of either YI or Y3 in the deletion strain leads to cell survival.
1). In addition, two recent independent reports show that RNR4 is
tial efforts have been focused on identifying the active important, but not essential. for yeast cell viability (12. 39).
he R2 subunit and the function of Y4 in diferric-Y- Third, studies of the mRNA levels of RNR2 and RNR4 aus a
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function of cell cycle suggest that the Y2 mRNA level varies
2-fold over the cell cycle, whereas that of Y4 mRNA remains
constant (7, 8). Thus, yeast cells can survive in the absence of Y4.
This observation seems to be at odds with all proposals made
thus far for the function of Y4.
Modified models for the function of Y4 can be proposed,
influenced by recent studies of metallo-cofactor biosynthesis in
a number of systems. Studies on iron-sulfur cluster assembly
(40), nickel cofactor assembly in urease (41), copper assembly in
copper zinc SOD (32, 33), and diferric-Y- assembly in R2 (3, 22)
have shown that reconstitutions of active cofactors from apo
proteins can occur in the absence of additional accessory protein
factors despite the requirement for proteins in vivo. In the first
three cases, biosynthetic pathways for cofactor assembly have
been identified and partially characterized. In the case of R2,
protein factors are likely, but they have not yet been identified.
One possibility is that apo heterodimer, Y2Y4, takes up iron
from a transporter or small iron chaperone protein in vivo.
Ferrous ion binding to Y2 could occur either by ferrous ion
binding initially to Y4 followed by its delivery to Y2 or by Y4
altering the local conformation of Y2, thus facilitating direct
access of iron into the Y2 active site. This reaction could be made
irreversible by rapid addition of 02 once two irons are in place
on Y2 and by the addition of one reducing equivalent from a yet
unknown factor.
The model in which Y4 delivers ferrous ion is less appealing
given that Y4A, with the truncated C-terminal tail (Y4 contains
three Asp and one Glu in the last 15 residues, whereas Y2
contains two Glu, one Asp, and one Gin in a different sequence
context), is active in cluster assembly in vitro. The kinetics of
assembly, however, have not been studied, and it is possible that
they are altered in comparison with the kinetics of cluster
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assembly with intact Y4. The importance of the C-terminal tail
of all R2s in interacting with R1 suggests that this truncation may
preclude testing our model in vivo (42, 43).
Y2Y4 heterodimer is clearly active and stable in vito. An
unresolved issue is whether this heterodimer can reorganize to
form Y2 and Y4 homodimers. To provide insight into the
differences between the homodimer and heterodimer interfaces,
crystallization efforts have been undertaken for Y2Y4, Y2, and
Y4. The structure of the heterodimer is presented in the
accompanying article (16). This structure in comparison with the
structures of E coili R2 (44, 45) and mouse M2 (46) and
structure-based sequence alignments with Y2 and Y4 have
suggested an experimentally testable hypothesis about how the
heterodimer could convert to the homodimers (16).
The most compelling argument at present for Y2Y4 being the
active R2 is the detection of 0.6 to 0.8 Y- per heterodimer. In no
other R2 characterized so far have two Y- been observed per
homodimer. This putative half-site reactivity interestingly has
been observed in many radical-using proteins including pyruvate
formate lyase, galactose oxidase, and the oxygen-evolving com-
plex in photosynthesis (3,47). The observation of one radical per
homodimeric molecule in these systems suggests that it is likely
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Structure of the yeast ribonucleotide reductase
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The R2 subunits of class I ribonucleotlde reductases (RNRs) house
a diferric-tyrosyl radical (Y.) cofactor essential for DNA synthesis. In
yeast, there are two R2 proteins, Y2 and Y4. Although both Y2 and
Y4 are homologous to R2s from other organisms, Y4 lacks three
conserved Iron-binding residues, and Its exact function Is unclear.
Y4 is required for assembly of the diferric-Y cofactor In Y2, and the
two proteins can form both homodimeric and heterodlmeric com-
plexes. The Y2Y4 heterodimer was crystallized from a mixture of
the two proteins, and Its structure was determined to 2.8 A
resolution. Both Y2 and Y4 are completely t helical and resemble
the mouse and Eschrchricha co R2s In overall fold. Three .w hellces
not observed In the mouse R2 structure are present at the Y2 N
terminus, and one extra N-terminal helix Is observed In Y4. In
addition, one of the eight principal hellces in both Y2 and Y4, sD,
Is shifted significantly from Its position In mouse R2. The het-
erodimer interface is similar to the mouse R2 homodimer Interface
in size and Interacting residues, but loop regions at the Interface
edges differ. A single metal ion, assigned as Zn(ll), occupies the Fe2
position In the Y2 active site. Treatment of the crystals with Fell)
results In difference electron density consistent with formation of
a dllron center. No metal-binding site is observed In Y4. Instead, the
residues In the active site region form a hydrogen-bonding net-
work Involving an arginine, two glutamlc acids, and a water
molecule.
D ibonucleotide reductases (RNRs) catalyze the reduction of
Rribonuclcotides to the corresponding deoxyribonucleotides,
an essential step in nucleotide metabolism in all organisms (1).
By providing a balnced pool of monomeric precursors for DNA
replication and repair, these enzymes play a crucial role in
control of cell proliferation. Members of the largest class of
RNRs. class 1, are found in all eukaryotes, in many prokaryotes,
and in several viruses. The catalytically active form of class I
RNRs is proposed to be an a:2 tetramer (2). The homodimeric
xa subunit, called RI, houses the active site and binding sites for
allosteric effectors. The S subunit, called R2, contains a diiron
cluster that in its reduced state reacts with dioxygen to form a
stable tyrosyl radical (Y.) and a diiron(III) cluster. This essential
Y. is proposed to generate a thiyl radical, located on a cysteine
residue in the RI active site, that initiates ribonucleotide reduc-
tion (3. 4).
The most extensively characterized class I RNR system is that
found in Escherichkl coli. Crystal structures of both the E. coli RI
(51) and R2 (6, 7) proteins have been determined, and the
mechanism of diferric-Y- cofactor assembly has been probed by
a variety of spectroscopic techniques (3). By contrast, less is
known about the structure and mechanism of eukaryotic class I
RNRs. A structure of mouse R2 is available (8). and cofactor
formation has been investigated (, 10). However, these studies
have proved more difficult because the diiron center in mouse
R2 is less stable than that in E. coli R2 (8. 11), and the kinetics
of cluster assembly are less amenable to detection of interme-
diates. Because eukaryotic class I RNRs have been a successful
target for anticancer drugs (12, 13), further understanding of
their structure, mechanism, and regulation is imperative.
An obvious choice for a eukaryotic model system is Saccha-
romyces cerevisiae. which contains four genes encoding RNR
subunits. The RNRI and RNR3 gene products, designated Yl
and Y3. correspond to the RI protein (14). The RNR2 gene
product, designated Y2, corresponds to R2 (15. 16). Both YI
(14) and Y2 (17) are essential for mitotic viability whereas Y3 is
not normally expressed, but can rescue cells deficient in Y (14).
The fourth gene product, RNR4 or Y4, is 56% identical to Y2
and also appears to be an R2 homolog (17, 18). Several features
of the Y4 sequence are intriguing. Although Y2 contains 16
critical residues conserved in almost all R2 proteins, 6 of these
residues are not conserved in Y4. In particular, 3 residues known
to coordinate iron in E. colh R2 are absent. Two histidines are
replaced by tyrosines, and a glutamic acid is changed to arginine,
suggesting that Y4 cannot accommodate a diiron center. In
addition, Y4 lacks the N-terminal 50 residues found in Y2 and
other eukaryotic R2s. Nevertheless, deletion of Y4 is lethal in
some yeast strains and impairs cell growth in others (17-20),
indicative of an important role in RNR function.
Initial efforts to purify and study the yeast RNR proteins were
hindered by a rapid loss of enzyme activity (21, 22), but
successful purification of all four subunits has been reported
recently (23, 24). A key finding of the work of Nguyen et al. (23)
is that Y4 is required to assemble the diferric-Y cofactor in Y2.
Unlike E. coli R2, addition of Fe(II) and O is not sufficient to
generate active Y2, but inclusion of Y4 yields active Y2 and
detectable Y. A Y- cannot be generated by addition of Fe(II)
and 02 to Y4 alone. consistent with the absence of iron ligands
in the Y4 sequence. These data, along with the observation that
Y2 and Y4 can form a complex i vvo (17, 23), led to the
proposal that Y4 delivers iron ions to the Y2 active site by the
formation of a heterodimeric complex (23). similar to that
suggested for the yeast copper chaperone for superoxide dis-
mutase (25). In this model, Y4 might then dissociate from Y2 to
allow the formation of Y2 homodimers. An alternative role of Y4
proposed by Chabes etra. (24) is that of a molecular, rather than
metallo, chaperone. In this scenario. Y4 facilitates folding of Y2,
stabilizes it in a conformation needed for cofactor assembly. and
remains associated for RNR activity (17. 18, 24). Recent obser-
vations, including those presented in the accompanying paper,
indicate that the Y2 and Y4 homodimers can indeed convert to
active heterodimers (24, 26). To help elucidate the function of
Y4 and to advance our understanding of eukaryotic RNRs. we
have determined the x-ray structure of the Y2Y4 heterodimer to
2.8 A resolution.
Abbrevations: RNR, ribonucleotlde reductase; R1, large subunit of ribonucleotide reduc-
tase; R2, small subunit of rlbonucleotde reductase; Y., tyrosyl radical; Y2 and Y4, small
subunits RNR2 and RNR4 of yeast rlbonudeotlde reductase; EMTS, ethylmercurthlosallcy-
late,
Data deposition: Refined coordinates have ben deposited In the Protein Data Bank,
www.rcb.org (PDB ID code JK0).
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Materials and Methods
Crystalizatlon and Data Colectlon. Y4 and His6-tagged Y2 were
purified as described (23, 26). Purified Y2was exchanged into 50
mM Tris (pH 7.8) and concentrated to 10 mg/ml in a Millipore
Microcon 10 centrifugal concentrator. Purified Y4 from a 144
mg/ml stock solution was diluted to 10 mg/ml with 50 mM Tris
(pH 7.8). The Y2 and Y4 protein solutions were then mixed in
equal volumes and diluted with 50 mM Tris (pH 7.8) to final
concentrations of 4 mg/mL This solution was incubated over-
night at 4°C before crystallization. Crystals were grown by using
the sandwich drop technique, in which a drop containing 5 A1
protein solution and 5 al precipitant solution is suspended
between two siliconized glass slides. The precipitant solution
consisted of 100 mM acetate buffer (pH 4.9), 14% wt/vol
polyethylene glycol (PEG) 4000, and 200 mM NaCI. The final pH
of the mixed drop was measured to be 5.3. Long rectangular
crystals of maximum dimensions 0.10 mm x 0.10 mm x 1.0 mm
appeared within 3-7 days. These crystals were transferred to a
cryosolution composed of the precipitant with 20% ethylene
glycol for 5 min and then flash cooled in liquid nitrogen. A 2.8-A
resolution data set was collected at Stanford Synchrotron Ra-
diation Laboratory at - 160'C by using a Mar 345 imaging plate
detector (NATIVE, Table 1). The crystals belong to the space
group P2,2121 with unit cell dimensions a = 92.9 A, b 93.0 A,
and c = 97.4 A.
Isomorphous heavy atom derivatives were prepared by soak-
ing crystals in solutions containing the precipitant supplemented
with 5% glycerol and 5 mM lead(II) acetate or 1 mM ethylmer-
Table 1. Data collection, phasing, and refinement statistics
NATNIVE* ANOMt
curithiosalicylate (EMTS) for 6 h, after which the crystals were
transferred to the cryosolution and flash cooled in liquid nitro-
gen. Anomalous data were then collected at a wavelength near
the x-ray absorption edge of the heavy atom. For Fe(II) soaking
experiments, Y2Y4 crystals were transferred into 10-g1 drops of
a thoroughly degassed cryosolution of 100 mM acetate buffer
(pH 5.4), 20% vol/vol ethylene glycol, 14% wt/vol PEG 4000,
and 200 mM NaCI to which solid ferrous ammonium sulfate was
added to a final concentration of 10 mM Fe(II). The crystals
were soaked in this cryosolution for -1 min and then flash
cooled in liquid nitrogen. Derivative data sets were collected at
the DuPont-Northwestern-Dow Collaborative Access Team
(DND-CAT) beamline at the Advanced Photon Source at
- 160'C by using a 2K x 2K Mar charge-coupled device (CCD)
detector (PB, EMTS, FE, Table 1). All data were processed with
the programs DENZO and SCALEPACK (27).
Strucen Dtermttlodn. Heavy atom sites for the Pb(II) and
EMTS derivatives were initially determined by Patterson anal-
ysis, and additional sites were located by using the program
SOLVE (28). Refinement of these sites followed by density
modification and phase extension to 3.1 A resolution with CNS
(29) yielded an interpretable electron density map in which two
molecules containing a number of long a helices were apparent.
The molecular model was refined by iterative cycles of rigid body
refinement to 3.0 A resolution, followed by minimization, sim-
ulated annealing, and restrained B-factor refinement to 2.8 A
resolution. After each cycle, the model was rebuilt by using the
pB EMTSt FEt
Data collection
Wavelength At
Resolution range, A
Unique observations
Total observations
Completeness. %
(I/sigma)
Phasing
Number of sites
Rcum1
Phasing power
(anomalousO)
Figure of merit
Refinement
Resolution range, A
Number of reflections
R factor**
Rftr.
Number of protein,
nonhydrogen atoms
Number of nonprotein
atoms
rms bond length, A
rms bond angles,'
Average B values, Az
Main chain
Side chain
0.946
15-28
20,645
65.155
99.9 (99.8)
0.063 (0.285)
83 (2.7)
1.700
25-3.1
15,836
222,390
99.9 (99.9)
0.081 (0.279)
12.7 (2.6)
0.939
25-3.1
15,682
66,218
99.0 (99.9)
0.078 (0.306)
7.2 (2.7)
3
0.84
0.79 (0.63)
1.000
25-3.6
8,432
47.522
85.9 (85.9)
0.077 (0.169)
7.4 (3.2)
2
0.85
0.74 (0.64)
0.40 (15-3.6 A)
9-2.8
19,752
0.243
0.296
4944
59
0.008
1.23
45.7
46.5
*Data collected at SSRL beamllne 9-1.
tData collected at the DND-CAT beamlilne at the APS. The NATIVE and ANOM data sets were collected from the same crystal.
tValues In parentheses are for the highest resolution shells 2.85-2.90 A for NATIVE and FE, 3.15-3. 10 A for ANOM and PB. and 3.66-3.60 A for EMTS.
'R - loes - wlal/Yc,, where the summation Is over all reflections.
AllI phasing statistics from CNS. Roam - lack of closure error/lsomorphous difference.
Phasing power - heavy atom structure factor/rms lack of closure error.
**R-factor - ZIFom, - F lJ/Foe.. Seven percent of the reflections were reserved for calculation of R.
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1.000
13-2.8
20,856
151.906
98.2 (99.8)
0.062 (0.330)
10.4 (2.3)
Fg. 1. Composite omit electron density map contoured at to for residues
270-279 of Y2 helix aF. Two of these residues, Glu-273 and HIs-276, are
coordinated to the znc Ion (graysphere). Awater molecule hydrogen bonded
to His-276 Is shown as a red sphere.
program o (30). The quality of the model was monitored by the
free R value calculated using 7% of the data. The locations of
sulfur atoms were determined from anomalous difference Fou-
rier maps generated from anomalous scattering data collected at
a wavelength of 1.7 A (ANOM, Table 1). These sites were used
to position methionine and cysteine residues in the two mole-
cules in the asymmetric unit, and clearly showed that the
asymmetric unit contained one monomer each of Y2 and Y4. In
addition, the electron density for numerous side chains, includ-
ing the two tyrosines in the Y4 active site region, indicated the
presence of two different proteins. The final model contains a
single Y2Y4 heterodimer, 58 solvent molecules, and one zinc ion
(Table 1). The Y2 model includes residues 26-359, and the Y4
model includes residues 11-90, 100-263, and 275-295. No
electron density was present for Y4 residues 91-99 and 264-274.
A portion of a composite omit electron density map is shown in
Fig. 1. Ramachandran plots generated with PROCHECK (31) show
that the model exhibits good stereochemistry, with 99.7% of the
Y2 residues and 98.8% of the Y4 residues in the most favored
and additionally allowed regions. Accessible surface area calcu-
lations were performed with the CCP4 program AREAIMOL (32).
Figures were generated with BOBSCRIPT (33). MOLSCRIPT (34),
and RASTER3D (35).
Results amd Disamokn
Overall Structure. The Y2Y4 heterodimer is similar to the E. coli
(6, 7) and mouse R2 (8) homodimers (Fig. 2). Both Y2 and Y4
are completely a helical and lack the # hairpins that constitute
the tip of the heart shape in the E. coli homodimer. Y2 is
composed of 13 a helices, the 8 longest of which (aA-aH) form
an a helical bundle like those in E. cdi and mouse R2. The visible
portions of Y4 include 10 a helices, 8 of which (aA-aH) form
the conserved 8-helix bundle structure (Figs. 2A and 4). No
electron density is present for the C-terminal 41 residues of Y2
and 51 residues of Y4, suggesting that these regions are disor-
dered. This observation is not surprising because the C termini
are essential for interaction with the YI subunit (26, 36) and, in
the mouse and E. coli systems, become structured only on
complexation of the two proteins (37, 38). Although the Y4 C
terminus is sensitive to proteolysis between residues 330 and 331
(26), SDS/PAGE analysis of dissolved heterodimer crystals
indicates that Y4 is intact in the crystal.
A striking feature of the Y2 molecule is the presence of 3 a
helices (a 1-a3) at the N terminus that encompass 44 residues not
observed in mouse R2 (8) (Figs. 2-4). Helix at interacts with aB
and aG, and helix a2 interacts with aD and aG. Helix a3 is
linked to aE by a hydrogen bond between Arg-66 and Glu-230.
Most of this region is not conserved in Y4. but the N-terminal
10 residues in the Y4 structure form a helix that corresponds to
Y2 a3. As a result of the extended Y2 N terminus, the Y2Y4
heterodimer is asymmetric. The presence of an ordered N
terminus in Y2 as compared with mouse R2 can be explained by
crystal packing interactions. Residues in the first 3 a helices of
Y2 provide most of the crystal packing contacts. Of 15 Y2
residues involved in lattice interactions. 13 are between residues
A
R
Fg. 2. Comparison of the Y2Y4 heterodmer with the mouse and E. coil R2 homodlmers. (A) Stereo view of the Y2Y4 heterodimer. The Y2 molecule Is shown
In red and the Y4 molecule In blue. The zinc Ion Is shown as a gray sphere. All secondary structure elements are labeled on Y2. and the eight principal helices
are labeled on Y4. (8) The mouse R2 homodlmer (PDB accession code IXSM). One subunit Is shown In red and the other In light blue. The Iron Ion Is shown as
a yellow sphere. The eight principal helices are labeled on both subunits. (C) The E coll R2 homodlmer (POB accession code IIB). One subunit Is shown In red
and the other In light blue. The iron lons are shown as yellow spheres. The eight principal helices are labeled on both subunits.
251
u
12 mim aesiin ar 50r·rrr~rn In lonst rom n QMOUNG r-U soularrvrm so1410 Wean 119aluae 0..sin w1uin waeSOvIAS as3.asiA
1Z
14 InMsa AI s
I"- saaMR211110 -n mmo
a. eas · NIIOIy N
14
f. eU
IM InT-YLP PZKUWNO
ammma mmar-yasw PsuEsa
asa mr-wV Vzonam"
onw e gPwssmv ge1asm
-MEWAevr amm m 12gina PnAe
110110Im M 1100Z QUO-AU I MASNUlouwvmpa smlb-ý NIEZONA o r"12
M -1, 11 N1 M
12 NOW"WP n
14 K2L2mw sommaS
fas Oiwsess VImwtNA
a. ownl asnrAS, inuaWM
Fig. 3. Stereo superpostion of Y2 (r, Y4 (blue) and moue R2 (ght blue).
Secondary structure elements are labeled for Y2. Helces*A-&H are present In
all three molecules and are labeled as for E. cot R2. The N-terminal region of
eB and the C-terminal region of AE, G,. and aH are rendered transparent to
emphasize helces a and &D. The zinc Ion In Y2 Is shown as a gray spher. and
the Iron Ion In mouse R2 s shown as a yellow sphere.
33 and 84. By contrast, the first visible N-terminal residue in the
mouse R2 structure appears to be pointed into a solvent channel.
Excluding the N terminus of Y2, Y2 and Y4 are quite similar
and can be superimposed with an rms deviation of 1.2 A for 251
Ca positions. The most significant deviation is in Y2 residues
189-207 and Y4 residues 137-157. This region in Y2 isa helical,
a5, but is a loop in Y4. Notably, Y2 a5 and the following helix,
aD, also differ significantly from the corresponding region in
mouse R2 (Fig. 3). Compared with their positions in mouse R2,
these helices are shifted by -5 A toward the N-terminal helices
in Y2 and away from the four-helix bundle that houses the iron
binding site (aB, aC. aE, and aF). The corresponding loop and
helix in Y4 are translated in the same direction. In addition, the
loop connecting Y2 a3 and aA and the analogous regions in both
Y4 and mouse R2 are all different from one another.
heteeder Interface. The Y2Y4 interface is very similar to the
mouse R2 homodimer interface both in size and in specific
interactions. On heterodimer formation, 2,517 A2(1,223 A2 from
Y2 and 1,294 A2 from Y4) accessible surface area is buried as
compared with 2,698 A2 (1,484 A _per monomer) for the mouse
R2 dimer. By contrast, .,6,000 A2 accessible surface area is
buried on formation of the E. coli R2 homodimer. Many residues
involved in protein-protein contacts are concentrated on helix
aC in both Y2 and Y4. Additional interactions involve residues
derived from aB, a5, and the loop connecting a3 and aA (Figs.
2A and 4). In mouse R2, Phe-102, Phe-165, and Ala-168 generate
a hydrophobic duster at the interface (8). The same cluster is
present in the Y2Y4 heterodimer, formed by Phe-107, Phe-171,
and Met-174 from Y2 and Phe-56, Phe-119, Met-122 from Y4.
Several interactions between charged residues are also observed.
Y2 Lys-101 is hydrogen bonded to Y4 Glu-60 and Y4 Glu-129,
and Y4 Lys-50 is hydrogen bonded to Y2 Glu-lll and Glu-181.
These two lysines correspond to mouse R2 Lys-96, which forms
a number of salt bridges. Many other residues located at the
heterodimer interface are conserved among Y2, Y4, mouse R2,
and E. coli R2, although the lengthening of helices aD and aE
in E. coii R2 render its interface significantly larger (Fig. 4).
Despite these similarities, variations among Y2 a5, the loop
connecting Y2 a3 and aA, and their structural counterparts in
Y4 and mouse R2 render the edges of the heterodimer interface
different from the edges of the mouse R2 homodimer interface.
As a result, Glu-84, Thr-86, Val-87, Leu-88, and Pro-90 in Y2 and
Arg-33, Phe-35, Val-36, Met-37, and Pro-39 in Y4 occupy
different positions than the equivalent residues in mouse R2.
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Rg.4. Structure-based sequence alignment of Y2 Y4 mouse R2. and E coil
R2. The positions of the Y2 secondary structure elents are shown above the
Y2 seene. IeHelIs a rehown as thk green lines, and loops are showln as
tMn blue lines. RegIons of the sequenes present In the crystal structures are
hghlghted In yellow. Conserved Iron IIgands in Y2, mouse R and E. coUl R2
and the correspondmng residues in Y4 are enoosed In black boxes. ResIdues
Inolved in dlmer formation are shown in magenta. The accessible surface
area of these resdues decreases by >1 A2 on dimer formation.
Y2 amd Y4 Acthe Site leglon The active site in Y2 contains all of
the residues used for diiron cluster formation in E. co/i R2 (6, 7)
(Figs. 4 and 5A). There are two histidines, His 179 and His-276,
three glutamic acids, Glu-176, Glu-239, and Glu-273, and a single
aspartic acid, Asp-145. In addition, a 7c peak in the position
occupied by Fe2 in E co/i R2 was evident in difference Fourier
maps. An anomalous difference Fourier map calculated using
the ANOM data set (Table 1) showed no density at this position.
Because this data set was collected at a wavelength near the iron
K edge, the absence of a peak at this site suggests that the metal
ion is not iron. An anomalous difference Fourier map calculated
using the NATIVE data set gave a 6or peak, however (Fig. 5A).
The NATIVE data set was acquired at a wavelength of 0.946 A,
which is closer to the absorption edges of zinc and of numerous
heavy metals. Based on the presence of this peak and the
observed coordination environment, the density was modeled as
a partially occupied Zn(II) ion. The zinc ion is coordinated by
one side chain caygen each from Glu-176, Glu-239, and Glu-273,
and by the 8 nitrogen of His-276 in a distorted tetrahedral
geometry. A single bound metal ion, assigned as Fe(III), is also
observed in the mouse R2 Fe2 site (8). Both His-276 and its
mouse R2 counterpart are hydrogen bonded to water molecules
rather than to other residues, as inE. coi R2 (Fig. 1). The second
histidine, His-179, is properly positioned to ligate a second metal
ion in the Fel site and is hydrogen bonded to Asp-272.
The aspartic acid, Asp-145, is not well ordered with a B-value
252
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Rg. 5. Active site regions of Y2 and Y4. (A) Stereo view
of Y2 active site region. One metal Ion, assigned as Zn(ll),
Is shown as a gray sphere. An anomalous difference
Fourier map calculated using the NATIVE data set (yel-
low, contoured at 3.2) and an Isomorphous difference
Fourier map calculated using the FE and NATIVE data sets
(blue, contoured at 6w) are superimposed. (B) Stereo
view of the Y4 active site regions. Key hydrogen bonding
Interactions are denoted with dotted lines. Asp-93 Is not
visible In the electron density map.
of - 80 A-. and was best modeled as pointing away from the Fe 1
site. In this position, one of its side chain oxygens is within
hydrogen bonding distance of a water molecule. By contrast, the
analogous aspartic acid in mouse R2 points toward the Fel site.
although it is farther away than the same residue in E. coli R2.
Because the crystals were grown at pH 5.3 and frozen at pH 4.9,
different protonation states could account for the apparent
flexibility of Asp-145. Residues 146-148 are also disordered.
suggesting that occupation of the Fe I site might be required to
order this region. The expected site of Y- formation. Tyr-183,
occupies the same position as in the other R2s. The combination
of the Asp- 145 conformation and the shifted position of helix aD
renders the Y2 active site even more exposed than the mouse R2
active site (8).
Three of the 6 Y2 active site residues are conserved in Y4, two
glutamic acids and the aspartic acid (Fig. 5B). Both Glu-124 and
Glu-186 occupy positions similar to those of their Y2 counter-
parts. A water molecule not observed in Y2 links Glu-186 to
Glu-124 and Gin-120. The aspartic acid, Asp-93, and surround-
ing residues 91-99 are not visible in the electron density map and
could not be modeled. Two tyrosines, Tyr-127 and Tyr-223.
replace the two histidines in the Y2 active site. The side chain
oxygen atoms of these two tyrosines are separated by 3 A, and
the side chain oxygen of Tyr-127 is hydrogen bonded to the side
chain of Asp-219. Perhaps the most unusual feature of the Y4
active site region is the presence of an arginine, Arg-220. One
Arg-220 71 nitrogen is hydrogen bonded to both side chain
oxygens of Glu-124, one of which also interacts with the Arg-220
E nitrogen. The other i nitrogen is -2.5 A from the side chain
oxygen of Tyr-194 and -3.5 A from the side chain of GIn-190.
These 2 residues, along with Asn-193. Tyr-127. Tyr-223, and
Arg-220, constitute the 6 of 16 critical eukaryotic R2 residues not
conserved in Y4. The identities and positions of the Y4 active site
residues strongly suggest that this site does not bind iron.
Moreover, no extra electron density attributable to a metal ion
is observed.
To further probe the iron binding capabilities of both Y2 and
Y4, heterodimer crystals were treated with ferrous ammonium
sulfate at pH 5.1. The soaking time had to be limited to 1 min
to preserve diffraction quality. A 2.8-A resolution isomorphous
difference Fourier map calculated using the FE and NATIVE
data sets revealed two peaks at the Y2 iron binding site: a 15cr
peak at the Fe2 site and a 10or peak at the Fel site (Fig. 5A). No
significant peaks were observed in the Y4 active site region or
anywhere else in the Y4 molecule, confirming that Y4 does not
bind iron under these conditions. The peaks in Y2 are 3.7 A
apart, a distance similar to the Fe*-Fe separation in reduced
wild-type E. coli R2 (39). The presence of these two peaks
demonstrates that Y2 can accommodate a diiron center. There
are several possible explanations for the lower intensity of the
Fel peak. First, the low pH of the crystallization (5.3) and
soaking (5.1) solutions could preclude proper assembly of the
diiron center. Alternatively. a longer soak time might be neces-
sary to fill the Fel site. Finally, the putative zinc ion already
present at Fe2 in some fraction of the molecules might prevent
binding at Fel in these molecules. Removal of this metal ion
could be necessary to properly assemble the diiron cluster.
Additional difference electron density observed near the Fe2 site
(Fig. 5A) is not consistent with a shift of either Glu-23Q or
Glu-273, but instead corresponds to a site occupied by exogenous
ligands in mutants of E. coli R2. A solvent molecule occupies this
site in the reduced D84E mutant (40). and azide is bound at this
position in the F208A/Y122F double mutant (41). It therefore
seems likely that an exogenous ligand is present in the iron-
treated Y2 crystals. A possible candidate for this ligand is acetate
ion because acetate is present in high concentrations in the
crystal soaking solution.
Function of Y4. Two possible roles for Y4 have been proposed
based on its initial characterization. First. Y4 could act catalyt-
ically as a metallochaperone. delivering iron ions to Y2 via a
transient heterodimeric complex (23). The inability to detect
ferric or ferrous iron binding to Y4 and the isolation (26) and
crystallization of a stable Y2Y4 heterodimer starting with the
two homodimers are not consistent with this function. In addi-
tion, activity assays demonstrate that Y4 activates Y2 stoichio-
metrically rather than catalytically (24. 26). and quantitative
Western analysis shows that the two proteins are present in
comparable amounts in yeast cells (26), although their localiza-
tion and concentration as a function of cell cycle have yet to be
determined. Finally, deletion of the Y4 C-terminal tail. initially
proposed to bind iron (23). does not interfere with iron loading
of Y2 in virm (24, 26). It therefore seems unlikely that Y4 binds
iron and delivers it directly to the Y2 active site.
The second proposed role of Y4 is that of a molecular
chaperone. facilitating folding of Y2 (24). Because the His,,-
tagged Y2 is amenable to purification, folded according to CD
spectroscopy (26). and well behaved in crystallization trials, Y4
does not appear to be essential for proper folding of this
His6-tagged form of Y2. It is possible, however, that Y4 stabilizes
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Y2 in the proper conformation for iron cluster assembly and Y-
formation. Even if Y4 does not directly insert iron into Y2, it
could promote interaction with another assembly protein or
simply hold Y2 in a position that renders the active site more
accessible to ferrous iron delivered by another protein or trans-
porter. If this is the only function of Y4, the two proteins might
be expected to dissociate after the diferric-Y- cofactor is gen-
erated. It is not yet known whether Y2 can form active ho-
modimers once the cofactor is assembled.
If the heterodimer does dissociate after cofactor assembly,
iron loading of Y2 might modulate the affinity of Y2 for Y4. For
example, the conformation of Asp-145 is expected to change on
iron binding. A shift of this residue toward the diiron center
could propagate changes in the adjacent helix aC, which houses
numerous residues involved in the heterodimer interface. In
particular, Lys-166 on helix aC is predicted to be near Y4 Lys-98,
which is disordered in the present structure. It is conceivable that
iron binding brings these two lysines closer together, increasing
electrostatic repulsion and facilitating dissociation of the het-
erodimer. Because the corresponding residue in Y2 and also in
mouse R2 is a glutamic acid (Fig. 4), a similar unfavorable
interaction would not occur in the Y2 homodimer.
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ABSTRACT: Class I ribonucleotide reductases (RNRs) catalyze the reduction of ribonucleotides to
deoxyribonucleotides. Eukaryotic RNRs comprise two subunits, the RI subunit, which contains substrate
and allosteric effector binding sites, and the R2 subunit, which houses a catalytically essential diiron-
tyrosyl radical cofactor. In Saccharomycecs ceretisiae, there are two variants of the R2 subunit, called
Rnr2 and Rnr4. Rnr4 is unique in that it lacks three iron-binding residues conserved in all other R2s.
Nevertheless. Rnr4 is required to activate Rnr2. and the functional species in vivo is believed to be a
heterodineric complex between the two proteins. The crystal structures of the Rnr2 and Rnr4 homodimers
have been determined and are compared to that of the heterodimer. The homodimers are very similar to
the heterodimer and to mouse R2 in overall fold, but there are several key differences. In the Rnr2
homodimer, one of the iron-binding helices, helix aB, is not well-ordered. In the heterodimer, interactions
with a loop region connecting Rnr4 helices aA and ca3 stabilize this Rnr2 helix, which donates iron
ligand Asp 145. Sequence differences between Rnr2 and Rur4 prevent the same interactions from occurring
in the Rnr2 homodimer. These findings provide a structural rationale for why the heterodimer is the
preferred complex in vivo. The active-site region in the Rnr4 homodimer reveals interactions not apparent
in the heterodimer, supporting previous conclusions that this subunit does not bind iron. When taken
together, these results support a model in which Rnr4 stabilizes Rnr2 for cofactor assembly and activity.
Ribonucleotide reductases (RNRs) 1 catalyze the reduction
of ribonucleotides to the corresponding deoxyribonucleotides
using free-radical chemistry (1). These enzymes are respon-
sible for maintaining proper levels of DNA precursors for
replication and repair and therefore play a crucial role in all
organisms (2). RNRs are divided into three classes based
on the nature of the catalytically essential radical. Class I
RNRs, found in mammals, plants, yeast, DNA viruses, and
Escherichia coli, consist of two dimeric subunits called RI
and R2. The RI subunit contains binding sites for substrate
and allosteric effectors, and the R2 subunit houses a diiron-
tyrosyl radical cofactor. Regulation of eukaryotic class I
RNRs during the cell cycle has been studied extensively (3,
4). but most biophysical studies of class I RNRs have focused
on the E. coli system (2). Because eukaryotic RNRs are
targets for anticancer drugs (5, 6), an understanding of their
tThis work was supported by NIH Grants GM58518 (to A.C.R.)
and GM29595 (to J.S.). W.C.V. was supported in part by NIH training
Grant GM08382, and D.L.P. was supported in part by NIH training
Grant 5T32 CA 091112-28.
I Coordinates have been deposited in the Protein Data Bank with
accession codes ISMQ for the Rnr2 homodimer and ISMS for the
Raur4 homodirner.
* To whom correspondence should be addressed. Telephone: (847)
467-5301. Fax: (847) 467-6489. E-mail: amyr(anorthwestem.edu.
Northwestern University.
"Massachusetts Institute of Technology.
1 Abbreviations: RNR, ribonucleotide reductase; Rnr2, yeast ribo-
nucleotide reductase Rnr2 protein; Rnr4, yeast ribonucleotide reductase
Rnr4 protein; PEG, polyethylene glycol; EMTS, ethylmercurithiosali-
cylate; rms, root mean square.
structure and function on the molecular level is highly
desirable, especially since the discovery of a human R2
variant regulated by the tumor suppressor p53 (7).
An obvious choice for a eukaryotic model system is
Saccharomvces cerevisiae class I RNR. In yeast, four genes
encode the RNR subunits. The RNR1 and RNR3 genes
encode Rl-like subunits, Rnrl and Rnr3. The Rnr3 subunit
is not essential and is induced in response to DNA damage
(8). The RNR2 (9, 10) and RNR4 (11, 12) genes encode the
Rnr2 and Rnr4 proteins, which correspond to the R2-like
subunits. The Rnr4 protein is unique in that it lacks 6 of 16
residues conserved in nearly all R2s, including three residues
involved in coordinating iron. As a result, Rnr4 cannot
accommodate a diiron center. Nevertheless, Rnr4 deletion
is lethal in some yeast strains and impairs cell growth in
others (11, 12). Initial insight into the possible function of
Rnr4 came from studies showing that Rnr4 is required to
assemble the diiron-tyrosyl radical cofactor in Rnr2 and that
Rnr4 forms a heterodimeric complex with Rnr2 (13-15).
On the basis of these data, it was proposed that Rnr4
functions either as a metallochaperone, inserting iron into
Rnr2 (13), or as a molecular chaperone. directing Rnr2
folding (14). However. Rnr4 does not bind iron, ruling out
a imetallochaperone fnction (15, 16). In addition, Rnr2 folds
independently of Rnr4 (15) and can be crystallographically
characterized (vide infra). A role in global folding is therefore
unlikely, but Rnr4 could still serve as a local folding aid.
holding Rnr2 in an appropriate conformation to receive iron
from another source.
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If Rnr4 is a local folding chaperone, it could either
dissociate from Rnr2 after the cofactor is inserted or remain
associated for activity. Several lines of evidence suggest that
the active form of yeast Rnr2 in vivo is the heterodimeric
complex between Rnr2 and Rnr4. First, the heterodimer
contains 0.6-0.8 tyrosyl radicals, a value comparable to that
observed for other R2 homodimers and suggestive of a
conserved half-site reactivity in all R2s (15). Second, Rnr2
and Rnr4 are present in comparable concentrations in vivo
(15). Third, Rnr2 and Rnr4 colocalize during the normal cell
cycle and redistribute similarly in response to genotoxic stress
(17). Understanding why yeast R2, unlike all other R2s
studied thus far, exists as a heterodimer is critical to further
use of yeast RNR as a model system. To elucidate why the
heterodimer might be the preferred complex in vivo, we have
determined the crystal structures of the Rnr2 and Rnr4
homodimers. A detailed comparison with the previously
determined structure of the heterodimer (16) reveals subtle
yet significant differences that provide new insight into the
relative stabilities of the different species.
EXPERIMENTAL PROCEDURES
Crystallization. Rnr4 and (His)6-tagged Rnr2 were purified
as described previously (15). Purified (His)6-Rnr2 was
diluted with 50 mM Tris at pH 7.5 to a final concentration
of 3 mg/mL. Crystals were obtained at 14 °C by using the
hanging-drop technique. Drops consisting of 1 uL of protein
solution and 1 uL of precipitant solution were equilibrated
versus 750 IL of precipitant solution composed of 100 mM
succinate at pH 4.8, 15% (w/v) polyethylene glycol (PEG)
3350, and 200 mM lithium acetate. Long rectangular crystals
of maximum dimensions 0.1 x 0.1 x 1.0 mm appeared
within 2-4 days. Crystals for data collection were transferred
to a cryosolution composed of the precipitant solution with
20% (v/v) ethylene glycol and flash-cooled in liquid nitrogen
after 1-2 min.
Purified Rnr4 for crystallization was diluted to 10 mg/
mL in 50 mM Tris at pH 7.5. Crystals were obtained at room
temperature by using the hanging-drop method. Drops
containing 3 uL of protein solution and 3 uL of precipitant
solution were suspended on the lid of a completely sealed
Petri dish containing 3 mL of precipitant solution. The
precipitant solution consisted of 50 mM HEPES at pH 7.5,
26% (w/v) PEG 1000, 5% (v/v) ethanol, 200 mM NaCl, and
1 mM ethylmercurithiosalicylate (EMTS). Large, fragile
crystals (0.2 x 0.2 x 1.5 mm) grew in the shape of
hexagonal rods within 3 days. Crystals for data collection
were prepared by layering a small amount of cryosolution,
comprising the precipitant plus an additional 20% (v/v)
ethylene glycol, over the crystallization drop. Large, single
crystals were quickly passed through the cryosolvent layer
using a rayon loop and immediately flash-cooled in liquid
nitrogen.
Data Collection and Stnwcture Determination. Diffraction
data (Table 1) were collected at the DuPont-Northwestern-
Dow Collaborative Access Team (DND-CAT) beamline at
the Advanced Photon Source at -160 °C and a wavelength
of 1.00 A using a 2K x 2K Mar CCD detector. The Rnr2
crystals belong to the space group P with unit cell
dimensions: a = 79.7 A, b = 79.6 A, c = 88.1 A, a =
Table 1: Data Collection and Refinement Statistics
Rnr2 Rnr4
Data Collection
resolution range (A) 87-3.10 12-3.10
unique observations 35 134 13 332
total observations 168 766 239 131
completeness (%) 94.6 (96.0) 93.6 (94.1)
Rqa 0.059 (0.294) 0.088 (0.424)
<I/o> 7.2 (2.5) 13.4 (2.4)
Refinement
resolution range (A) 25-3.10 12-3.10
number of reflections 34 663 12 869
R factorb 0.272 0.266
R free 0.303 0.305
number of protein, nonhydrogen atoms 10 694 5182
number of nonprotein atoms 0 4
rms bond length (A) 0.010 0.008
rms bond angles (deg) 1.6 1.4
average B values (A2)
main chain 68.4 71.2
side chain 71.5 71.7
rasr = XlId b l Ianlla, where the summation is over all
reflections. Values in parentheses are for the highest resolution
shells, 3.27-3.10 A for Rnr2 and 3.15- 3.10 A for Rnr4. b R factor =
MZIFn - FIfIXF . For calculation of R free, 9 and 5 of the
reflections were reserved for Rnr2 and Rnr4. respectively.
83.5 °, fi = 83.5 °, and y = 70.8 °. The Rnr4 crystals belong
to the space group P6 1 with unit cell dimensions: a = b =
79.6 A, and c = 218.1 A. The Rnr2 'data were processed
with MOSFLM (18) and SCALA (19), and the Rnr4 data
were processed with DENZO and SCALEPACK (20).
The structures of the Rnr2 and Rnr4 homodimers were
solved by molecular replacement with AMoRe (19) and CNS
(21) using a monomer of Rnr2 or Rnr4 from the heterodimer
structure (16) as a starting model. Both models were refined
by iterative cycles of X-ray weight optimization, rigid-body
refinement, restrained individual B factor refinement, energy
minimization, and low-temperature torsional simulated an-
nealing in CNS (21). Noncrystallographic symmetry re-
straints were used throughout the refinements. Adjustments
to the models were performed in XtalView (22) and 0 (23)
using composite omit 2Fo - F, electron density maps. The
progress of the refinement was monitored by the free R value.
The Rnr2 model consists of two homodimers. One monomer
in each of the two dimers includes residues 26-144 and
150-359, and the second monomer includes residues 26-
57, 69-144, and 150-359. No electron density was visible
for residues 145-149 in all four monomers. The final Rnr4
model consists of one homodimer with residues 3-305 and
315-325 for each monomer. In addition, four strong peaks
(> la) in difference Fourier maps were modeled as mercury
ions derived from EMTS. Ramachandran plots generated
with PROCHECK (24) indicate that the models exhibit good
geometry with 99.7% of the Rnr2 residues and 98.3% of
the Rnr4 residues in the most favored and additionally
allowed regions. Accessible surface-area calculations were
performed with the CCP4 program AREAIMOL (19) or with
CNS (21) using a molecular probe of radius 1.4 A. Residues
involved in crystal-packing contacts and the dimer interfaces
were identified with the CCP4 program CONTACT (19) or
CNS (21). Figures were generated with MOLSCRIPT (25)
and RASTER3D (26).
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FIOLRE 1: Stereoviews of (a) the heterodimeric compla (PDB accession code IJKO) between Rnr2 (pink) and Rnr4 (green). (b) the Rnr2
homodimer, and (c) the Ram4 homodimer. The flexible loop connecting helices a3 and OA is shown in yellow. For the Rnr4 homodiner,
the C-terminal helix spanning residues 315-325 is shown in blue.
RESULTS AND DISCUSSION
Rnr2 Homodimer. The overall fold of the Rnr2 monomer
is very similar to its fold in the heterodimeric complex (parts
a and b of Figure 1). The eight longest helices (aA-oH)
form an a-helical bundle like those in E. coli (27) and mouse
R2 (28). Two smaller helices, a4 and 0S, cap the eight helix
bundle. The Rnr2 model contains three additional N-terminal
helices (al-a3) encompassing residues 26-70. This part
of the sequence was also observed in the heterodimer but
not in the crystal structure of mouse R2. In the heterodimer
structure, the presence of an ordered N terminus in Rnr2
was attributed to participation of the three helices in crystal-
packing interactions (16). In the Rnr2 homodimer, the N
terminus of one monomer is involved in crystal contacts,
but the N terminus of the second monomer is exposed to a
solvent channel. As a result, residues 58-68 are not visible
in the second monomer. The N terminus of Rnr2 and
mammalian R2 subunits is more extended than that in Rnr4.
plant, or E. coli systems. In mice, part of this sequence is
important for R2 protein degradation during mitosis (29).
The C-terminal 40 residues of Rur2, which were not observed
in the heterodimer structure, are also not visible in the
homodimer structure. These residues are crucial for interac-
tion with the RI subunit (14, 30, 31). For the mouse and E.
coli proteins, the C termini only become structured upon
complex formation between the two subunits (32, 33).
The Rnr2 monomer from the homodimer can be super-
imposed on that from the heterodimer with an rms deviation
of 0.42 A for 329 Ca coordinates. There are no significant
structural changes (Figure 2). The only major difference
between Rnr2 in the homodimer and in the heterodimer is
more disorder in helix aB. For the Rnr2 homodimer, this
region has high B values and residues 145-149 could not
be modeled. This helix 1aB is not only part of the central
core of the eight helix bundle but also provides one of the
ligands, Asp 145, to the diiron center. Aside from the absence
of Asp 145, all of the other ligands provided to the diiron
center occupy the same positions as in the heterodimer
structure. In the heterodimer, strong electron density in the
Rnr2 active site was modeled as a single Znn ion based on
anomalous difference Fourier maps calculated at different
wavelengths (16). In contrast, no significant extra electron
density is observed in the Rnr2 homodimer active site.
257
FRouRE 2: Stereo superposition of Rm2 in the homodimer (magenta), Rnr2 in the heterodimer (blue, PDB accession code 1JKO), Rnr4 in
the homodimer (green), Rnr4 in the terodimer (d, PDB accession code IJKO), and mouse R2 (yellow. PDB accession code IXSM).
Rnr4 Homodimer. The fold of the Rnr4 monomer is very
similar to that observed in the heterodimer with a core of
eight a helices (parts a and c ofFigure 1). In Rnr4, the helical
character of the region corresponding to a5 is disrupted by
Pro 146. For the homodimer, the visible part of the
N-terminal sequence begins at residue 3 as compared to 11
for Rnr4 in the heterodimer. These additional residues
comprise a short a helix that points in a different direction
than the analogous ca2 in Rnr2. Notably, the Rnr4 model
includes 20 additional residues (296-305 and 315-325) at
the C terminus not observed in the heterodimer (Figure Ic).
The presence of a helix comprising residues 315-325 is
especially surprising. This helix is not connected to the C
terminus but could be traced clearly in the electron density
map based on the presence of two aromatic residues, Phe
316 and Tyr 323. Four residues derived from this helix are
involved in key crystal-packing interactions, explaining why
this sequence, which is expected to be ordered only in the
presence of the Rnrl subunit, is visible. These residues in
the Rnr4 homodimer structure provide the first glimpse of
the C terminus of any R2 subunit.
The Rnr4 monomers from the homodimer and the het-
erodimer can be superimposed with an rms deviation of 0.87
A for 257 Ca coordinates. Although the overall fold of Rnr4
remains the same, the loop connecting helices a3 and aA
has adopted a different conformation, shifting toward the loop
between helices cB and aC (Figure 2). This shift is likely
due to the presence of the ordered helix comprising residues
315-325. In both halves of the Rnr4 monomer, this loop
packs against residues 315-325 from symmetry-related
molecules, preventing it from assuming the conformation
observed in the heterodimer. The largest shift in the loop is
observed at residues Arg 34 and Phe 35, of which the CaL
atoms move -8.5 A relative to their positions in the
heterodimer. As a result, Phe 35 occupies different pockets
in the two structures. In the Rnr4 homodiner, the side chain
of Phe 35 is packed against the phenol group of Tyr 99 and
the alkane side chain of Lys 98 from the second monomer.
The amino group of Lys 98 is within hydrogen-bonding
distance of Ser 128 from the same monomer, further
stabilizing this arrangement. In the heterodimer, Phe 35
stacks against the side chain of Rnr2 Phe 201, located in a
region structurally distinct from that analogous to Rnr4
residues 98-99. Rnr4 Arg 34 also occupies different
positions in the two structures. In the homodimer, Arg 34
interacts with Glu 102 from the second monomer, whereas
in the heterodimer, Arg 34 does not participate in the dimer
interface but, instead, forms a salt bridge with Glu 112 from
the same monomer.
Another important difference between the Rnr4 ho-
modimer and Rnr4 in the heterodimeric complex is that
residues 91-99 from helix aB, which could not be modeled
in the heterodimer, are visible, most likely because of the
interaction with Phe 35 from the opposite monomer. These
residues correspond to the disordered region encompassing
residues 145-149 in the Rnr2 homodimer and include Asp
93, the equivalent of the iron ligand Asp 145 in Rnr2.
Unexpectedly, the side chain of Asp 93 is not located within
the "active site" region of Rnr4 (Figure 3). Instead, Asn 94
points into the active site and forms a hydrogen bond with
Ser 128. Similar to the heterodimer structure, Arg 220
interacts with Glu 124, but an additional hydrogen bond
between Glu 124 and Asn 97 is also observed. A water
molecule present in the heterodimer was not modeled in this
structure because of the low resolution. This arrangement
of residues in the Rnr4 active-site region supports previous
conclusions that Rnr4 does not bind iron (15, 16).
Dimer Interfaces. The dimer interfaces in the two ho-
modimers and the heterodimer are similar in size, with buried
surface areas of 2517 (1223 A2 for Rnr2 and 1294 A2 for
Rnr4), 2339, and 2462 A2 for the heterodimer, the Rnr2
homodimer, and the Rnr4 homodimer, respectively. These
values are comparable to the 2967 A2 buried surface area in
mouse R2. The interface comprises residues located primarily
on helices CaA and aC and is capped by the loop connecting
cLA and a3. On each side of the interface, this loop extends
over the other monomer (Figure 1). Both hydrophobic and
hydrophilic residues participate in key interactions at the
interface. In Rnr2, residues Phe 107, Phe 171, and Met 174
form a central hydrophobic patch. The equivalent residues
in Rnr4 are Phe 56, Phe 119, and Met 122. This hydrophobic
patch is flanked by salt bridges. In Rnr2, the side chain of
Lys 101 from one monomer is hydrogen-bonded to the side
chains of Gl 111 and Glu 181 from the second monomer
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FIGURE 3: Stereoview of the Rnr4 active-site region.
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FlouRE 4: Dimer interface residues derived from the loop region connecting a3 and aA. (a) Sequence alignment of loop residues. Swiss-
Prot accession codes: S. cerevisiae Rnrt. RIR2_YEAST; S. cerecisiae Rnr4, RIR4_YEAST: S. pombe Rnr2, RIR2_SCHPO: Mus rnusculus
Rur2, RIR2_MOUSE; Homo sapiens Rar2, RIR2_HUMAN; Brachvdanio rerio Rur2, RIR2_BRARE; Drosophila melanogaster Rnr2,
RIR2_DROME; Caenorhabditis elegans Rnr2, RIR2 CAEEL. (b) Stereoview of dimer interface interactions involving these residues and
the nearby segment of helix aB including iron ligand Asp 145. The Rnr2 homodimer is shown in pink. and the heterodimer is shown in
green (Rnr4) and light pink (Rur2).
and vice versa. Similarly. Rnr4 Lys 50 interacts with Rnr4
Glu 60 and Glu 129. In the Rnr2 homodimer, an additional
close contact is observed between the two Val 153 residues,
housed on helix caB.
The conservation of these interactions among the two
homodimers and the heterodimer indicates that the individual
monomers are well-suited to form different dimer combina-
tions. The core interface is the same regardless of which
monomers are present. Nevertheless, the tyrosyl radical
content, quantitative Western blotting (15), and subcellular
localization patterns (17) indicate that the heterodimer is the
active species in vivo. Furthermore, several empirical
observations imply that the heterodimer may be the more
stable species. First, soluble, folded Rnr2 cannot be obtained
without a (His)6 tag (13. 14). Second. the heterodimer can
be selectively crystallized from a mixture of purified Rnr2
and Rnr4 homodimers (16). How are varying stabilities
conferred in the context of such similar dimer interfaces?
The capping loop region connecting a3 and aA provides
part of the answer. In contrast to the interactions in the central
interface region, interactions involving this loop are not
completely conserved.
In particular, Phe 35 in Rnr4 is replaced with a threonine.
Thr 86. in Rnr2 (Figure 4a). In the heterodimer. Phe 35 from
Rnr4 extends into a pocket lined by Rnr2 Phe 201 and Rnr2
His 205 from helix a5. stacking nicely with Phe 201. The
same interaction cannot be formed by Rnr2 Thr 86 in the
Rnr2 homodimer (Figure 4b). Notably. only Rnr2 has a
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threonine at this position, whereas most other organisms
contain a conserved phenylalanine residue (Figure 4a).
Several other Saccharomvces species, including S. castelifi,
S. mikatae, S. bavanus, and S. kudriavzevii, contain either a
threonine, serine, or histidine at this position (34). All of
these species also have a gene encoding an Rnr4-like protein.
The potential significance of this substitution in Rnr2 is
underscored by the observation that the one Saccharomyces
species, S. k1uyveri, that does contain a phenylalanine at this
position in Rnr2 does not appear to have a protein corre-
sponding to Rnr4. Moreover, other fungi that only have an
Rnr2-like protein, including Schizosaccharomvyces pombe,
Kluvveromvces walti, and Ashbya gossvpii, also contain a
phenylalanine at this position.
Another difference involving the loop connecting a3 and
aA involves Rnr4 Arg 33. In the heterodimer, this residue
is hydrogen-bonded to the side chain of Rnr2 Asn 202. The
Rnr2 residue analogous to Rnr4 Arg 33 is Glu 84. In the
Rnr2 homodimer, the shorter side chain of Glu 84 does not
interact with residues on the other monomer but instead
points toward the solvent (Figure 4b). In contrast, the second
arginine in the loop sequence is well-conserved (Rnr2 Arg
85 and Rnr4 Arg 34). In the Rnr2 homodimer and in the
heterodimer, it forms an intramonomer hydrogen bond with
a glutamic acid residue at the beginning of helix aC (Rnr2
Glu 164 and Rnr4 Glu 112). In the Rnr4 homodimer, Arg
34 from one monomer interacts with Glu 102 from the
second monomer. When taken together, these interactions
result in helix caB, which houses the iron ligand Asp 145,
being more exposed in the Rnr2 homodimer than in the
heterodimer (Figure 4b), and explain why residues 145-
149 are disordered in the homodimer. The heterodimer might
therefore be preferred in vivo because helix aB is held in
the appropriate conformation to form and stabilize the di-
iron center.
Comparison to Mouse R2. The structures of the Rnr2 and
Rnr4 monomers from the two homodimers are very similar
to that of the mouse R2 monomer, with rms deviations of
1.00 A for 250 Rnr2 Ca coordinates and 1.24 A for 247
Rnr4 Ca coordinates. The most significant difference is the
position of Rnr2 helices aD and aS and the corresponding
Rnr4 helices (Figure 2). As noted previously (16), these
helices in Rnr2 are shifted by -5 A away from the four-
helix bundle that houses the diiron center, rendering the
active site even more accessible than that in mouse R2 (28).
In mouse R2, the loop region connecting a3 and oaA adopts
a conformation intermediate between those observed in the
Rnr4 and Rnr2 homodimer structures (Figure 2). Residue
Phe 81 from this loop (Phe 35 in Rnr4, Figure 4a) is located
in a pocket lined by the alkane side chains of Asn 143 and
Glu 144 and the Ca atom of Gly 140 from the second
monomer. These residues, which are proximal to iron ligand
Asp 139, are derived from the part of helix aB that is poorly
defined in the Rnr2 homodimer (residues 143-151). Analo-
gous to the heterodimer, interactions involving Phe 81 likely
stabilize this helix. Like the heterodimer and the Rnr2
homodimer, the preceding residue Arg 80 (Figure 4a) forms
a hydrogen bond with Glu 158 from the same monomer.
Another notable difference between mouse R2 and yeast
Rnr2 is the conformation of the aspartic acid residue in the
active site. In Rnr2, this residue, Asp 145, is either not visible
(homodimer) or points away from the iron-binding site
(heterodimer). The equivalent residue in mouse R2, Asp 139,
was modeled pointing toward the diiron center, although the
iron-binding site closer to this residue and to the tyrosyl
radical site was not occupied (28). Interestingly, these
different positions of the active-site aspartic acid are all
observed at relatively low pH values (mouse R2, pH 4.7;
Rnr2 homdimer, pH 4.8; and heterodimer, pH 5.3). It may
be that a higher pH value would affect the position of this
residue in the yeast system. Raising the pH of mouse R2
crystals from pH 4.8 to 6.0 allowed loading of two, rather
than one, cobalt ions, suggesting that pH can affect the metal
center in mouse R2 (35). However, recent studies of diferrous
E. coil R2 suggest that pH does not significantly affect the
coordination geometry (36).
Conclusions. In summary, the Rnr2 and Rnr4 monomers
in the homodimeric and heterodimeric complexes are very
similar in their overall fold to one another and to mouse R2.
In the Rnr2 homodimer, helix oaB, which provides iron ligand
Asp 145, is notably less-ordered than in the heterodimer.
The ordering of this helix in the heterodimer can be attributed
to interactions with the loop connecting Rnr4 helices oA
and a3, which adopts a considerably different conformation
than in the Rnr4 homodimer. In particular, the interaction
of this loop with Rnr2 compensates for the presence of a
threonine residue, Thr 86, in a position occupied by a
phenylalanine in other eukaryotic R2s. In contrast, other
interactions at the dimer interfaces are highly conserved
among the two homodimers and the heterodimer. The current
data therefore suggest that the role of Rnr4 is to stabilize
helix aB and provide a structural rationale for the het-
erodimer being the active species in vivo. It is likely that
Rnr4 stabilizes Rnr2 both for assembly of the diiron center,
perhaps by facilitating interactions with yet to be identified
metal-delivery factors, and for subsequent enzyme activity.
Why yeast RNR has evolved to function optimally with only
one diiron-tyrosyl radical cofactor per dimer remains unclear
but supports the notion that half-site reactivity is a general
feature of radical-containing enzymes (1).
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The fidelity of DNA replication and repair processes I critical for
maintenance of genomic stability. Rlbonucleotide reductase (RNR)
catalyzes the rate-limiting step In dNTP production and thus plays
an essential role In DNA synthesis. The level and activity of RNR are
highly regulated by the cell cycle and DNA damage checkpoints,
which maintain optimal dNTP pools required for genetic fidelity.
RNRs are composed of a large subunit that binds the nucleoside
diphosphate substrates and allosteric effectors and a small subunit
that houses the dl-ron tyrosyl radical cofactor essential for the
reduction process. In Saccharomyces cerevlslae, there are two large
subunits (Rnrl and Rnr3) and two small subunits (Rnr2 and Rnr4).
Here we report the subcellular localization of Rnrl-4 during
normal cell growth and the redistribution of Rnr2 and Rnr4 In
response to DNA damage and repllational stress. During the
normal cell cycle, Rnrl and Rnr3 are predominantly localized to the
cytoplasm and Rnr2 and Rnr4 are predominantly present In the
nucleus. Under genotoxic stress, Rnr2 and Rnr4 become redistrib-
uted to the cytoplasm In a checkpoint-dependent manner. Subcel-
lular redistribution of Rnr2 and Rnr4 can occur In the absence of the
transcriptional Induction of the RNR genes after DNA damage and
likely represents a posttranslatlonal event. These results uggest a
mechanism by which DNA damage checkpoint modulates RNR
activity through the temporal and spatial regulation of its subunits.
ukaryotic cells have evolved complex surveillance mechanisms
L(i.e.. checkpoints) to respond to genotoxic stress by arresting the
cell cycle and inducing the transcription of genes that facilitate
repair (1, 2). Failure of DNA damage response can result in
genomic instability and cancer predisposition (3, 4). In mammalian
cells the protein kinases ATM, ATR, and CHK2 are crucial for
activating signaling pathways for cell survival after DNA damage
(5-7). In the yeast Saccharomyces cerevisiae, the ATR homologue
Mccl and CHK2 homologue Rad53 are key regulators of cellular
response to DNA damage, controlling the GI, S, and G2 cell cycle
checkpoints as well as transcriptional induction (8). Dunl,a protein
kinase similar to Rad53, is also involved in these processes (9, 10).
Among the best-studied transcriptional targets of the Mecl/
Rad53/Dunl checkpoint pathway are the genes encoding ribonu-
cleotide reductase (RNR; refs. 9 and 11-13).
The enzymatic activity of RNR depends on the formation of a
complex between two different subunits. RI and R2. The large
subunit RI is a dimer and contains the active site for reduction of
nucleoside diphosphate (NDP) substrates and the effector sites that
control substrate specificity and enzymatic activity. The small
subunit R2 is also a dimer that houses the di-iron tyrosyl radical (Y-)
cofactor essential for NDP reduction. The active form of RNR is
proposed to be a 1:I complex of RI and R2 (14-16).
In budding yeast there are four RNR genes, two that code for
a large subunit (RNRI and RNR3) and two that code for a small
subunit (RNR2 and RNR4). RNRI is essential for mitotic growth;
RNR3 is barely transcribed under normal conditions but highly
inducible by genotoxic stress (17). RNR2 is essential for mitotic
viability whereas removal of RNR4 is lethal in some strains and
causes conditional lethality in others (12, 18. 19).
A major focus in the field has been to establish the compo-
sition of the active forms of RNRs. In vitr it has been shown that
Rnr4 is essential to form the di-iron Y' cofactor in Rnr2 and that
the heterodimer containing one monomer of Rnr2 and one of
Rnr4 is the active small subunit (20-22). This heterodimer
complexed with Rnrl has been shown to be active in vitro (20.
21). The role of the inducible Rnr3 in dNTP formation is the
subject of ongoing investigations (23).
The activity of RNR is tightly regulated by both the cell cycle
and environmental cues. thereby maintaining balanced dNTP
pools for high-fidelity DNA replication and repair (24. 25).
Failure to control the levels of the dNTP pools and/or their
relative amounts leads to cell death or genetic abnormalities (I 1.
26. 27). The regulation of RNR involves multiple mechanisms
(Fig. 1). One mechanism is damage-induced transcription me-
diated by the Mecl/Rad53/Dunl checkpoint kinases that in-
crease RNR gene transcription by inhibiting the Crtl repressor
(11). A second mechanism also involves the Mecl/Rad53/Dun 1
pathway and regulates RNR activity by phosphorylation-
mediated removal of Smll, an inhibitor of RNR (28-32). A third
mechanism involves allosteric regulation (33. 34).
In this work, we examined the subcellular localization patterns
of the yeast RNR subunits under normal growth conditions and
after treatment by DNA-damaging or replication-blocking
agents. We found that under normal conditions, the large and
small subunits of yeast RNR are sequestered in the cytoplasm
and the nucleus, respectively. After genotoxic stress, Rnrl
remains in the cytoplasm, whereas Rnr2 and Rnr4 undergo
nuclear to cytoplasmic relocalization. This redistribution seems
to be mediated by the Mecl/Rad53/Dunl checkpoint kinase
pathway and can occur in the absence of damage-induced
transcription of RNR2 and RNR4. Our results suggest a fourth
mechanism for the regulation of RNR activity and support a
model in which cells control the levels of the RNR holo-enzyme
through changing the subcellular localizations of its subunits,
thereby optimizing cellular capacity for dNTP production in
response to genotoxic stress.
Materials and Methods
General Genetik ethods. Growth and maintenance of yeast
strains as well as genetic manipulations were as described (35).
pMH726 is the HA-RNRI (HA, hemagglutinin) integration
construct (KAN Ap): pMH944 contains ADHI(1.1 kb)-3Mvc-
RNR2 (Ap CEN LEU2). pMH969 contains ADHI(0.4 kb)-HA-
RNR4 (At CEN TRPI). All yeast strains were derived from the
W303 parental strain Y300 (MA Ta, canl-100, ade2-1. his3-11.15.
u2-3,112 trpl-l, ura3-1) except when indicated otherwise.
Relevant genotypes of these strains are MHY341 LA4-RNRI;
MHY374 hugl::HIS3; MHY375 smll::HIS3: MHY380
Abbrevatlons: RNR, rlbonucleotide reductase HU. hydroyurea; MMS. methyl methane-
sulfonate; HA hemagghlinn; IMF, IndlrectImmunolluoresce; DAPI 4'.6d1amldlno2-
phenyllndole.
tTowhom correspondence should be addressed. E-mall: mlngxla.huangOuchsc.edu.
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Fig. 1. A schematic representation of different mechanisms Involved In the
regulation of RNR activity by the DNA damage checkpot paways
mad53::HIS3, smll::HIS3; MHY385 mecl:•HIS3, smll:HIS3;
MHY390n r2: TRPI, pMH944; MHY392 dunl :HIIS3; MHY393
mr2::TRPI, dunl::HIS3, pMH944; MHY424 mr4::LEUZ
pMH969;, MHY451 rm4:LEU2Z dunl:.HIS3 pMH969; MHY472
cdcl3-1; DY024 MA Ta, cdc7-1, adeZ ade3, ra3, cyhZ e rp l,
barl; K1994 MATa, cdcl5-2, ura3, IeuZ rpl, adeZ his3; and
1825-1B MATa, cdc16-12A barl, trpl, canl, hs3, leul, ur3,
GALpsi+.
Antbodies (Abk). Polyclonal Abs against all four RNR subunits
were generated in rabbits by using recombinant proteins ex-
pressed in Escherichia coi (22) and purified by immunoaffinity
protocols as described (36). Monoclonal anti-Myc (9E10) and
anti-HA (12CA5) were purchased from Roche Applied Sciences
(Indianapolis), and anti-HA (16B12) was purchased from Co-
vance Innovative Antibodies (Princeton). Horseradish peroxi-
dase-, FITC-, and Cy3-conjugated goat-anti-mouse and goat-
anti-rabbit Abs were purchased from Jackson ImmunoResearch.
Polyclonal anti-Adhl (alcohol dehydrogenase) and anti-Rad53
were gifts from R. Sclafani (University of Colorado Health
Sciences Center) and S. Elledge (Baylor College of Medicine,
Houston), respectively.
idirect immeumtherescee (IM) Fluorescence and differential
interference contrast (DIC) microscopy were performed with an
E-800 microscope (Nikon). Images were acquired with a Cool-
SNAP-HO 12-bit monochrome digital camera (Roper Scientific,
Trenton, NJ) by using the METAMORPH imaging system (Uni-
versal Imaging, Media, PA). Yeast cells were fixed in 0.1 M
potassium phosphate (KP) buffer (pH 6.5) with 4% formalde-
hyde at 30"C for 15 min and treated with zymolyase 100,00(ff
(ICN) at 10 #Lg/ml in 0.1 M KP buffer (pH 7.0) + 1.2 M sorbitol
at 37"C for 10-15 min. All of the following incubations were
done at room temperature in PBS plus 1% BSA: primary Abs
were incubated for 3 h at a dilution of 1:200 (mAbs) or
1:1,000-1:10,000 (polyclonal Abs), FITC- or Cy3-conjugated
secondary Abs were incubated at a 1:200 dilution for 1.5 h, and
4',6-diamidino-2-phenylindole (DAPI; 1 p&g/ml) for 3 min to
visualize DNA.
Protein Extracts and Westera m t Analy. Yeast cells were har-
vested from early log-phase cultures (1-2 x 107 cells per ml). For
Rnr2 and Rnr4 Western blots, protein extracts were prepared by
glass bead disruption (BeadBeater, Biospec Products, Battles-
ville, OK) in 25 mM Hepes (pH 7.5), 5 mM MgCIz, 50 mM KCI,
10% glycerol, 0.1 mM DTT, 1 mM phenylmethylsulfonyl fluo-
ride, I 1&M aprotinin, 0.1 mM benzamidine, and 0.1 p&g/ml each
of antipain, leupeptin, pepstatin A, and soybean trypsin inhib-
itor. Protein extracts were centrifuged at 13,000 x g for 15 min
and the supernatants were separated on SDS/10% PAGE gels.
For Rad53 Western blots, protein extracts were prepared from
trichloroacetic acid (TCA)-treated cells. Exponentially growing
cells (10 ml) were collected by centrifugation at 2,000 x g,
washed with 2 ml of 20% TCA, and resuspended in 100 1l of 20%TCA. Cells were disrupted with glass beads on a BeadBeater and
centrifuged at 800 x g for 10 min. The pellets were resuspended
in 100 pl of 2 times SDS gel-loading buffer plus 50 pl of 1 M Tris
base to adjust the pH, and sonicated at 20% output level
(Branson Sonifier 250) for 5 sec. Samples were boiled for 5 min,
followed by centrifugation at 800 x g for 10 min. The superna-
tants were separated on 8% SDS/PAGE gels. For immunoblot-
ting, protein extracts were transferred to nitrocellulose mem-
branes after electrophoresis. The membranes were incubated
with primary Abs for 22 h. Blots were developed with peroxi-
dase-labeled secondary Abs by using an enhanced chemilumi-
nescence substrate (NEN). Primary Abs were used at the
following dilutions: 12CA5 at 1:1,000; 9E10 at 1:1,000; anti-
Rnr2, anti-Rar4, and anti-Rad53 at 1:10,000, and anti-Adhi at
1:2,500.
DttlM ve Subcelua LocazatUon Patrm o to e E RN uNlsdts. We
determined the subcellular localization of the yeast RNR sub-
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Fig. 2 The large and small subunits of RNR are localized in dlstinctive
subcellular compartments. (A) Subcellular localization of RNR subunit For
Rnr3 staining, otf mutant cells were used. () Quantification of RNR subcel-
Iular ocalizalon. Three Independent cultureswre processed for IMFanalysis.
Foreach pelment. 200celswerecounted Percentages of cells with distinct
localization patterns were represented as follows: dark bar, cells with a
predominantly nuclear signa hatched bar. cells with a predomnantly cyto-
plasmc signal open bar. cells with ubiquitous fluorescence In both the
nulew andthcytoplam (no dffrence eorbas, SD. (Q Quantlflcationof
Rnr4 localization in cels synchronized n S phase. WT and dunl cells were
released from -factormaedlated G, block and harvested In mid-S phase (30
min after relese) for IMF. Similar resultswere observed for Rnr2. The symbols
for bar representaton are the same as in B.
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Fig.3. RNR small subunits become redistributed under genotoxc stress. () ColocalIzation of Rnrl and Rnr4 nthe cytoplasnm after MMStreatment. An HA-RNR
strain was grown to early log phase and split in half, one half was left untreated (UN) and the other was treated with 0.02% MMS for 2 h. Cells were processed
for IMF by using a mouse anti-HA and a rabbit anti-Rnr4. Cy3-conJugated (red) goat-anti-mouse and FITC-conJugated (green) goat-anti-rabbit Abs were used
to detect HA-Rnrl and Rnr4. respectively. DNA was visualized by DAPI (blue). (8) Quantification of Rnr2 and Rnr4 localization changes after HU and MMS
treatment. Counting of IMF and the symbols for bar representation were the same as in the Fig. 2 legend.
units by IMF using the appropriate polyclonal Abs. In early
log-phase cultures, >9'0% of the cells display an Rnrl signal that
is predominantly cytoplasmic, while 80-90% of the cells exhibit
Rnr2 or Rnr4 signals that are predominantly nuclear (Fig. 2).
Previous studies have shown that the RNR3 transcript is detected
at very low levels during normal cell growth but is highly induced
by genotoxic stress (12, 17). Accordingly, Rnr3 was detected by
IMF only in WT cells treated with the replication-blocking agent
hydroxyurea (HU) or the DNA-damaging agent methyl meth-
anesulfonate (MMS). or in crtl mutant cells where RNR3 is
expressed at high levels due to transcriptional derepression (11).
Interestingly, under each of these conditions, Rnr3 was predom-
inantly present in the cytoplasm (Fig. 2; data not shown).
Given that 10-15% of cells in asynchronous cultures display
Rnr2 and Rnr4 signals that are equally distributed in both the
nucleus and the cytoplasm (Fig. 2B), we wanted to test whether
the localization of both Rnr2 and Rnr4 is cell cycle-regulated. To
this end. we synchronized cells in G, by a-factor and examined
Rnr2 and Rnr4 localization from the released culture by IMF.
Although Rnr2 and Rnr4 signals are predominantly nuclear
throughout the cell cycle, their nuclear localization decreases
during S phase with a more ubiquitous localization pattern in
-40% of the cells (Fig. 2C).
We further characterized the subcellular localization patterns
by visualizing the large and small RNR subunits simultaneously.
To this end, we genomically tagged Rnrl with an in-frame
amino-terminal fusion of an HA epitope under the endogenous
RNRI promoter. Yeast cells containing HA-RNRI exhibited no
difference in growth rate either under normal conditions or in
media containing HU or MMS as compared with WT cells,
indicating that the HA-Rnrl functions normally. Coimmunos-
taining of HA-Rnrl and Rnr4 revealed their distinctive cyto-
plasmic and nuclear localization patterns, respectively, with no
significant overlap in the superimposed images (Fig. 3A Upper).
Taken together, these results indicate that Rnrl and Rnr3 are
localized primarily to the cytoplasm, whereas Rnr2 and Rnr4 are
predominantly in the nucleus.
Redistrlbution of RNRSmall Subunits in Response to DNA Damage and
ReIplcational Stress. We were interested in understanding whethe r
DNA damage and replicational blockage might affect the sub-
cellular localization patterns of RNR subunits. Two hours after
exposure to HU or MMS. >80% of the cells have Rnr2 and Rnr4
signals that are predominantly cytoplasmic. In contrast. Rnrl
localization does not change (Fig. 3). Changes in the Rnr2 and
Rnr4 localization patterns occur as early as 15-30 min after cells
encounter HU or MMS. The percentage of cells that display a
cytoplasmic signal increases with time, reaching maximum at 2 h
(data not shown).
Regulation of DNA Damage-induced RNR Small Sduunit Redlstrilbutlon
by the Mecl/RadS3/Dunl Pathway. To gain insights into the
mechanism(s) of damage-induced RNR small subunit redistri-
bution, we examined Rnr2 and Rnr4 localization patterns in cells
deficient for the checkpoint kinases Dunl, Rad53, and Mecl
after MMS and HU treatment. After MMS treatment, all three
checkpoint kinase mutants fail to relocalize Rnr2 and Rnr4 (Fig.
4). Our results indicate that the nuclear to cytoplasmic redistri-
bution of Rnr2 and Rnr4 depends on the Mecl/Rad53/Dunl
pathway.
The response to HU treatment was similar but distinct from
that induced by MMS. Although WT cells exhibited obvious
nuclear to cytoplasmic redistribution of the small subunit, the
dunl, rad53smll, and meclsmil mutant cells showed an inter-
mediate phenotype. The majority (>50%) of these mutant cells
have equal signal intensity in both the nucleus and the cytoplasm,
and a smaller fraction (20-40%) of the cells has Rnr4 retained
in the nucleus. Interestingly, although 10-20% of dunland
meclsmll mutant cells have Rnr4 in the cytoplasm, no cytoplas-
mic Rnr4 signal is observed in radS3smll mutant cells.
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Fig. 4 RNR sma ll uAu redistribution s regulated by the DNA damage checkpont knass.EaEarly log-ph cultures were treated with 150 mM HU or 0.02%MMS for 2 h and then procesed for IMF. Shown here are the rests of nr4 (smlar results were also obsed for nr2a Isogenk strans were dunl::HIs3.
radS3=HIS3 sml::KAN, met Ml:HIS sml:KAN,. smlf::KAN, and hugl::HS13. Each xperlnentwa performed in duplitcte with 200 cels counted. Each pie chart
represents the percentage of celkwith aspecfic IMF pattern dark, nuclear; hatched, cytoplanic whlt. no dfference between the nudeus and the cytoplasm.
To look for additional factors involved in subunit redistribu-
tion, we examined mutants containing a deletion in SML] or
HUGI, both of which are targets of the Mecl/Rad53/Dunl
kinases. Smll, an inhibitor of RNR, is targeted for degradation
through activation of the Mecl/Rad53/Dunl kinase cascade
during S phase and in response to DNA damage (28-31).
Removal of SMLI bypasses the essential functions of MECI and
RADS5 (28). HUGI is a transcriptional target of the Crtl
repressor and seems to be involved in the Mecl-mediated
checkpoint response (37). Our results showed that neither SMLI
nor HUGI plays a major role in the HU- or MMS-induced RNR
redistribution (Fig. 4).
edistldutln of b2 ad br4 Is blAepm Iset o eir Trawip-
tonaml iducti. Because RNR2 and RNR4 transcripts are both
induced in response to genotoxic stress (12) and a 2-4-fold
increase in both protein levels has been observed after HU and
MMS treatment (Fig. 5 A and B), it is possible that the
Rnr2/Rnr4 redistribution is due to increased expression of both
the proteins in the presence of HU and MMS. To separate the
transcriptional induction pathway from changes in protein sub-
cellular localization patterns, we substituted the native RNR2
and RNR4 promoters with the heterologous ADHI promoter
because its activity was not affected by HU or MMS treatment
(38). Different regions of theADHI promoterwere chosen based
on their relative transcriptional activation strength. A 3Myc-
Rnr2 was driven by a 1.1-kb region of the ADH1 upstream
sequence (ADHIL); an HA-Rnr4 was fused to a 0.4-kb region(ADHis). Both constructs can replace the function of the
endogenous genes by supporting growth of the cognate deletion
mutants. Moreover, the 3Myc-Rnr2 and HA-Rar4 levels pro-
duced from the ADHL and ADHs promoters, respectively, are
comparable to the endogenous protein levels (data not shown),
and both tagged proteins are localized to the nucleus under
normal growth conditions (Fig. 5 G and H). HU and MMS
treatment does not have an effect on protein levels of ADHL-
3Myc-Rnr2 and ADH1s-HA-Rnr4 (Fig. 5 C-F). Visualization of
Rnr2 and Rnr4 by IMF demonstrated that both proteins become
significantly redistributed after HU and MMS treatment (Fig. 5
G and H). Furthermore, the MMS-induced Rnr2 and Rnr4
redistribution was not observed in a dunl mutant strain (data not
shown). We conclude that Rnr2 and Rnr4 redistribution is not
merely due to the increase in both protein levels after HU and
MMS treatment and that Mecl/Rad53/Dunl can regulate Rnr2
and Rnr4 redistribution in the absence of their transcriptional
induction.
isrbton of INR Smul S b Ikqulres Passage Through G1
Phse. A normal yeast cell cycle takes 90-120 min with - 30 min
in S phase. HU blocks cells in S phase and MMS slows the rate
of S phase progression (39). However, the nuclear to cytoplasmic
redistribution of Rnr2 and Rnr4 was detected as early as 15-30
min after HU and MMS treatment (data not shown), suggesting
that their relocalization can occur outside of S phase. This notion
is supported further by our observation that the RNR redistri-
bution also occurs in cells undergoing mitosis (i.e., large-budded
cells with divided nuclei in both the mother and daughter cells).
To understand further the effect of cell cycle on damage-induced
redistribution, we arrested cells at different stages of the cell
cycle by using conditional alleles of specific cdc mutants. At the
nonpermissive temperature, the cdc7-1 cells arrest at GI/S
transition point before DNA replication origins are fired (40),
the cdc16-123 cells arrest at early anaphase (41), and the cdc15-2
cells arrest at telophase (42). When these mutant cells were
treated with MMS at nonpermissive temperatures, Rnr2 and
Rnr4 still became redistributed (Fig. 64). Moreover, both Rnr2
and Rnr4 underwent nuclear to cytoplasmic relocalization when
the cdcl3-1 cells were shifted from permissive temperature to
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FIg. 5. DNA damage-induced RNR small subunit redistribution Is indepen-
doentof transcriptional Induction. (A and 8) Induction of endogenousRnr2 and
Rnr4 by HU and MMS. Early log-phase cultures were treated with 150 mM HU
or 0.02% MMS for 2 h and processed for Western blot by using anti-Rnr2 and
anti-Rnr4. Two Isoforms of Rnr2 were observed. The same blot was reprobed
with anti-Adhi to visualize Adhl. which served as a loading control. Analysis
was performed by densitometry, correcting nr2 and Rnr levels for Adht.
Each bar (black, Rnr2; white, Rnr4) s the mean of the sampes shown In A plus
two additional blots (n - 3). (C and 0) No Induction of ADH promoter-driven
Rnr2 by either HU or MMS. A 3MYC-RNR2 driven by a 1.1 .kbADH1 promoter(ADHIt-RNR2) was Introduced Into an r2 deletion strain. Coils were treated
with HU and MMS, and Rnr2 evelswere detected by anti-Myc and normalized
to Adhl signals on the same blot. (E and F) No Induction of ADHM promoter-
driven Rnr4 by either HU or MMS. An HA-W.R4 driven by a 0.4-kb ADHI
promoter (ADH1tRNVM) was Introduced Into an rrvs deletion strain. Cells
were treated with HU and MMS. and Rnr4 levelswero detected by anti-HA and
normalized to Adhi signal on the same blot. (G and H) Quantification of
ADHI,-Rnr2 (G) and ADHsRnr4 (H) localization after genotolic stress. The
symbols for bar representation are the same as In the fig. 2 legend.
nonpermissive temperature and thereby arrested at G2 (Fig. 68),
suggesting that the endogenous DNA damage signal generated
by cdcl3-1 (43) was sufficient to activate the RNR redistribution
in G32. These data strongly suggest that damage-induced RNR
redistribution can occur outside of S phase.
Surprisingly, when a-factor-arrested G, cells were treated with
HU and MMS, Rnr2 and Rnr4 remained in the nucleus after 2 h
of treatment (Fig. 6 C and D). We surmised that the failure of
Gn cells to relocalize Rnr2 and Rnr4 after genotoxic stress might
be due to inefficient activation of the Mecl/Rad53/Dunl kinase
cascade. To directly test this hypothesis, we used a Western blot
to examine Rad53 phosphorylation by detecting its electro-
phoretic mobility, which is an indicator of the activation of the
known DNA damage checkpoint pathways (44). Rad53 phos-
phorylation was clearly detectable in asynchronous cultures
treated with HU and MMS (Fig. 6E). In contrast, Rad53 from
G, cells under the same treatment showed no significant change
in mobility (Fig. 6E). Taken together, we propose that under our
experimental conditions, the Mecl/Rad53/Dunl checkpoint
pathway is not activated sufficiently in G, cells to mobilize RNR
small subunit redistribution.
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Ftg. Cell cycle effect on Rnr2 and Rnr4 redistribution Induced by genotoxic
stress. (A) Change of Rnr4 nuclear localization in cdc mutants treated with
MMS. cdc7-l, cdcf6-723, and cdclS-2 cells were arrested at 376C for 2 h,
treated with 0.02% MMS for an additional 2 h, and processed for IMF. The
percentage of cells displaying a predominantly nuclear Rnr4 signal was cal-
culated by counting 200 cells per expelment, each done In duplicate. (8) Loss
of Rnr4 nuclear localization Induced by cdcl3-t-medlated DNA damage. A
cd&1c3-7 culture was grown at 239C to early log phase and shifted to 376C for
2 h. Cells wore quantified as described In A. (C) No change In Rnr2 and Rnr4
localization In G1 cells treated with HU or MMS. Asynchronous cultures wereblocked In G, with a-factor (a F). The arrest was maintained while cells were
treated with 150 mM HU or 0.02% MMS for 2 h, and then processed for IMF.
The percentages of each coll population with a predominantly nuclear signal
for Rnr2 (black bar) or Rnr4 (white bar) were quantified as described in A. (D)
A representative collage of Rnr4 IMF Images In MMS-treated. a-factor-
arrested G, cells. (E) Comparison of HU- and MMS-lnduced RadS3 phosphor-
ylation between cells In an asynchronous (Asy) culture and G6-arrested (a F)
cell.
Dbaonon
Compartmentalization of macromolecules provides eukaryotic
cells with effective means to regulate fundamental processes,
including gene expression, signal transduction, and cell cycle
progression (45). For example, several cell cycle regulators, such
as mammalian Cdc6, cyclinB/Cdkl, and yeast Mcm2-7, function
through nucleocytoplasmic shuttling at different stages of the
cell cycle (46-49). Our results show that the subcellular local-
ization of the small subunit of RNR (presumably a heterodimer
of Rnr2/Rnr4), a key enzyme required for DNA precursor
synthesis, is regulated by the DNA damage checkpoint pathways.
We have further shown that this redistribution can occur inde-
pendently of transcriptional induction. The human RNR sub-
units RI, R2, and p53R2 have recently been shown to undergo
cytoplasmic to nuclear relocalization after UV irradiation (50).
Interestingly, whereas the yeast small subunit relocalizes to the
cytoplasm where the large subunit resides, the human large
subunit translocates together with the small subunit to the
nucleus after genotoxic stress.
Our finding that HU induces partial redistribution of Rnr2 and
Rnr4 in mecl, rd53, and dunal mutants suggests a checkpoint-
independent mechanism. As HU physically blocks the cells in S
phase via nucleotide depletion. the HU-induced change in Rnr2
and Rnr4 localization in these mutants is likely to reflect a
checkpoint-independent process that normally occurs during S
phase. This hypothesis is also consistent with our observation
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that both WT and dunl cells exhibit a more ubiquitous local-
ization pattern of Rnr2 and Rnr4 when synchronized in S phase.
RNR is capable of catalyzing dNTP production only if both
subunits are present in a complex and therefore they must be
present in the same subcellular compartment. The different
subcellular localization of RNR subunits raises the question of
how one obtains sufficient dNTPs for replication during normal
cell growth. The more ubiquitous localization pattern of Rnr2
and Rnr4 during a synchronized S phase and the nuclear to
cytoplasmic redistribution of both proteins after genotoxic stress
suggest that the cytoplasm is the preferred site of dNTP syn-
thesis. The sequestration of the two subunits of RNR in different
compartments under normal conditions may serve to modulate
cellular dNTP pools and thus ensure accuracy of DNA replica-
tion, whereas their colocalization under genotoxic stress allows
maximum potential of RNR enzyme activity required for repair
of DNA lesions.
Our data have also provided insight into the catalytically active
form of RNR. Early genetic studies suggested that the Rnr2/
Rnr4 heterodimer is active in nucleotide reduction when com-
plexed with Rnrl (12, 19). However, the Rnr2 homodimer must
also be capable of catalyzing nucleoside diphosphate reduction,
because deletion of RNR4 is not lethal in some genetic back-
grounds (19). This finding raises the issue as to what the active
form of the small subunit is in viv (i.e., heterodimer or
homodimer). Recent biochemical studies have demonstrated
that the heterodimer is active in nucleotide reduction and that
neither the Rnr2 nor Rnr4 homodimer is active due to inability
to generate the di-iron Y- cofactor (20, 21). Our findings that
Rnr2 and Rnr4 are colocalized during normal cell cycle pro-
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gression and that both undergo similar redistribution after
genotoxic stress provide strong n vive evidence for the impor-
tance of the heterodimeric species.
Several lines of evidence suggest that the regulation of RNR
activity plays a critical role in maintaining a proper dNTP pool
for high-fidelity DNA replication and repair processes both
under normal growth conditions and in response to DNA
damage (26, 27, 51, 52). Inhibition of p53R2 expression has been
shown to compromise DNA repair capacity and cell viability
under various genotoxic stress conditions, demonstrating that
p53R2 is essential for DNA repair and cell survival (26). Indeed,
a point mutation in pS3R2 that results in loss of RNR activity has
been identified in a colorectal cancer cell line HCT116 that
shows increased apoptosis in response to y-irradiation (52). In
budding yeast, overexpression of RNR2 has been associated with
chromosome instability (53). On the other hand, disruption of
RNR allosteric regulation can lead to increased mutation rate
and genomic instability (27). Our results suggest that yeast has
evolved a mechanism by which it regulates RNR activity through
sequestration of its subunits during normal cell cycle progression
and colocalization after DNA damage. It will be interesting to
determine whether defects in this regulatory process will have
any effect on the fidelity of DNA replication and repair and the
viability of cells under genotoaic stress.
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